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status.  (Not all prohibited bases apply to all programs.)  Persons with 
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TARGET Center at (202) 720–2600 (voice and TDD). 
 
To file a complaint of discrimination, write USDA, Director, Office of Civil Rights, 
Room 326–W, Whitten Building, 1400 Independence Avenue, SW, Washington, 
DC  20250–9410 or call (202) 720–5964 (voice and TDD).  USDA is an equal 
opportunity provider and employer. 
__________________________________________________________  
Mention of companies or commercial products in this report does not imply 
recommendation or endorsement by the U.S. Department of Agriculture over 
others not mentioned.  USDA neither guarantees nor warrants the standard of 
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factually on available data and to provide specific information. 
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Executive Summary 
 
Background 
 
The Biotechnology Regulatory Services (BRS) program of the U.S. 
Department of Agriculture’s (USDA) Animal and Plant Health Inspection 
Service (APHIS) regulates the safe introduction (environmental release, 
interstate movement, and importation) of genetically engineered (GE) 
organisms.  APHIS regulates under the authority of the Plant Protection 
Act of 20001 (PPA), as amended, which combines the authorities of 
several previous acts, including the Federal Plant Pest Act and the Plant 
Quarantine Act (PQA).  USDA first implemented regulations for GE 
organisms in 1987, and they have been revised several times2 to better 
oversee new technologies and increase APHIS’ efficiency. 
 
Under the Coordinated Federal Framework for Regulation of 
Biotechnology (51 Federal Register (FR) 23302), USDA works with the 
Food and Drug Administration (FDA) and the Environmental Protection 
Agency (EPA) to ensure that the development and testing of 
biotechnology products occur in a manner that is safe for plant and animal 
health, human health, and the environment.  USDA and EPA are the 
agencies responsible for protecting U.S. agriculture and the environment.  
EPA is responsible for the human/animal health and environmental safety 
of any pesticidal substance produced in GE plants.  FDA is responsible for 
the safety of the whole food product other than the pesticidal component 
regulated by EPA. 
 
On January 23, 2004, APHIS published an announcement in the Federal 
Register of its intent to prepare a programmatic environmental impact 
statement (EIS) to evaluate the environmental impacts arising from 
alternatives the agency is considering in the revision of its biotechnology 
regulations.  The decision to revise APHIS regulations grew out of 
interagency discussions, which were led by the Office of Science and 
Technology Policy and included EPA and FDA.  This draft programmatic 
EIS will thus analyze the environmental impacts on the human 
environment resulting from APHIS’ current regulations for GE organisms 
as well as to analyze the potential environmental impacts, if any, on the 
human environment resulting from any revisions or changes to APHIS’ 
current regulations for GE organisms. 
 
 
1 The Plant Protection Act of 2000, 7 United States Code (U.S.C.) 7701.  
2 68 FR 46434 (plant producing industrial compounds); 62 FR 19903 (extensions); 60 FR 43567 
(notifications); 58 FR 17044 (notifications and petitions for nonregulated status); 55 FR 53275 
(interstate movement of Arabidopsis); 53 FR 12910 (interstate movement of micro-organisms). 
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Purpose and Need 
 
The U.S. Department of Agriculture (USDA) Animal and Plant Health 
Inspection Service (APHIS) regulates the environmental introduction of 
genetically engineered (GE) organisms, including crop and noncrop 
plants, vertebrate and invertebrate animals, and micro-organisms.  APHIS 
regulations are grounded in the most up-to-date science and are designed 
to provide a level of oversight appropriate for the safe introduction of GE 
organisms.  APHIS is considering whether revisions to its regulations are 
necessary.  One purpose of such revisions would be to address current and 
future technological trends resulting in GE plants with which the agency is 
less familiar, such as plants with environmental stress tolerance or 
enhanced nutrition, and plants engineered for new purposes such as 
biofuels or for production of pharmaceutical or industrial compounds.  
Additionally, the regulations would be revised to ensure a high level of 
environmental protection, to create regulatory processes that are 
transparent to stakeholders and the public, to consider the efficient use of 
agency resources, to ensure that the level of oversight is commensurate 
with the risk, and to ensure conformity with obligations under 
international treaties and agreements, such as World Trade Organization 
(WTO) agreements.  Any revision of the regulations would be consistent 
with Executive Order 12866. 
 
In accordance with the National Environmental Policy Act of 1969 
(NEPA), as amended, the Council on Environmental Quality (CEQ) 
regulations for implementing NEPA, the USDA regulations implementing 
NEPA, and APHIS’ NEPA Implementing Procedures, APHIS has 
prepared a draft EIS (DEIS).  The purpose of this DEIS is to provide an 
environmental analysis that compares the impacts of various alternatives 
to the current regulations.  The DEIS will inform the public about the 
potential environmental impacts resulting from the possible regulatory 
changes.  The DEIS, along with public comments on the document, will 
provide agency decisionmakers with a full range of alternatives, assist 
them in selecting a preferred alternative, and help inform the 
decisionmakers in the rule revision process. 
 
Method 
 
The analysis of the APHIS regulatory program and proposed alternatives 
includes many issues affecting the current program.  During a scoping 
process, interested stakeholders, government agencies, and the public 
raised issues that should be addressed in the preparation of the DEIS.  
Public scoping for this DEIS started January 23, 2004, when APHIS 
published a Notice of Intent (NOI) in the Federal Register to prepare an 
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EIS and began accepting comments on 11 broad categories of questions 
posed in the NOI.  In addition to gathering written comments during the 
comment period, APHIS gathered oral comments during meetings with 
23 stakeholder groups in February and March 2004, as well as during a 
meeting with the National Association of State Departments of 
Agriculture (NASDA) in June 2004.  APHIS also sponsored a survey of 
its members by the National Plant Board (NPB) in regards to 
biotechnology issues affecting State regulatory officials.  The survey 
results were posted on the NPB Web site3 in February, 2006. 
 
All comments and proposed alternatives received were evaluated on the 
basis of whether they addressed the issues in question, whether they were 
based on valid science, and whether they were reasonable and practicable.  
The results of the scoping process assisted APHIS in the formulation of 
the alternatives that are analyzed in this DEIS. 
 
In this document, the various issues and regulatory alternatives are 
examined by APHIS, the impacts of each alternative are presented, and 
APHIS’ preferred alternative is described.  The DEIS examines aspects of 
the biological, physical, sociocultural, and economic environments that 
may be affected by APHIS’ current biotechnology regulations and the 
proposed alternatives described in this document.  Because it is not 
possible to compare the impacts of the alternatives under consideration 
quantitatively, APHIS used qualitative parameters in its analysis. 
 
Current APHIS Regulations 
 
Current APHIS regulations for GE organisms are based on authority in the 
PPA to regulate the introduction of organisms that may be plant pests or 
for which there is reason to believe are plant pests.  Applicants must 
submit required information for environmental release, movement, or 
importation for review by regulatory scientists who evaluate the risks 
posed by the introduction and the procedures that the applicant will use to 
minimize those risks.  Depending on the nature of the GE organism, an 
applicant applies for either a permit or a notification.  APHIS authorizes 
introductions after considering the organism, the nature of the genetic 
engineering, and the ways in which the GE organism is likely to interact 
with the environment. 
 
A notification is a more streamlined authorization process that is used only 
for plants with traits considered to be low risk.  To qualify for a 
notification, the GE plant must meet strict eligibility requirements to 
ensure that it poses a minimal plant pest risk.  The GE plant must also be 
 
3 <http://nationalplantboard.org/docs/2006_brs_review.pdf> 
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grown under conditions designed to meet performance standards ensuring 
confinement of the regulated material.  The remaining organisms—
including plants that are genetically engineered to produce pharmaceutical 
or industrial compounds—are subject to the permitting process. 
 
Permits are designed to ensure the safe introduction of any GE organism 
over which APHIS has authority.  All required information submitted in a 
permit application is reviewed by APHIS scientists.  Confinement 
conditions and standard operating procedures are tailored on a case-by-
case basis to maintain confinement of the GE organism throughout the 
course of the introduction.  APHIS requires that all plants genetically 
engineered to produce pharmaceutical or industrial compounds be grown 
under extremely strict management protocols.  These plants are grown in a 
way that maintains confinement of the plant to the release area, with 
additional precautions taken to prevent the escape of pollen, seeds, or 
plant parts from the field test site. 
 
APHIS works to ensure that notification and permit holders maintain 
regulatory compliance by providing guidance and through procedures that 
include violation-prevention efforts, site audits and inspections, 
documentation of compliance infractions, and mitigation and enforcement 
actions to address any infractions.  In addition, APHIS requires the 
submission of field reports which, in addition to other information, must 
inform the agency if any adverse effects are noted during any 
environmental release of GE organisms. 
 
After a GE organism has been field tested extensively and the developer 
can show that the organism is not a plant pest and can safely be removed 
from APHIS oversight, the developer may request the deregulation of the 
organism by filing a petition for a “determination of nonregulated status.”  
After the applicant submits the required data and it has been reviewed by 
the agency, APHIS prepares an environmental assessment (EA) and if 
warranted, an EIS to analyze the potential impacts the plant may have on 
the human environment and seeks public comment as required by NEPA.  
APHIS approves a petition only when it reaches the conclusion that 
potential plant pest risks posed by the GE organism are not greater than 
those posed by similar, non-GE organisms.  Once APHIS has deregulated 
an organism, it may be freely moved and planted without the requirement 
of permits or other regulatory oversight by APHIS.  Deregulated status 
may be extended to GE organisms which APHIS determines are similar to 
previously deregulated organisms.  Conversely, given new information, 
APHIS may determine that a previously deregulated GE organism poses a 
plant pest risk and should, therefore, be brought back under agency 
oversight. 
 
  
Alternatives 
 
APHIS developed specific regulatory alternatives to address each of 
114 issues identified by the agency and elaborated upon through the 
scoping process.  This DEIS compares environmental impacts associated 
with implementing each alternative.  For each issue a “No Action” 
alternative, in which pertinent regulations are not changed, was also 
analyzed and considered.  Each of the alternatives is analyzed in the DEIS, 
and a Preferred Action, consisting of a combination of preferred 
regulatory alternatives, is chosen. 
 
1. Issue 1 APHIS is considering the broadening of its regulatory scope beyond 
genetically engineered organisms that may pose a plant pest risk to 
include genetically engineered plants that may pose a noxious weed 
risk and genetically engineered organisms that may be used as 
biological control agents.  Do regulatory requirements for these 
organisms need to be established?  
 
Given the rapid advances in biotechnology, the present scope of 
regulations may not be of sufficient breadth to cover the full range of GE 
organisms and the full range of potential agricultural and environmental 
risks posed by these organisms, including risks to public health.  
Historically, APHIS has used only the authority in the PPA that was 
originally granted in the Federal Plant Pest Act and the Plant Quarantine 
Act.  Specifically, the agency has used its authority to protect against plant 
pests as the basis for regulating GE organisms.  The PPA, however, 
redefined authorities and responsibilities for the agency.  Changes are now 
being considered in recognition of these responsibilities and in light of 
these new technologies. 
 
2. Issue 2 APHIS is considering revisions to the regulations to increase 
transparency and to address advances in technology that may create 
new products and concerns. Should a new system of risk based 
categories be designed to deal with new products and new concern?  If 
so, what criteria should be used to establish the risk-based categories? 
 
Fundamentally, APHIS has always used a risk based approach in 
regulating GE organisms.  However, there is public interest in 
understanding how APHIS regulates various types of organisms according 
to risk and familiarity.  In addition, there is a trend toward more highly 
varied organisms and the risk assessment process may need greater 
flexibility to handle this variety.  In recognition of these issues, the agency 
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4 Issue 10 in the NOI involved relief of regulatory requirements for low-risk materials.  Rather than list 
regulatory relief alternatives separately, they have been incorporated into the discussion of the other 
issues, where appropriate. 
is considering revising the regulations to make the use of risk-based 
categories – where GE organisms are classified according to risk and 
familiarity so that oversight and confinement vary by category – more 
explicit.  Redefined categories may provide added flexibility to better 
regulate diverse organisms and new types of traits, and provide better 
clarity to the regulated community and to the public, which may in turn 
promote greater confidence in the system. 
 
APHIS is considering ways to provide regulatory flexibility for future 
decisions by accommodating commercialization of certain genetically 
engineered organisms while continuing, in some cases, to regulate the 
organisms based on minor unresolved risks. Other regulated articles 
could be treated as they have been under the current system, in which 
all regulatory restrictions are removed.  What environmental factors 
should be considered in distinguishing between these kinds of 
decisions? 
3. Issue 3 
 
Once an article has been deregulated, APHIS cannot place any restrictions 
or requirements on its use, short of re-regulating the article.  Restrictions 
and requirements have not been deemed necessary in the past because 
BRS risk assessments have concluded that the GE plants APHIS has 
deregulated pose no greater risks than conventionally bred plants.  
However, APHIS recognizes that future development and 
commercialization of plants with less familiar traits may pose new 
challenges for the agency because even a thorough assessment may not 
resolve all unknowns regarding an article proposed for deregulation.  
These unknowns may justify continued scrutiny and data collection or use 
restrictions, even while allowing planting of the article without a permit.  
Therefore, APHIS is exploring a system that could give increased 
flexibility for handling special cases involving less familiar traits by 
creating provisions that allow for imposition of conditions for unconfined 
release.  This could facilitate commercialization, while requiring 
appropriate restrictions or monitoring. 
 
Are there changes that should be considered relative to environmental 
review of, and permit conditions for, genetically engineered plants 
that produce pharmaceutical and industrial compounds? 
4. Issue 4 
 
Genetic engineering technology has advanced to the point where 
organisms can be developed that produce novel proteins and other 
substances with biological activity or industrial utility.  The gene products 
made by pharmaceutical and industrial plants may have biological activity 
or may pose other hazards not associated with proteins and other 
substances commonly found in the food supply.  In practice, any changes 
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in the confinement of plants producing pharmaceutical and industrial 
compounds would be based on risk, not solely on the type of plant. 
 
The definition of noxious weed in the PPA includes not only plants, 
but also plant products.  Based on that authority, APHIS is 
considering the regulation of nonviable plant material.  Is the 
regulation of nonviable material appropriate and, if so, in what cases 
should we regulate? 
5. Issue 5 
 
In some special cases, certain nonviable material originating from a field 
test (e.g., cell debris, leaves, stems, roots, or seeds) may pose unique types 
of environmental or human health risks. Currently, APHIS regulates 
organisms that pose a plant pest risk and does not regulate nonliving 
material derived from GE organisms.  By definition, plant pests are living 
organisms.  However, the noxious weed definition offers an opportunity to 
regulate nonviable plant products that could “injure or cause damage to 
crops.”  Because there may be cases in which potential risks could justify 
the regulation of nonviable material, APHIS is considering whether it 
should regulate nonviable material in those cases.  
 
APHIS is considering establishing a new mechanism involving 
APHIS, the States, and the producer for commercial production of 
plants not intended for food or feed in cases where the producer 
would prefer to develop and extract pharmaceutical and industrial 
compounds under confinement conditions with governmental 
oversight, rather than grant nonregulated status.  What should be the 
characteristics of this mechanism? 
6. Issue 6 
 
For organisms that cannot meet the criteria for deregulation, APHIS is 
considering whether a new type of permitting system would be more 
appropriate in terms of efficiency and effectiveness than the current 
system.  In addition, there is much public and State interest in these types 
of plantings and a new mechanism may increase transparency and allow 
for greater State involvement. 
 
The current regulations have no provision for the low-level presence 
of regulated articles in commercial crops, food, feed, or seed of GE 
plant material that has not completed the required regulatory 
processes.5  Should low-level occurrence of a regulated article be 
exempted from regulation? 
7. Issue 7 
 
Executive Summary vii 
                                                                     
5 In the NOI, the term adventitious presence was used to refer to the “intermittent low levels of 
biotechnology-derived genes and gene products occurring in commerce that have not gone through 
all applicable regulatory reviews.”  However, APHIS realizes that this term means different things to 
various interests around the world; hence, we will avoid its use elsewhere in the main body of the 
EIS.   
As with traditional plant breeding, large scale annual field testing of GE 
plants that have not completed all applicable reviews may result in 
materials from these trials occasionally being detected at low levels in 
commercial commodities and seeds.  Current regulations do not expressly 
allow for any such occurrence, though experience continues to show that 
such occurrences can occur.  In a 2002 Office of Science and Technology 
Policy (OSTP) notice,6 APHIS committed to conducting a risk-based 
regulatory program that minimizes the occurrence of these materials and 
includes safety criteria under which these materials would be allowed at 
low levels in commercial commodities and seeds. 
 
Should APHIS provide expedited review or exemption from review 
for certain low-risk, imported GE commodities intended for food, 
feed, or processing that have received all necessary regulatory 
approvals in their country-of-origin and are not intended for 
propagation in the United States? 
8. Issue 8 
 
APHIS anticipates an increasing number of requests to import regulated 
GE organisms that are not intended for propagation, such as organisms 
that are intended for direct use as food, feed, or for processing.  The 
current regulatory system was designed to handle such requests using 
permits and notifications.  However, in anticipation of this increase, 
APHIS’ goal is to design an efficient system that protects U.S. agriculture 
and human health without erecting unnecessary trade barriers.  To that 
end, the agency has evaluated several different alternatives.   
 
Currently, genetically engineered Arabidopsis spp. are exempt from 
interstate movement restrictions under 7 CFR 340.2 because they are 
well understood and extensively used in research.  Should the 
movement of genetically engineered Arabidopsis spp. or other GE 
organisms be exempted from movement restriction? 
9. Issue 9 
 
Currently, genetically engineered Arabidopsis spp. and a few other 
organisms are exempt from interstate movement restrictions under 7 CFR 
340.2 because they are well understood and extensively used in research.  
The agency is considering whether to expand the current exemption from 
interstate movement restrictions to other well-studied, low-risk, GE 
research organisms.  Such a change would create a consistent, risk based 
approach to organisms with similar risk profiles. 
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6  67 FR 50577 
  
What environmental considerations should be evaluated if APHIS 
were to move from prescriptive container requirements for shipment 
of GE organisms to performance-based container requirements, 
supplemented with guidance on ways to meet the performance 
standards? 
10.  Issue 10 
 
APHIS regulations prescribe the use of several types of packaging to 
prevent the escape, dissemination, and environmental persistence of GE 
organisms.  Nevertheless, based on APHIS’ experience, there are other 
types of containers that can be used to safely move GE organisms.  APHIS 
often grants applicants a variance to use a different container to transport a 
GE organism in a way other than prescribed by the regulations; however, 
reviewing these requests takes agency resources.  APHIS is considering 
alternatives that will reduce the need for variances but still facilitate the 
safe movement of GE organisms. 
 
The Proposed Action 
 
With respect to the issues and associated alternatives, APHIS has made a 
preliminary determination that action should be taken, and that the action 
will require revision of the regulations at 7 Code of Federal Regulations 
(CFR) part 340.  Regulatory revisions under consideration are based on 
Agency experience and utilize new provisions of the PPA of 2000.  They 
have the potential to increase effectiveness, efficiency, and transparency 
and decrease negative environmental impacts.  They reflect the current 
thinking and should not be considered as final or as a rule proposal. 
 
APHIS’ preliminary determinations are discussed immediately below.  For 
the reader’s convenience, each determination as presented is accompanied 
by a parenthetical reference to its corresponding issue number noted 
earlier in this Executive Summary. 
 
APHIS has made a preliminary determination that oversight should be 
increased by expanding the scope of regulations to utilize authorities in the 
PPA other than just the plant pest provision, specifically, the authority 
over noxious weeds and biological control organisms (issue 1).  The 
noxious weed provision, in particular, will increase oversight of GE plants 
by increasing the scope of what is regulated and by allowing a broader 
consideration of risks.  APHIS has also made a preliminary determination 
to explicitly consider risks to public health in its regulation.  Use of this 
feature would allow APHIS to consider what is known about the potential 
hazards of the introduced proteins and other substances to humans or 
animals, if inadvertently consumed or released.  This information could, in 
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turn, be used to impose appropriate regulatory safeguards on introductions 
of GE organisms.   
 
APHIS has made a preliminary determination to adopt an expanded tiered 
permitting system based on potential environmental risk and familiarity 
(issue 2).  A detailed example of such a system is described in this DEIS.  
The goals, with respect to the tiered system, are to increase transparency 
with respect to how the agency handles various types of GE organisms and 
also to be highly flexible, such that the agency could move GE organisms 
among the tiers as new information becomes available.  For well 
characterized low-risk GE organisms, APHIS would continue to use a 
process similar to the current notification process found in 7 CFR § 340.3; 
however, a preliminary determination has been made that the term 
notification should no longer be used.  Notification would, for the most 
part, become the lowest risk “permit” in order to increase transparency and 
avoid confusion about the status of these organisms as regulated articles.  
 
Other changes under consideration can be integrated easily into a tiered 
permitting system.  For example, the agency has made a preliminary 
determination to exempt organisms in the tier type representing the most 
studied and familiar GE organisms from the requirement of a permit for 
interstate movement (issue 9).  Likewise, the policy that the agency is 
considering for dealing with low level presence of regulated 
biotechnology materials, when detected in commercial seed and 
commodities, could be linked to the tiered permitting system (issue 7).  
APHIS currently thinks the safety criteria for the most familiar and lowest 
risk permit tier type could also serve as the criteria under which APHIS 
would not take or order remedial action when regulated materials are 
detected at low levels in seeds or commodities. 
 
The agency has also made a preliminary determination to adopt a new 
system in which organisms could be fully deregulated or in which the 
agency could retain oversight in specific cases as needed (issue 3).  It is 
envisioned that the vast majority of organisms would be fully deregulated 
and that this determination would be synonymous with deregulation under 
the current system.  The new system could include processes and criteria 
to allow release and use, with some restrictions, for special cases where 
there were minor risks that could be mitigated with conditions for safe 
commercial use. 
 
The Agency has also considered various alternatives with respect to 
producing pharmaceutical compounds in plants, including whether food 
crops should be used and whether they should be allowable for open air 
introductions.  APHIS has made a preliminary decision that under highly 
stringent conditions and with abundant oversight, including a 
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consideration of food safety, food crops can be safely used for production 
of these compounds (issue 4). This does not mean that this option would 
be allowed in all cases.  Rather, should APHIS, based on its review of the 
GE organism and consideration of the potential risks, allow open air 
testing in appropriate cases. 
 
The agency has made a preliminary determination to create a multi-year 
permit for GE organisms, with stringent oversight, in cases where 
developers are not interested or would not qualify for deregulation but 
plan to produce under permit.  This would cover situations where 
producers are able to commercialize with relatively small plantings (e.g. 
industrial and pharmaceutical plants) (issue 6).  Regulatory rigor would 
remain high to protect the environment, but efficiency and transparency 
would increase.  The State partnership would be strengthened under this 
new system.  The system would rely on multiyear permits and intensive 
reviews of standard operating procedures (SOPs), as well as audits and 
inspections.  Though the new system under consideration could be used 
for pharmaceutical and industrial plants, the agency might also find it 
appropriate for other types of GE plants.   
 
APHIS has made a preliminary determination that it would be beneficial 
to regulate nonviable plant material originating from field tests (issue 5) 
when there is reason to believe, based on scientific review, that such 
debris might be harmful to the environment if it were allowed to remain.  
Such an approach could allow the agency to retain oversight if regulations 
or permit conditions are violated such that nonviable material poses a 
hazard (e.g., potential food contamination). 
 
APHIS has made a preliminary determination to have a new regulatory 
mechanism to allow for imports of commodities for nonpropagative use, 
that is, for food, feed, or processing, in cases where these commodities 
might not have been deregulated in the United States (issue 8).  With this 
approach, we could establish criteria to ensure safety and allow for 
additional environmental review when appropriate.  Allowing such 
imports without prior deregulation would not obviate the need to comply 
with requirements at other agencies, such as FDA and EPA. 
 
This document identifies alternatives which the agency has preliminarily 
determined would increase regulatory efficiency.  These alternatives could 
be adopted independently of any other alternatives described in the EIS, 
including any changes in regulatory scope.  One provision, mentioned 
earlier, is to exempt certain GE organisms from the need for a permit prior 
to interstate movement (issue 9).  Another is to allow for a mechanism by 
which certain classes of GE organisms might be excluded from regulatory 
oversight after review by the agency (issue 1).  This provision would 
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relieve the need for event-by-event deregulation of that class of organism.  
The agency also favors moving toward performance-based packaging 
container requirements as opposed to the prescriptive system which 
presently exists (issue 10).  The agency recognizes that there are numerous 
types of appropriate containers that can meet a given safety standard. 
 
The environmental impacts of the changes discussed above have been 
analyzed in the chapter 4.C of this document.  The environmental 
protections provided by these changes would either exceed or be 
approximately equal to the current system.  In some cases, APHIS favors 
changes because of additional protections.  In other cases, a similarly 
protective regulatory mechanism is favored because it is either more 
efficient or more transparent than the current mechanism. 
 
Administrative Changes to APHIS Rules 
 
As a part of the revision to 7 CFR part 340, APHIS may also make several 
administrative changes to its rules in order to improve their clarity, 
coordination, and execution.  No significant environmental impacts from 
these changes are anticipated. 
 
Public Comment Sought 
 
This DEIS is a comprehensive document designed for more 
environmentally informed decisionmaking for future regulation of GE 
organisms under the agency’s purview.  APHIS now seeks public 
comments on this DEIS.  Following consideration of the comments, 
APHIS will issue a final EIS in accordance with NEPA.  Supplements to 
the final EIS may be necessary as new or improved processes are 
developed, changes occur in the program or its administration, or coverage 
of the document is expanded. 
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I. Purpose and Need 
 
The U.S. Department of Agriculture (USDA) Animal and Plant Health 
Inspection Service (APHIS) regulates the environmental introduction of 
genetically engineered (GE) organisms, including crop and noncrop 
plants, vertebrate and invertebrate animals, and micro-organisms.  APHIS 
regulations are grounded in the most up-to-date science and are designed 
to provide a level of oversight appropriate for the safe introduction of GE 
organisms.  APHIS is considering whether revisions to its regulations are 
necessary.  One purpose of such revisions would be to address current and 
future technological trends resulting in GE plants with which the agency is 
less familiar, such as plants with environmental stress tolerance or 
enhanced nutrition, and plants engineered for new purposes such as 
biofuels or for production of pharmaceutical or industrial compounds.  
Additionally, the regulations would be revised to ensure a high level of 
environmental protection, to create regulatory processes that are 
transparent to stakeholders and the public, to consider the efficient use of 
agency resources, to ensure that the level of oversight is commensurate 
with the risk, and to ensure conformity with obligations under 
international treaties and agreements, such as World Trade Organization 
(WTO) agreements.  To this end, this draft environmental impact 
statement (DEIS) was prepared to provide agency decisionmakers with a 
full range of regulatory alternatives and assist them in selecting a preferred 
alternative. 
 
A.  Background 
 
Over the past 2 decades, it has become clear that genetic engineering is a 
powerful tool for creating improved crop varieties that can be integrated 
into existing agricultural production systems, and it has the potential to 
benefit agriculture, the environment, human health, and the U.S. economy.  
The International Service for the Acquisition of Agri-Biotech Applications 
has recently reported that GE crops were grown on 222 million acres (or 
90 million hectare (ha)) in 2005 by 8.5 million farmers in 21 countries.  
This marks an 11-percent increase from 200 million acres in 2004.  The 
United States was the largest adopter of GE crops, with 123 million acres 
planted in 2005.7  Consistent with the Coordinated Framework for 
Regulation of Biotechnology (51 Federal Register (FR) 23,302 (June 26, 
1986)), USDA works with the Environmental Protection Agency (EPA) 
and the Food and Drug Administration (FDA) to make sure that the 
development and commercialization of GE agricultural products are done 
safely. 
 
7  http://www/isaaa.org/kc/ 
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USDA first implemented regulations (7 Code of Federal Regulations 
(CFR) part 340) for GE organisms in 1987.  Under these regulations, 
plants, micro-organisms, fungi, insects, and mollusks were subject to 
regulation if they have the potential to pose a plant-pest risk as defined in 
the regulations.  The regulations established a permitting system to 
authorize importation, interstate movements, and environmental release of 
GE organisms. 
 
The regulations have been revised several times8 to accommodate new 
technologies and to increase APHIS’ efficiency.  For example, a revision 
in 1993 introduced the notification option for authorizing introductions.  
This process was more streamlined than a permit application but originally 
could be used for only six crops considered by the agency to be low risk 
and with which the agency was highly familiar.  In addition, the genes and 
transformation methods used had to comply with specific safety criteria 
that established a very low potential to pose a plant-pest risk. 
 
Another revision in 1993 established a process in which an applicant could 
petition the agency to determine if a GE plant should be deregulated.  In 
considering a petition, APHIS carefully reviews the data submitted by the 
applicant, typically amassed during several years of field testing, and also 
weighs other information, including pertinent scientific studies.  APHIS’ 
analyses are grounded in almost 100 years of experience protecting U.S. 
crops from plant pests, beginning with the enactment of the Plant 
Quarantine Act (PQA) of 1912.  APHIS deregulates a biotechnology-
derived plant if the agency finds that the plant poses no plant pest risks to 
the United States. 
 
In 1997 the regulations were again revised.  At that time, the eligibility for 
the notification procedure was extended to cover all plants with the 
exception of federally listed noxious weeds and other plants considered by 
APHIS or a State government to be weeds in the area of the proposed field 
test.  The other eligibility requirements remained the same. 
 
APHIS is again considering whether there is a need to revise its 
regulations.  The need for these considerations and consequently the need 
for an EIS are being driven by several timely issues, most of which are 
associated with emerging technologies used to develop the organisms 
regulated by APHIS.  Crop plants bearing genes for insect resistance and 
herbicide tolerance currently make up the bulk of APHIS-authorized 
introductions, but there are many genes being studied with which APHIS 
                                         
8 68 FR 46434 (plant producing industrial compounds); 62 FR 19903 (extensions); 60 FR 43567 
(notifications); 58 FR 17044 (notifications and petitions for nonregulated status); 55 FR 53275 
(interstate movement of Arabidopsis); 53 FR 12910 (interstate movement of micro-organisms). 
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may be less familiar.  For example, one new trend is the use of GE plants 
traditionally used for food and feed as a means to produce not food but 
compounds for pharmaceutical or industrial use.  Another trend is the 
growing diversity in the types of genes being tested, for example, the 
enormous number of genes emerging from the rapidly expanding field of 
plant genomics research. 
 
APHIS anticipates that a growing number of permit applications will be 
submitted to the agency for the introduction of organisms with traits such 
as increased nutritional quality, enhanced agronomic performance, 
improved disease resistance, or the production of novel substances.  In 
addition, many of the GE plants now being field tested were produced 
without using plant pests or plant-pest genetic sequences.  Researchers are 
also beginning to focus more on perennial plants, such as grasses or trees, 
which may be capable of establishing and persisting outside the site of 
introduction.  (See table 1–1 for a list of crops and traits that APHIS 
expects to be developed in the future and possible concerns that have been 
raised regarding the field testing of those materials.) 
 
Our evaluation of the current program is being driven by a need to respond 
to emerging trends such as those exemplified in table 1–1, and in the 
process, the agency will consider opportunities for utilizing the expanded 
regulatory authority that exists in the Plant Protection Act (PPA) of 2000.  
In addition, the revisions would address process efficiency to reduce 
regulatory burdens and make better use of APHIS resources by focusing 
oversight where it is most needed. 
 
Table 1–1. Types of Crops and Traits in APHIS-Regulated Articles and 
Possible Issues Raised By Field Testing Them. 
Crop or Trait Issues for Field Testing 
Perennial crops Environmental persistence 
Pharmaceutical or industrial compound 
produced 
Inadvertent commingling of potentially 
toxic materials with food 
Stress or disease resistance Development of invasive weeds 
Altered nutritional qualities Impacts on herbivores 
Phytoremediation Concentration of toxic substances 
Insect resistance Development of resistant insects 
Herbicide resistance Changes in herbicide usage 
 
APHIS also hopes to increase the transparency of its regulatory processes 
and to engender greater public participation in APHIS decisionmaking.  
The purpose of this DEIS is to provide a detailed environmental analysis 
that compares the impacts of the Action alternative (i.e., revising the 
regulations) with the No Action alternative (i.e., retaining the current 
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regulations).  A decision to revise APHIS regulations may involve many 
individual changes, and each proposed change will be discussed and 
analyzed separately, for the sake of clarity. 
 
The EIS will help guide agency decisionmaking in selecting between the 
alternatives and should also contribute greatly to the transparency of the 
process by providing ample opportunity for public input and comment on 
the DEIS and by laying out clearly the rationale for any changes. 
 
B.  APHIS Statutory Authority 
 
This section discusses APHIS’ general statutory authority to regulate GE 
organisms as known or potential plant pests. 
 
In 1987, APHIS regulated GE organisms under the authorities of the 
Federal Plant Pest Act (FPPA)(7 United States Code (U.S.C.) §§ 150aa–
150jj, repealed), and the PQA (7 U.S.C. §§ 151–167, repealed) by issuing 
regulations that effectively classified most GE organisms as plant pests or 
potential plant pests.  The regulations govern the “introduction of 
organisms and products altered or produced through genetic engineering 
which are plant pests or which there is reason to believe are plant pests.”  
The introduction of such organisms is prohibited unless APHIS authorizes 
the introduction. 
 
To date, APHIS has authorized over 15,000 field releases involving GE 
organisms.9  Of these, the vast majority involve GE plant species.  Less 
than one percent of the total number of authorized field releases involved 
nonplant species. 
 
APHIS currently derives its authority to write regulations from provisions 
of the PPA, which is a part of the larger Agriculture Risk Protection Act of 
2000.  The PPA (7 U.S.C. § 7701 et seq.) was enacted in June 2000 to 
consolidate and expand several older laws relating to the regulation of 
plant pests and diseases, including the FPPA, the PQA, and the Federal 
Noxious Weed Act (formerly 7 U.S.C. § 2801 et seq.).  The PPA was 
enacted to strengthen and clarify USDA’s authority to protect American 
agriculture against invasion by foreign plants pests and diseases, and the 
Act specifically provided authority over biocontrol agents.  The PPA 
repealed these old laws but included a savings clause (7 U.S.C. § 7758(c)) 
which provided that regulations promulgated under them would remain in 
effect until APHIS issued new regulations under the PPA.  APHIS’ current 
regulations are, therefore, based on its authority to regulate plant pests 
originally granted in the FPPA and PQA. 
 
9  http://www.isb.vt.edu/cfdocs/foe;dtests1.cfm
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The PPA provides APHIS with broader authority to regulate GE 
organisms than the previous statutes.  The PPA confers very broad 
authority on the Secretary of Agriculture to prevent the dissemination of 
plant pests, noxious weeds, and biological control organisms into or within 
the United States. 
 
In the PPA, Congress recognized that— 
 
“…the unregulated movement of plant pests, noxious 
weeds, plants, certain biological control organisms, plant 
products, and articles capable of harboring plant pests or 
noxious weeds could present an unacceptable risk of 
introducing or spreading plant pests or noxious weeds 
(7U.S.C. §7701(7)).” 
 
Congress charged the Secretary of Agriculture with the task of facilitating 
exports, imports, and interstate commerce in agricultural products, “in 
ways that will reduce, to the extent practicable, as determined by the 
Secretary, the risk of dissemination of plant pests or noxious weeds”  
(7 U.S.C. § 7701(3)). 
 
Under the PPA, APHIS is responsible for preventing the importation and 
interstate dissemination of plant pests and noxious weeds.  The PPA 
authorizes APHIS to regulate, “any plant, plant product, biological control 
organism, noxious weed, article, or means of conveyance” that could 
spread a plant pest or noxious weed (§ 7712).  The definition of “plant 
pest” in the PPA is broad and includes living organisms that could injure, 
damage, or cause disease in any plant or plant product (§ 7702(14)).  The 
definition of “noxious weed” in the PPA is arguably even broader than the 
definition of plant pest; it includes— 
 
“…any plant or plant product that can directly or indirectly 
injure or cause damage to crops (including nursery stock or 
plant products), livestock, poultry, or other interests of 
agriculture, irrigation, navigation, the natural resources of 
the United States, the public health, or the environment. 
(7702(10)).” 
 
The PPA also granted broad authority over biological control organisms, 
defined as, “any enemy, antagonist, or competitor used to control a plant 
pest or noxious weed” (7 U.S.C. § 7702(2)). 
 
APHIS regulates potential plant pests and potential noxious weeds both 
those that are naturally occurring and those that are genetically 
engineered.  APHIS’ regulations in 7 CFR § 330.200 are applicable to 
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persons seeking to import or move interstate, plant pests and noxious 
weeds that are naturally occurring and have not resulted from genetic 
engineering.  Regulations in 7 CFR part 340 apply to introductions of GE 
organisms but apply only to GE organisms that are plant pests or potential 
plant pests: APHIS does not currently regulate GE organisms as potential 
noxious weeds.  Under current regulations, APHIS treats regulated GE 
organisms similarly to naturally occurring plant pests or potential plant 
pests.  In both cases, a permit must be obtained from APHIS prior to 
importation, interstate movement, or environmental release, for example, 
field testing. 
 
C.  Interrelationships with Other Federal Agencies 
 
Under the current system of regulating plant pests and potential plant 
pests, APHIS has broad jurisdiction over GE organisms that have been 
developed for release into the environment.  Two other agencies also have 
regulatory authority over many GE organisms.  Through a registration 
process that is independent of APHIS, EPA regulates the sale, distribution, 
and use of pesticides in order to protect health and the environment.  This 
includes pesticides that are produced by organisms developed using 
techniques of modern biotechnology. 
 
Under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA), 
the Biopesticides and Pollution Prevention Division of the Office of 
Pesticide Programs regulates the distribution, sale, use and testing of 
pesticidal substances produced in plants and microbes as well as the 
microbes themselves if EPA considers them to be biocontrol agents or 
pesticidal in function.  Under FIFRA, EPA also regulates the herbicides 
that are applied to GE herbicide-tolerant crops, and under the Federal 
Food, Drug, and Cosmetic Act (FFDCA), EPA regulates pesticide 
residues.  Additionally, under section 5 of the Toxic Substances Control 
Act (TSCA), EPA acquires information in order to identify and regulate 
potential hazards and exposures of all new chemicals intended for entry 
into commerce that are not specifically covered by other regulatory 
authorities, for example, substances other than food, drugs, cosmetics, and 
pesticides.  TSCA’s applicability to the regulation of products of 
biotechnology is based on the interpretation that micro-organisms are 
chemical substances under TSCA. 
 
FDA is responsible for ensuring the safety and proper labeling of all plant-
derived foods and feeds, including those developed through genetic 
engineering.  All foods and feeds, whether imported or domestic and 
whether derived from plants modified by conventional breeding 
techniques or by genetic engineering techniques, must meet the same 
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rigorous safety standards.  Under the FFDCA, it is the responsibility of 
food and feed manufacturers to ensure that the products they market are 
safe and properly labeled.  In addition, any food additive, including ones 
introduced into food or feed by way of plant breeding, must receive FDA 
approval before marketing.  To help sponsors of foods and feeds derived 
from GE plants comply with their obligations, FDA encourages them to 
participate in its voluntary consultation process.  In that process, sponsors 
provide to FDA data and information that summarizes the basis on which 
the sponsors have concluded that a GE food is as safe as comparable non-
GE food in the food supply.  FDA believes that developers of 
bioengineered food that is intended to be commercially marketed have 
followed the recommendations in FDA's guidance documents for 
consulting with FDA. 
 
APHIS has consulted with and requested both agencies’ input during the 
preparation of this DEIS.  Both agencies have provided their comments to 
APHIS, and APHIS now invites both agencies to comment on this 
published draft.  It is APHIS’ intention that the alternatives analyzed in 
this DEIS will be consistent with the Coordinated Framework and will be 
compatible with the authorities of EPA and FDA.  This DEIS will not 
affect the authorities of EPA, FDA, or any other agency, nor is it APHIS’ 
intention for the proposed revision process to have any such effects.  The 
proposed revision process will not force EPA, FDA, or any other agency 
to revise its regulations. 
 
D. Biotechnology Regulatory Services Regulatory   
System 
 
Companies and organizations that wish to introduce a regulated GE 
organism into the United States must obtain APHIS permission if that 
organism is a plant pest or is believed to be a plant pest.  Applicants must 
submit all plans for interstate movement, importation, or environmental 
release for review by regulatory scientists, who evaluate the procedures 
that the applicant will use to ensure that the GE organism will not escape 
into the environment or persist there.  Depending on the nature of the GE 
organism, an applicant files either a notification or a permit application.  
APHIS evaluates the application to determine whether the proposed 
testing or movement conditions are adequate to confine the GE organism.  
Biotechnology Regulatory Services (BRS) of USDA–APHIS also works 
closely with States to be sure that they are aware of environmental releases 
taking place within their jurisdiction, to explain how the releases are 
performed and confined, and to allow them to request any additional 
conditions in accordance with the PPA.  To ensure compliance with the 
permitting conditions, BRS inspects release sites and audits records 
maintained by permit holders. 
 
Currently, most regulated GE plants are introduced (i.e., imported, moved 
interstate, or released into the environment) under “notification,” which is 
a streamlined review process.  Applicants may use the notification process 
only for plants with traits that BRS considers to have little potential to 
pose plant-pest risks and with which the agency is highly familiar.  
Examples of plants introduced under the notification process are those 
altered to induce insect resistance or herbicide tolerance. 
1. The 
 Notification 
 Process 
 
To qualify for the notification process, the GE plant must meet six 
requirements to ensure that it does not pose a potential plant-pest risk: 
 
1. The plant species must be a species that APHIS has determined may 
be safely introduced; it may not be a plant recognized by APHIS as a 
noxious weed; nor can it be a noxious weed in the area where any 
field testing is proposed. 
 
2. The introduced genetic material must be stably integrated. 
 
3. The function of the introduced genetic material must be known and 
its expression in the regulated article does not result in plant disease. 
 
4. The introduced genetic material does not produce an infectious 
entity, toxicants to nontarget organisms likely to feed or live on that 
plant species, or products intended for pharmaceutical or industrial 
use. 
 
5. The introduced genetic sequences derived from plant viruses do not 
pose a significant risk of the creation of any new plant virus; and 
 
6. The plant has not been modified to contain certain genetic material 
derived from an animal or human pathogen (7 CFR § 340.3(b)). 
 
Applicants must also agree to adhere to performance standards set forth by 
APHIS for proper confinement of the GE plants.  The goal of proper 
confinement is to ensure that the GE plants do not persist in the 
environment.  APHIS requires that applicants provide detailed information 
about the plant (e.g., the source and identity of any genes introduced, the 
method of genetic engineering, and the size, duration, and location of the 
field release).  If a plant does not meet the criteria for notification, the 
applicant must obtain a permit (7 CFR § 340.4) in order to introduce the 
organism. 
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When APHIS receives a notification application, it is reviewed by a staff 
biotechnologist to verify that the application is complete and that the GE 
plant proposed for introduction meets the criteria for a notification.  If 
BRS completes the review process and finds that all regulatory 
requirements have been met, the notification is authorized in a process 
termed “acknowledgement,” and the applicant is free to proceed with the 
proposed introduction under the terms of the notification after the 
acknowledgement.  BRS’ acknowledgement of a notification usually 
applies for 1 year from the date of introduction (7 CFR § 340.3(e)(4)). 
 
2. The 
 Permit 
 Process 
The permit process is for GE plants that cannot be introduced under 
notification—such as plants that produce pharmaceutical or industrial 
compounds—and for any nonplant GE organisms covered in the 
regulatory definition of “plant pest.”  Conditions imposed on field releases 
performed under a permit are typically more restrictive than those imposed 
on releases done under notifications, and according to APHIS regulations, 
the applications may take up to 120 days to process.  Applicants must also 
apply for permits for the interstate movement or importation of a regulated 
article, which take up to 60 days to process.  Upon approval, permits are 
generally valid for 1 year from the date of issue and are renewable. 
 
For an environmental release, permit applicants must provide APHIS with 
details about all introduced genetic material and gene products, the 
biology of the organism, its origin, its intended use, and procedures for 
field production and isolation.  For movement or importation permits, 
applicants must also disclose the destination, the means of movement, and 
procedures to safeguard against the escape of the GE organism.  For the 
importation of a GE organism, an applicant must submit an application for 
each individual shipment.  Using the information supplied by the 
applicant, APHIS scientists create a set of permit conditions with which 
the applicant must comply or face potential enforcement action.  Although 
there are some conditions common to most permits for GE plants (e.g., 
sound agronomic practices), permit conditions for nonplant GE organisms 
are developed on a case-by-case basis. 
 
Applicants may also request nonrenewable, “comprehensive” permits, 
under which multiple phenotypes, genes, and donors, and all anticipated 
field test sites and movements for a single crop are included in a single 
application.  Very few applications for comprehensive permits are 
received. 
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APHIS forwards the applications for all permits and notifications, with 
any confidential business information (CBI) redacted, to State regulators 
in the States to which regulated articles will be moved or in which a field 
release is planned.  This is done to notify States of the requested action 
and to allow States to review and comment on proposed releases, 
importations, or movements.  The response from individual States varies:  
some agree to the proposed introduction under the conditions imposed by 
APHIS while others request additional permit conditions.  For various 
reasons (e.g., lack of resources), some States choose not to respond. 
 
Most permits and notifications are done under a categorical exclusion 
under APHIS’ NEPA implementation regulations; however, if a permit 
application or notification involves new species or new organisms or novel 
modifications that raise new issues, APHIS will prepare an environmental 
assessment (EA) in compliance with the National Environmental Policy 
Act of 1969 (NEPA), as amended, the Council on Environmental Quality 
(CEQ) regulations for implementing NEPA, the USDA regulations 
implementing NEPA, and APHIS’ NEPA Implementing Procedures.  In 
the EA, APHIS assesses the potential for the proposed introduction to 
cause significant impacts to the human environment.  APHIS makes draft 
EAs available to the public for comment, responds to these comments, and 
publishes a final EA before it determines whether the permit will be 
granted.  If APHIS determines in the EA process that the proposed 
introduction of a GE organism will cause significant impacts to the human 
environment, NEPA requires that an EIS be prepared prior to deciding 
whether to allow the introduction to proceed. 
 
Developers of new GE organisms can petition APHIS for a “determination 
of nonregulated status.”  In the petition, a company or organization must 
submit data to demonstrate that the organism poses no greater plant-pest 
risk than the non-GE version of the organism.  The necessary data 
includes, at a minimum, a description of the biology of the organism 
before it was genetically engineered; differences between the GE 
organism and the original organism; and  field reports for all releases the 
petitioner conducted involving the GE organism.  Depending on the 
organism and the GE trait involved, the petitioner may also need to 
consult with EPA or FDA.  To date, GE plants are the only GE organisms 
that have been deregulated through the petition process. 
3. Petition for 
 Deregulation 
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Before a GE organism can be deregulated, APHIS prepares an EA or an 
EIS, in compliance with NEPA, to analyze the impacts the organism may 
have on the human environment.  This assessment includes an 
examination of potential impacts on plant and animal life and specifically 
looks for possible impacts on threatened and endangered species (TES), 
using an ESA assessment which asks specific questions regarding the 
likelihood that the deregulation of a GE plant would impact TES or critical 
habitat.  APHIS’ TES analysis takes into account the likelihood that a 
deregulated GE plant may be adopted and grown throughout the United 
States.  APHIS publishes in the Federal Register all EAs and EISs it 
  
develops and seeks public comment, in compliance with the National 
Environmental Policy Act of 1969 (NEPA), as amended, the Council on 
Environmental Quality (CEQ) regulations for implementing NEPA, the 
USDA regulations implementing NEPA, and APHIS’ NEPA 
Implementing Procedures.  APHIS approves petitions only when it reaches 
the conclusion that potential plant-pest risks are no greater than those 
posed by appropriate non-GE comparator organisms.  Petitioners are 
notified within 180 days after receipt of their completed petition that it has 
either been granted or denied.  According to the regulations, APHIS may 
approve a petition “in whole or in part.”  However, to date, no petitioner 
has requested, nor has APHIS granted, partial approval of a petition for 
nonregulated status. 
 
Since 1987, APHIS has overseen the deregulation of more than 70 GE 
organisms, all of which are plants.  Of these approved organisms, 
approximately 40 percent were engineered for herbicide tolerance and 
approximately 25 percent for insect resistance.  Corn, tomatoes, and cotton 
are the most frequently deregulated organism.  (See 
<http://www.aphis.usda.gov/brs/not_reg.html>.)  Each deregulation to 
date covers not only the original transformed genotypes described in the 
petition but all progeny that may be subsequently created from the original 
genotypes.  If APHIS becomes aware of information that indicates that a 
deregulated article poses a plant pest risk, it can be re-regulated by the 
agency.   
 
If an applicant wishes to seek nonregulated status for a GE organism that 
is similar to one already deregulated by the agency, the applicant may file 
an extension request.  The agency reviews data submitted by the applicant 
and then determines if the new organism is in fact the same as the 
previously deregulated organism with respect to risks.  If so, the agency 
can extend the nonregulated status to cover the new organism.  Also, 
APHIS can, in the absence of an applicant’s request, independently 
determine that a particular organism is sufficiently similar to a previously 
deregulated organism such that it can be granted nonregulated status. 
4. Extension 
 Requests 
 
5. Compliance 
 with BRS 
 Regulations 
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It is the responsibility of APHIS to establish and enforce regulations that 
protect American agriculture, the food supply, and the environment while 
allowing for the safe field testing, importation, and movement of GE 
organisms.  APHIS determines the conditions under which GE organisms 
can be introduced into the United States and allows their introduction only 
after all necessary safeguards are put into place.  Failure to adhere to 
APHIS regulations and all permit conditions can result in serious 
penalties, which can be up to $500,000 for all violations adjudicated in a 
single proceeding.  In addition violators may be held responsible for any 
necessary remediation. 
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APHIS–BRS’ compliance unit works to ensure that notification and 
permit holders maintain regulatory compliance by providing guidance and 
through procedures that include violation-prevention efforts, site audits 
and inspections, documentation of compliance infractions, and mitigation 
and enforcement actions to address any infractions.  In addition, 
researchers are required to inform APHIS if any adverse effects are noted 
during the field testing of GE organisms.  Compliance specialists and 
APHIS inspectors perform both targeted and random inspections and 
audits of field releases to thoroughly monitor potential compliance 
problems. 
 
E. Scoping 
 
The analysis of the current APHIS–BRS regulatory program and proposed 
alternatives cover many issues affecting the current program.  Such issues 
were identified in a scoping process during which interested stakeholders, 
government agencies, and the public raised issues that should be addressed 
in the preparation of the final EIS.  Public scoping is required under the 
National Environmental Policy Act of 1969 (NEPA), as amended, the 
Council on Environmental Quality (CEQ) regulations for implementing 
NEPA, the USDA regulations implementing NEPA, and APHIS’ NEPA 
Implementing Procedures.  Scoping for this DEIS began on January 23, 
2004, when APHIS gave notice in the Federal Register (69 FR 3271) of 
its intent to prepare a DEIS.  The notice listed a range of issues to be 
discussed in the EIS: 
 
1. Should APHIS continue to regulate GE organisms solely on the basis 
of potential risks as plant pests, or should they also be regulated based 
on other potential risks such as those for noxious weeds and biological 
control organisms? 
 
2. Should a new system of risk-based permit categories be designed to 
deal with new products and new concerns? 
 
3. Should APHIS continue to accommodate commercialization but in 
some cases grant conditional approvals when additional information is 
needed about particular regulated articles proposed for deregulation? 
 
4. Should APHIS modify its rules for regulating and confining plants 
producing pharmaceutical and industrial compounds? 
 
5. Should APHIS regulate nonviable plant material derived from 
regulated plants? 
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6. Should there be a new mechanism to provide oversight for 
pharmaceutical plants and other GE plants that are being produced 
commercially? 
 
7. Should low-level occurrence of a regulated article be exempted from 
regulation? 
 
8. Should low-risk organisms intended for importation for a 
nonpropagative use be exempted from regulatory review or be subject 
to expedited review? 
 
9. Should interstate movement of GE Arabidopsis or other GE organisms 
be exempted from movement restrictions? 
 
10. Should APHIS consider relieving other regulatory requirements when 
the environmental risk is low? 
 
11. Should APHIS switch from prescriptive packaging-container 
requirements to performance-based ones? 
 
The notice solicited public involvement in the form of written comments 
regarding the above issues and alternatives for regulatory revision.  
Written comments were accepted from the public during an extended 
comment period which lasted until April 13, 2004.  (See 
<http://www.aphis.usda.gov/brs/eis/eis_comments.html> and appendix C.) 
 
Oral comments were received from stakeholders (the regulated 
community, nongovernmental organizations, and university faculty) 
during meetings with APHIS staff, occurring late February and early 
March 2004.  Twenty-three groups participated in the comment process, 
and all comments were transcribed and have been made available on the 
APHIS Web site.  (See 
<http://www.aphis.usda.gov/brs/stakeholder_minutes.html> and appendix 
D.)  In addition, APHIS–BRS sponsored a 3-day conference and workshop 
with the National Association of State Departments of Agriculture 
(NASDA) in June 2004.  During this meeting, State agriculture personnel 
were able to voice their concerns and suggestions for APHIS’ rule revision 
process.  (See appendix E for a summary of the results of the NASDA 
discussions.) 
 
F. Scoping Analysis and Documentation 
 
All comments and proposed alternatives received were evaluated on the 
basis of whether they addressed the issues in question, whether they were 
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based on valid science, and whether they were reasonable and practicable.  
The results of the scoping process assisted APHIS–BRS in the formulation 
of the alternatives that are analyzed in this DEIS.  Relevant issues raised 
through the scoping process were incorporated into the formulation of the 
regulatory alternatives as described in chapter 2. 
 
A summary of the public comments, those of the stakeholder sessions, and 
those of NASDA representatives are provided in appendix C, D, and E 
respectively.  For the sake of transparency, the actual text of all public 
comments and the transcripts from the stakeholder sessions have been 
published on the APHIS Web site. 
 
G. Requirements for Further Environmental Analysis 
 
This DEIS is a programmatic document that analyzes the environmental 
impacts of an entire regulatory program.  As such, the DEIS addresses 
these impacts at a general level because of the broad area over which these 
impacts might occur.  Project-specific NEPA analyses and documentation 
on proposed actions, such as permit applications and deregulation 
decisions, may be prepared on individual project levels, and public 
involvement will be solicited in accordance with the National 
Environmental Policy Act of 1969 (NEPA), as amended, the Council on 
Environmental Quality (CEQ) regulations for implementing NEPA, the 
USDA regulations implementing NEPA, and APHIS’ NEPA 
Implementing Procedures.  These NEPA analyses will be tiered to this 
DEIS and other applicable EISs where appropriate. 
 
APHIS will issue a final programmatic EIS that addresses public 
comments received on this DEIS, in accordance with NEPA.  Supplements 
to the final programmatic EIS may be necessary as new or improved 
processes are developed, changes occur in the program or its 
administration, or coverage of the document is expanded.  Two classes of 
supplements will be produced: 
 
• Insignificant Supplements:  Supplements that cause no substantive 
change in emphasis or classes of activities and do not have significant 
environmental impacts (40 CFR § 1508.27). 
 
• Significant Supplements:  Supplements that substantively change 
program emphasis or that have potentially “significant” impacts to the 
environment (40 CFR § 1508.27). 
 
Insignificant supplements will be made by the APHIS Administrator or his 
or her delegated representative with appropriate public notification.  
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Significant supplements will be subjected to NEPA analysis and put in 
force with the appropriate NEPA documentation and determination as 
required by CEQ and APHIS NEPA implementing regulations. 
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II.  Proposed Program Alternatives 
 
Genetic engineering refers to the process in which genes or other genetic 
elements from one or more organisms are inserted into the genetic 
material of a second organism using molecular biology methods.  Moving 
a new gene or genes in this way allows researchers to introduce useful 
new traits into an organism from individuals of the same species or from 
unrelated species. 
 
The U.S. Department of Agriculture (USDA) Animal and Plant Health 
Inspection Service (APHIS) is responsible for regulating the introduction 
(importation, interstate movement, and environmental release) of 
genetically engineered (GE) organisms that are known to, or could, pose a 
plant-pest risk.  GE organisms are considered to have the potential to pose 
a plant-pest risk if the donor organism, recipient organism, vector, or 
vector agent used in their creation is a member of a genus (listed in the 
regulations at 7 Code of Federal Regulations (CFR) part 340) known to 
contain plant pests. 
 
APHIS established Biotechnology Regulatory Services (BRS) in August 
2002, by combining units within the agency that dealt with various aspects 
of the regulation of biotechnology.  APHIS exercises its authority through 
regulations (7 CFR part 340) promulgated under the Plant Pest Act 
(FPPA).  APHIS has regulated biotechnology since 1987, ensuring the 
safety of 15,000 authorized field releases. 
 
A. Biotechnology Regulatory Services’ Goals 
 
BRS’ goal is to protect America’s agricultural and natural resources by 
ensuring the safe development of GE organisms using a risk-based 
regulatory framework, grounded in science.  In the implementation of our 
mission and vision, BRS has established five guiding principles, consistent 
with Executive Order 12866, that set program direction and provide the 
foundation for decisionmaking: 
 
1. Rigorous, thorough, and appropriate regulation supported by strong 
compliance and enforcement. 
 
2. Transparency of the regulatory process and regulatory decisionmaking. 
 
3. A science-based system in place to ensure sound decisionmaking and 
assure safety. 
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4. Communication, coordination, and collaboration with the full range of 
stakeholders. 
 
5. International leadership in capacity building for science-based policy 
and standards. 
 
   How the Draft Environmental Impact Statement Was   
   Developed 
 
APHIS has more than 19 years of experience safely regulating the 
introduction of GE organisms, operating under the five guiding principles 
listed above.  To ensure that these regulatory goals can continue to be met, 
APHIS decided to undertake an evaluation of potential revisions to 
APHIS’ regulations to address changes that have occurred in the field of 
agricultural biotechnology since the agency’s regulations were first 
published in 1987. 
 
On January 23, 2004, APHIS published in the Federal Register a Notice 
of Intent (NOI) to prepare a programmatic environmental impact 
statement (EIS), in compliance with the National Environmental Policy 
Act (NEPA) and APHIS’ own NEPA implementation rules.  The NOI 
posed several questions in broad categories related to issues that could be 
of concern.  The 60-day comment period closed on March 23, 2004, but 
was extended on March 26 for another 15 days, closing on April 13, 2004.  
Approximately 4,000 public comments were received and reviewed by 
APHIS.  Approximately 3,600 of these comments were form letters that 
expressed general opposition to GE organisms with particular concern 
being directed at plants genetically engineered to produce pharmaceutical 
compounds.  These and all other comments were analyzed, and APHIS 
collected all unique issues. 
 
In February and March 2004, the agency held meetings with numerous 
stakeholders—including biotechnology crop manufacturers, university 
researchers, food milling and processing organizations, and public-interest 
citizens’ groups.  In June 2004, APHIS met with representatives from 
State departments of agriculture to get their perspective on its regulatory 
program for biotechnology. 
 
APHIS used all the comments that it collected from the Federal Register 
notice and various meetings in scoping the draft EIS (DEIS) to ensure that 
the agency was addressing all pertinent issues and that the EIS examined 
appropriate environmental impacts that could possibly result from 
revisions to the regulations.  The results of the scoping process are 
summarized throughout this chapter in the context of the major issues 
discussed in the NOI. 
  
Next, APHIS developed alternatives, that is, specific actions that might be 
taken to address each of the issues identified by the agency.  These 
alternatives were then elaborated through the scoping process.  The 
alternatives were independent of each other but not mutually exclusive:  
the alternative chosen to address one particular issue would not necessarily 
dictate which alternative would need to be chosen to address a different 
issue.  In several cases, more than one alternative could be adopted to 
address a single issue.  For each issue, APHIS articulated a “No Action” 
alternative, which means the pertinent regulations would not be changed.  
When appropriate, alternatives incorporated suggestions derived from the 
public scoping process. 
 
B. Issues and Alternatives 
 
In this section below, each of the issues,10 is restated along with a list of 
possible alternatives for action. 
 
APHIS is considering the broadening of its regulatory scope beyond 
genetically engineered organisms that may pose a plant pest risk to 
include genetically engineered plants that may pose a noxious weed 
risk and genetically engineered organisms that may be used as 
biological control agents.  Do regulatory requirements for these 
organisms need to be established?  
1. Issue 1 
 
Given the rapid advances in biotechnology, the present scope of 
regulations may not be of sufficient breadth to cover the full range of GE 
organisms and the full range of potential agricultural and environmental 
risks posed by these organisms, including risks to public health.  
Historically, APHIS has used only the authority in the PPA of 2000 that 
was originally granted in the FPPA and the PQA.  Specifically, the agency 
has used its authority to protect against plant pests as the basis for 
regulating GE organisms.  The PPA, however, redefined authorities and 
responsibilities for the agency.  Changes are now being considered in 
recognition of these responsibilities and in light of these new technologies. 
 
Alternatives Relating to the Scope of Regulations
 
Consideration of Noxious Weed Risks 
 
Certain organisms that can cause harm or injury to plants or plant products 
are defined by the PPA as “plant pests” (7 United States Code (U.S.C.) 
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10 Issue 10 in the NOI involved relief of regulatory requirements for low-risk materials.  Rather than list 
regulatory relief alternatives separately, they have been incorporated into the discussion of the other 
issues, where appropriate. 
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7702(14)).  APHIS has used its authority to regulate the introduction and 
movement of plant pests as the basis for its regulation of GE organisms.  
Specifically, APHIS regarded any GE organism as a regulated article if the 
donor organism, recipient organism, vector, or vector agent used to alter or 
produce the organism is a plant pest.  In addition, APHIS asserted its 
authority if there was a reason to believe the organism could pose a plant-
pest risk.  The “reason to believe” clause has generally been interpreted to 
mean that APHIS has ultimate discretion in determining whether a given 
organism has the potential to pose a plant-pest risk.  As a matter of 
practice, the agency has used this discretion any time there was 
uncertainty with respect to an organism’s plant-pest potential.  Because 
most GE plants use sequences from plant pests, and because the reason-to-
believe clause broadens the scope of agency discretion, APHIS believes 
that its current regulations provide very broad jurisdiction over GE plants. 
 
The question has arisen whether a GE organism that does not present a 
potential plant-pest risk might pose other potential risks that are addressed 
by the PPA.  One of the reasons for this question is the growing use of 
gene regulatory sequences from sources other than plant pests, whereas in 
the past, most gene regulatory sequences were from plant viruses or plant-
pathogenic bacteria.  A report by the National Academy of Sciences’ 
National Research Council (NRC), entitled Environmental Effects of 
Transgenic Plants:  The Scope and Adequacy of Regulation (NRC, 2002), 
suggested that USDA should clarify the scope of its coverage.  In NRC’s 
opinion, some GE plants not automatically meeting the regulatory 
definition of a plant pest “lead to instances where public health or 
environmental issues might not be adequately addressed.”  The NRC also 
argued that USDA should regulate all transgenic plants, as there is no 
scientific basis on which to forecast which ones might pose a risk. 
 
Recently, new types of traits have been engineered, such as GE plants that 
produce proteins and other substances for use in pharmaceutical or 
industrial products.  These types of traits would not be likely to confer a 
plant-pest risk to the plants but may pose other types of risks (e.g., health 
risks to humans) or environmental risks (e.g., toxicity to animals) that may 
not involve injury to plants or plant products.  APHIS does not currently 
regulate GE plants or other organisms on the basis of their potential to 
pose these types of risks. 
 
Therefore, APHIS is exploring the use of other authorities, in addition to 
its plant-pest authority, that might be appropriate to regulate GE 
organisms.  Specifically, the PPA authorizes the regulation of “noxious 
weeds,” which are defined as: 
“…any plant or plant product that can directly or indirectly 
injure or cause damage to crops (including nursery stock or 
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plant products), livestock, poultry, or other interests of 
agriculture, irrigation, navigation, the natural resources of 
the United States, the public health, or the environment.   
7 U.S.C. 7702(10).” 
 
Proposing to regulate under the “noxious weed” provisions of the PPA 
would not mean that APHIS has determined that all GE plants are noxious 
weeds.  However, APHIS has reason to believe it is possible for a plant to 
be genetically engineered with genes that might give the plant the 
characteristics of a noxious weed, and APHIS wants the ability to ask not 
only whether a GE organism is a plant pest, but also whether a GE plant 
may be considered a noxious weed. 
 
There are many instances in which the noxious weed authority would 
allow APHIS to assess risks beyond plant pest risks.  Many developers are 
combining multiple GE traits in a single plant variety, and these gene 
combinations may have noxious weed effects but no plant pest effects.  
For example, a plant could be genetically engineered with genes to 
increase its fitness to the point where the plant could become invasive in 
the wild.  This situation could be exacerbated if the plant had weedy wild 
relatives.  Alternatively, a plant could be engineered to produce a 
substance with the potential to be toxic, allergenic, or otherwise 
biologically active in humans, and its unconfined release could pose risks 
to public health.  Some plants engineered to produce pharmaceutical or 
industrial compounds might be examples.  GE plants may also be 
developed with transgenes of unknown function, and it would be 
important for APHIS to be able to look at the broadest range of possible 
impacts resulting from releasing the plant in the environment. 
 
The use of this authority could, therefore, provide APHIS with additional 
information to ascertain whether the introduction of any GE plant intended 
for use in the environment could result in agricultural or environmental 
harm.  Of particular interest is that, using the noxious weed provision, 
APHIS would have authority to consider public health effects of GE 
plants.  This could be used to consider the safety of a new protein or other 
substances both in setting conditions for environmental release and in the 
decision to deregulate.  APHIS might require that questions of food safety 
be addressed before deregulating a GE plant. 
 
One active area of research is in the use of genetic engineering to produce 
and enhance biological control organisms, which are defined in the PPA 
as, “any enemy, antagonist, or competitor used to control a plant pest or 
noxious weed” (7 U.S.C. 7702(2)).  At present, such organisms would be 
regulated as GE organisms by APHIS only if they also fit the plant-pest 
criteria used in the definition of a regulated article.  However there is 
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concern that all genetically engineered biological control organisms 
should be evaluated, using the broader authority in the PPA, until it has 
been determined that they do not pose risks to agriculture and the 
environment.  The rationale is that many biological control organisms 
used to date have themselves been plant pests, or if not, they are used in 
such a way that they interact directly with plant pests or noxious weeds in 
order to exert their intended effect.  Thus, it is appropriate to evaluate 
genetically engineered biological control organisms to ensure that they do 
not pose a direct or indirect plant pest or noxious weed risk.  These 
changes should enhance the agency’s ability to prevent the dissemination 
of plant pests and noxious weeds by expanding the scope to include some 
organisms that might pose such risks, but that are not expressly covered in 
our current regulations. 
 
Event-based Versus Trait-based Regulation 
 
Currently, APHIS regulates GE organisms as “transformation events.”  An 
event is a single successful insertion of a gene or gene fragment into a 
cell’s genetic material or a successful deletion of a gene or gene fragment 
from a cell.  Each event can be genetically unique, even if the event results 
from a single transformation experiment in which many individual cells 
were treated under identical conditions.  Biotechnology techniques allow 
scientists to regenerate entire organisms, such as whole plants, from a 
single cell.  A plant produced from one transformed cell may also be 
called an event.   
 
Typically, APHIS receives field test applications from researchers who 
wish to test a population of genetically identical plants resulting from a 
single transformation event.  Each transformation event is given individual 
consideration by APHIS biotechnologists for introductions authorized 
under notifications and permits and when a petition for determination of 
nonregulated status is received.  This approach is compatible with a 
definition of a regulated article that includes the noxious weed and 
biological control organism provisions as well as potential plant pest risk.  
One alternative is to continue to regulate on an event-by-event basis, but 
to utilize new provisions in the PPA, specifically those for noxious weeds 
and biological control agents as described above. 
 
Although the NRC has stated that an event-by-event approach, that is, 
using genetic transformation alone, is a practical and useful trigger for 
regulation, the NRC has consistently stated that once a GE organism is 
deemed subject to regulation, the focus should be on the assessment of the 
phenotype of the GE organism which results from the genetic engineering 
process (NRC, 1989; NRC, 2000; NRC, 2002).  An alternative approach 
to event-by-event regulation would be a trait-based approach.  GE plants 
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would be regulated based on the engineered genes in the plant (the 
genotype) and the traits resulting from those genes (the phenotype), 
particularly traits that cannot be expressed by an organism through any 
means other than genetic engineering.  Such traits are functionally 
unknown in the organism and may have ecosystem-level effects and 
effects on the fitness of the organism that are also unknown.  This is of 
special concern for organisms that have wild or feral, sexually compatible 
relatives in the environment (Strauss, 2003).  An important difference in 
this approach as compared to APHIS’ current system is that once an 
organism of a particular phenotype was deregulated, plants produced 
subsequently using genetic engineering that have the same transgene and 
phenotype would be considered familiar, and, therefore, they would not 
trigger regulation. 
 
If a trait-based alternative were adopted, APHIS would still need to rely 
on one or more provisions in the PPA, regulating each novel phenotype 
and assessing whether it created the potential for the GE organism to be a 
plant pest or noxious weed.  From a regulatory standpoint, APHIS could 
elect to concentrate its resources on those organisms developed through 
genetic engineering that exhibit novel phenotypes, that is, phenotypes 
unknown within the species or within sexually compatible relatives and 
exclude from regulation those organisms that have a familiar phenotype.  
Questions regarding familiarity are based on available scientific data, such 
as data published in scientific journals, data developed by permit 
applicants, and information collected by the agency itself. 
 
APHIS would then focus on plant phenotypes with which there is little or 
no experience in the plant-breeding, agronomic, or ecological 
communities.  Organisms exhibiting phenotypes not possible to generate 
through any means other than genetic engineering would be considered 
regulated articles.  However, APHIS recognizes that the agency may, over 
time, gain familiarity even with completely novel traits, for example, a 
trait for environmental stress tolerance that enabled the plant to thrive 
outside the normal range of the parent plant or its relatives. 
 
Excluding Certain Organisms Based on Risk 
 
The agency is considering whether organisms should be excluded from 
regulatory oversight after it is demonstrated that they pose no risk or 
which are adequately regulated by another Federal agency.  It has been 
suggested that existing scientific data be used to identify GE organisms 
that require little or no oversight based on the plant–trait combination 
(Hancock, 2003).  The specifics of how the exclusion mechanism would 
work could be either an administrative action, analogous to a deregulation 
under the current system, or a rule-making mechanism that would be 
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followed for all excluded organisms or classes.  If deregulation or some 
synonymous mechanism were to be used as the exclusion mechanism, it 
would be applied to classes of organisms, not individual events. 
 
The agency may wish to use such a mechanism to exclude certain types of 
organisms that APHIS deems safe based on an extensive history of safe 
use (e.g., the nptII gene).  GE organisms that are regulated effectively by 
other agencies (e.g., a GE biological control organism regulated by the 
Environmental Protection Agency (EPA) under the Federal Insecticide,  
Fungicide, and Rodenticide Act (FIFRA)) might be excluded as well. 
 
Another example of a GE organism which might be considered for 
exclusion would be one in which DNA used to develop a GE plant was 
derived from the same species or a sexually compatible species 
(intrageneric).  Highly domesticated plant species with no wild or weedy 
relatives that have been genetically engineered with intrageneric DNA 
would be expected to pose environmental impacts comparable to the same 
plants modified via conventional breeding (Strauss, 2003).  Conventional 
plant breeding is considered to be a safe process with few significant 
environmental impacts, except for a few isolated cases (NRC, 1989; 
2000).  More importantly, agricultural science has experience in managing 
the type of risks that may rarely occur.  For well over 100 years, plants 
have been modified using classical and other breeding techniques for the 
safe development of new varieties that have been evaluated through 
standardized, structured variety trials.  Plant breeders have many 
established protocols for handling and eliminating undesirable phenotypes 
produced as a byproduct of creation of genetic variation, and these 
protocols are applied when any type of plant is used in breeding programs, 
including GE plants.   Therefore, for plants genetically engineered using 
intrageneric DNA, the risks appear no greater than for plants produced via 
conventional breeding, which are not subject to Federal regulation. 
 
A mechanism to exclude certain organisms from regulatory oversight 
could be used in association with any scope of regulation under 
consideration, including the No Action alternative.  The consequence of an 
exclusion is that the excluded item is no longer considered by APHIS to 
be a regulated article.  APHIS envisions that the regulated community 
could apply for an exclusion, or an exclusion could originate within the 
agency itself.  Exclusions would apply to classes of organisms based on 
the engineered trait.  For example, one might exclude all organisms in 
which the only transgene expressed was a particular marker gene.  The 
exclusion decisionmaking process would be fully documented and NEPA-
compliant, and it would include opportunity for public comment. 
 
 
  
   Alternatives Related to Issue 1 
 
1. No Action—continue to regulate GE organisms as potential plant 
pests, and use genetic transformation as the trigger for regulation 
(event-by-event). 
 
2. Expand the scope of what is regulated by adding considerations of 
noxious weed risk and regulating GE biological control organisms in 
addition to evaluating plant pest risks, and use genetic transformation 
as the trigger for regulation.  Continue to regulate event-by-event. 
 
3. Expand the scope of what is regulated by adding considerations of 
noxious weed risk and regulating GE biological control organisms in 
addition to evaluating plant pest risks.  Use novelty of the trait in the 
species as the trigger for regulation.   
 
 In addition, the following alternative could be used in conjunction 
with any of the above to exclude certain organisms based on risk: 
 
4. Exclude specific classes of highly familiar organisms and highly 
domesticated, nonweedy crop plants and, potentially, those regulated 
by another Federal Agency from regulation. 
 
APHIS is considering revisions to the regulations to increase 
transparency and to address advances in technology that may create 
new products and concerns.  Should a new system of risk based 
categories be designed to deal with new products and new concern?  If 
so, what criteria should be used to establish the risk-based categories?  
2. Issue 2 
 
There is public interest in understanding how APHIS regulates various 
types of organisms according to risk and familiarity.  In addition, there is a 
trend toward more highly varied organisms, and the risk assessment 
process may need greater flexibility to handle this variety. The current 
system of notifications and permits needs to be more transparent to the 
public, and developers have a vested interest in knowing how organisms 
that they are developing will be regulated.  In addition, the term 
“notification” has proven somewhat misleading in that it does not clearly 
convey that these introductions are subject to full APHIS oversight:  no 
GE organisms may be imported, moved interstate, or released into the 
environment without active approval from APHIS.  In recognition of the 
issues above, the agency is considering risk-based categories in which GE 
plants are classified according to risk and familiarity so that oversight and 
confinement vary by category.  Redefined categories may provide added 
flexibility to better regulate diverse organisms and new types of traits and 
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provide better clarity to the regulated community and to the public, which 
may in turn promote greater confidence in the system. 
 
APHIS currently uses a two-tiered approach to evaluate the risk of 
introducing GE plants.  Introductions of GE plants that meet specific 
eligibility criteria based on their very low plant-pest potential can be 
authorized using the notification option, while plants that do not meet the 
eligibility criteria and all other types of organisms must use the permit 
option.  The notification option has been an effective regulatory tool: the 
process features a simplified submission format, expedited agency review, 
and reduced regulatory burdens for both applicants and the agency while 
still ensuring safety.  As part of the notification process, APHIS 
biotechnologists review all applications individually; APHIS requires 
effective confinement measures; all field releases are subject to inspection; 
and APHIS can impose severe penalties for noncompliance.  Any new 
system that APHIS considers will incorporate salient aspects of the 
notification system to ensure the continued safe introduction of GE plants. 
 
The types of organisms authorized under permit are highly varied, and the 
risk assessment process needs great flexibility to handle this variety.  
Within the class of organisms that require permits, there are subclasses 
such as micro-organisms, insects, and plants, including pharmaceutical 
and industrial plants, which do not meet the eligibility criteria for 
notification.  Though each of these subclasses uses the same basic 
permitting procedure, reviews and assessment are done on a case-by-case 
basis and mandated permit conditions are unique for each permit.  
Pharmaceutical and industrial plants are subject to additional conditions, 
as detailed in the March 10, 2003, Federal Register notice (APHIS, 2003) 
and other guidance on the APHIS–BRS Web site. 
 
APHIS is considering whether greater clarity will be provided by revising 
existing tiers and creating additional tiers, such that similar organisms 
could be grouped into tiers, thereby allowing for the applications and 
reviews to be structured in the most appropriate way for the organisms in 
that tier type.  The appropriate tier for an organism expressing a transgenic 
trait or group of traits would be determined by various risk factors 
associated with the introduction of a particular GE organism.  Similar to 
current practice, APHIS would consider several factors, including the 
biology of the organism, the nature of the transgenic traits expressed by 
the organism, the degree to which APHIS was familiar with the organism 
and the traits, and the size and duration of the introduction. 
 
In scoping meetings held with stakeholders in January 2004, several 
industry representatives expressed a preference for a case-by-case review 
without tiers.  Their opinion was that this approach was the most firmly 
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grounded in science because no preconceptions or assumptions entered 
into the evaluation.  One example the stakeholders raised is the permitting 
of plants producing pharmaceutical or industrial substances.  Placing a 
particular GE organism into a risk category because it produces a 
substance with pharmaceutical or industrial properties does not take into 
account the nature of the substance itself.  For example, the substance may 
have already passed food-safety assessment by FDA and, therefore, likely 
poses no risks to the human environment.  The stakeholders felt that a 
case-by-case evaluation reduces arbitrary placement into risk categories.  
It is not APHIS’ intent to create risk categories that do not take into 
account the nature of the substance itself or to evaluate organisms based 
on preconceived notions or assumptions that are not grounded in science.  
The intent of creating a tiered system is to create greater predictability and 
transparency for both the regulated community and the public and to 
allocate agency resources effectively.  A pure case by case approach 
would not meet APHIS needs, because it would be more difficult for the 
public and the regulated community to ascertain from the results of each 
determination whether there is a predictable and consistent method for the 
determinations,.  In addition, this system would use more agency 
resources because even GE organisms with which APHIS has a great deal 
of experience would require a full, individualized analysis. 
 
Alternatives 3 and 4, below, propose increasing the number of tiers to 
reflect the diversity of GE organisms that APHIS must evaluate.  The 
difference between alternatives 3 and 4 is that the fourth alternative 
proposes to establish a separate permit type specifically for the regulation 
of nonplant GE organisms, for example, micro-organisms, insects, and 
other animals that can be plant pests.  Tiers would be based on potential 
risks and familiarity with the organisms, and the degree of confinement 
and oversight would vary by tier type.  As under the current system, the 
permit requirements could be tailored, based on APHIS' evaluation of the 
organism.  Familiarity is important because unfamiliar organisms may 
pose risks that the agency does not currently recognize and with which the 
agency may have little mitigation experience.   
 
Although APHIS currently sees very few permit applications for nonplant 
GE organisms, the agency recognizes that, based on advances described in 
the scientific literature, applications for the introduction of nonplant GE 
organisms may begin to increase.  Increased numbers of applications and 
agency experience gained with nonplant GE organisms may, at some 
point, justify the creation of dedicated risk-assessment tiers for these 
organisms.  Alternative 3 would require creation of tiers for plants and 
nonplant organisms alike in the revised rules, whereas alternative 4 allows 
for creation of tiers for plants while continuing to handle nonplant GE 
organisms on a case-by-case basis for the foreseeable future. 
   Alternatives Related to Issue 2 
 
1. No Action—continue to use a two-tiered system (notifications and 
permits). 
 
2. Abolish categories and treat all future proposals for the introduction of 
GE organisms on a case-by-case basis. 
 
3. Establish a tiered permitting system for all organisms based on newly 
devised criteria. 
 
4. Establish a tiered permitting system for plants based on newly devised 
criteria and evaluate permit applications for introductions of nonplant 
organisms on a case-by-case basis. 
 
APHIS is considering ways to provide regulatory flexibility for future 
decisions by accommodating commercialization of certain genetically 
engineered organisms while continuing, in some cases, to regulate the 
organisms based on minor unresolved risks. Other regulated articles 
could be treated as they have been under the current system, in which 
all regulatory restrictions are removed.  What environmental factors 
should be considered in distinguishing between these kinds of 
decisions? 
3. Issue 3 
 
Once an article has been deregulated, APHIS cannot place any restrictions 
or requirements on its use, short of re-regulating the article.  Restrictions 
and requirements have not been deemed necessary in the past because 
BRS risk assessments have concluded that the GE plants APHIS has 
deregulated pose no greater risks than conventionally bred plants.  
However, APHIS recognizes that future development and 
commercialization of plants with less familiar traits may pose new 
challenges for the agency because even a thorough assessment may not 
resolve all unknowns regarding an article proposed for deregulation.  
These unknowns may justify continued scrutiny and data collection or use 
restrictions, even while allowing planting of the article without a permit.  
Therefore, APHIS is exploring a system that could give increased 
flexibility for handling special cases involving less familiar traits by 
creating provisions that allow for imposition of conditions for unconfined 
release.  This could facilitate commercialization, while requiring 
appropriate restrictions or monitoring. 
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Under the current system, APHIS has not placed any restrictions or 
requirements on the use of a GE organism that has been fully deregulated 
because a GE organism is not fully deregulated until a thorough review 
concludes that it poses no plant-pest risks. 
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In evaluating the data submitted by the applicant, the agency considers the 
biology of the plant, potential interactions between the plant and the 
environment, and the nature of the inserted gene.  Key biological features 
of the plant that are considered are whether it is an annual or perennial 
plant, whether it has sexually compatible relatives in the United States, 
whether the plant exhibits weedy characteristics, and how the plant is 
pollinated.  The nature of the inserted gene is also considered.  Some data 
requirements may relate specifically to the function of the gene.  Other 
data requirements are more general and are aimed at determining whether 
the engineered crop has unanticipated characteristics that would render it 
phenotypically different than the non-engineered counterpart. 
 
APHIS has deregulated more than 70 organisms representing 12 plant 
species.  Although not every one of these organisms is being grown 
commercially, many of them have been adopted by farmers both in the 
United States and elsewhere (ISAAA, 2006).  In spite of widespread 
cultivation of GE crops, there have been no reports of deregulated GE 
plants causing harm to agriculture or the human environment. 
 
Most of the deregulated plants exhibit one of two traits—herbicide 
tolerance or insect resistance—and APHIS has extensive experience 
evaluating the agronomic and environmental impacts of these traits.  
APHIS has deregulated plants with other traits, such as viral disease 
resistance and altered fruit quality, and there most likely will be an 
increase in the types of trait–plant combinations proposed for 
deregulation. 
 
The development of plants with less familiar traits may pose new 
challenges, and a thorough assessment may not resolve all unknowns 
regarding an article proposed for deregulation.  These unknowns may 
justify continued scrutiny and data collection or restrictions on use.  
Therefore, APHIS is exploring partial deregulation to increase its ability to 
address risks by applying appropriate restrictions or monitoring 
requirements while accommodating commercialization. 
 
Although APHIS has not approved the partial deregulation of any 
regulated article to date, a system in which partial oversight could be 
retained would allow the commercial production of a regulated article with 
appropriate restrictions or requirements.  For example, an applicant may 
have geographically limited field-performance data for a crop intended for 
nationwide release.  The placing of restrictions on the crop could enable 
the commercial sale and growth of the crop in regions where its 
performance is well documented but require that additional data be 
collected in specific geographic regions.  This partial oversight might be 
accomplished under the current regulations by choosing to deregulate  
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in part or through some new regulatory mechanism designed specifically 
to deliver such flexibility.  Another example where restrictions might be 
used to address a minor risk includes plants engineered for environmental 
remediation of heavy metals.  Because of the potential environmental 
benefit, deregulation might be desirable; however, complete deregulation 
would be inappropriate due to the need to ensure proper disposal of plant 
material after remediation had occurred. 
 
Currently, all deregulated GE plants can be used in breeding programs 
without regulatory restrictions.  This is consistent with the findings that 
they pose no plant pest risks.  Thus, if two deregulated plant lines with 
different traits are bred together or “stacked,” the new line with the two 
traits combined is not regulated.  Implementing a mechanism for partial 
deregulation might also give the agency a useful additional mechanism to 
place restrictions on certain stacked traits.  While this has not been 
deemed necessary for the plant–trait combinations that have been 
deregulated to date, it might be a mechanism that could be deployed in the 
future for less familiar traits. 
 
APHIS would use this mechanism only if there was a reason to believe 
there would be an interaction with certain other genes or traits that could 
result in environmental harm.  In these cases, if a developer wanted to 
cross a partially deregulated plant with another variety that was not 
allowed under the terms of the deregulation, the developer might have to 
treat the offspring of the cross as a regulated article and additional review 
would be required before the new variety could be approved for 
unconfined release.  This approach would allow APHIS to mitigate any 
additional potential environmental effects that might arise as a result of 
stacking of particular types of genes in certain plant species. 
 
The proposed alternative would retain the option for full removal of 
agency oversight (currently obtained through deregulation), but also allow 
for a new option that allowed for a continued level of oversight as 
necessary to mitigate minor risks.  The alternative would also allow the 
agency to conditionally approve petitions if to do so would mitigate any 
adverse environmental impacts that may result from the use of the article. 
 
   Alternatives Related to Issue 3 
 
1. No Action—continue with a system granting full nonregulated status 
to crops that removes them from all regulatory obligations under 
7 CFR part 340. 
 
2. Continue to allow for the option of granting full nonregulated status 
and develop appropriate criteria and procedures through which crops 
  
can be removed from permitting but some degree of agency oversight 
as necessary to mitigate any minor risks is retained. 
 
Are there changes that should be considered relative to environmental 
review of, and permit conditions for, genetically engineered plants 
that produce pharmaceutical and industrial compounds?  
4. Issue 4 
 
Genetic engineering technology has advanced to the point where 
organisms can be developed that produce novel proteins and other 
substances with biological activity or industrial utility.  The gene products 
made by pharmaceutical and industrial plants may have biological activity 
or may pose other hazards not associated with proteins and other 
substances commonly found in the food supply.  APHIS will examine this 
issue in the DEIS, taking into account the current rigorous permit 
conditions, multiple annual inspections required for these plants, and the 
nature of the compounds produced by these plants.  In practice, any 
changes in the confinement of plants producing pharmaceutical and 
industrial compounds would not apply solely to those plants, but to a risk 
tier that might include those plants. 
 
Currently APHIS permit conditions prescribe various measures, used in 
combination, to create a confined field release.  These measures can 
include: 
 
• Geographic isolation of the field test from other growing crops, 
• Temporal (time of planting) separation of the field test from plants 
of the same species to prevent simultaneous availability of viable 
transgenic pollen and receptive flowers outside the test plot, 
• Physical barriers to gene flow (e.g., bagging flowers),  
• Biological barriers to gene flow (e.g., male sterility), and 
• Requirement for dedicated planters and harvesters and APHIS-
approved cleaning protocols for other equipment 
 
The measures are crop-specific and are determined by plant biology 
factors, such as whether the plant is an annual or perennial, whether it has 
sexually compatible relatives in the United States, whether the plant 
exhibits weedy characteristics, and how the plant is pollinated.  In addition 
to the stringent permit conditions, multiple annual inspections ensure 
compliance.   
 
For example, if corn is used to produce a pharmaceutical substance and an 
applicant wishes to perform a field test of this plant, no other corn may be 
grown within 1 mile of the field-test site (68 FR 11337).  This distance is 
eight times the distance required in the production of foundation corn 
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seed.  In APHIS’ experience, plants expressing pharmaceutical or 
industrial traits are no more likely to escape from field tests or persist in 
the environment than plants expressing other traits.  However, it has been 
suggested that plants engineered to produce substances not intended for 
food use, as handled under APHIS’ current regulatory system, pose 
unacceptable risks to human health, the environment, and to trade. 
 
Several alternatives to address this issue are under consideration.  
Alternative 2 is a variation on the No Action alternative in which GE 
plants producing proteins or other substances whose safety has not been 
addressed would have much more restrictive requirements for outdoor 
testing, but would not be banned from consideration for outdoor testing.  
Alternative 3 is the most restrictive approach to GE plants producing 
pharmaceutical or industrial substances, namely that no such plants would 
be considered for outdoor testing.  The only way these plants could be 
grown would be under contained conditions, for example, in enclosed 
growth chambers or other facilities such as abandoned mines, so that 
environmental releases are highly unlikely.  A corollary of this approach, 
Alternative 4, is that no plants producing pharmaceutical or industrial 
substances may be released into the environment if that plant species is 
used for food or feed purposes.  Nonfood or nonfeed plants expressing 
pharmaceutical or industrial traits could be field tested under an APHIS 
permit but with stringent conditions. 
 
In Alternative 5, field tests of nonfood or nonfeed plants would be allowed 
under APHIS permit, and field tests of food or feed crops would also be 
allowed if the food safety issues have been addressed.  This review would 
guarantee that, should the confinement measures used with an APHIS-
permitted field test fail, any escape of the plant from the test site would 
not result in any significant harm to humans or the environment. 
 
   Alternatives Related to Issue 4 
 
1. No Action—continue to allow food and feed crops to be used for the 
production of pharmaceutical and industrial compounds and to allow 
field testing under very stringent conditions. 
 
2. Continue to allow food and feed crops to be used for the production of 
pharmaceutical and industrial compounds.  The agency would impose 
confinement requirements, as appropriate, based on the risk posed by 
the organism and would consider food safety in setting conditions. 
 
3. Do not allow crops producing substances not intended for food uses to 
be field tested, that is, these crops could be grown only in contained 
facilities. 
  
4. Allow field testing only if the crop has no food or feed uses. 
 
5. Allow field testing of food/feed crops producing substances not 
intended for food uses only if food safety has been addressed. 
 
The definition of noxious weed in the PPA includes not only plants, 
but also plant products.  Based on that authority, APHIS is 
considering the regulation of nonviable plant material.  Is the 
regulation of nonviable material appropriate and, if so, in what cases 
should we regulate? 
5. Issue 5 
 
In some special cases, certain nonviable material originating from a field 
test (e.g., cell debris, leaves, stems, roots, or seeds) may pose unique types 
of environmental or human health risks. Currently, APHIS regulates 
organisms that pose a plant pest risk and does not regulate nonliving 
material derived from GE organisms. By definition, plant pests are living 
organisms.  However, the noxious weed definition provides authority to 
regulate nonviable plant products that could “injure or cause damage to 
crops.”  Because there may be cases in which potential risks could justify 
the regulation of nonviable material, APHIS is considering whether it 
should regulate nonviable material in those cases.  
 
The agency considers non-living material generally not to be a significant 
risk to the environment because non-living material cannot result in the 
dissemination or persistence of GE organisms.  Most, if not all, field tests 
of GE organisms conducted under an APHIS permit result in nonviable 
material being produced in the form of nonpropagable GE material (e.g., 
cell debris, leaves, stems, or roots) in addition to the desired product (e.g., 
seeds).  The desired product is removed by the researcher, and byproducts 
are disposed of according to the terms of the permit, which may include 
such methods as autoclaving, placing in a landfill, burying, plowing into 
the soil, or burning.  The purpose of these processes is to ensure that any 
residual propagable material is destroyed so that it cannot escape into the 
environment at large.  The current regulations focus on the destruction of 
viable propagules as these items have the potential to produce a new 
generation of the organism. 
 
The noxious weed definition in the PPA includes plants as well as plant 
products thus providing an opportunity for APHIS to expand its regulatory 
scope. This does not mean that APHIS has determined that all GE plants 
are noxious weeds, but this would allow the agency to ascertain if the 
nonviable material could pose agricultural or environmental harm.  
Therefore, APHIS is considering whether it might be advantageous (e.g., 
in cases where permit conditions had been violated or when the nonviable 
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material was determined to be toxic) to regulate nonviable material that 
might pose an environmental risk. 
 
   Alternatives Related to Issue 5 
 
1. No Action—do not regulate nonviable GE material. 
 
2. Regulate nonviable GE plant material in certain circumstances, based 
on the risks posed. 
 
3. Regulate all nonviable GE plant material. 
 
6. Issue 6 APHIS is considering establishing a new mechanism involving 
APHIS, the States, and the producer for commercial production of 
plants not intended for food or feed in cases where the producer 
would prefer to develop and extract pharmaceutical and industrial 
compounds under confinement conditions with governmental 
oversight, rather than grant nonregulated status.  What should be the 
characteristics of this mechanism? 
 
For organisms that cannot meet the criteria for deregulation, APHIS is 
considering whether a new type of permitting system would be more 
appropriate in terms of efficiency and effectiveness than the current 
system.  In addition, there is much public and State interest in these types 
of plantings and a new mechanism may increase transparency and allow 
for greater State involvement. 
 
Currently, GE plants producing pharmaceutical or industrial compounds 
or expressing other traits not intended for food/feed uses have not been 
deregulated.  APHIS anticipates that field tests for these plants would 
likely be conducted annually, in the same location, and under the same 
permit conditions each year; however, APHIS’ regulations require a full 
permit application for these plants year after year and repeatedly 
reviewing identical annual applications would be very inefficient.  A new 
type of permitting process could continue to ensure safety but increase the 
efficiency of issuing annual permits for repeating field tests.  This 
mechanism might also apply to other types of GE organisms or 
appropriate activities, such as repetitive research. 
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Due to the value of the pharmaceutical or industrial substances 
synthesized by these plants, after the plants are harvested under APHIS-
approved permit conditions; the valuable substance may be extracted from 
the plant material, and the substance may be sold commercially.  It is 
possible and even likely, that many of these substances do not pose a 
human-health risk in food and also that they do not pose a risk to 
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agriculture or the environment. However, some of these substances may 
be allergenic, toxic, or otherwise biologically active in humans and APHIS 
requires extraordinary safeguards to ensure that they are not found in 
commodity food or feed channels. 
 
Alternative 2 would create a new permitting process, which begins with 
the submission of a full permit application for the first annual cycle of the 
field tests.  This application would receive full APHIS review, permit 
conditions and confinement measures would be prescribed, and, if all 
regulatory requirements are met, the permit would be issued.  For 
subsequent years, the applicant would submit a multiyear plan that 
integrates all standard operating procedures (SOPs) and all management 
practices designed to confine the planting and minimize its potential to 
cause environmental impacts.  After APHIS review and approval of the 
management plan, the applicant would be issued a multiyear permit 
designed specifically to address the needs and issues surrounding 
production.  APHIS would also consider measures such as Quality 
Control/Quality Assurance procedures, ISO quality management 
standards, and other technical standards, if appropriate.  The applicant 
would be required to conduct the field release in all subsequent years 
exactly as prescribed in the permit.  APHIS would monitor SOPs for 
repetitive activities.  Any changes to the original permit application or 
approved SOPs would have to be submitted to APHIS for approval prior 
to implementation.  These fields would still be subject to inspection.  Also, 
APHIS would rely on additional auditing to ensure compliance with all 
conditions and to ensure activities are conducted according to approved 
SOPs. 
 
   Alternatives Related to Issue 6 
 
1. No Action—continue to authorize field tests of crops not intended for 
food or feed use under permit.  Require application and review of 
these permits on an annual basis. 
 
2. Allow for special multi-year permits, with ongoing oversight.  The 
new system would maintain these crops under regulation, but APHIS 
oversight would be exercised in a different manner than under the 
current system of permits. 
 
 
 
 
 
 
The current regulations have no provision for the low-level presence 
of regulated articles in commercial crops, food, feed, or seed of GE 
plant material that has not completed the required regulatory 
processes.11  Should low-level occurrence of a regulated article be 
exempted from regulation? 
7. Issue 7 
 
As with traditional plant breeding, large scale annual field testing of GE 
plants that have not completed all applicable reviews may result in 
materials from these trials occasionally being detected at low levels in 
commercial commodities and seeds.  Current regulations do not expressly 
allow for any such occurrence, though experience continues to show that 
such occurrences can occur.  In a 2002 Office of Science and Technology 
Policy (OSTP) notice,12 APHIS committed to conducting a risk-based 
regulatory program that minimizes the occurrence of these materials and 
includes safety criteria under which these materials would be allowed at 
low levels in commercial commodities and seeds. 
 
Adventitious presence in the NOI referred to low levels of biotechnology-
derived genes and gene products occurring in commerce that have not 
gone through all applicable regulatory reviews.  However, APHIS realizes 
that this term means different things to various interests around the world; 
hence, its use elsewhere in the main body of the EIS will be avoided.  
Many groups, including some importers of U.S. agricultural products, use 
the term to refer to the presence of any biotechnology-derived products 
when found in a product that is intended to be free of such materials, even 
when the biotechnology-derived products completed deregulation by 
APHIS and all other applicable reviews.  Once the materials have 
completed all applicable reviews, they are considered as safe as other non-
GE varieties and, as such, are not regulated. Thus, APHIS views the 
presence of deregulated materials as a marketing issue outside of its 
authority. 
 
In practice, APHIS has considered these situations on a case-by-case basis 
and believes there are situations in which occurrence of regulated material 
at low level should be non-actionable, meaning that commodities or seeds 
with the low levels of the regulated articles could be moved and otherwise 
introduced without a need for permits or notifications.  These 
determinations are based on safety and might be made in cases where the 
material is similar to a deregulated GE organism and APHIS determines 
that the presence of the regulated material does not pose a plant pest risk.  
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11 In the NOI, the term adventitious presence was used to refer to the “intermittent low levels of 
biotechnology-derived genes and gene products occurring in commerce that have not gone through 
all applicable regulatory reviews.”  However, APHIS realizes that this term means different things to 
various interests around the world; hence, we will avoid its use elsewhere in the main body of the 
EIS.   
12  67 FR 50577 
  
 
II.  Proposed Program Alternatives 37 
In other instances, in which the regulated material is very different from 
any deregulated GE organisms and there may be a potential plant pest risk, 
APHIS has determined that any amount would be considered actionable 
and the agency would act as necessary under the regulations to prevent 
dissemination of the regulated material.  In all cases, APHIS completes a 
risk assessment to determine the agency response.  It is important to note 
that under the current system and any proposed revision to the system, the 
developer is still responsible for complying with regulations.  Thus, the 
material might be safe and non-actionable, but the developer might still be 
found to be in violation and subject to penalties.  On March 29, 2007, 
APHIS published its Policy on Responding to the Low-level Presence of 
Regulated Genetically Engineered Plant Materials in the Federal Register 
(72 FR 14649). 
 
APHIS and the U.S. government have been aware for some time that the 
occasional detection of regulated material in commercial crop seeds is a 
potential outcome of field tests conducted under experimental protocols 
generally used for notifications.  This is due to cross pollination and also 
commingling from shared equipment and facilities.  In the majority of 
cases, this low level occurrence will be of minimal risk, and this should be 
accounted for in any regulatory scheme since oversight should be 
commensurate with risk.  In addition, new incidents will inevitably result 
from the importation of seeds and commodities from countries where such 
material has been fully approved but has not completed all U.S. reviews. 
 
There have been several incidents where regulated articles have been 
detected in commodities or seeds.  In one of the first, the agency became 
aware that there were low levels (<1 percent) of plant varieties that had 
not been deregulated in the United States in imported seeds.  These 
varieties were evaluated by FDA to determine that there were no food-
safety issues.  The seeds were genetically engineered to be herbicide 
tolerant, and the imported varieties were very similar to a variety that had 
been deregulated in the United States.  The developer filed extension 
requests (7 CFR § 340.6(e)) that, if granted by APHIS, would result in 
nonregulated status being extended from a previous deregulation to cover 
the imported varieties as well.  While intended to be an expedited review, 
the required data package and established review practices are such that 
extension requests can be similar in terms of regulatory burden to regular 
petitions for nonregulated status.  The extension requests for the crop were 
granted, but it became apparent that it would be advantageous to have a 
policy for dealing with low-level presence of regulated articles that met 
certain safety criteria. 
 
In another case, a company found that some of their breeding lines being 
used for production of commercial seed were, in fact, a different line that 
 
38 II.  Proposed Program Alternatives 
                            
had not been deregulated.  However, as with the previous example, the 
line that had not been deregulated was very similar to a line that had 
already been deregulated.  All expressed proteins were identical.  In this 
case, USDA quarantined the seeds and EPA issued a “Stop Sale Order” to 
halt commercial sales of seed for planting and restrict seed movement 
except for specifically identified regulatory needs or destruction.  USDA, 
in conjunction with EPA, undertook an extensive investigation into the 
unauthorized movement, release, and sales of the corn seeds for planting.  
The company was required to remove all seeds from the commercial sales 
channel, and APHIS provided regulatory oversight for the destruction of 
the remaining stocks.  Based on its own safety assessment, which 
concluded that there were no safety issues, APHIS decided that it would 
not attempt to remove any low levels of this variety that might exist in 
commodities. 
 
In yet another case, a small number of volunteer plants from a previous 
field test were harvested with a subsequent crop resulting in a very small 
amount of regulated debris in the harvested crop.  In this case, APHIS 
considered this debris as unacceptable because of the nature of the protein 
involved.  Accordingly, the agency took action to ensure that the crop was 
quarantined and subsequently destroyed. 
 
APHIS recognizes the need for a clear regulatory approach to address the 
science issues described above, and many stakeholders have advocated 
that establishing this policy should be a very high priority for APHIS.13  
These stakeholders include industry associations, crop associations, and 
commodity trade organizations.  Also, in August 2002, the Office of 
Science and Technology Policy initiated the coordination of a 
Government-wide approach involving the establishment of early food-
safety assessments at EPA and FDA, and the revision of APHIS’ field 
testing program. 
 
APHIS has already made some important changes.  Permit requirements 
for the field testing of plants with genes producing pharmaceutical 
compounds have been strengthened significantly, as announced in the 
March 10, 2003, Federal Register notice (APHIS 2003).  Plants with 
genes producing industrial compounds are now subject to the permitting 
system as described in the August 6, 2003, interim rule (finalized on 
May 4, 2005), whereas, some of these plants previously qualified for field 
testing under notification.  Pharmaceutical and industrial plants are 
confined with such stringency that their testing and production is not 
expected to result in detection in commercial products. 
                                         
13  On March 30, 2007, APHIS published its “Policy on Responding to the Low-Level Presence of 
Regulated Genetically Engineered Plant Materials (http://www.aphis.usda.gov/brs/ 
fedregister/RBS_20070330a.pdf). 
  
APHIS would generally consider any presence of materials engineered for 
pharmaceutical or industrial uses as actionable, but changes might be 
possible under the new regulations for specific organisms such that they 
could be reclassified based on safety.  Thus, if the regulated gene products 
have been reviewed for food safety and meet the criteria that APHIS 
establishes in the revised regulations, presence of the material may not be 
cause for agency action.  The safety criteria that APHIS establishes will be 
applied to any such occurrence of a regulated article, regardless of whether 
it occurs in commodities or seeds that are domestic or imported.  The goal 
of revising APHIS regulations on this issue is to create a uniform policy 
for regulated gene products so that public, foreign, and domestic 
stakeholders can be assured of the safety of any gene product that occurs 
at low levels in commercial commodities and seeds.   
 
   Alternatives Related to Issue 7 
 
1. No Action—allow field testing to continue using current confinement 
strategies to reduce the likelihood of regulated articles occurring in 
commercial commodities or seeds. 
 
2. Establish criteria under which occurrence of regulated articles would 
be allowable, that is, considered not-actionable by APHIS.  Do not 
allow field testing of crops that do not meet all of criteria, including 
addressing food safety issues if applicable (i.e., if the GE plant is a 
food crop). 
 
3. Establish criteria under which occurrence of regulated articles would 
be allowable, that is, considered not-actionable by APHIS.  Allow 
field testing and impose confinement strategies based on whether a 
plant meets the criteria. 
 
4. Impose a very strict confinement regime on all field tests, as is 
currently done for pharmaceutical and industrial crops that would 
further reduce the likelihood of regulated articles occurring in 
commercial commodities or seeds. 
 
Should APHIS provide expedited review or exemption from review 
for certain low-risk, imported GE commodities intended for food, 
feed, or processing that have received all necessary regulatory 
approvals in their country-of-origin and are not intended for 
propagation in the United States? 
8. Issue 8 
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APHIS anticipates an increasing number of requests to import regulated 
GE organisms that are not intended for propagation, such as organisms 
that are intended for direct use as food, feed, or for processing.  The 
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current regulatory system was designed to handle such requests using 
permits and notifications.  However, in anticipation of this increase, 
APHIS’ goal is to design an efficient system that protects U.S. agriculture 
and human health without erecting unnecessary trade barriers.  To that 
end, the agency has evaluated several different alternatives.   
 
APHIS recognizes the need to reevaluate requirements for imported 
commodity shipments containing GE plant products that are intended for 
food, feed, or other uses and not intended for propagation.  APHIS 
requires an importation permit for GE plants for food, feed, or for 
processing, such as canola for processing into oil and feed, or fresh fruits 
and vegetables for direct consumption if they have not been deregulated.  
However, because these materials will be used only for nonpropagative 
purposes, they can be presumed to pose less risk to agriculture than an 
equivalent crop intended for large-scale planting due to the reduced 
magnitude of environmental exposure.  On rare occasions, APHIS has 
allowed certain materials to be imported, on a case-by-case basis, for 
nonpropagative purposes if the agency is familiar with the plant-trait 
combination, and determines that the intended use poses a low risk of 
environmental harm and environmental persistence. 
 
In reevaluating its regulations, APHIS recognizes that in many cases it 
may not be necessary to perform full environmental risk assessments for 
GE plants imported for nonpropagative uses to ensure environmental 
safety, recognizing that other safety issues may also be subject to EPA and 
FDA oversight.  Because these materials are not intended for field testing, 
it is an inefficient use of APHIS resources to subject them to the same 
scrutiny given materials proposed for full deregulation.  An appropriate 
risk assessment could be based on APHIS’ familiarity with the GE trait, 
the biology of the plant, its intended use, proposed containment measures, 
and any environmental review data generated by the exporting country’s 
regulatory body. 
 
In addition to domestic environmental concerns, APHIS recognizes that 
regulations on imported commodities have international implications.  For 
example, the Cartagena Protocol on Biosafety (CPB) 
(http://www.biodiv.org/biosafety/default.asp) is an international treaty that 
provides a framework for the safe transboundary movement of living 
genetically modified organisms (LMOs) with the goal of protecting 
biodiversity.  While the United States is not a party, U.S. exporters need to 
comply with regulations implemented by importing parties in accordance 
with the CPB.  Currently, distinctions are made within the CPB between 
the importation of LMOs intended for intentional introduction into the 
environment and LMOs imported only for food, feed, or for processing 
(LMOFFPs), and the Protocol describes a separate, less burdensome 
  
procedure governing the importation of LMOFFPs.  The different 
procedures set out under the CPB reflect the understanding that these 
imports will generally pose a substantially lower potential risk to the 
environment or to biodiversity than LMOs intended for field testing.   
 
APHIS needs to consider how its regulatory changes might coordinate or 
conflict with existing international agreements related to agriculture, food, 
or trade.  At the same time, APHIS needs to continue to provide leadership 
for countries in the early stages of developing their own regulations. 
 
   Alternatives Related to Issue 8 
 
1. No Action—continue to evaluate commodity importation requests on a 
case-by-case basis. 
 
2. Establish criteria that will be applied to determine the appropriate level 
of risk assessment for imported GE commodities.  This alternative 
could include a decision to exempt certain organisms or to allow 
importation under conditions that minimize environmental release. 
 
3. Disallow importation of any commodity pending full APHIS approval 
for deregulation. 
 
4. Accept any importation of a product from a foreign country that has 
evaluated the safety of the product and approved it for unconfined 
environmental release. 
 
5. Accept any importation of a product from a foreign country that has 
evaluated the safety of the product and approved it for unconfined 
environmental release using a review process equivalent to APHIS’. 
 
Currently, genetically engineered Arabidopsis spp. are exempt from 
interstate movement restrictions under 7 CFR 340.2 because they are 
well understood and extensively used in research.  Should the 
movement of genetically engineered Arabidopsis spp. or other GE 
organisms be exempted from movement restriction? 
9. Issue 9 
 
Currently, genetically engineered Arabidopsis spp. and a few other 
organisms are exempt from interstate movement restrictions under  
7 CFR 340.2 because they are well understood and extensively used in 
research.  The agency is considering whether to expand the current 
exemption from interstate movement restrictions to other well-studied, 
low-risk, GE research organisms.  Such a change would create a 
consistent, risk based approach to organisms with similar risk profiles. 
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The 2002 NRC report entitled Environmental Effects of Transgenic 
Plants:  The Scope and Adequacy of Regulation (NRC, 2002) cited the 
need to focus regulatory oversight on GE plants that pose the highest risk 
while not placing unnecessary burdens on those posing low risk.  APHIS 
recognizes that it is important to find ways to reduce regulatory costs and 
burdens when risk is low.  One approach is to expand the provision for 
unregulated interstate movement of certain well-studied research 
organisms that present little, or no environmental risk.  Such an action 
would be based on risk and available scientific data.  This expansion could 
offer substantial regulatory relief to small startup companies, public 
institutions, and academic researchers, whose resources are often strained 
to comply with regulations for GE organisms. 
 
   Alternatives Related to Issue 9 
 
1. No Action—Require interstate movement authorizations for all 
organisms on the list in 7 CFR § 340.2(b). 
 
2. Exempt a class of GE plants or organisms that are well-studied and 
present little or no environmental risk from permit requirements for 
interstate movement as is currently done for Arabidopsis. 
 
3. Create a process to apply for an interstate movement exemption for a 
particular species. 
 
What environmental considerations should be evaluated if APHIS 
were to move from prescriptive container requirements for shipment 
of GE organisms to performance-based container requirements, 
supplemented with guidance on ways to meet the performance 
standards? 
10. Issue 10 
 
APHIS regulations prescribe the use of several types of packaging to 
prevent the escape, dissemination, and environmental persistence of GE 
organisms.  However, based on APHIS’ experience there are other types 
of containers that can be used to safely move GE organisms.  APHIS often 
grants applicants a variance to use a different container to transport a GE 
organism in a way other than prescribed by the regulations but reviewing 
these requests takes agency resources.  APHIS is considering alternatives 
that will reduce the need for variances but still facilitate the safe 
movement of GE organisms. 
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Alternative 2, below, proposes to replace the current list of prescribed 
transport containers with performance standards for all containers used to 
move regulated articles.  In other words, rather than describe in the 
regulations how containers must be constructed, APHIS would specify 
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what the containers must do and how they must perform, namely they 
must prevent spillage, leakage, escape, and other environmental releases 
of regulated articles.  Having performance standards for transport 
containers would obviate the need for variances and would therefore 
reduce the burden on applicants as well as increase the efficient use of 
APHIS resources.  The regulated community would be responsible for the 
design of appropriate containers that will prevent environmental releases.  
Each applicant would certify that the proposed transport containers will 
meet APHIS performance standards.  The use of containers that fail to 
meet those standards will result in an APHIS enforcement action. 
 
Alternative 3 proposes to add new APHIS approved containers to the 
current list in the regulations, thus reducing the number of variance 
requests that must be processed and reducing the regulatory burden on 
applicants.  These new container types could reflect the specialized needs 
of applicants who would in the past have been forced to ask for a variance. 
 
   Alternatives Related to Issue 10 
 
1. No Action—retain current list of approved containers and issue 
variances when necessary. 
 
2. Switch to performance-based standards for all transport containers. 
 
3. Expand current list of approved containers and issue variances when 
necessary. 
 
C. Alternatives Rejected From Further Consideration 
 
APHIS assembled a comprehensive list of regulatory alternatives and 
alternatives that might be implemented in the regulatory revision process.  
The original list of alternatives was intended to be inclusive rather than 
selective, so initially APHIS considered all ideas.  The agency individually 
evaluated each alternative on the basis of legality, environmental safety, 
efficacy, and practicality to identify which alternatives would be further 
considered during rulemaking.  Based on this evaluation, APHIS rejected 
several alternatives.  In the interest of transparency, these alternatives are 
discussed briefly below along with the specific reasons for rejecting each. 
 
One regulatory alternative that APHIS considered but rejected was not to 
regulate GE organisms at all.  FDA and EPA would continue to examine 
the impacts of the subset of GE organisms over which they have authority, 
but APHIS would no longer consider the risks to U.S. agriculture posed by 
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the release of GE organisms.  APHIS is forced to reject this alternative as 
unreasonable due to a clear Congressional mandate as stated in the PPA— 
 
“…the unregulated movement of plant pests, noxious 
weeds, plants, certain biological control organisms, plant 
products, and articles capable of harboring plant pests or 
noxious weeds could present an unacceptable risk of 
introducing or spreading plant pests or noxious weeds…  
§ 402(7).” 
 
Without APHIS oversight, GE organisms with the capability of becoming 
plant pests or noxious weeds could be released, thus causing an 
“unacceptable risk” to the practice of agriculture in the United States.  
Allowing such risks would be a clear dereliction of APHIS’ 
congressionally designated duty.  The proposed wholesale deregulation of 
all GE organisms must, therefore, be rejected. 
 
The opposite alternative, which APHIS considered but also rejected, was 
that the release of all GE organisms be forbidden.  APHIS determined that 
this alternative is unreasonable.  GE corn, soybeans, and cotton plants that 
have completed the deregulation process are planted on more than 
100 million acres in the United States.  GE crops are grown on more than 
200 million acres worldwide.  A ban of all GE organisms would 
necessitate a complete restructuring of American agriculture as well as the 
seed industry and cause profound disruption of international trade in 
agricultural commodities.  These crops are regarded as safe based on 
experience and the potential benefits that they bring to agriculture would 
not be realized if there was a complete ban.  Lastly, such a ban would 
contravene clear congressional directives in the PPA.  The Secretary of 
Agriculture is directed, through APHIS, to facilitate— 
 
“… the smooth movement of enterable plants, plant 
products, biological control organisms, or other articles 
into, out of, or within the United States… (and to facilitate) 
exports, imports, and interstate commerce in agricultural 
products and other commodities that pose a risk of 
harboring plant pests or noxious weeds in ways that will 
reduce, to the extent practicable, as determined by the 
Secretary, the risk of dissemination of plant pests or 
noxious weeds… § 402(3)(5).” 
 
The question as to how to balance this facilitation with the protection of 
U.S. agriculture is unequivocally answered by Congress, which states 
that— 
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“…decisions affecting imports, exports, and interstate 
movement of products regulated under (the Plant Protection 
Act) shall be based on sound science… § 402(4).” 
 
A risk-management process based on sound science must, therefore, 
consider a growing body of scientific evidence documenting the safe use 
of GE organisms in U.S. agriculture, and in the rest of the world, to 
determine whether their use poses any unacceptable risks.  Because 
Congress has mandated a science-based approach in APHIS regulations 
and because there is no basis in science for banning all uses for GE 
organisms, a blanket ban of GE organisms would contravene 
congressional intent and must be rejected. 
 
APHIS rejected two other alternatives because they removed all APHIS 
oversight of important issues, risking serious compromise of 
environmental safety.  The first of these involved the regulation of 
imported GE plants.  It was proposed to allow the exporting country alone 
to determine the safety of GE commodities imported into the 
United States.  APHIS concluded that delegating all authority to the 
exporting country, regardless of that country’s regulatory scheme for GE 
organisms and its ability to implement those regulations, would create an 
unacceptably high risk that an organism with which APHIS was 
unfamiliar could be imported and cause significant environmental damage. 
Similarly, APHIS rejected an alternative to allow permit applicants to 
select any transport container, at their discretion, for the interstate 
movement of GE organisms.  APHIS oversight of transport containers is 
crucial to the safe interstate movement of GE organisms.  This oversight is 
most effective and efficient if exercised early in the movement process, 
when specifying the criteria for transport containers. 
 
Finally, APHIS considered and rejected alternatives for dealing with the 
interstate movement of well-studied, low-risk research organisms because 
they provided incomplete solutions.  APHIS considered two alternatives—
one dealing solely with exemptions for specific GE plants and one dealing 
solely with exemptions for specific micro-organisms.  Either of the 
alternatives could be adopted, but neither dealt with the issue in its 
entirety.  APHIS deemed a provision dealing with both groups of 
organisms more effective. 
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III. Affected Environment 
 
Under the Plant Protection Act, APHIS has been authorized to regulate the 
importation, interstate movement, and environmental release (field testing) 
of GE organisms that are potential plant pests, GE organisms that are 
potential noxious weeds and GE organisms that are biological control 
organisms.  The importation and interstate movement of GE organisms are 
extremely unlikely to affect the environment because the organisms 
remain under containment throughout the process.  The release of GE 
organisms into the environment, under APHIS oversight, may result in 
environmental effects. 
 
It is possible for the APHIS-authorized field testing of a GE organism to 
occur, with appropriate conditions to ensure confinement, in any U.S. 
State, commonwealth, or territory.  Therefore, the geographic extent of the 
affected environment under consideration in this DEIS is the entire 
United States and its territories.  Environmental releases of regulated 
articles will occur in discrete locations known by APHIS, under conditions 
designed to confine the article to the field test site.  If APHIS deregulates a 
GE organism, the organism could be released anywhere in the 
United States because APHIS considers a deregulated GE organism to 
pose no plant pest risks. 
 
This chapter introduces those aspects of the natural and physical 
environment, as well as interrelated socioeconomic factors that may be 
affected by the current regulations administered by APHIS–BRS as well 
as the alternatives as described in this DEIS.  Chapter IV.A further 
discusses and analyzes, in depth, those issues identified by the agency and 
by the public and other stakeholders during scoping, including aspects of 
the environment that have the potential to be significantly affected by 
current or proposed APHIS–BRS program activities.  The following topics 
will be presented in this chapter: 
 
• Plants 
• Insects and animals 
• Agronomic practices 
• Micro-organisms 
• Socioeconomic issues  
 
Plants—Plants engage in numerous physical and biochemical processes 
which affect humans and the environment.  Plants produce food and fiber 
for humans and for animals, both domesticated and wild.  Plants alter the 
atmosphere, removing carbon dioxide from the air and adding oxygen.  
They modulate air and soil temperature and create microenvironments for 
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other organisms.  Plants modify soil structure through root growth and 
stabilize soil, thus reducing erosion, and plants add organic matter to the 
soil which feeds micro-organisms and improves soil quality.  Plants also 
interact with each other by competing for sunlight, water, and soil 
nutrients.  In addition, plant reproduction affects the environment through 
the release of pollen, fruits, and seeds.  Weeds are plants which can 
compete so effectively with crop plants that they may reduce the value of 
the crop.  Plants produce a large variety of chemical substances that may 
affect the local environment or provide economic value to humans.  Like 
classical breeding, genetic engineering can alter the value of a plant to 
humans and may also affect one or more of the physical or biological 
interactions between plants and their environment. 
 
Insects and Animals—Many insects and other animals are intimately 
associated with plants.  These associations can be harmful, as in the case 
of animals that feed on plants, causing injury or even the death of the 
plant, resulting in economic losses.  There are also positive associations—
animals like bees and hummingbirds pollinate plants, and ladybugs eat 
harmful insect pests.  In other cases, the association may be neutral, that 
is, the animal may merely live on or near the plant.  GE traits in plants 
may alter these associations or create new ones. 
 
Agronomic Practices—The vast majority of plants that APHIS has 
permitted for field testing, and ultimately deregulated, have contained GE 
traits, specifically, herbicide tolerance and insect resistance, that directly 
affect agronomic practices, that is, the methods a grower uses to grow the 
crop.  As GE crops continue to be developed, APHIS expects many new 
traits to be expressed such as ones affecting nutritional quality, ones 
enabling environmental stress tolerance, and new traits for disease or 
insect resistance or herbicide tolerance.  Some of these traits, like those 
affecting nutritional quality, may have little or no impact on agronomic 
practices.  Others, like those for stress tolerance, may markedly affect how 
crops are grown.  For example, a drought-tolerant crop could change how 
a farmer manages soil water.  Drier fields could, in turn, affect insect pest 
populations and disease prevalence and, thus, further alter how the farmer 
manages the crop.  Novel disease resistance, insect resistances, or 
herbicide tolerance traits could be expected to alter agronomic practices 
much in the same way as the currently available traits do, that is, some 
practices would change in frequency, others may be eliminated, and some 
new practices may be added, depending on the trait. 
 
Micro-organisms—Plants also have a variety of interactions with micro-
organisms.  Certain soil microbes, like Rhizobium bacteria and some 
fungi, associate with plant roots and provide additional nutrition to the 
plants via various mechanisms.  Conversely, many micro-organisms 
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(bacteria, fungi, and viruses, among others) cause serious plant diseases, 
resulting in enormous economic losses.  There are also neutral 
associations—many yeasts, for example, live on plant leaves without 
causing any harm to the plant; other micro-organisms help decompose 
dead plant material in the soil.  Creating disease-resistant plants through 
genetic engineering could change some of these negative associations but 
other GE traits, such as those affecting nutritional quality or plant 
structure, could alter other plant-microbe interactions. 
 
Socioeconomics—Although most Americans are not producers of 
agricultural commodities, the availability, variety, price, and safety of 
food and fiber crops affects the lives of all Americans.  By extension, 
changes to the methods of agricultural production in the United States may 
also affect anyone who produces, sells, processes, or consumes these 
products.  Beyond ensuring that GE crop plants pose no plant pest risks, 
APHIS needs to consider and address, when appropriate, the social, 
cultural, and economic effects resulting from any significant 
environmental impact of regulating GE plants and from changing APHIS’ 
regulatory approach. 
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IV.  Environmental Consequences 
 
In the United States, genetically engineered (GE) organisms have been 
field-tested since the 1980s and grown commercially on millions of acres 
since the mid-1990s.  Developers and researchers monitor field tests while 
growers, extension agents, and researchers scrutinize commercially grown 
GE crops.  The Animal and Plant Health Inspection Service (APHIS) is 
not aware of any verifiable reports of environmental harm or harm to 
human health resulting from such field tests or from commercial use of 
GE plants.   
 
The agency recognizes, however, that it cannot make general conclusions 
about the safety of GE organisms based on the existing body of science.  
In addition, new technology can lead to the development of novel types of 
GE organisms that may have a greater propensity for environmental 
impact, both positive and negative, than those field-tested to date.  
Therefore, even though past environmental releases have been conducted 
safely and commercial products are being safely grown and consumed, 
APHIS will continue to rigorously scrutinize new scientific developments 
as well as the potential environmental impacts of any proposed changes in 
its regulations. 
 
This chapter examines how the implementation of current APHIS 
biotechnology regulations and possible changes in them might impact the 
quality of the environment.14
 
Section A of this chapter provides general background information for 
nonspecialist readers to better understand the discussions that appear later 
in the document.  This section is divided into four subsections: 
 
• Section A.1 provides an overview of plant and seed biology and 
concludes with a general discussion of the future of agricultural 
plant biotechnology. 
 
• Section A.2 provides a general introduction concerning how the 
potential effects of GE organisms on the environment are typically 
assessed.   
 
• Section A.3 discusses general topics relevant to the consideration 
and risk assessment of GE plants. 
 
                                         
14  The scientific information in this chapter was subjected to a peer review in accordance with 
guidance issued by the Office of Management and Budget and by the USDA.  For more details about 
the peer review process for this draft EIS and for the peer review process in general, please see 
<http://www.aphis.usda.gov/peer_review/peer_review_agenda.shtml>. 
• Section A.4 closes this chapter with further illustrations of how 
potential impacts of GE plants on the human environment are 
assessed.  This subsection discusses several examples of GE 
modifications for specific plant qualities.  Accompanying these 
examples are brief descriptions of some of the risk assessment 
issues associated with each of the modifications.   
 
Section B of this chapter describes the regulatory features of APHIS’ 
current system and how these features function together to reduce the 
likelihood of significant negative impacts. 
 
Section C of this chapter describes the impacts of the individual No Action 
alternatives with respect to 10 specific issues.  For each issue, the No 
Action alternative is followed by an analysis that compares it to one or 
more alternatives for new approaches. 
 
A.  Impacts of Genetically Engineered Organisms 
 
This subsection briefly introduces the general ways in which plants, 
animals, insects, and micro-organisms affect the environment.  Because 
GE plants currently comprise most of the releases of GE organisms into 
the environment, this subsection provides a general introduction focused 
on two broad plant related topics:  1) plant biology and crop improvement 
and 2) seed biology and commercial seed production.   
1. Introduction 
to Biological 
Factors 
 
a. Plant Biology and Crop Improvement 
 
Plants exist in agricultural, managed ecosystems and wild, unmanaged 
ecosystems, and they interact with the environment in both (Janick 
et al.,1981).  What follows is a summary of basic plant interactions in 
three defined contexts—the physical environment, the physiological 
environment, and the ecological environment.   
 
The discussions are brief and broad but provide a basis for understanding 
how plants function in the environment and why plant breeders are 
attempting to modify those functions.  Generally, breeders are attempting 
to enhance plant performance, which relates to a plant’s ability to benefit 
from its positive interactions with the environment while suffering 
minimally from negative interactions (Allard, 1964). 
 
For this discussion, genetic engineering is considered one tool among 
others that are available to plant breeders to add a desirable trait to a plant 
variety. 
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(1) Physical Environment 
 
Except for parasitic plants, which grow partially within other plants, and 
epiphytic plants, which grow on other plants, most plants grow partially 
embedded in soil or in or on water.  Many plants are capable of limited 
directional growth but most plants cannot move large distances (Wareing 
and Phillips, 1981); therefore, they are forced to obtain nutrients and water 
from nearby sources.   
 
Terrestrial plants produce roots to absorb water and nutrients from the soil 
and to anchor themselves physically in the soil, but roots also directly 
affect the soil.  Roots create spaces in soil for the passage of air, water, 
and soil organisms.  In addition to these physical changes, roots release 
organic compounds which alter nutrient availability and accelerate soil 
development.  As roots die and decompose, they contribute organic matter 
to the soil, improving its texture and its ability to retain water and 
nutrients.  Plant roots also anchor soil particles and reduce soil erosion 
(Brady, 1974). 
 
Plant breeders are frequently interested in developing varieties with robust 
growth, including root growth.  Root-growth traits may alter nutrient 
absorption and drought tolerance but may also affect soil water 
distribution and irrigation practices and possibly soil stability and erosion.  
Among the GE traits currently under APHIS’ oversight, only a few have 
the purpose of altering plant morphology.  However, APHIS anticipates 
that altered morphology traits may be developed by researchers more 
frequently in the future. 
 
Because adequate water is essential for survival and growth, plants have 
developed elaborate systems to absorb, transport, and retain water (Janick 
et al., 1981).  Although roots can grow toward sources of soil water, soil 
water generally can move in the soil faster than roots can grow to reach it.  
Plants, therefore, use their own tissues to store water when it is readily 
available and use various means, such as waxy leaf coatings, to restrict 
water loss when water is not available (Esau, 1977).  Some water loss is 
unavoidable, however; and through transpiration, plants lose water from 
aboveground surfaces and convey water from the soil into the air.   
 
Depending on the environment to which a plant is adapted, too much or 
too little water may be harmful or fatal.  Some plants have adapted the 
means to temporarily withstand flooding or drought, and plant breeders 
are actively working on developing these traits in crop plants in order to 
enable crop production in areas with less than optimal water availability.  
Drought tolerance may increase the range of environments where a crop or 
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wild plant can grow successfully and alter water management practices for 
growers. 
 
Green plants have a profound affect on the Earth’s atmosphere.  As a 
result of photosynthesis, plants remove carbon dioxide from the air and 
produce carbohydrates, which plants use as their primary form of stored 
energy, as well as to increase biomass.  The oxygen produced as a 
byproduct of photosynthesis is released by plants back into the 
atmosphere.  Plants also reverse this process when carbohydrates are 
utilized for energy, producing carbon dioxide and water while using up 
oxygen (Bidwell, 1974). 
 
Plants have anatomical, morphological, and physiological adaptations to 
allow the exchange of internal oxygen and carbon dioxide with gases in 
the atmosphere while conserving water to maintain a healthy water 
balance.  Traits that modify these plant characteristics could affect 
photosynthesis, water efficiency, and irrigation practices. 
 
Light provides the energy driving the photosynthetic process.  During 
periods of inadequate light, plants cannot produce new carbohydrates and 
are forced to use stored carbohydrates to survive.  When light is limited, 
such as when plants grow in shade, the plants that best exploit the 
available light may outcompete less efficient plants (Janick et al., 1981).  
Plants use both structural means, such as producing larger leaves or 
growing taller then their neighbors, and physiological means, such as 
producing more chlorophyll, to better utilize limited amounts of available 
light (Bidwell, 1974).  Plant breeders exploit these adaptations to produce 
crop varieties that make the most of available light.  Plants able to better 
exploit sunlight may grow successfully in environments previously 
unsuitable for crop production.  In addition, a plant that uses light more 
efficiently may be grown at higher density (i.e., more plants per acre), 
thereby changing some crop-management practices. 
 
(2) Physiological Environment 
 
A plant’s physiological environment, in general, refers to a plant’s 
surroundings that influence its activities at a biochemical level—
specifically, its ability to absorb, produce, and store nutrients and other 
substances. 
 
Photosynthesis is a critical plant activity.  It involves three processes:  
absorption and retention of energy from sunlight, conversion of light 
energy into chemical energy, and stabilization of chemical energy into 
stored energy in the plant (Bidwell, 1974).  The process of photosynthesis 
can be accomplished in several subtly different ways.  Variations in 
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photosynthetic processes have evolved that enable adaptation to specific 
environmental conditions, such as low light or restricted water.  These 
adaptations may be biochemical or anatomical, resulting from one or more 
genetic changes in the plant.  Although breeders have been trying to 
improve photosynthetic efficiency for many years, success has been 
limited for a variety of reasons (Richards, R.A., 2000).  Alterations to 
photosynthetic efficiency may affect yields but increased yields may be 
dependant on additional water and fertilizer.  Changes in photosynthetic 
efficiency may change overall environmental fitness which could affect 
both crops and wild plants bearing the traits. 
 
Although they produce carbohydrates to be used as energy via 
photosynthesis, plants are still reliant on the soil as a source of mineral 
nutrition.  Nitrogen, phosphorus, potassium, iron, magnesium, and other 
elements must be absorbed by plant roots and transported to tissues where 
they participate in myriad biochemical reactions necessary for plant 
survival and growth.  For the most part, these minerals are either already 
present in the soil or have been added by a grower in the form of fertilizer.  
Plants rely on the fact that soil water dissolves the minerals and makes 
them available for uptake by the roots (Van der Have, 1979).  It may be 
possible to produce plants through genetic engineering that are better able 
to take up minerals from the soil or that are able to use soil minerals more 
efficiently.  Such traits could increase plant fitness and possibly alter crop 
management practices, specifically how much fertilizer a grower needs to 
use to achieve optimal yield. 
 
Certain symbiotic soil micro-organisms associate with plant roots to 
increase nutrient availability.  For example, Rhizobium bacteria associate 
with the roots of some plants, mostly legumes, take nitrogen from the air 
(which cannot be used directly by plants) and convert it into ammonium, 
which can be taken up by plant roots.  Certain soil fungi, called 
mycorrhizal fungi, associate with plant roots making some soil nutrients, 
like phosphorus, more available for uptake (Brady, 1974).  Breeders are 
interested in increasing the number of plant species able to associate with 
these micro-organisms, and other researchers are working with the micro-
organisms themselves to improve their efficiency as nitrogen-fixing 
symbionts.  Increasing the benefit obtained from symbiotic relationships 
with soil microbes, through genetic changes in either the microbe or the 
plant, may increase plant fitness, increase the geographic ranges of some 
crops and possibly lessen the amount of fertilizer growers need to apply or 
otherwise change soil fertility management practices. 
 
In addition to carbohydrates, fats, and proteins made by plants for growth, 
plants also make a wide variety of additional substances called secondary 
metabolites.  Secondary metabolites do not appear necessary for growth 
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but many have important functions in such areas as disease resistance, 
reproduction, and herbivory reduction (Verpoorte et al., 2002).  Many of 
these substances are of interest to breeders, either because the secondary 
metabolite makes the plant more tolerant of environmental stress or 
because the metabolite is valuable to humans for pharmacological or other 
purposes.  Altering secondary metabolite production may change 
environmental stress tolerance, or it may result in a plant with higher value 
as a crop because the metabolite itself is useful. 
 
(3) Ecological Environment 
 
In most environments where plants grow, one or more resources (e.g., 
light, water, nutrients, and space) are in limited supply, and plants growing 
together in the same location are generally competing with each other for 
the same resources.  When the plants are a managed crop, the grower 
attempts to supply limited resources to the crop so that the individual 
plants are not competing with each other and are each growing at or near 
full potential (Janick et al., 1981).  However, other plants growing with the 
crop can also benefit from the resources provided by the grower and take 
them from the crop.  These plants are considered weeds and are removed 
when possible to reduce unnecessary competition and waste of resources 
intended for the crop.  Breeders are always looking to develop crops that 
make more efficient use of resources to reduce competition and reduce 
inputs from the grower.  In unmanaged environments, wild plants also 
compete for resources, but because no grower is supplementing their 
supply of resources, plants with more competitive adaptations and more 
efficient resource use may tend to grow better and reproduce more than 
their less competitive neighbors. 
 
Two positive interactions between plants and other organisms, Rhizobium 
bacteria and mycorrhizal fungi, were discussed above.  There are other 
examples of positive associations between plants and other organisms.  
Plants are pollinated by a variety of insects, birds, and mammals.  Many 
animals assist plants by disseminating their fruits and seeds; still other 
animals, such as ladybugs, help plants by eating insect pests, like aphids.  
Other associations appear neutral, as far as the plant is concerned.  In 
some cases, plants provide a beneficial habitat for the organism, for 
example, when a spider builds a web using a plant for support.  Another 
kind of neutral association between plants and other organisms occurs 
after plants die.  Dead plant material provides food to a wide variety of 
organisms from vertebrate and invertebrate animals to thousands of micro-
organisms, which all feed on the plant debris until it is completely broken 
down.  APHIS is unaware of research into GE traits altering these types of 
positive and neutral interactions between plants and other organisms; 
however, the agency anticipates that such traits, if developed, could affect 
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plant fitness and may also affect the associated organisms, as well as other 
organisms. 
 
There are many associations between plants and other organisms in which 
the plant suffers some harm.  The organism may eat the plant or feed from 
the plant.  For example, caterpillars, aphids, and nematodes all get 
nutrition from plants at the plant’s expense.  Organisms such as bacteria, 
fungi, and viruses cause plant diseases that can either kill the plant or 
weaken it so that it cannot reproduce or compete with weeds.  The 
organism may use the plant to launch an attack on other plants, as a means 
of completing its life cycle, or as a place to overwinter.  Obviously, 
breeders care a great deal about minimizing the occurrence and intensity 
of these negative interactions and focus significant efforts to develop 
disease resistant crops (Fehr, 1987).  Complicating the use of disease-
resistant crops is the evolution of new strains of disease organisms that can 
overcome the plant’s resistance.  Disease and insect resistance derived by 
either genetic engineering or conventional breeding are traits with which 
APHIS is very familiar, and the agency anticipates continued interest in 
the development of these traits.  Such traits could be expected to increase 
plant fitness, change crop-management practices (especially pesticide use) 
and potentially raise questions of impacts on nontarget organisms and 
development of resistance within pest populations. 
 
In general, APHIS expects plant breeders to continue to improve crop 
performance and value using traditional breeding and GE traits.  APHIS 
currently examines the potential impact of the trait on the health of the 
plant and on the environment with which the plant interacts. 
 
b. Seed Biology and Commercial Seed Production 
 
This section will look at the biological nature of seeds and will briefly 
describe how seeds are produced for commerce. 
 
(1) The Role of Seeds 
 
Seeds produced by plants have been the foundation of agricultural 
development by the human race for well over 10,000 years.  During this 
time, humans have progressively transformed selected plant species from 
wild progenitors into highly specialized crops.  Seeds are used as a source 
of energy and nourishment for human and animal consumption.  They 
produce fibers used in clothing and construction.  They are a source of raw 
materials for manufacturing an ever-broadening array of commercial 
products, and they are becoming an increasingly valuable source of 
renewable energy.  The market value of agricultural seeds produced for 
planting each year is tens of billions of dollars worldwide.  The world 
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production of major grains and oilseeds produced from seed is 
approximately 2.5 billion tons, worth more than $1/2 trillion. 
 
(2) The Biology of Seeds 
 
Seeds contain the genetic instructions passed down from their parents and 
serve as the conduits for transferring that genetic information to the next 
generation.  Plants have developed a wide array of mechanisms to increase 
the chances of successfully passing genetic information on to the next 
generation. 
 
Most crop plants reproduce sexually, which increases variation among the 
offspring and has advantages in natural evolution, but sexual reproduction 
requires a carefully orchestrated interaction between male and female 
gametes.  Successful mechanisms involve variations in flower 
morphology, mechanisms of pollen dispersal, self-incompatibility (a 
mechanism to promote outcrossing), and sensitivity to environmental cues. 
 
Knowledge of these reproductive strategies has enabled humans to 
transform wild progenitors into agronomically useful crops through many 
generations of crossing plants followed by the selection of desirable 
individuals in the progeny.  These same reproductive strategies, however, 
can create challenges for maintaining genetic purity of seeds, particularly 
in crops that utilize natural environmental conditions to aid pollen and 
seed dispersal. 
 
Although there are many physical variations, all plants produce flowers 
with the same basic anatomy.  The stamen contains the male reproductive 
parts (anthers), which produce pollen.  The pistil carries the stigma (the 
pollen receiving structure) and contains the female reproductive parts 
(ovules), which house the egg cells. 
 
“Complete” flowers contain both male and female reproductive parts.  
Plants with perfect (complete) flowers are largely self-pollinated, although 
it is still possible for pollen from another plant to cause fertilization under 
certain conditions.  This can have a significant impact on the genetics of a 
population. 
 
The flowers of some plants require cross-pollination (i.e., pollination by 
another flower).  Maize tassels, for example, produce flowers that do not 
usually develop female structures and produce only pollen.  The flowers 
on the rachis (ear) do not develop male floral structures and require pollen 
from the tassel for pollination.  This mechanism of separating male and 
female flower parts increases the probability of cross-pollination.  The 
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flowers of some plant species (termed self-incompatible) cannot pollinate 
themselves, which maximizes mixing of genes between plants. 
 
It is important to understand that most plants, including crop plants, fall 
somewhere in the middle of these extreme reproductive strategies.  Self-
crossing plants are rarely 100 percent self-fertilizing, and many cross-
pollinating plants are not entirely self incompatible.  This leads to a range 
of observed outcomes that must be considered when discussing plant 
reproduction. 
 
(3) Pollen and Seed Dispersal 
 
Forcing cross-pollination in crops with perfect self-pollinated flowers, 
such as soybean and wheat, requires that either pollen be inactivated or 
anthers be physically removed before they mature and release pollen.  In 
either case, the pollen from another plant is delivered to the stigma. 
 
In plants that are self-incompatible or have separate male and female 
flowers, pollen must be delivered to the female flowers by wind dispersal, 
animals, or, in most cases, insects.  Corn pollination, for example, relies 
on wind dispersal of pollen.  This reproductive strategy requires the corn 
plant to produce a large abundance of pollen that must travel through the 
air before landing on female flowers on the same or another plant. 
 
Plants that rely on cross-pollination create challenges for those concerned 
with genetic purity:  breeders, seed producers, grain growers, and 
sometimes consumers.  For example, with few exceptions, the female 
flowers of corn will accept pollen from any corn plant.  The seed industry 
continues to refine isolation standards and develop novel genetic, physical, 
and chemical mechanisms to minimize cross pollination (for corn, see 
Beck, 2004), and employs the latest pollen dispersal models to predict loss 
of genetic purity under field conditions (Fonseca et al., 2004). 
 
(4) Seed Development, Maturation, and Long-term Viability 
 
After fertilization, the developing seed becomes the primary recipient for 
water and photosynthetic products of the plant, rapidly gaining weight due 
to embryo development.  The seed must store the chemicals that will be 
used to feed the growing seedling at the early stages of seed germination.  
The chemical composition of a seed is determined by genetic and 
environmental factors.  Carbohydrates, fats and oils, and proteins are 
among the most important seed-stored compounds. 
 
Wild plants must disperse their seeds into the environment in order to 
propagate and they have evolved a variety of mechanisms to accomplish 
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this.  In general, humans have selected for crops that have reduced or 
entirely lost their ability to disperse seeds as part of the domestication 
process.  This greatly improves the ability of farmers to collect the seeds 
for use as food or for propagating their crops.  Still, many crops have not 
been fully domesticated and may retain some portion of their ancestral 
seed dispersal mechanisms.  For example, in oilseed rape or canola the 
loss of grain prior to harvest represents a significant production problem.  
Even in crops that are highly domesticated, seeds retention is rarely 
perfect and seeds may be dispersed during the harvesting process.  
Mechanisms of seed dispersal are relevant to the discussion of gene flow 
into unmanaged environments. 
 
After physiological maturity, the seeds of many species dehydrate, which 
helps seeds survive cold winters and dry periods.  These seeds have the 
ability to dehydrate to very low moisture content while remaining viable, 
even though their moisture content is 8 percent to 12 percent (well below 
the 70 percent water that makes up all living tissues in plants).  Not all 
seeds, however, will undergo dehydration:  seeds from plants adapted to 
tropical environments usually do not dehydrate as much as those from 
temperate climates.  At low temperatures and moisture content, seed 
metabolism diminishes and seed aging slows.  Depending on seed 
composition, original seed quality, and storage conditions, seeds can be 
stored for several months to several years in an insect-free, low 
temperature, and dry environment.  In some instances, seeds have been 
known to survive for 100 years or more. 
 
(5) Accumulation of Storage Materials 
 
Seeds, primarily cereals and legumes, make up 70 percent of the food 
consumed in the world.  Seeds store large amounts of chemical substances 
such as proteins, carbohydrates, and lipids (fats and oils), in order to 
provide food to the seedling at the early stages of germination and growth. 
 
Proteins are made primarily of amino acids.  Enzymatic proteins catalyze 
biochemical reactions in plant cells.  Some proteins make up structural 
components of cells and others are important stored food components of 
many seeds, especially legumes. 
 
Carbohydrates are the most important storage compounds in the seeds of 
cereal crops.  Starch and hemicellulose, the two main forms of 
carbohydrates stored in seeds, are the source of simple sugars needed for 
germination. 
 
Lipids or fats serve as energy storage within the seed and are an important 
part of all cell membranes.  Lipids are also used in food and animal feed 
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and in industrial applications.  Fatty acids from seeds contain larger 
amounts of unsaturated fatty acids (those containing one or more double-
bonds within their molecule) than lipids of animal origin, and these plant 
lipids are used increasingly in processed foods. 
 
DNA is a natural component of all plant tissues, including seeds.  The 
DNA content of the seed is vital because it provides the biochemical 
instructions for germination growth and development of the new plant.  
DNA is broken down during digestion when eaten, and its consumption in 
food, regardless of genetic information content, has no impact on human 
health. 
 
(6) Opportunities for Genetic Modification 
 
Nutritional studies also indicate that seeds are important sources of 
vitamins, antioxidants, and phytohormones.  During the past 2 decades, 
there have been major advances in the understanding of biosynthetic 
processes controlling the synthesis and accumulation of these products in 
seeds.  In concert with the development of molecular biological 
techniques, this knowledge has made it possible to modify seeds from crop 
plants to improve human health and produce raw materials for nonfood 
uses.  Transforming seeds for these purposes may involve the addition of 
genes not currently present in the plant.  Numerous studies to date indicate 
that seeds of some plants can be induced to synthesize and accumulate 
various novel compounds.  For plants that will be produced in large scale 
such transformations need to be made with minimal effect on seed 
development, seed physical characteristics, and viability.  It is likely the 
accumulation of normal seed storage components will need to be modified 
as well if seeds are to accumulate new compounds in sufficient quantity.  
A new genotype with poor agronomic characteristics and low capacity for 
seed production will not survive long in the seed industry. 
 
(7) Commercial Seed Production 
 
Before the 19th century, farmers generally saved seed for next year’s 
planting, and seed commerce was limited to the replacement of stocks that 
had become mixed or degraded.  The advent of modern plant-breeding 
methods has led to the importance of seed as a commercial product valued 
for its particular trait purity and quality components. 
 
The increased sophistication of plant breeding to produce crops meeting 
very specialized needs and market niches has in recent decades increased 
the need for high standards of seed genetic purity in order to ensure 
identity preservation in increasingly diversified markets.  In addition, the 
production practices associated with certification of seed have become an 
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important tool for controlling fungal, bacterial, and viral pathogens that 
depend on seed transmission for the spread of disease (Cook, R.J., 2000). 
 
This section of the document describes in broad terms the two paths taken 
by commercial seed producers in developing and producing seed: 
traditional breeding and genetic engineering.   
 
As background, these discussions are preceded with information 
concerning the trade and value of commercial seed.  Additionally, to assist 
in understanding, basic information is included concerning plant 
pollination and a description of the differences between breeder seed, 
foundation seed, and certified seed during seed stock production. 
 
Commercial Seed Trade and Value 
 
Seeds are internationally traded commodities.  The United States is the 
largest producer and consumer of seeds in the world.  An estimated 
$5.7 billion worth of commercial seeds are produced annually in the  
United States, which has a 19-percent share of the $30-billion world seed 
market.  Maize seed is the largest segment of the U.S. domestic-planting 
seed market valued at $2.2 billion.  Annual U.S. seed exports and imports 
are estimated roughly at $800 million and $400 million, respectively, thus 
providing a net trade surplus.  The United States exports seeds mainly to 
Mexico, Canada, Italy, Japan, and Argentina; imports come mainly from 
Canada, Chile, the Netherlands, and China. 
 
In the United States, farmers purchase a large portion of seeds from 
commercial sources, and the commercial sector is engaged in production, 
conditioning, distribution, and marketing of seeds.  Government policies 
and regulations impact interstate movement of seeds within the  
United States, and have an even greater effect on international seed 
commerce.  These laws, policies, and regulations control plant variety 
protection, variety registration, truthful labeling, phytosanitary 
certification, and seed certification.  Science-based policies and 
regulations are vital to the harmonization of the protocols for import and 
export among countries to promote global seed trade. 
 
Self-pollinating Plants Versus Outcrossing Plants 
 
For commercial seed producers, one of the principal seed quality concerns 
is genetic purity.  To discuss genetic purity it is useful to divide plants into 
self-pollinated and outcrossing because genetic purity is linked to these 
modes of seed fertilization.  Of course, all combinations of intermediates 
and some unusual cases exist. 
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It is simpler to produce seeds from self-pollinating plants than from 
outcrossing plants.  Seed production of self-pollinated plants starts with 
the production of so-called breeder seed by self-pollination in research 
nurseries, followed by repeated cycles of seed production in plots that are 
checked for off-types.  Self-pollinated plants are well-adapted for 
inbreeding and, as a result, are less likely to be used as commercial 
hybrids. 
 
In outcrossing plants, the chain of breeding and production steps includes 
opportunities for both pollen flow and mixing.  Insect pollination of 
outcrossing plants is common, and when it occurs it adds complexity to 
pollen control.  It is much easier to produce hybrid varieties in outcrossing 
plants, and this makes the use of hybrids much more common in 
outcrossing crops than in self-pollinating ones. 
 
Crop Improvement Through Traditional Breeding 
 
Delivery of genetic improvements is one of the most important roles of the 
seed industry.  Conventional breeding, at its most basic, is a process in 
which differences in plants are observed in small populations.  The 
differences are compared with the needs of the person doing the selection 
for the best plants, and the plants that most fit the selector’s needs are 
saved and perpetuated.  Other variants are eliminated from selection.  In 
modern plant breeding, breeders apply the principal of selecting favorable 
varieties using a range of modern methods including genetic, molecular 
biology, and statistical analysis. 
 
Breeder Seed 
 
Breeder seed is usually produced in research nurseries where individual 
plants can be inspected and where pollination control can be maintained.  
Intensive observation of individual plants allows high levels of purity to 
be maintained.  The use of breeder seed keeps the seed system from 
accumulating unintended genes indefinitely over time.  For some 
noncommercial and traditional landrace or heirloom varieties, there may 
not be an effective breeder’s seed system. 
 
Foundation and Certified Seed 
 
Lower grades of seed are produced from breeder seed.  Foundation seed is 
produced directly from breeder seed or other foundation seed under 
conditions designed to maintain specific genetic purity and identity of the 
seed.  Certified seed is produced from breeder or foundation seed under 
conditions designed to maintain satisfactory genetic purity and identity.  
Certified seed is the highest grade of seed ordinarily planted by farmers. 
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For outcrossing plants, unintended crossing during open pollination is the 
major source of unintended (“off-type”) pollinations in the field.  Isolation 
and borders effectively limit the level of unintended off-types in the final 
product and their use is supported by decades of experience with plant 
breeders and the seed industry.  Experimentation has shown that 
pollination of outcrossing plants declines rapidly with increasing distance 
from the source.  The vast majority of unintended outcrosses and off-type 
plants come from adjacent fields, although rare, long-range crossing does 
occur.  The advent of DNA-detection technology provides a sensitive 
means for monitoring gene transmission and has led to recent 
controversies over inadvertent trait occurrence which, in turn, has lead to 
tightening of production standards and practices for all seed-production 
systems.  Regardless, for an open-pollinated plant, outcrossing at low 
frequencies will always be a possibility. 
 
The other possible source for unintended presence of off-type genotypes in 
seed of both outcrossing and self-pollinated plants is commingling.  Seed 
mixing during harvest, transport or storage tends to be a large source of 
impurities.  In outcrossing plants, industry experience indicates that field 
contamination is a more frequent source of off-type genotypes than is 
mixing in planting, harvest, transport, and processing.  However, careful 
application of the procedures for field production, transport, and 
processing of corn, for example, normally results in the production of both 
hybrid and self-pollinated seed that is at least 99 percent pure. 
 
Technical Innovation and Seed 
 
Breeding makes changes by combining great numbers of genes and sorting 
out useful changes by selecting among progeny.  Genetic engineering 
selects a specific DNA sequence and makes it work in a new place.  The 
changes made by genetic engineering are minor in comparison to the 
amount of DNA in the plant, typically 1 or 2 genes inserted among 
approximately 30,000.  After a trait has been successfully incorporated, it 
can be added to other varieties of the same species by conventional 
breeding techniques. 
 
The emergence of specialized food crops (e.g., zero trans fat crops) and 
nonfood varieties (pharmaceutical and industrial plants) increases the need 
to consider heightened standards for preventing pollen outflows and seed 
mixing in specialty seed production and brings up the special need to 
isolate nonfood varieties from food varieties. 
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Seed Quality and Regulation 
 
The primary quality characteristics are physical purity, presence of other 
crop seeds and weed seeds (especially noxious weeds), germination, 
varietal purity, disease status, and moisture.  Special germination tests for 
difficult conditions may add important information.  However, the 
customer cannot readily observe the quality of purchased seed.  Seed laws 
ensure that the seed merchant is providing accurate information.  Both 
Federal and State governments have seed laws, and the International Seed 
Testing Association provides global standards for germination testing for 
international commerce.  All official seed-certifying agencies belong to 
the Association of Official Seed Certifying Agencies (AOSCA), which 
establishes minimum standards for each crop.  Individual certifying 
agencies may set higher standards than AOSCA, but not lower. 
 
Many countries have customer-protection regulations that require varieties 
to meet performance standards.  Varieties that meet the standards are 
described and registered and are then eligible for certification.  The  
United States has few regulations of this type.  Certification by the 
Organization for Economic Cooperation and Development provides 
international mutual recognition of certification.  In the United States, both 
varieties and genes can be patented.  Varieties can also be protected under 
plant breeder rights.  The International Union for the Protection of New 
Varieties of Plants coordinates a simplified plant breeder’s rights system 
with standardized claims. 
 
c. The Future of Agricultural Plant Biotechnology 
 
The first decade of commercial plant agricultural biotechnology has seen 
remarkable growth, from a mere 6 million acres in GE crops in 1996 to 
more than 220 million acres in 21 countries in the 2005 growing season.  
This represents between 4.5 and 6.3 percent of the world’s total arable 
land.  The year 2005 also marked the point where cumulatively more than 
1 billion commercial acres of GE crops had been grown worldwide.  This 
rapid growth has more recently slowed due to a combination of many 
complex market factors.  This situation is further exacerbated by the fact 
that the vast majority of GE crop plants only carry two production-
oriented traits—glyphosate herbicide resistance and insect resistance, and 
some regional markets for these two traits may be reaching near 
saturation. 
 
Notwithstanding these concerns, continued worldwide expansion in the 
use of GE plants is likely.  This is exemplified by the activities of 
government regulators around the globe who are working to create 
regulatory regimes which allow GE plants and plant products to reach the 
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marketplace while assuring that the products are safe for people and the 
environment.  Concomitant with this governmental activity, the academic, 
nonprofit, and corporate communities are working on creating new 
identity preservation, quality and trait assurance programs, and market-
channeling mechanisms to allow GE plant products to flow in commerce 
without the inadvertent contamination of other products. 
 
Looking to the future, there are four areas of GE crop trait developments 
that may experience rapid growth and significant worldwide 
commercialization in the next decade.  These developing crop traits would 
focus on efforts to address environmental stress on plants, and to produce 
plant-derived biofuels, plant-produced proteins, and substances with 
industrial applications.  
 
Due to a decreasing supply of high-quality crop production land, drought, 
desertification, salinization, and global warming, there is a critical need 
for culturally acceptable food, fiber, and feed plants that can flourish 
under these environmental stresses.  There is a broad scientific effort to 
identify and introduce traits that will allow plants to deal with these 
environmental stresses, especially for use in developing nations. 
 
With the rapid escalation in petroleum and fossil-fuel prices, significant 
scientific effort is being expended to develop renewable plant-derived 
fuels.  The most interesting GE plant-derived biofuels from an 
intermediate-term development period of 10 to 15 years are ones that may 
be grown, extracted, and utilized without further modification or with 
limited modification, much like existing biodiesel products.  Members of 
the plant kingdom are capable of synthesizing an extremely wide variety 
of chemical substances and are fully capable of producing large, complex 
proteins in useful quantities.   
 
The next 10 years will see an increase in the development of GE plant-
derived protein products such as vaccines, enzymes, biologicals, and new, 
custom-designed, therapeutic proteins to treat cancer, birth defects, and 
chronic ailments.   
 
The fourth area that seems destined for increased development and 
commercialization in the next decade is nontraditional industrial chemicals 
such as adhesives, improved or unique plant-derived fiber, lubricants, 
pharmaceuticals, nutritional supplements, and food-derived health 
supplements. 
 
 
 
 
  
To understand how APHIS’ current biotechnology regulations and 
possible changes to them might impact the quality of the human 
environment, it is important to understand the basic principles and 
approach for conducting risk assessments of GE organisms. 
2. Assessing 
Effects on the 
Human 
Environment 
 
To begin, this section gives a general introduction to how potential effects 
of GE organisms on the human environment are typically assessed.  
 
Section A.3, which immediately follows, discusses several issues of 
potential impacts that have been and will continue to be considered in 
completing risk assessments for specific GE organisms.   
 
Section A.4 then discusses several examples of GE modifications for 
specific plant qualities and elaborates on the risk assessment issues 
associated with them.  Among other modifications, this subsection 
provides information concerning GE insect-resistant crop plants modified 
to express genes from Bacillus thuringiensis (Bt). 
 
As a reminder, it is critical to note that the particular regulatory action and 
decision required determines the type of risk assessment performed as well 
as the specific NEPA environmental documents that are prepared.  
Moreover, both the risk assessments and the NEPA documents are always 
prepared on a case-by-case basis.  The specific regulatory action and 
decision required will dictate which NEPA environmental document will 
be prepared (i.e., a categorical exclusion, an environmental assessment, or 
an EIS).  We emphasize that this DEIS does not contain risk assessments 
for specific organisms since those assessments are done on a case-by-case 
basis.  The purpose of this DEIS is to analyze the environmental impacts 
on the human environment resulting from APHIS’ current regulations for 
GE organisms as well as to analyze the potential environmental impacts, if 
any, on the human environment resulting from any revisions or changes to 
APHIS’ current regulations for GE organisms.  Project-specific analyses 
and documentation on proposed actions performed under the regulations, 
such as permit applications and deregulation decisions, may be prepared 
on individual project levels, and public involvement will be solicited in 
accordance with the National Environmental Policy Act of 1969 (NEPA), 
as amended, the Council on Environmental Quality (CEQ) regulations for 
implementing NEPA, the USDA regulations implementing NEPA, and 
APHIS’ NEPA Implementing Procedures.  These analyses will be tiered to 
this DEIS and other applicable EISs. 
 
Since the advent of biotechnological methods, a wealth of experience with 
risk assessment has been accumulated worldwide, resulting in a robust 
international consensus on the general principles and methodology for risk 
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assessments regarding GE organisms.  The overall methodology for risk 
assessment typically follows a number of steps: 
 
1. Hazard identification—An identification of any novel genotypic and 
phenotypic characteristics associated with the GE organism that may 
have adverse effects in the potential receiving environment;  
 
2. Likelihood estimation—An evaluation of the likelihood of these 
adverse effects being realized, taking into account the level and kind of 
exposure of the likely potential receiving environment to the GE 
organism;  
 
3. Consequence evaluation—An evaluation of the consequences should 
these adverse effects be realized; 
 
4. Overall risk estimation—An estimation of the overall risk posed by the 
GE organism based on the evaluation of the likelihood and 
consequences of the identified adverse effects being realized; and 
 
5. Risk management—A recommendation as to whether or not the overall 
risks are acceptable or manageable, including, where necessary, 
identification of strategies to manage these risks, including monitoring. 
 
In the process of conducting the steps outlined above, a risk assessment 
takes into account the relevant characteristics of the recipient organism, 
host organism, or parental organisms; the inserted genes and sequences 
and related information about the donor(s) and the transformation system; 
the resulting GE organism; the detection and identification of the GE 
organism; the organism’s intended use (e.g., the scale of the activity—
field test or commercial use); and the likely receiving environment. 
 
For the purposes of further describing risk assessments for GE organisms, 
this subsection discusses several issue areas of potential impact that have 
been and will continue to be considered in completing risk assessments for 
specific organisms.  
  
3. General 
Topics 
Relevant to 
Risk 
Assessments 
The issue areas discussed below are:  potential changes in weediness and 
invasiveness; potential effects of GE plants on soil; and potential impacts 
of GE plants on human health. 
 
a. Potential Changes in Weediness and Invasiveness 
 
A key consideration in assessing the potential risks of GE plants is 
whether or not changes in weediness or invasiveness have occurred or are 
likely to occur as a result of the genetic modification. 
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(1) Crop Plants and Weediness 
 
Plants can evolve into weeds in three basic ways:  (1) wild plants can, 
through unintentional selection in managed settings, gain the ability to 
invade managed habitats; (2) genes can be exchanged between cultivated 
crops and wild (noncultivated) relatives such that the wild relatives 
become weeds; and (3) weedy traits can be selected in crop plants such 
that the crop itself becomes a weed.  It has been suggested that certain 
traits introduced through genetic engineering of crop plants might confer 
weedy characteristics to the plants, thereby, creating new weeds in 
managed areas.  However, it is unlikely that new weeds or invasive plants 
would be created in this way (Martinez-Ghersa, 2003). 
 
There are many common definitions of a weed, but most involve not a 
specific biological feature but rather how weeds are regarded by people 
(Booth, Murphy, and Swanton, 2003; King, 1966).  The term “weed” is 
commonly defined as a plant growing where it is not wanted, due to its 
interference with human activities or human welfare (Anderson, 1977).  
For the purposes of this DEIS, the weediness of GE plants and wild 
relatives with acquired GE traits in agroecosystems and other areas 
managed by humans will be discussed separately from the invasiveness of 
these plants into unmanaged ecosystems. 
 
There are also several common definitions of “invasive species” in the 
scientific literature (Richardson et al., 2000; Colautti and MacIsaac, 2004; 
Pyšek et al., 2004).  In this DEIS, an invasive species is defined as an 
introduced species that has a substantial or transformative impact in the 
unmanaged environment. 
 
All crop plants can be considered weeds when they persist as volunteers 
growing from seed left in a field after harvest.  However, some plants have 
more weedy characteristics than others.  Using common definitions such 
as the one given above, it is not possible to know whether any plant, GE or 
not, will be considered a weed in some particular instance.  APHIS 
approaches this dilemma by comparing the biology of the GE plant to its 
nonengineered counterpart, usually the same plant without the GE trait.15  
In this way, conclusions can be drawn as to whether a GE plant is different 
than its nonengineered counterpart in its basic phenotypic characteristics 
and life history.  It may be difficult to predict, based on phenotype, 
whether or not a GE plant would become a weed, but any significant 
change in environmental fitness might trigger the need for heightened 
                                         
15  APHIS has developed and made available on the Internet, 
http://www.aphis.usda.gov/brs/international_coord.html, a list of biological characteristics that 
petitioners for nonregulated status should address in their data set.  The list is found in appendix II of 
the Canada/U.S. 2001 Bilateral Agreement on Agricultural Biotechnology. 
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scrutiny.  To date, the incorporation of GE traits in crop plants has not 
resulted in the creation of novel weeds. 
 
(2) Wild Relatives With Acquired Genetically Engineered Traits As 
Weeds 
 
Many of the concepts and proposed mechanisms by which transgenes 
might increase the fitness and consequently, the weediness of plants would 
also apply to their wild relatives (Jenczewski, Ronfort, and Chèvre, 2003).  
An important difference, however, is that crop plants often are themselves 
not very weedy and have a low propensity for persistence when not 
managed in an agricultural context.  In contrast, wild relatives, by their 
nature, may have weedy characteristics and an ability to persist in the 
environment.  Hybridization of many species of traditional crop plants 
with their wild relatives is well established, and it is believed that the 
resultant gene flow may contribute to the evolution of weediness 
(Ellstrand, Prentice, and Hancock, 1999), but such instances are rare 
(Martinez-Ghersa, 2003). 
 
In classic studies on the origin and evolution of weeds, Baker (1965, 1974) 
listed characteristics typically associated with weedy plants.  The 
following is that list as adapted by Rissler and Mellon (1996): 
 
1. Seeds germinate in many environments. 
 
2. Seeds remain viable a long time. 
 
3. Plants grow rapidly through vegetative phase to flowering. 
 
4. Plants produce seeds continuously as long as the growing season 
permits. 
 
5. Flowers are self-compatible but not obligatorily self-pollinated. 
 
6. Pollen from flowers that are cross-pollinated is carried by 
nonspecialized flower visitors (usually insects) or by wind. 
 
7. Plants produce large numbers of seeds in favorable environmental 
circumstances. 
 
8. Plants produce seeds in a wide range of environmental circumstances. 
 
9. Plants are adapted for both long-distance and short-distance dispersal. 
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10. If perennials, the plants have vigorous vegetative reproduction or 
regeneration from fragments. 
 
11. If perennials, the plants readily break near the soil line to prevent easy 
withdrawal from the soil. 
 
12. Plants compete by special means such as forming rosettes, choking 
growth, or producing toxic chemicals.  
 
Keeler (1985) reviewed the evolution of weeds from crop plants focusing 
on the characteristics described by Baker that may distinguish weeds.  She 
listed characteristics associated with weediness in certain species and 
noted that many of these characteristics are known to be controlled by 
single genes.  Her work showed uneven distribution of such characteristics 
among crops, weeds, and other plants.  While the most serious weeds had 
an average of 10 or 12 weedy characteristics, other randomly surveyed 
plants averaged 7, and crop plants averaged only 5.  Thus, it seemed 
unlikely that most crops would acquire enough of these characteristics to 
become weedy, even if the traits could be inherited as single loci.  While 
noting several limitations to her study, she concluded that GE crops with 
low weediness and no weedy relatives are no more likely to be the source 
of significant weed populations than their nonengineered counterparts. 
 
However, Williamson, studying invasiveness, concluded that neither those 
traits listed by Baker, nor any others, can accurately predict which plants 
could become weeds (Williamson, 1993).  He proposed, rather, that any 
such list of characteristics would have to be specific for groups of closely 
related species and noted that small genetic changes can sometimes spur 
large ecological changes.  He concluded that GE plants have the potential 
to become weeds because the genetic changes may have unexpected 
environmental effects; however, he also concluded that the proportion of 
GE plants that will become weeds is very small (Williamson, 1993).  This 
conclusion was based on an earlier study of invasive species which had led 
to his formulation of the “10:10 rule.”  According to this rule, 
approximately 10 percent of introduced species will become established 
and truly naturalized, and 10 percent of those will become pest species.  
Hence, for introduced species, as a rough estimate, only 1 percent will 
become pest plants.  This rule could be applied equally well, and with 
equal validity, to traits that have been introduced using conventional 
breeding, such as pest resistance, or those which can be acquired naturally 
or introduced through conventional breeding efforts, such as herbicide 
resistance. 
 
It has been suggested that the release of organisms with novel phenotypes 
bears similarities to the introduction of nonnative species (Marvier, 2001).  
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However, the usefulness of such a model for evaluating the risks of GE 
crops has been questioned (Hancock and Hokanson, 2001).  The argument 
against exotic plant species as a useful analogy is that many of them are 
already good colonizers in their native habitats and carry an array of traits 
associated with weediness.  Thus, when they are introduced into a new 
environment where there are few or none of the factors which may have 
limited their numbers in their native environment, populations can 
sometimes explode to fill an ecological niche. 
 
There are examples of nonnative plants, such as field bindweed, 
quackgrass, and Canada thistle in heavily managed habitats, and kudzu, 
purple loosestrife, and cheatgrass in less-managed or unmanaged habitats, 
becoming weeds and causing significant impact to the environment, 
resulting in huge economic costs.  This is in contrast to the antecedents of 
most GE crops, which are generally poor colonizers outside of the 
agroecosystem designed for their cultivation. 
 
The traits selected for domestication and the ongoing development of most 
crop plants typically have made them less fit than their undomesticated 
counterparts in situations where the crop plants are not managed (Gepts, 
2004).  Although there are exceptions, as discussed above, crop plants 
generally have relatively few weediness traits.  Thus, there are multiple 
and complex constraints that limit the weediness and invasiveness of 
typical agronomic crops and in most cases, only one such constraint would 
be removed by the addition of a single gene through genetic engineering.  
Hancock and Hokanson (2001) concluded that the risk of deploying GE 
plants can be effectively determined by considering the phenotype 
conferred by the transgene and the invasiveness of the antecedent crop.   
 
Crawley et al. (2001) performed one of the few studies of GE plants where 
potential weediness and invasiveness were measured directly.  This was 
done by monitoring different habitats for 10 years following the 
cultivation of four different GE crops, namely herbicide-tolerant sugar 
beet, maize, and rape, and potato producing either a Bt toxin or pea lectin.  
In none of the cases did the researchers find the GE crops to have 
increased fitness over that of the conventional controls, and no unintended 
effects for the particular crops were identified.  The most important factor 
to consider in interpreting these results, however, is that the particular 
traits studied would not be expected to increase fitness, except for the Bt 
toxin under certain conditions.  The authors noted that the results might be 
different for other types of traits, such as drought tolerance or certain pest 
resistance genes that might confer a fitness advantage under field 
conditions. 
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Pest resistance genes have been the focus of much attention in regards to 
plant fitness.  Virginia Polytechnic Institute and State University’s 
Information Systems for Biotechnology, with support from USDA, 
sponsored a workshop on “The Ecological Effects of Pest Resistance 
Genes in Managed Ecosystems” (Traynor and Westwood, 1999).  Many 
participants felt that the types of pest-resistance traits being tested or 
released commercially were not fundamentally different from those 
introduced through conventional breeding and as such, would present 
similar ecological risks.  However, some participants disagreed and 
contended that some transgenes could have a much greater impact on 
weediness.  Most participants agreed that gene stacking (i.e., insertion of 
multiple transgenes) to confer a broad spectrum of pest resistance would 
be less predictable, with respect to ecological consequences, than single-
trait resistance. 
 
Snow et al. (2003) reported field studies of wild sunflower populations 
carrying a Bt cry1Ac transgene acquired via experimental hybridization to 
a noncommercial GE crop line and backcrossed into the wild-type plants.  
The Snow team observed decreased insect pest damage and increased 
fecundity (seed production) for the experimental unmanaged populations 
carrying the transgene versus those without it.  This observation suggests 
the possibility that, by conferring increased fitness, the transgene could 
have an ecological impact on wild sunflower populations, by increasing 
the number of modified plants within a population, by creating more such 
populations, or by creating more extensive seed banks of such plants. 
 
(3) GE Crops and Invasiveness 
 
In addition to the development of weediness, there is concern that GE 
crops may escape cultivation and persist to a significant degree in 
unmanaged ecosystems.  It is also conceivable that a transgene from a GE 
crop could be transferred via cross-pollination to a wild relative of the 
crop, producing hybrid offspring containing the transgene that could 
themselves persist in the environment, or through introgression (by 
repeated natural backcrossing), resulting in the incorporation of the 
transgene in the genome of the wild relative. 
 
(4) Gene Flow via Escape of GE Crops 
 
For a GE crop to become established in an unmanaged habitat, seeds or 
other propagative structures must be transported from cultivated land to 
the habitat.  This can occur via seed spillage during the movement of 
harvesting equipment between cultivated fields or during the transport of 
harvested seed, or seed can be moved by animal activity, wind, or water.  
The abandonment of farms or fields is another potential method of GE 
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crops being introduced to an unmanaged environment, but only for 
deregulated GE crops.16  Nonseed propagative plant material, such as 
stolons or rhizomes, could be moved via mowing equipment or by animal 
activity, wind, or water.  However, the movement of seeds or other 
structures is independent of any transgenes in the crop genomes with 
which APHIS is familiar, so the escape of a GE crop is not inherently 
more likely than the escape of any other crop (Keeler, 1985).  Although it 
is conceivable that transgenes increasing seed-dispersal rates could be 
engineered into crop plants, it is highly unlikely that this would be done.  
A primary goal for crop variety development is the prevention of seed loss 
via seed dispersal mechanisms (Frary and Doğanlar, 2003) because the 
seed or fruit is usually the plant part with the highest value.  However, if 
seed-dispersal genes were to be altered in a crop plant, the resulting GE 
plants would merit increased scrutiny to verify that gene flow was not 
increased in ways causing significant environmental effects. 
 
(5) Gene Flow Via Hybridization With Wild Relatives 
 
The exchange of genes between crop plants and sexually compatible wild 
plants has occurred ever since plants were first domesticated.  It is 
possible that a transgene could be established in the genome of a wild 
relative of the GE crop as a result of an initial hybridization between a GE 
crop and its wild relative, followed by introgression of the transgene into 
the wild relative’s genome (Gealy, Mitten, and Rutger, 2003; Halfhill et 
al., 2004; Légère, 2005; Pilson and Prendeville, 2004).  For a transgene to 
become incorporated in a wild crop relative, crop pollen carrying the gene 
would first need to be carried via wind or insects or other pollinators to a 
plant present in the crop field as a weed or present in a nearby unmanaged 
habitat.  Conversely, pollen from a wild crop relative in the unmanaged 
habitat could be carried via wind or insects or other pollinators to a crop 
plant growing in a cultivated field.  Hybrid seed produced in the crop field 
would have to be harvested along with the crop and be spilled onto 
noncultivated land, as discussed above, or dispersed by an animal, 
whereas, the movement of crop pollen onto uncultivated land could result 
in the production of hybrids with no seed movement necessary. 
 
Hybridization between a GE crop and a wild relative is dependent on 
several key factors:  simultaneous flowering, sexual compatibility, and 
proximity sufficiently close to allow pollen movement between the two 
plants.  The first two factors are determined by the specific crop and wild 
relative, and can result in little or no outcrossing, as in the case of wheat, 
or frequent outcrossing, as in the case of rice, (Ellstrand, Prentice, and 
 
16  Under the terms of APHIS permits, fields planted with regulated GE plants may not be abandoned 
until it is established that there is no potential for any GE plants to volunteer in subsequent growing 
seasons. 
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Hancock, 1999).  However, even when a crop can hybridize with a wild 
relative, the plants must be close enough together to allow pollination to 
occur.  Again, this factor is different for every crop plant and depends on a 
variety of characteristics (including whether the crop is pollinated by 
wind, insects, or other pollinators), to what extent the crop is self-
pollinated, how long-lived the pollen is, and how the crop is cultivated.  
However, these parameters have been studied in-depth in many 
agronomically important crops, and the Association of Official Seed 
Certifying Agencies has established standard growing conditions for crop 
seed production in many crops which result in very low levels of 
outcrossing (AOSCA, 2003). 
 
(6) Invasiveness Potential 
 
Only a small fraction of introduced species become successfully invasive 
(Ellstrand and Schierenbeck, 2000), and there is no evidence that crops 
improved via genetic engineering are more likely than conventional crops 
to be invasive.  The potential for a GE crop or a GE crop/wild-relative 
hybrid to become invasive depends, first, on the ability of the plant to 
become established in the environment and second, on its ability to 
successfully persist and thrive.  Very few crops have been shown to be 
persistent and invasive outside of cultivation (Hancock and Hokanson, 
2001).17  Initial establishment of a crop plant will depend on the crop’s 
ability to survive without any human intervention.  This includes 
successfully competing with other plants for nutrients, water, pollinators, 
and sunlight; surviving attacks by diseases, insects, and other herbivores; 
and producing sufficient progeny or propagative structures to maintain its 
presence in the environment (Brown and Mitchell, 2001; Ellstrand and 
Schierenbeck 2000; Mitchell and Power, 2003).  The particular transgene 
introduced into the crop may also have some effect on the plant’s survival.  
Because the weediness and invasiveness of a particular crop is known 
throughout the U.S. range where the crop is produced, the invasiveness of 
a GE crop possessing one or more transgenes can be estimated by 
evaluating the environmental fitness impacts of the individual introduced 
genes (Hancock and Hokanson, 2001). 
 
In the case of GE crop/wild hybrids, establishment will depend on the 
fertility and overall vigor of the hybrid plants and their progeny (Vacher 
et al., 2004) as well as on the nature of the transgene.  For example, 
naturally occurring hybrids between wheat and its distant relative jointed 
goatgrass are occasionally found, but the hybrids are usually self-sterile 
                                         
17  Crops considered to be persistent and sometimes invasive include barley, rapeseed, rice, 
sorghum, sunflower, and wheat.  Crops considered to be persistent but not invasive include apple, 
asparagus, blueberry, cranberry, pear, poplar, spruce, and strawberry (Hancock and Hokanson, 
2001).  
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due to a lack of proper chromosome pairing (Guadagnuolo, Savova-
Bianchi, and Felber, 2001; Morrison et al., 2002; Seefeldt et al., 1998).  
However, it is also possible for interspecific and intergeneric crosses to 
exhibit enhanced fitness through heterosis, an increase of genetic diversity 
caused by hybridization (Vacher et al., 2004).  A hybrid may possess a 
novel combination of traits, making it more able to adapt to an ecological 
niche than either of the parents (Ellstrand and Schierenbeck, 2000).  In 
other words, each type of hybrid may exhibit unique and possibly 
unexpected characteristics.  For example, hybrids between oilseed rape 
and wild radish are more fit when wild radish is the maternal parent 
(Gueritaine et al., 2002).  But even so, fitness is very low and dependent 
on the particular environmental circumstances (Al Mouemar and 
Darmency, 2004; (Gueritaine et al., 2002).  Fortunately, years of 
experience with cultivation and plant breeding have resulted in an 
extensive and growing body of information regarding the likelihood of 
hybridization between crops and their wild relatives and the fitness and 
fertility of these hybrids (Arriola, 1997; Stewart, Halfhill, and Warwick, 
2003). 
 
(7) Persistence of GE Crops in Natural Environments 
 
The likelihood for a GE plant to persist in the environment depends 
primarily on the plant species and on the ecosystem in question, including 
competing species, diseases and herbivorous pests, and the physical 
environment.  One factor that can be analyzed experimentally is whether 
the GE version of a crop plant has better field performance, that is, is more 
fit, or persists longer than a conventionally bred version of the crop.  A 
recent study asked this question using GE and conventional varieties of 
corn, oilseed rape, sugar beet, and potato growing for 10 years in 
12 natural habitats in Britain.  The transgenes studied were for herbicide 
resistance, Bt toxin, and pea lectin (Crawley et al., 2001).  The study 
found that none of the GE crops were more fit or persisted longer in the 
environment than the conventional crop counterparts.  Establishment of 
seedlings of the herbicide-resistant corn and rapeseed was significantly 
lower than for the conventional versions of the crops, and survival of the 
GE potato lagged behind that of conventional potato (Crawley et al., 
2001).  However, it must be noted that none of the transgenes at issue in 
the study were intended to increase plant fitness in natural habitats. 
 
There is little evidence that beneficial agronomic traits moved into crops 
via conventional breeding have led to the development of invasiveness in 
crop plants (Duvick, 1999).  Similarly, it is unlikely that the mere entry of 
a GE crop plant into an unmanaged ecosystem will result in the permanent 
establishment of the plant in that ecosystem.  To evaluate the 
environmental impact of a GE crop, researchers begin with the body of 
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knowledge developed through years of cultivating the non-GE version of 
the crop, including any information about its weedy or feral tendencies.  It 
is then possible to superimpose any effects of the transgene on the already 
familiar traits of the non-GE crop (Parker and Kareiva, 1996).  A 
systematic experimental approach, where the field performance of a GE 
crop and its non-GE counterpart are thoroughly compared in the 
greenhouse and in the field, should indicate whether the transgene has any 
unexpected effects on characteristics that could contribute to invasiveness 
(Wang et al., 2003). 
 
The transgene may or may not confer any advantage to the GE plant, 
depending on the nature of the gene, the ecosystem, and the presence of 
human intervention or other factors that may provide sporadic or 
continuously acting selection pressure such as herbicide application, insect 
or disease attack, or environmental stress.  Without this pressure, the 
transgene’s effects would not be expected to manifest themselves, and the 
GE plant would be expected to be phenotypically indistinguishable from 
its non-GE counterparts in that particular environment (Vacher et al., 
2004).  For example, a transgene conferring herbicide tolerance would not 
increase fitness for the recipient plant unless the natural habitat was 
regularly treated with the appropriate herbicide (Pilson and Prendeville, 
2004; Metz, Stiekema, and Nap, 1998).  Lacking such management, the 
GE plants would not be expected to be any more fit than conventional 
plants of the same species (Pilson and Prendeville, 2004; Gueritaine et al., 
2002).  If, however, regular herbicide applications were used, the GE 
individuals could have a significant advantage over their non-GE 
counterparts.  However, not every transgene would be expected to respond 
to selection pressure.  For example, a crop containing a transgene that 
alters a food-quality trait is unlikely to have any effect on plant fitness 
because there is unlikely to be a corresponding selection pressure for the 
trait (Parker and Kareiva, 1996). 
 
If the transgene confers insect or disease resistance, the recipient plant 
may gain a fitness advantage, but only if the insect pest or disease 
organism ordinarily acts to control the normal distribution or role of that 
plant in that particular environment (Parker and Kareiva, 1996).  In that 
case, it would be expected for the GE plant, whether crop or wild-relative 
hybrid, to have a fitness advantage over other plants in the environment 
(Vacher et al., 2004).  The greater the impact of the insect pest or disease 
on the vigor and reproductive potential of the plant population, the more 
likely it is for the GE plant to have a fitness advantage over non-GE 
counterparts (Parker and Kareiva, 1996).  Over the course of many 
generations, with continuous selection pressure from the insect pest or 
disease, the GE plant could become invasive, in the case of a crop plant, or 
could replace the non-GE population, in the case of a GE wild relative. 
 
78 IV.  Environmental Consequences 
If the transgene in question confers an agronomic characteristic, such as 
drought tolerance or increased photosynthetic efficiency, the recipient 
plant could become invasive or replace its non-GE counterpart but only if 
a corresponding environmental stress consistently acts to control the plant 
populations in that ecosystem (Pilson and Prendeville, 2004). 
 
APHIS anticipates that as plant genetic-engineering technology advances, 
applicants will propose, with greater frequency, field tests of plants with 
traits such as increased photosynthetic efficiency and tolerance to various 
environmental stresses.  Such traits, either singly or in combination, could 
contribute to the invasiveness of a GE crop, or GE crop/wild-relative 
hybrid, or introgressed progeny.  However, given that most crop plants are 
not naturally invasive and that most cultivated crops possess several 
domestication traits (Frary and Doğanlar, 2003; Gepts, 2002), such as 
dwarfing, nonshattering seed heads, and larger fruits, which usually are 
disadvantageous in unmanaged ecosystems, it has been proposed that a 
single plant would have to possess several transgenes conferring improved 
fitness characteristics before it would become invasive (Hancock and 
Hokanson, 2001).  The insertion of multiple genes affecting fitness in a 
single plant, so-called stacking, is more likely as genetic engineering 
technology advances, and plants with such gene stacks would receive 
additional scrutiny to determine their potential for weediness or 
invasiveness. 
 
A single instance of gene flow to an unmanaged ecosystem or a transgene 
into a wild relative may not result in the development of an invasive 
population of GE plants (Ellstrand and Schierenbeck, 2000; Siemann and 
Rogers, 2001).  Even if the initial introduction succeeds, a lag time of 
several generations may be necessary during which time the introduced 
species may undergo genetic adaptation, ultimately making the plants 
better able to survive in their new environment than other species or non-
GE populations of the same species (Siemann and Rogers, 2001; Willis, 
Memmott, and Forrester, 2000).  Multiple introductions via repeated 
instances of gene flow may be necessary before a potentially invasive 
species can become established (Pilson and Prendeville, 2004; Ellstrand 
and Schierenbeck, 2000).  Delays in the development of invasiveness may 
also depend on the crop or crop relative in question (Ellstrand and 
Schierenbeck, 2000).  For example, trees, shrubs, and other perennial 
plants with long reproductive cycles may take decades or longer to 
develop invasiveness, assuming no human intervention, while annual 
plants or short-lived perennials may become invasive only a few years 
after an inadvertent instance of gene flow (Ellstrand and Schierenbeck, 
2000).  Minimizing the size and frequency of transgene flow to 
unmanaged ecosystems is, therefore, the most direct way to minimize the 
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development of invasiveness both in the short term and over long lag 
periods. 
 
b. Potential Effects of GE Plants on Soil 
 
In assessing the potential risks of GE plants, another key consideration is 
whether or not modified organisms will alter or impact the soil 
environment.   
 
Plants and the soil and water environments in which they reside are 
inarguably intertwined.  The plant-soil matrix is a complex environment of 
interactions between abiotic and biotic components.  These interactions 
can be considered on both a small and large scale.   
 
On the small scale, seeds germinate within the soil; the resulting seedlings 
and plants interact with the soil and also the micro-organisms and water 
within it to obtain nutrients.  The nutrients fuel vital functions, such as 
growth and reproduction.  The soil is then enriched through plant 
decomposition by scavengers and other soil-dwelling organisms.   
 
Interactions also exist on a large scale.  Traditional agricultural practices, 
including tillage, irrigation, and herbicide and pesticide use have 
significant and predominately detrimental environmental impacts 
(Ammann, 2005).  Both scales of interactions should be considered when 
evaluating the potential effects of GE plants on soil and water 
environments. 
 
Soil is a highly dynamic environment.  A single gram of soil typically 
contains millions of individual organisms, including several thousand 
species of bacteria alone (Torsvik et al., 1994).  These organisms enable 
decomposition, which leads to soil formation, aeration, and nitrogen 
fixation, and aid in root function (Giller et al., 1997).  The immense 
number of organisms and the complicated and poorly understood 
relationships between these organisms, the environment, and plants 
complicate the analysis of the potential effects of introducing GE plants 
and other organisms (Lilley et al., 2006). 
 
The text that follows discusses the factors that are considered when 
evaluating the potential effects of particular genes on the soil and 
groundwater environments. 
 
(1) Accumulation and Persistence 
 
Some traits added to plants via genetic engineering involve the production 
of one or more substances that the plant would normally not produce.  
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Novel chemical substances produced by GE plants may enter the 
environment from leaf shedding, root exudates, and decomposition 
(Donegan et al., 1997).  If these substances do not dissipate at a rate at 
least equal to the rate of the products’ entry to the soil system, 
bioaccumulation and biomagnification may result.  Bioaccumulation is the 
increase in concentrations of chemicals in biological systems over time as 
compared to the chemical’s concentration in the environment.  This occurs 
when a chemical becomes more and more concentrated as it moves up the 
food chain. 
 
Additionally, herbivorous animals that feed on these plants and 
subsequently die, either due to natural causes or due to consuming a 
pesticidal substance such as a Bt toxin, may also add these novel chemical 
substances to the soil environment.  The substances in the plant may not 
necessarily be in the same form in the insect.  For example, the Bt 
protoxins made by insect-resistant GE plants are modified in the guts of 
susceptible insects (Höfte and Whiteley, 1989). 
 
Bt crops offer the best-studied example to date of accumulation, 
persistence, and residual toxicity within the soil (Clark et al., 2005; Höfte 
and Whiteley, 1989; Saxena et al., 1999).  For example, studies have 
compared the decomposition rates of Bt and non-Bt crop residues, 
although with inconsistent results (Cortet, 2006; Stotzky, 2004).  The 
binding of chemical substances by soil particles is also a factor.  The Bt 
toxins adsorb and bind rapidly (< 30 minutes) to clays and organic matter 
within the soil, allowing the Bt toxins to persist and also to remain toxic to 
insect larvae (Stotzky, 2000, 2002).  In nonflooded soils, the Bt toxins 
released from root exudates and biomass of Bt corn were bound to soil 
particles and remained larvicidal for at least 180 days (Tapp and Stotzky, 
1998), and toxins remained detectable in the biomass of Bt corn 3 years 
after incorporation into soil (Saxena and Stotzky, 2003).  The Bt 
endotoxin associated with Bt crops appears to degrade rapidly in water, 
with a half-life between 4 and 10 days, depending on the presence of 
micro-organisms (Douville et al., 2005).  This result suggests that the 
persistence of Bt toxin in water bodies adjacent to land planted with Bt-
engineered crops is not a significant concern; however, more studies need 
to be done to further evaluate persistence in soil and sediments in water 
bodies.  Obviously, soil and natural bodies of water are not sterile 
environments, and many abiotic and biotic factors will affect persistence 
such as soil type, aeration, water movement, and soil biota activity. 
 
GE plants may add more than novel chemical substances into the soil.  
DNA is also released into the soil as organisms decompose.  Clay minerals 
bind DNA molecules and can prevent vertical movement of DNA within 
the soil and thus, delay DNA degradation by protecting free DNA from 
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degradation (Greaves and Wilson, 1970).  The presence of DNase in the 
soil can also affect the accumulation and persistence of DNA in soil 
(Blum, Lorenz, and Wackernagel, 1997; and Dunfield and Germida, 
2004).  Studies so far have demonstrated persistence of GE DNA in soil 
from several days (Widmer et al., 1997) to at least 2 years (Gebhard and 
Smalla, 1999).  The impacts of DNA in the soil are discussed later in this 
section. 
 
Biomagnification and bioaccumulation of products released by GE 
organisms should be considered and compared with similar, potentially 
cumulative effects from traditional crops (Sanvido et al., 2006).  APHIS is 
unaware of any studies or data demonstrating bioaccumulation or 
biomagnification as a result of planting GE plants.  In cases where, 
biomagnification and bioaccumulation are likely, expression of transgenes 
in GE organisms can be manipulated in ways that may mitigate those 
undesirable phenomena.  For example, new techniques that limit the 
expression to specific plant parts rather than the whole plant or prevent 
expression except in the presence of specific environmental stimuli can 
significantly limit how much of these products enter the soil. 
 
(2) Water and Movement Away From the Site 
 
Water can move products from GE organisms away from the immediate 
site of entry into the soil environment.  Precipitation, runoff, and irrigation 
will provide transport for these products through the soil column.  These 
products can enter groundwater, where they may be transported to larger 
underground reservoirs used for drinking water, or to neighboring streams 
via underground conduits.  Soil factors affecting how water will move GE 
products include, but are not limited to, soil type, texture, permeability, 
and the depth of the water table. 
 
Besides interactions on the small scale (e.g., increasing the number of 
organisms that are exposed as products of GE crops are carried by water 
out of the rhizosphere), there are large-scale impacts that should be 
considered.  For example, currently available GE glufosinate- and 
glyphosate-tolerant crops allow farmers to replace triazine and 
chloroacetanilide herbicides with less toxic and less environmentally 
damaging glufosinate- and glyphosate-based herbicides.  These herbicides 
are readily degraded by soil-dwelling bacteria and fungi.  Accordingly, 
they have a lower potential to reach water resources, leading to reduced 
risk of drinking water contamination and improvements in the water 
quality of vulnerable watersheds (Wauchope et al., 2001). 
 
 
 
 
82 IV.  Environmental Consequences 
(3) Interactions With Soil Organisms 
 
Soil- and plant-associated microbial communities and their interactions are 
not well understood, and modern agricultural cropping systems can affect 
these interactions (Dunfield and Germida, 2004).  Soil communities are 
incredibly diverse and include beetles, springtails, mites, worms, spiders, 
nematodes, fungi, bacteria, and other organisms.  Only a small portion of 
species within the classes of soil organisms have been described.  For 
example, as many as 35,000 soil-dwelling fungi have been identified, 
while the projected number is greater than 100,000 (Hawksworth, 1991).  
These organisms improve the entry and storage of water, soil mixing, 
resistance to erosion, plant nutrition, and breakdown of organic matter 
(Giller et al., 1997).  
 
Plants develop mutually beneficial relationships with soil organisms in the 
rhizosphere, and these relationships are heavily affected by metabolites 
released by plants into the soil.  Root exudates have been proposed to be 
the most important factor in the development of the rhizosphere microflora 
(Lynch and Whipps, 1991).  Genetic modifications in plants may alter 
these root exudates and affect the associated microflora (Pilson and 
Prendeville, 2004).  The incorporation of plant residues into the soil may 
affect organisms that are not directly associated in a mutualistic 
relationship with the plant but serve indirectly beneficial functions (e.g., 
scavengers and decomposers), or that protect plants from detrimental 
micro-organisms (Bashan and Holguin, 1998).  The degree to which these 
effects result in measurable changes to soil ecosystems may be difficult to 
assess.  Additionally, the origin of the transgene should be considered.  
For example, soil-dwelling organisms are likely to have had previous 
exposure to proteins from Bacillus thuringiensis, a naturally occurring soil 
bacterium, which potentially mitigates the impact of Bt crops on soil 
ecosystems. 
 
It is difficult to summarize the results of studies evaluating the impact of 
GE plants on soil-dwelling organisms because these impacts are tightly 
associated with the plant, the engineered trait, and the environment 
(Griffiths, Geoghegan, and Robertson, 2000).  The specific soil-associated 
community is also difficult to characterize.  The microbial community 
found at one field site may be entirely different from that at another field 
site (Dunfield and Germida, 2001; Blackwood and Buyer, 2004; 
Muchaonyerwa et al., 2004; Wu et al., 2004; Castaldini et al., 2005; 
Saxena and Stotzky, 2001; Donegan et al., 1996; Duan et al., 2004; and 
Milling et al., 2004).  The results of studies evaluating soil effects from 
GE plants thus far suggest that the impact on the microbial and 
invertebrate communities from GE crops, as compared to conventional 
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crops, was minor when compared to other factors, such as seasonal and 
environmental effects (Sanvido, et al., 2006; Milling et al., 2004). 
 
Interactions between the plant and soil organisms may also change due to 
unintended effects on plant traits and defense abilities, leading to reduced 
plant fitness.  For example, studies have suggested that the application of 
glyphosate increased populations of various fungi in the soil (Brammall 
and Higgins, 1987) and also suppressed natural plant defenses and 
enhanced disease susceptibility in crops and weeds (Wrather, Stienstra, 
and Koenning, 2001; and Myers et al., 1999).  However, further studies 
have been unable to link glyphosate resistance with disease susceptibility 
(Sanogo, Yang, and Schrem, 2000).  Certainly non-GE plants are not 
immune to changes in the soil community and disease prevalence due to 
unpredictable environmental events.  Also, it is not clear that genetic 
modification necessarily makes plants more susceptible to deleterious soil 
organisms. 
 
Large-scale interactions resulting from standard agricultural practices 
could influence the incorporation of products from GE plants into the soil 
and the exposure of soil organisms.  For example, the tillage system 
employed by the grower could influence the amount of interaction that 
occurs between GE plant-produced proteins and other substances and the 
microbial community (Angle, 1994).  Direct-seed (no-till) cropping 
systems preserve fertile soil and reduce the amount of sediment that enters 
streams adjacent to farmland, a major pollutant of streams.  A report 
released by the Conservation Technology Information Center identified 
the largest growth in no-tillage practice occurring where herbicide-
tolerance technology is utilized, achieving weed control through the 
application of herbicides without damaging the crop (Fawcett and Towery, 
2002).  No-till systems keep the GE plant material at the surface, limiting 
contact with soil organisms to those at the surface.  On the other hand, 
with conventional tillage the GE plant material will be incorporated into 
the soil, potentially diluting the products but also increasing the number of 
organisms exposed. 
 
(4) Horizontal Gene Transfer  
 
Horizontal gene transfer (HGT) is the natural transfer of genetic material 
from one organism (the donor) to another organism (the recipient) that is 
not sexually compatible with the donor (Gay, 2001).  Though HGT is 
thought to be extremely rare, the transfer of chromosomal DNA between 
bacterial species is considered to represent a significant mechanism for 
their evolution (Nielsen, Bones, Smalla, van Elsas, 1998).  Plant DNA can 
persist in the soil (Gebhard and Smalla, 1999), triggering concern that 
transgenes from GE plants may spread horizontally to bacteria. 
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HGT is relevant to the assessment of risks to the soil environment because 
of the nature of some of the genes used to develop GE organisms.  For 
example, there is concern that bacterial antibiotic resistance markers, used 
in the process of selecting GE cells, may undermine the clinical use of 
antibiotics (Metz and Nap, 1997).  Theoretically, resistance could spread 
to recipient micro-organisms in soil or in the digestive tracts of humans 
and livestock (Dröge, Pühler, and Selbitschka, 1998).  There is general 
consensus that such HGT from plant tissue to micro-organisms would 
happen at extremely low frequencies and has not been observed under 
natural conditions (i.e., in the absence of heavy selection pressure), but 
must be considered on a case-by-case basis, taking into account the nature 
of the antibiotic resistance and its occurrence in the environment. 
 
The plant surface and the immediately surrounding environment have 
been shown to be areas where HGT could occur, likely due to nutrient 
availability, high humidity, and proximity of colonizing bacteria on the 
limited growth surface (Björklöf et al,. 1995).  Studies have been made of 
HGT in terrestrial and aquatic habitats by viruses (Kidambi, Ripp, and 
Miller, 1994) and by natural transformation, the uptake of free DNA into 
competent bacteria (Bertolla et al,. 1999).  Particular elements within the 
rhizosphere and certain plant exudates can affect transformation 
frequencies (Nielsen and van Elsas, 2001).  However the rate of natural 
transformation in soil is extremely low; in sterile soil, natural 
transformation has been shown to occur at rates below 10-7 transformants 
per recipient (Nielsen, van Elsas, and Smalla, 2000) and is estimated to be 
as low as 10-10 or 10-11 transformants per recipient in nonsterile soil 
(Smalla, Borin, Heuer, Gebhard, van Elsas, and Nielsen, 2000).  These 
rates are much less frequent than natural spontaneous mutation rates in 
bacteria (Drake et al., 1998). 
 
There are a number of mitigating factors that suggest that HGT is not a 
significant concern when examining the potential effects of GE plants on 
soil-dwelling organisms.  First, several events would have to take place 
successfully for HGT to occur.  In order for natural transformation, that is, 
uptake of free DNA by soil bacteria, to occur in the soil environment, free 
DNA needs to be available.  The persistence of DNA in the soil was 
discussed above.  There must also be bacteria in close proximity to the 
free DNA which are capable of taking up the DNA.  Some bacteria, called 
“naturally competent,” have evolved the ability to transport free DNA 
from outside the bacterial cell into the cytoplasm; however, not all 
bacterial species are competent, and not all competent bacteria are 
competent all of the time.  The transgene must then be incorporated and 
maintained by the recipient organism (Gebhard and Smalla, 1998).  
Maintenance of the transgene requires that the alteration is nondetrimental 
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to the fitness of the organism and therefore, will not be negatively affected 
by selection. 
 
Transfer of a plant gene to a bacterium does not equal functionality in the 
bacterium.  Regulatory sequences (promoters, enhancers) may not work 
and introns may not be recognized in the recipient (Conner, Glare, and 
Nap, 2003).  As the risk of HGT from GE plants is considered, it is 
necessary to bear in mind that the transgene portion of a GE plant’s DNA 
is a very small part of its total DNA.  Therefore, the likelihood that a piece 
of native DNA undergoes HGT is significantly greater than for a given 
piece of transgene DNA (Conner, Glare, and Nap, 2003). 
 
Second, the antibiotic-resistance genes commonly used for genetic 
engineering have limited use in treating infections.  The most popular 
selectable marker gene, nptII, confers resistance to kanamycin, which has 
limited therapeutic value as an antibiotic; hygromycin, another antibiotic 
used in molecular biology, is too toxic for therapeutic use (Conner, Glare, 
and Nap, 2003).  New genetic transformation methods rely less on 
antibiotic-resistance marker genes, either by using other types of markers 
or by eliminating marker genes entirely.  As a result, the already small 
potential HGT of antibiotic-resistance genes is likely to continue to 
diminish in significance. 
 
Third, although HGT between bacteria has been extensively demonstrated 
in natural systems (Nielsen et al., 1998), no evidence has been found of 
plant DNA moving to native soil micro-organisms (Badosa, Moreno, and 
Montesinos, 2004; Heinemann and Traavik, 2004; and Maynard Smith, 
Dowson, and Spratt, 1991).  The lack of information on the abundance of 
naturally competent bacteria in the environment, frequencies of 
transformation processes, and environmental factors triggering these 
processes makes predicting HGT from plants to bacteria difficult 
(Gebhard and Smalla, 1999).  However, the probability of HGT is 
extremely low, and the evidence, thus far, indicates that HGT does not 
pose a significant risk for the transfer of traits from GE organisms.   
 
In conclusion, comparing the risks of GE plants and their non-GE 
counterparts for the management of physical, chemical, and biological 
aspects of soil ecology is important for sustainability of agroecosystems.  
The dynamic nature of the soil and its components and the lack of 
comprehensive research on soil interactions make it difficult to draw any 
definitive conclusions about the effects of products derived from GE 
plants entering the system Bruinsma et al., 2002).  Traditional agriculture 
and its associated activities have significant, often detrimental, impacts on 
soil’s abiotic and biotic components, and it is, thus far, unclear whether 
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introducing GE materials increases or possibly alleviates these detrimental 
impacts. 
 
c. Genetically Engineered Crops and Potential Impacts on 
Human Health 
 
In addition to considerations of potential weediness, invasiveness, and soil 
impacts, another critical focus in assessing the potential risks of GE plants 
is upon the potential impacts of GE crops on human health.  By its nature, 
this area of consideration is the one which receives the widest public 
attention. 
 
This section briefly addresses some of the prominent issues associated 
with the safety of GE crops used as human food and animal feed.  The 
issues addressed in this section, ranging from potential allergenicity and 
toxicity to nutritional quality, are more thoroughly reviewed in numerous 
publications and guidance documents that are publicly available.  The 
NRC (NRC, 2004), the Codex Alimentarius Commission (Codex, 2003, 
2003), and the United Nation’s Food and Agriculture Organization (FAO) 
and World Health Organization (WHO) (FAO/WHO, 2000, 2001) have 
developed guidance for assessing the safety of foods derived from GE 
crops.  In addition, numerous other publications are available from 
researchers and others that address the safety assessment of foods derived 
from GE crops (Astwood and Fuchs, 1996; Fuchs and Astwood, 1996; 
Fuchs and Goodman, 1998; Lehrer, Horner, and Reese, 1996; Mendelsohn 
et al., 2003; Metcalfe, Fuchs et al., 1996; Metcalfe, 2003). 
 
As essential background for this section, it is important first to 
acknowledge the history of genetic modification and briefly discuss those 
Federal agencies that have regulatory roles concerning GE organisms and 
products. 
 
The term “genetic modification” can be used to describe various methods 
of altering a plant’s genetic makeup resulting in the expression of different 
traits or characteristics than its parent (NRC, 2004).  In fact, crop plants 
have been genetically modified throughout history to produce plants with 
desired traits (Day, 1996; Kessler et al., 1992; NRC, 2004).  Crop 
developers introduce many new crop varieties intended for food and feed 
into the market every year that may have characteristics such as insect 
resistance, higher yield, or improved nutritional attributes (Fuchs and 
Astwood, 1996; Kessler et al., 1992; Metcalfe, Astwood et al., 1996).  
Each method of genetic modification, including the two most common 
methods currently employed—traditional breeding and genetic 
engineering—requires some level of human intervention (NRC, 2004).  
Traditional breeding techniques have been employed for centuries, while 
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genetic engineering became a prominent method of plant genetic 
modification only late in the 20th century (Kessler et al., 1992; NRC, 
2004). 
 
All methods of genetic modification alter a plant’s genetic makeup 
resulting in changes in characteristics such as plant color, flavor, nutrient 
content, disease resistance, and tolerance to environmental stress (Kessler 
et al., 1992).  While many of the potential changes in the plant’s genetic 
makeup will be intentional, a number of unintentional changes can also 
occur (Fuchs and Astwood, 1996; Kessler et al., 1992; Metcalfe, Astwood 
et al., 1996).  These unintentional changes can have positive, as well as 
negative, effects on human health.  In most instances, phenotypic changes 
such as plant color, growth, and production can be identified during the 
plant breeding and selection process, while some changes such as changed 
levels of compositional components (e.g., nutrients, allergens, toxicants, 
and antinutrients) may not be apparent without additional analysis. 
 
Traditionally, new varieties of whole foods have not been subjected to 
extensive chemical, toxicological, or nutritional evaluation prior to 
marketing (CODEX, 2003).  The regulatory agencies that oversee the 
safety of food from GE plants do not evaluate food from new, traditionally 
bred crop varieties for human or animal health safety (NRC, 2004).  While 
most crops naturally produce some level of allergens, toxins, and 
antinutrients, standard plant-breeding practices allow for monitoring the 
levels of potentially hazardous substances (NRC, 2004).  The history of 
crop development has shown that, except in very rare instances, these 
standard crop-development techniques include steps that make it possible 
to identify potential hazards in crop lines developed for commercialization 
(Kessler et al., 1992; NRC, 2004; Pastorello et al., 1998). 
 
Unlike traditional breeding, genetic engineering gives developers the 
ability to move genes into crop plants from organisms that may not have 
historically been part of the diet of humans and animals.  Given this 
potential, there is some concern about the possibility of moving into a crop 
used for food or feed a gene whose gene product may be allergenic or 
toxic (NRC, 2004).  While the ability to move potentially toxic or 
allergenic genes is not unique to genetic engineering, biotechnology 
techniques can enable the movement of genes between a broader group of 
species (e.g., plants, insects, and micro-organisms). 
 
The U.S. Government is guided by a Coordinated Framework (51 FR 
23302, 1986) which outlines the roles of APHIS, EPA, and FDA in the 
oversight of GE crop safety.  The Coordinated Framework concluded that 
the products of biotechnology do not differ fundamentally from 
unmodified organisms or from conventional products; that the product, 
 
88 IV.  Environmental Consequences 
rather than the process, should be regulated; that the regulations should be 
based on the end use of the product; and that review should be conducted 
on a case-by-case basis.  The Coordinated Framework states that no new 
statutes (laws) are needed to regulate biotechnology products, but that new 
regulations would be required.  While the regulatory authority for APHIS 
focuses on plant health, both EPA and FDA have responsibility to ensure 
the safety of human food and animal feed derived from GE plants.  EPA is 
responsible for the human/animal health and environmental safety of any 
pesticidal substance produced in these plants.  FDA is responsible for the 
safety of the whole food product other than the pesticidal component 
regulated by EPA. 
 
(1) Potential Allergenicity of Newly-expressed Proteins in Foods 
Derived from GE Plants 
 
Agricultural crops and the thousands of different proteins that they contain 
are common components of our food supply.  Some of these proteins have 
been well characterized while others have undergone little or no scrutiny.  
Nevertheless, we know that humans have been exposed to a wide variety 
of foods for thousands of years, and consumption of the vast majority of 
proteins found in foods presents little or no risk of adverse reactions 
(Metcalfe, Fuchs et al., 1996). 
 
However, there are a number of proteins that have been identified or 
characterized for their ability to induce allergic reactions (Fuchs and 
Astwood, 1996).  While more than 160 foods and food-related substances 
have been associated with allergic reactions, a small group of foods 
including eggs, milk, fish, crustaceans, mollusks, peanut, soybean, wheat, 
and tree nuts are responsible for greater than 90 percent of allergic 
reactions in adults (Fuchs and Astwood, 1996).  Overall, only a small 
portion of the adult population—less than 2 percent—is considered to 
have food allergies (Kimber, Lumley, and Metcalfe, 1997).  While the 
severity of food allergy can vary significantly, when an allergy to a food 
item is confirmed, individuals are usually allergic to only a few specific 
proteins in one or two specific foods (Metcalfe, Fuchs et al., 1996).  On a 
percent basis, children have food allergies slightly more frequently than 
adults, with children being most frequently allergic to milk and eggs.  
Most food allergies in children disappear by adulthood (Kimber, Lumley, 
and Metcalfe, 1997; Metcalfe, Fuchs et al., 1996). 
 
Although scientific methods continue to evolve, there is no one test that 
can be used to assess the allergenic potential of a protein (Goodman et al. 
2005; Spök et al. 2005).  Because of this, the potential allergenicity of a 
protein is typically assessed based on its source and structural 
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characteristics when compared to the structural characteristics of known 
allergens. 
 
(a) Approaches to Allergenicity Assessment 
 
Several scientific literature reviews focus on engineered foods and food 
allergy published by members of industry and academia (Astwood and 
Fuchs, 1996; Astwood, Leach, and Fuchs, 1996; Gendel, 1998; 1998a; 
Lehrer, Horner, and Reese, 1996; Sampson and Metcalfe, 1992).  In 1996, 
the International Food Biotechnology Council (IFBC), in collaboration 
with the Allergy and Immunology Institute (AII) of the International Life 
Sciences Institute (ILSI), published a peer-reviewed report that proposed 
an approach to evaluating allergenicity of proteins in bioengineered foods 
(Metcalfe, Fuchs et al., 1996).  The approach taken by the scientists 
participating in this effort used a decision tree for the assessment of 
potential allergenicity. 
 
In 2000, FAO and WHO convened a Joint Expert Consultation on Foods 
Derived from Biotechnology and published a report on the safety aspects 
of bioengineered plants that included a discussion of allergenicity 
(FAO/WHO, 2000).  That report supported the approach to allergenicity 
assessment described in the 1996 ILSI/IFBC report and adopted a slightly 
modified version of the 1996 ILSI/IFBC decision tree. 
 
In January 2001, the Joint FAO/WHO Consultation on Foods Derived 
from Biotechnology was convened specifically to provide scientific advice 
in relation to the assessment of allergenicity of GE foods (FAO/WHO, 
2001).  The consultation focused on several items, including the general 
issues of allergenicity of bioengineered foods, the reevaluation of the 
decision tree for the assessment of allergenicity of bioengineered foods 
developed in the 2000 FAO/WHO report (FAO/WHO, 2000), and the 
development of standardized procedures for the use of the decision tree.  
After consideration of the current status of scientific information and 
extensive discussion, these scientists developed a new decision tree.  It 
built upon previous approaches to examining allergenicity but also 
included several additional strategies.  These strategies are targeted serum 
screening of proteins from sources with no known history of allergenicity, 
targeted serum screening of protein from sources with no sequence 
homology to known allergens, the use of animal models, and the 
elimination of human testing. 
 
In 2003, the Codex Alimentarius Commission adopted internationally 
accepted principles and guidelines for the evaluation of the safety of foods 
derived from GE plants, including “Principles for the Risk Analysis of 
Foods Derived from Modern Biotechnology” and “Guidelines for the 
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Conduct of Food Safety Assessment of Foods Derived from Recombinant-
DNA Plants” (Codex Plant Guideline).  The Codex Plant Guideline 
contains an annex on the Assessment of Possible Allergenicity (Codex 
Allergenicity Annex) (Codex, 2003), which is reproduced below.  The 
Codex Allergenicity Annex acknowledged that there is no definitive test 
that can be relied upon to predict allergic response in humans to a protein 
new to the food supply and recommended a “weight of evidence” 
approach.  In the development of this approach, scientific information, 
previously published allergenicity assessment strategies, and countries’ 
experience in assessing the safety of new proteins in foods derived from 
GE crops were all taken into account. 
 
ANNEX:  ASSESSMENT OF POSSIBLE ALLERGENICITY 
 
Section 1—Introduction 
 
1.  All newly expressed proteins18 in recombinant-DNA plants that could 
be present in the final food should be assessed for their potential to cause 
allergic reactions.  This should include consideration of whether a newly 
expressed protein is one to which certain individuals may already be 
sensitive as well as whether a protein new to the food supply is likely to 
induce allergic reactions in some individuals. 
 
2.  At present, there is no definitive test that can be relied upon to predict 
allergic response in humans to a newly expressed protein: therefore, it is 
recommended that an integrated, stepwise, case-by-case approach, as 
described below, be used in the assessment of possible allergenicity of 
newly expressed proteins.  This approach takes into account the evidence 
derived from several types of information and data since no single 
criterion is sufficiently predictive. 
 
3.  The endpoint of the assessment is a conclusion as to the likelihood of 
the protein being a food allergen. 
 
Section 2—Assessment Strategy 
 
4.  The initial steps in assessing possible allergenicity of any newly 
expressed proteins are the determination of the source of the introduced 
protein; any significant similarity between the amino acid sequence of the 
protein and that of known allergens; and its structural properties including 
 
18  This assessment strategy is not applicable for assessing whether newly expressed proteins are 
capable of inducing gluten-sensitive or other enteropathies.  The issue of enteropathies is already 
addressed in Assessment of possible allergenicity (proteins), paragraph 42 of the Guideline for the 
Conduct of Food Safety Assessment of Foods Derived from Recombinant-DNA Plants.  In addition, 
the strategy is not applicable to the evaluation of foods where gene products are down regulated for 
hypoallergenic purposes. 
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but not limited to, its susceptibility to enzymatic degradation, heat 
stability, and/or acid and enzymatic treatment. 
 
5.  As there is no single test that can predict the likely human IgE response 
to oral exposure, the first step to characterize newly expressed proteins 
should be the comparison of the amino acid sequence and certain 
physicochemical characteristics of the newly expressed protein with those 
of established allergens in a weight of evidence approach.  This will 
require the isolation of any newly expressed proteins from the 
recombinant-DNA plant, or the synthesis or production of the substance 
from an alternative source, in which case the material should be shown to 
be structurally, functionally, and biochemically equivalent to that 
produced in the recombinant-DNA plant.  Particular attention should be 
given to the choice of the expression host since post-translational 
modifications allowed by different hosts (i.e., eukaryotic vs. prokaryotic 
systems) may have an impact on the allergenic potential of the protein. 
 
6.  It is important to establish whether the source is known to cause 
allergic reactions.  Genes derived from known allergenic sources should 
be assumed to encode an allergen unless scientific evidence demonstrates 
otherwise.  
  
Section 3—Initial Assessment 
 
Section 3.1—Source of the Protein 
 
7.  As part of the data supporting the safety of foods derived from 
recombinant-DNA plants, information should describe any reports of 
allergenicity associated with the donor organism.  Allergenic sources of 
genes would be defined as those organisms for which reasonable evidence 
of IgE-mediated oral, respiratory or contact allergy is available.  
Knowledge of the source of the introduced protein allows the 
identification of tools and relevant data to be considered in the 
allergenicity assessment.  These include the availability of sera for 
screening purposes; documented type, severity, and frequency of allergic 
reactions; structural characteristics and amino acid sequence; 
physicochemical and immunological properties (when available) of known 
allergenic proteins from that source.   
 
Section 3.2—Amino Acid Sequence Homology 
 
8.  The purpose of a sequence homology comparison is to assess the extent 
to which a newly expressed protein is similar in structure to a known 
allergen.  This information may suggest whether that protein has an 
allergenic potential.  Sequence homology searches comparing the structure 
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of all newly expressed proteins with all known allergens should be done.  
Searches should be conducted using various algorithms such as FASTA or 
BLASTP to predict overall structural similarities.  Strategies such as 
stepwise contiguous identical amino acid segment searches may also be 
performed for identifying sequences that may represent linear epitopes.  
The size of the contiguous amino acid search should be based on a 
scientifically justified rationale in order to minimize the potential for false 
negative or false positive results.19  Validated search and evaluation 
procedures should be used in order to produce biologically meaningful 
results. 
 
9.  IgE cross-reactivity between the newly expressed protein and a known 
allergen should be considered a possibility when there is more than 
35 percent identity in a segment of 80 or more amino acids (FAO/WHO 
2001) or other scientifically-justified criteria.  All the information 
resulting from the sequence homology comparison between the newly 
expressed protein and known allergens should be reported to allow a case-
by-case scientifically based evaluation. 
 
10.  Sequence homology searches have certain limitations.  In particular, 
comparisons are limited to the sequences of known allergens in publicly 
available databases and the scientific literature.  There are also limitations 
in the ability of such comparisons to detect non-contiguous epitopes 
capable of binding themselves specifically with IgE antibodies. 
 
11.  A negative sequence homology result indicates that a newly expressed 
protein is not a known allergen and is unlikely to be cross-reactive to 
known allergens.  A result indicating absence of significant sequence 
homology should be considered along with the other data outlined under 
this strategy in assessing the allergenic potential of newly expressed 
proteins.  Further studies should be conducted as appropriate (see also 
sections 4 and 5).  A positive sequence homology result indicates that the 
newly expressed protein is likely to be allergenic.  If the product is to be 
considered further, it should be assessed using serum from individuals 
sensitized to the identified allergenic source. 
 
Section 3.3—Pepsin Resistance 
 
12.  Resistance to pepsin digestion has been observed in several food 
allergens; thus a correlation exists between resistance to digestion by 
                                         
19  It is recognized that the 2001 FAO/WHO consultation suggested moving from 8 to 6 identical 
amino acid segments in searches.  The smaller the peptide sequence used in the stepwise 
comparison, the greater the likelihood of identifying false positives; inversely, the larger the peptide 
sequence used, the greater the likelihood of false negatives, thereby, reducing the utility of the 
comparison. 
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pepsin and allergenic potential.20  Therefore, the resistance of a protein to 
degradation in the presence of pepsin under appropriate conditions 
indicates that further analysis should be conducted to determine the 
likelihood of the newly expressed protein being allergenic.  The 
establishment of a consistent and well-validated pepsin degradation 
protocol may enhance the utility of this method. However, it should be 
taken into account that a lack of resistance to pepsin does not exclude that 
the newly expressed protein can be a relevant allergen. 
 
13.  Although the pepsin resistance protocol is strongly recommended, it is 
recognized that other enzyme susceptibility protocols exist.  Alternative 
protocols may be used where adequate justification is provided.21
 
Section 4—Specific Serum Screening 
 
14.  For those proteins that originate from a source known to be allergenic, 
or have sequence homology with a known allergen, testing in 
immunological assays should be performed where sera are available.  Sera 
from individuals with a clinically validated allergy to the source of the 
protein can be used to test the specific binding to IgE class antibodies of 
the protein in in vitro assays.  A critical issue for testing will be the 
availability of human sera from sufficient numbers of individuals.21  In 
addition, the quality of the sera and the assay procedure need to be 
standardized to produce a valid test result.  For proteins from sources not 
known to be allergenic, and which do not exhibit sequence homology to a 
known allergen, targeted serum screening may be considered where such 
tests are available as described in paragraph 17. 
 
15.  In the case of a newly expressed protein derived from a known 
allergenic source, a negative result in in vitro immunoassays may not be 
considered sufficient, but should prompt additional testing, such as the  
 
20  The method outlined in the U.S. Pharmacopoeia (1995) was used in the establishment of the 
correlation (Astwood et al., 1996). 
21  Report of Joint FAO/WHO Expert Consultation on Allergenicity of Foods Derived from 
Biotechnology (2001): section “6.4 Pepsin Resistance.” 
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possible use of skin test and ex vivo protocols. 22 23  A positive result in 
such tests would indicate a potential allergen.  
 
Section 5—Other Considerations 
 
16.  The absolute exposure to the newly expressed protein and the effects 
of relevant food processing will contribute toward an overall conclusion 
about the potential for human health risk.  In this regard, the nature of the 
food product intended for consumption should be taken into consideration 
in determining the types of processing which would be applied and its 
effects on the presence of the protein in the final food product.  
  
17.  As scientific knowledge and technology evolves, other methods and 
tools may be considered in assessing the allergenicity potential of newly 
expressed proteins as part of the assessment strategy.  These methods 
should be scientifically sound and may include targeted serum screening 
(i.e. the assessment of binding to IgE in sera of individuals with clinically 
validated allergic responses to broadly related categories of foods); the 
development of international serum banks; use of animal models; and 
examination of newly expressed proteins for T-cell epitopes and structural 
motifs associated with allergens.   
 
(2) Potential Toxicity of Proteins Newly Expressed in Foods Derived 
From GE Plants 
 
As previously discussed, crop plants contain thousands of proteins and 
other substances that have become a normal part of the human and animal 
diet.  Fortunately, the vast majority of substances found in crop plants do 
not cause adverse health effects in humans and animals (Fuchs and 
Astwood, 1996; Kessler et al., 1992; Metcalfe, Astwood et al., 1996).  
However, all foods, regardless of their source or method of development, 
can potentially contain toxins and other dangerous substances.  Because of 
familiarity gained during development of crop plants over many centuries 
and the inclusion of these crops in mammalian diets, much is known about 
the toxins, antinutrients, and other undesirable substances that can occur 
naturally in crop plants (CODEX, 2003; NRC, 2004).  In addition to 
information available in the primary published literature, the Organisation 
for Economic Co-operation and Development has published a number of 
                                         
22  According to the Joint Report of the FAO/WHO Expert Consultation on Allergenicity of Foods 
Derived from Biotechnology (22-25 January 2001, Rome, Italy) a minimum of 8 relevant sera is 
required to achieve a 99 percent certainty that the new protein is not an allergen in the case of a 
major allergen.  Similarly, a minimum of 24 relevant sera is required to achieve the same level of 
certainty in the case of a minor allergen.  It is recognized that these quantities of sera may not be 
available for testing purposes. 
23 Ex vivo procedure is described as the testing for allergenicity using cells or tissue culture from 
allergic human subjects (Report of Joint FAO/WHO Expert Consultation on Allergenicity of Foods 
derived from Biotechnology). 
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consensus documents for a variety of crop plants that provide details about 
crop biology and composition, including the presence of potentially 
harmful substances (OECD, 2004). 
 
While it is important to know what harmful substances can be found in our 
food crops, it is also important to have knowledge about what levels of 
these substances have been safely consumed in the past and do not pose a 
threat to human or animal health.  This knowledge gives plant breeders the 
ability to identify breeding lines containing elevated levels of these toxins 
relatively early in the breeding process and therefore avoid introducing 
these potentially harmful crops into the food supply (NRC, 2004).  This 
same knowledge is also valuable to crop developers who use genetic 
engineering as a method of plant genetic modification.  An important 
consideration for GE crop developers is not only what toxins may 
naturally occur in a plant but also whether there are any unintended 
changes in the plant as a result of the transformation process that 
potentially introduces new harmful substances or increases levels of those 
that naturally occur in the plant (CODEX, 2003; NRC, 2004). 
Once an assessment is completed on the plant itself to identify potential 
unintended changes resulting from the transformation, the safety 
assessment should then consider the donor, chemical nature, and function 
of the newly expressed substance (CODEX, 2003; NRC, 2004). 
 
If the GE plant expresses a new protein or other substance that will be 
present in the food, then the toxicity of that protein or substance may be 
assessed in several ways.  These include conducting an amino acid 
sequence-similarity comparison to known toxins and antinutrients; 
studying the substance’s stability to heat, processing, and digestion; 
completing acute oral toxicity tests using surrogate animals (where 
appropriate); reviewing previous exposures in human or animal diets; and 
reviewing the identity, source, and function of the substance (CODEX, 
2003; EPA, 2000; NRC, 2004, FAO/WHO 2000 [2000 Joint Expert 
Consultation on Foods Derived from Biotechnology]).   
 
(a) Exposure 
 
As mentioned, it is important to consider whether a substance found in a 
plant is likely to be harmful; the identity, source, and function of a 
substance can be useful in determining whether its presence in food is 
likely to be harmful.  If the substance is likely to be harmful, it is 
important to consider the level of exposure to the substance that is harmful 
(Day, 1996; NRC, 2004).  Assessing whether the level of exposure would 
be safe can either be accomplished by considering available data based on 
prior exposure to the substance in the diets of humans or animals or by 
using surrogate animal testing, which will be discussed later in this section 
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(CODEX, 2003; NRC, 2004).  If the substance has previously been a part 
of the human or animal diet, then information should be available about 
history of safe consumption, the levels of exposure that are considered 
safe, or if there have been adverse effects resulting from consumption of 
the substance.  If there has been no previous exposure, then consideration 
should be given to how much and in what form exposure to the expressed 
substance will occur.  For instance, consideration should be given to 
whether the food is processed prior to consumption and, if so, whether 
processing removes the substance from the food. 
 
(b) Amino Acid Sequence Similarity 
 
Most proteins and other substances that are known to be mammalian 
toxins have been well studied (Ecobichon, 1993; EPA, 2000; Majak, 
1995).  The amino acid sequences of many known mammalian toxins have 
been elucidated and entered into publicly available databases.  These 
databases are powerful tools that can be used as part of the safety 
assessment for substances expressed in GE plants.  An amino acid 
sequence comparison can be used to identify structural and functional 
relatedness of a substance to known toxins and antinutrients (CODEX, 
2003; EPA, 2000).  Therefore, the amino acid sequence comparison can 
provide valuable information about the relatedness of a substance to a 
known toxin, and is considered to be an integral part of the assessment of 
potential toxicity (CODEX, 2003; NRC, 2004). 
 
(c) Digestibility 
 
For proteins found in the mammalian diet, the assumption is that these 
proteins are broken down into amino acids or peptides as part of the 
digestion process (EPA, 2000).  Stability of a protein to digestion can be 
assessed using in vitro methods in which the protein is subjected to 
simulated gastric fluid, and then examined by gel electrophoresis (EPA, 
2000; NRC, 2004).  While in vitro digestion alone is not a sole 
determinant of the potential for a protein to be a toxin, it can contribute to 
the overall characterization of a protein (CODEX, 2003; EPA, 2000; 
NRC, 2004). 
 
(d) Surrogate Animal Testing 
 
Unlike the allergenicity assessment for proteins, surrogate animal testing 
can be performed, when warranted, to assess the potential toxicity of a 
protein or other expressed substance.  The use of animal models, where 
warranted, can be a significant part of the assessment of the toxicity of 
substances, such as pesticidal substances, expressed in GE plants (EPA, 
2000; NRC, 2004).  The use of surrogate animals allows for determination 
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of whether a substance is potentially a mammalian toxin and at what 
exposure levels a potential toxin can induce adverse effects.  However, 
there are limitations to the use of animal models, such as when they are 
used to assess the safety of whole foods (CODEX, 2003).  Feeding 
surrogate animals certain whole foods or diets comprised entirely of one 
food can induce adverse effects on the animal that are not related to the 
test substance itself (CODEX, 2003); therefore, the use of surrogate 
animals may not be appropriate when attempting to identify any potential 
unintended effects that may occur as a result of genetic engineering. 
 
(3) Composition of Foods from Genetically Engineered Plants 
Compared to Their Traditional Counterparts  
 
When performing the food safety assessment of a food derived from a GE 
plant, a key step in the safety-assessment process is the concept of 
“substantial equivalence.”  Substantial equivalence does not constitute a 
safety assessment; rather, it represents the starting point in the safety 
assessment of a new food, relative to its conventional counterpart.  It aids 
in the identification of potential safety and nutritional issues, and is 
considered to be the most appropriate strategy for safety assessment of 
foods derived from recombinant-DNA plants (Codex, 2003).  Analysis of 
key compositional components, along with other data and information, 
addresses the issue of whether there have been any unintended changes in 
the composition of the food resulting from the genetic engineering process 
(NRC, 2004). 
 
Food from each variety of crop developed via genetic engineering should 
be analyzed to determine the concentrations of key components (e.g., key 
nutrients, antinutrients, toxins, and allergens).  These results should be 
compared to what are considered normal levels of these components in 
parental or nontransformed lines of the same crop (CODEX, 2003; NRC, 
2004).  The Codex Plant Guideline defines key nutrients and key 
antinutrients as those found in a particular food that may have a substantial 
impact on the overall diet (CODEX 2003).  If this analysis identifies any 
differences in composition of statistical significance, then these observed 
differences should be assessed in the context of the natural range of 
variation for that parameter to determine if the differences have biological 
significance (CODEX, 2003; NRC, 2004).   
To further illustrate how potential impacts of GE plants on the human 
environment are assessed, this subsection discusses several examples of 
GE modifications for specific plant qualities.  Accompanying these 
examples are described the risk assessment issues associated with each of 
the modifications as discussed.   
4. Examples of 
Assessing 
Potential 
Impacts of 
Genetically 
Engineered 
Plants on the 
Human 
Environment 
 
Plant stress can come from abiotic sources such as temperature or wind 
extremes, drought or flooding, inadequate nutrition, soil salinity and 
chemical toxicity, and biotic sources such as weeds, herbivores, pests and 
diseases.  Optimal growth results from an interplay of many factors 
throughout the growing season or life of the plant, and less than ideal 
growth effects range from minor to severe, which can result in a lower 
yield or even total crop failure.  A plant weakened by one or more stresses 
is consequently more susceptible to other stresses.  For example, if the soil 
has an inadequate amount of an essential nutrient, the plant may be less 
able to defend itself against insect pests, which may, in turn, make the 
plant less able to resist pathogens such as viruses or fungi. 
 
Although the varying spectrum of factors affecting a growing plant is vast, 
the plant does not have an infinite repertoire of responses.  The ways 
plants respond to many stresses are now known in considerable 
physiological and molecular detail, and common mechanisms of response 
to diverse stresses have been found (Wang et al., 2003; Odjakova and 
Hadjiivanova, 2001; Singh et al., 2002; Gachamo et al., 2003; van Loon et 
al., 2006; Kang et al., 2005).  This detailed understanding of the 
mechanisms by which a plant copes with stresses provides opportunities 
for conventional breeding, as well as genetic engineering, to improve the 
ability of crop plants to deal with these adverse factors.  The following 
sections discuss examples of GE crops, all intending to improve crop 
responses to different stresses, and briefly outline some of the potential 
environmental considerations associated with each trait. 
 
a. Genetically Engineered Insect-resistant Crop Plants 
 
In general, all plants have the ability to repel, destroy, or mitigate pests.  
While the mechanisms of plant pest resistance remain a mystery in most 
cases, all plants are resistant to most pests.  In other words, plant pest 
susceptibility is generally the exception (CAST, 1998).  For centuries, 
farmers and plant breeders have used insect and disease resistance genes 
from wild relatives to improve crop plants.  This is, however, an ongoing 
process because often insects overcome the resistance. 
 
Agricultural biotechnology has increased the number of ways in which 
plants can made resistant to pests.  Since the early 1990s, many biotech 
companies and public institutions (e.g., government and universities) have 
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invested considerable research and development efforts on GE plants 
resistant to insect pests.  To date, only insect-resistant plants expressing 
genes from Bacillus thuringiensis (Bt) have been deregulated by APHIS 
and registered for commercial use by EPA.  Bt proteins have been used for 
more than 40 years as microbial insecticides, which are sprayed on crop 
plants.  However, their use in commercial agriculture has been limited 
because the proteins are short-lived in the environment, and sprays can 
protect only aboveground portions of the plant.  Genetic engineering of 
plants that contain Bt proteins in all tissues continuously throughout the 
growing season has overcome many of the limitations of Bt microbial 
insecticides. 
 
Bt is a naturally occurring, Gram-positive bacterium found in many 
environments including soil, insects, stored-product dust, and deciduous 
and coniferous leaves.  There are two current types of Bt proteins used as 
insecticides: “crystal” proteins and “vegetative insecticidal” proteins.  
Crystal proteins, called Cry toxins or delta-endotoxins, form within the 
spores of Bt bacteria.  When ingested by a susceptible insect, these 
proteins readily bind to receptors on the midgut, insert into its membrane 
(Gill, Cowles, and Pietrantonio, 1992; Schnepf et al., 1998), and form 
pores causing destruction of cells, leading to starvation, gut paralysis, 
septicemia (blood poisoning), and death of the insect (Schnepf et al., 
1998). 
 
Commercialization of Bt crops has resulted in fewer insecticide 
applications and thus, lower management costs (Fitt, 2000; Schnepf et al., 
1998; Sankula et al., 2005).  Also, one notable advantage of GE 
insecticidal crops over conventional insecticides is the high specificity of 
the Bt toxins, which minimizes potential toxic effects on nontarget insects 
(Betz, Hammond, and Fuchs, 2000; Macintosh et al., 1990).  Bt crops may 
also reduce the need for synthetic insecticides which, in turn, would 
decrease risks to the environment and effects on nontarget organisms, 
including beneficial insects. 
 
Issues that are typically considered in risk assessment of Bt crops include 
potential effects on non target organisms, potential unintended effects on 
the target organism, and potential changes in toxicity and allergenicity 
(Shelton et al., 2002). 
 
(1) Potential Effects on Nontarget Organisms 
 
As the inserted genes code for insecticidal toxins, there is reason to 
consider in the risk assessment the question of potential effects on 
nontarget organisms, including beneficial organisms (Pilson and 
Prendeville, 2004).  The scenarios that would be considered are (1) direct 
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effects in the case of other insects or other animals eating the GE plants 
with the Bt gene, and (2) indirect effects in the case of other animals that 
consume the target insects due to (a) indirect consumption of the Bt toxin 
or (b) reduced numbers of prey.  In the cases of the GE plants with Bt 
genes to date, the gene products are well known to specifically target a 
small group of Lepidoptera or Coleoptera (depending on the specific Bt 
gene).  For example, isopods and earthworms can safely consume Bt corn 
plant residues (Clark et al., 2006; Vercesi et al., 2006).  The likelihood of 
those insects being directly affected by the Bt toxin depends on the size of 
crop, that is, in cases of small scale field tests, any impact at the 
population level of affected insects is very unlikely.  In cases of large scale 
commercial use, the estimation of likelihood should consider the presence 
of potentially affected insects and their feeding behavior on the plant in 
question. 
 
When sensitive insects are not present in the area of planting or do not use 
the crop involved as their main source of food, then a significant impact at 
the population level of those insects is very unlikely.  A variety of studies 
have been done to address this issue and, although some results show a 
modest effect (Zangerl et al., 2001), most suggest no significant or adverse 
affects on non-target insects when controls involve insecticide sprayed 
fields, which is more reflective of actual agronomic practice (Marvier 
et al., 2007; Sears et al., 2001; O’Callaghan et al., 2005). 
 
(2) Potential Unintended Effects on the Target Organism 
 
The continuous production of Bt proteins on large acreages may increase 
the potential for target insects to become resistant to Bt proteins through 
constant selection pressure on target and nontarget susceptible insects 
(Tabashnik et al., 2003; Tabashnik et al., 2006).  These concerns resulted 
in the requirement of insect resistance management (IRM) strategies for 
good stewardship of these crops, and EPA has been the lead Government 
agency regulating IRM for Bt crops.  Written reports on various aspects of 
IRM are submitted to EPA to aid in the evaluation of the success of 
resistance management for Bt crops.  Although information is often shared 
between EPA and APHIS, most of the IRM materials and reports are not 
submitted to or reviewed by APHIS as part of deregulation. 
 
An IRM strategy is developed by incorporating several factors into a 
single plan to delay resistance of target pests to Bt crops (EPA-SAP, 
1995)— 
? knowledge of Bt proteins, their targets, and their alternative modes 
of action, 
? knowledge of pest ecology and biology, 
? appropriate dosages for Bt proteins, 
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? appropriate refuge design, and integrated pest management (IPM) 
of the refuge and Bt crop, 
? plans for monitoring, reporting, and mitigating incidents of insect 
resistance, and 
? communication and educational strategies on the use of the 
product. 
 
Thorough knowledge of pest biology is essential to the effective use of 
plants expressing Bt proteins and to the management of insect resistance 
to Bt proteins.  For example, feeding behavior of the target pest may 
influence the optimal location within the plant for Bt protein expression, 
as well as dosage expression.  Larval and adult movement (within and 
between fields, and in overwintering habitats) may affect the types, sizes, 
and management of refuges developed for IRM.  Reproduction (egg-
laying habits, mating preferences, and generations per year) will also 
influence the development of resistance management plans, particularly 
when implemented to encourage random mating of insects residing in Bt 
and non-Bt crops. 
 
Another important component of IRM is determining the effective and 
appropriate dosage of Bt protein.  The February, 1998, FIFRA Scientific 
Advisory Panel (SAP) Subpanel on Bacillus thuringiensis (Bt) Plant-
Pesticides and Resistance Management determined that a high-dose 
strategy, together with a refuge strategy, is necessary to mitigate resistance 
of stalk-boring Lepidoptera (e.g., moths) in Bt corn (EPA-SAP, 1998).  A 
“high dose” is defined as 25 times the protein dose necessary to kill all 
susceptible lepidopteran insects (EPA-SAP 1998).  For coleopteran 
(beetle)-active Bt products, the definition of a high dose has not been 
determined, nor has it been concluded that a high dose is necessary to 
mitigate resistance for these types of insects. 
 
However, within a population of insects exposed to a high-dose strategy, 
may be a few insects resistant to that high dose of Bt protein.  If a crop 
producing that protein is used repeatedly in the same location, it is 
theoretically possible for these few resistant insects to multiply to form a 
larger Bt-resistant population.  To minimize the incidence of such large 
Bt-resistant populations, IRM strategies include the use of refuges or 
refugia. 
Structured refuges are areas containing non-Bt host plants.  Insects feeding 
on these plants will not be exposed to the Bt protein, and Bt-resistant 
insect populations should not develop on these plants. Refuges therefore 
provide sufficient Bt-susceptible adult insects to mate with any Bt-
resistant adult insects that may survive on Bt crop plants.  These matings 
result in Bt-susceptible offspring which decreases the number of resistant 
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insects and dilutes the frequency of resistance genes (Tabashnik et al., 
2004). 
 
Refuge size, proximity to the GE crop, and refuge management are 
believed critical for resistance management.  Refuge size and location 
must be structured to maximize the potential for mating between 
susceptible insects (from the refuge) and possible resistant survivors (from 
the Bt field).  Currently, refuges are planted with a similar hybrid, in close 
proximity to, and concurrently with, the Bt crop (Shelton et al., 2002).  
Refuges are treated as needed to control insect pests with non-Bt 
insecticides or other appropriate IPM practices, and managed according to 
standard practices in the Bt field. 
 
As more Bt products are commercialized, it is theoretically possible for 
insect pests to come into contact with multiple Bt insecticidal proteins 
during their development.  If the insecticidal proteins produced by the Bt 
plants all have similar modes of action, pests may develop cross-resistance 
(resistance to all proteins using that mode of action) (Tabashnik et al., 
1994).  One potential method to circumvent or delay cross-resistance is to 
plant two or more Bt crops, each of which produces a Bt protein with a 
mode of action different from the others.  The theory behind spatial 
refuges is that it is very unlikely that a pest population would develop 
resistance to multiple unrelated proteins.  However, for many pests, a 
single individual will only experience a single plant and therefore, a single 
Bt protein (mode of action) during its development.  Because many pest 
larvae do not move from plant to plant and would not be exposed to 
multiple Bt proteins, spatial refuges have not been implemented.  Other 
methods for decreasing the likelihood of insect resistance is by 
incorporating two Bt genes with different mechanisms into a single plant, 
termed stacking (Zhao et al., 2005) or by altering the toxicity of the 
protein (Mehlo et al., 2005).  The chance that an individual in the 
population would possess resistance to both mechanisms and escape 
mortality in order to propagate resistance in the population is 
exponentially lower than with a single Bt gene.  This strategy is only 
effective if both genes are deployed simultaneously, before resistance has 
developed in the population to overcome either mechanism.  
 
(3) Monitoring and Mitigation 
 
Identifying populations of resistant insects through a comprehensive 
resistance monitoring plan is one method to test the effectiveness of 
resistance management programs and detect the onset of resistance before 
widespread crop failure occurs.  However, monitoring and detecting pest 
resistance to a Bt protein is a difficult and imprecise task requiring a high 
level of sensitivity and accuracy.  Appropriate resistance monitoring 
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requires baseline susceptibility data prior to initiation of a monitoring 
program.  In addition to baseline susceptibility data, information is needed 
to determine how many individuals need to be sampled and in how many 
locations.  The chances of finding resistant larvae in a Bt crop depend on 
the level of pest pressure, the frequency of resistant individuals, the 
location and number of samples that are collected, and the sensitivity of 
the detection technique. 
 
Because there have been no confirmed instances of pest resistance to Bt 
crops currently planted, there has been no need to implement mitigation 
measures, and their success has not been evaluated.  Mitigation may 
involve:  
 
• informing customers and extension agents in the affected areas of 
suspected or confirmed resistance,  
 
• increasing monitoring in the affected areas,  
 
• implementing alternative means to reduce or control target pest 
populations in the affected areas,  
 
• implementing a structured refuge in the affected areas, and  
 
• halting Bt seed sales in the affected and bordering counties until an 
effective local management plan has been implemented. 
 
(4) Grower Stewardship 
 
Growers are an essential element for the implementation and success of an 
IRM plan as they are responsible for planting refuges according to 
guidelines, and for monitoring fields for unexpected pest damage.  
Therefore, an education program that informs growers why IRM is needed 
and provides guidance on how to implement appropriate strategies is 
necessary.  EPA requires registrants to obtain technology use agreements 
from growers that outline IRM requirements and acknowledges the 
growers’ responsibility to comply with them.  The agreement states that 
growers received a product use guide provided by the company selling the 
Bt seed.  Technical bulletins, grower guides, sales materials, training 
sessions, Web sites, toll-free numbers for questions or further information, 
and educational publications have been recommended as tools to educate 
growers.  Educational materials should be consistent and reflect the most 
current resistance-management guidelines to help ensure compliance with 
IRM requirements.  It takes time and money to comply with IRM 
requirements, and there is a concern that if IRM requirements are too 
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complex or time-consuming, growers may avoid planting Bt crops or not 
adhere to IRM strategies (Langrock et al., 2003). 
 
(5) Potential Changes in Toxicity and Allergenicity to Mammal, 
Avian, and Aquatic Organisms 
 
EPA-registered Cry proteins have been considered safe because the 
intestinal walls of mammals do not have the endotoxin receptor necessary 
for the toxic effect, and the proteins are degraded quickly in the stomach 
(Sacchi et al., 1986; Shimada et al., 2005; Shimada et al., 2006).  
Vegetative insecticidal proteins (VIPs) are secreted proteins derived from 
the vegetative growth stage of Bt.  When ingested, the protein binds to 
midgut cells, attacks the epithelial layer of the midgut, and eventually 
causes death (Lee et al., 2003).  VIPs have a similar mode of action as Cry 
proteins, but VIPs associate with different midgut binding sites (Cao-Guo 
et al., 1997; Lee et al., 2003; Yu et al., 1997).  Both Bt Cry proteins and 
VIPs have been deregulated by APHIS, and Cry proteins have been 
registered for commercial use by EPA. 
 
As part of the ecological risk assessment, EPA also considers potential 
risks to mammals, birds, and fish.  Although wildlife may be exposed to 
Bt protein, there is no evidence to date that shows toxicity to wild or 
domesticated mammals, fish, or avian species, and there are no reports of 
adverse effects from the commercial poultry industry after several years of 
using Bt corn in poultry feeds (Shimada, 2006a; Taylor et al., 2005).  
Potential for accidental aquatic exposure from Bt crops is extremely small, 
and there is no evidence for sensitivity of aquatic species to Bt proteins 
(EPA–BPPD, 2001).  APHIS, as part of its ecological risk assessment, 
also considers potential risks of GE plants to migratory birds under the 
Migratory Bird Act and threatened and endangered species under the 
Threatened and Endangered Species Act. 
 
b. Genetically Engineered Stress-tolerant Plants 
 
Plants have, to various degrees, tolerances against abiotic stresses, such as 
drought, salinity, and low nutrient availability.  While some specialized 
wild plants, such as succulents, can have high tolerances against stresses, 
most crop plants are managed with the goal of minimizing environmental 
stresses. 
 
There is intense interest in the development of drought- and salinity-
tolerant plants.  The size of the human population is increasing, creating a 
need for increased agricultural production.  At the same time, most prime 
farmland is already under cultivation and growers are considering the use 
of more marginal lands.  Decreasing availability of fresh water and 
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changes in rainfall patterns due to climate change provide some of the 
impetus to modify plants for drought-tolerance.  Soil salinity is increasing 
in irrigated cropland, with approximately 20 percent of such land 
experiencing salt stress at some level (Yamaguchi and Blumwald, 2005; 
Yeo, 1998).  The increased probability of salt-stress conditions is 
promoting the development of salt-tolerant plants.  The objectives of much 
biotechnological research, therefore, is to obtain plants that can be grown 
under dry conditions and on marginal, saline land, leading to increased 
productivity and reduced use of water in agriculture, which is of particular 
importance to developing countries (Vinocur et al., 2005). 
 
Another stress-tolerant phenotype being developed is the ability of plants 
to withstand low levels of nutrient (fertilizer) availability through 
increased nutrient assimilation or utilization, which has potential benefits 
in cost and pollution reduction.  Increases in nitrogen utilization efficiency 
of crop plants have the potential to decrease fertilizer costs to farmers by 
decreasing the nitrogen applications required for adequate yield 
production, as well as reducing nitrogen runoff and subsequent water 
contamination (Oliveira et al., 2002).  Tobacco modified to increase 
ammonium assimilation, and thus increase nitrogen efficiency, resulted in 
plants with greater biomass and leaf-soluble protein compared with non-
GE tobacco plants (Oliveira et al., 2002), indicating that increased 
nitrogen utilization efficiency is possible.  Nutrient utilization for 
phosphorus is also being examined as a potential modification for crop 
plants.  More than 30 percent of cropland experiences phosphorus 
deficiency (Vance, Uhde-Stone, and Allan, 2003).  GE tobacco plants 
modified for increased phosphorus utilization exhibited significantly 
greater growth and higher phosphorus concentrations in phosphorus-
deficient conditions than nontransformed plants (Lung et al., 2005) and 
Arabidopsis (Xiao et al., 2006).  Thus, genetic modifications that alter the 
assimilation and utilization efficiency of nutrients can result in increased 
nutrient content of the plant. 
 
Of the more than 15,000 permits and notifications that APHIS has 
acknowledged or issued, less than 400 applications include plants that 
have been genetically engineered for stress-tolerance.  As this area of 
biotechnology research continues to move from the strictly experimental 
to product-development stage, stress-tolerant phenotypes and the 
mechanisms underlying the tolerance will become more refined and better 
understood.  Subsequently, because insect herbivores show sensitivity 
toward changes in plant nutrient content, future field studies involving 
stress-tolerant plants and other GE phenotypes that change plant nutrient 
or defensive chemical content may have the ability to establish any 
positive or negative relationships between these GE plants and their insect 
herbivores. 
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As the appearance of GE plants tolerant of abiotic stress is a relatively 
new development in biotechnology, this section can offer only a sampling 
of the potential effects and does not exhaustively address risk assessment.  
Issues that would be considered in risk assessment of stress-tolerant crop 
plants include potential effects on plant-insect interactions and potential 
changes in weediness. 
 
(1) Potential Effects on Plant-insect Interactions 
 
When plants experience abiotic stress, a multitude of physiological 
changes occur.  For example, when plants experience drought and salinity 
stress, protein metabolism and amino acid synthesis are impaired (Hsiao, 
1973).  Under such conditions, existing proteins may be broken down, 
resulting in increased levels of available nitrogen and amino acids 
(Brodbeck and Strong, 1987); (Bohnert, Nelson, and Jensen, 1995; 
Delauney and Verma, 1993).  These stress-induced changes in plant 
physiology are widely thought to positively influence insect herbivores 
due to favorable modifications in plant nutrient content.  In particular, the 
plant experiences an increase in amino acids and nitrogen (Bentz and 
Townsend, 2001; Busch and Phelan, 1999) or increase the concentration 
of other food resources (Chen and Welter, 2002; Richardson et al., 2002). 
 
GE plants engineered for stress tolerance show an increase in nutrient 
content, either nitrogen or phosphorus, either through accumulation of 
nitrogen-based osmoprotectants or through more efficient use of nutrients.  
Although nitrogen has traditionally been recognized as a limiting nutrient 
for insect herbivores (Mattson, 1980; McNeill and Southwood, 1978; 
White, 1993), from the few studies that have investigated the effects of 
phosphorus limitation on insects, there is evidence showing that it can be 
an important determinant of survivorship (Ayers et al., 2000; Clancy and 
King, 1993), fecundity (Popp et al., 1989), body size (Busch and Phelan, 
1999; Janssen, 1994), oviposition (Skinner and Cohen, 1994), growth rate 
(Perkins et al., 2004), and population density (Schade et al., 2003).  Thus, 
genetic modifications that result in plants with increased nitrogen or 
phosphorus content may potentially affect insect herbivore populations on 
stress-tolerant plants because of the sensitivity of insect herbivores to 
nitrogen and phosphorus content.  It should be pointed out that, although 
plant-insect actions are relatively well characterized, these effects are not 
limited to insects.  Other plant pests, pathogens or non-target organisms 
may require similar consideration. 
 
However, not all stress-induced changes in plant physiology will 
positively affect insect herbivores.  Defensive chemical compounds, 
collectively called “allelochemicals,” are produced by the plant to affect 
  
 
IV.  Environmental Consequences 107
insect herbivores in a negative manner, such as decreasing survival 
(Brodbeck and Strong, 1987; White 1993; Gershenzo,n 1984; Inbar, 
Doostdar, and Mayer, 2001; Mattson and Haack, 1987, 1987).  Different 
insects feed on plants in different ways.  For example, some insects chew 
plant tissues while others suck plant fluids from vascular tissue.  Because 
allelochemicals are much less concentrated in vascular tissue compared to 
leaf tissue (Raven, 1983), insect species that feed in vascular tissue (sap-
feeding insects such as aphids) may respond more positively to plant stress 
than chewing insects, such as caterpillars, that feed on leaf tissue with 
higher levels of defensive chemicals (Larsson, 1989).  As plants are 
engineered to become tolerant of abiotic stress, there is a need to consider 
the complex interactions between GE stress-tolerant plants and insect 
herbivores. 
 
(2) Potential Changes in Weediness 
 
The ability to tolerate environmental stress enables plants to survive 
unfavorable conditions.  Therefore, one of the key questions for the risk 
assessments of stress-tolerance traits will be whether they will also change 
the potential for crop plants to become weedy or cause them to become 
more invasive.  The weediness or invasiveness of a plant depends on many 
different characteristics such as persistence, reproductive strategy, and 
dispersal and other factors such as the receiving environment and its 
climate.  As discussed earlier, it is not very likely that a change in one 
particular trait would suddenly make a plant become weedier.  However, it 
is theoretically conceivable that a change in abiotic stress resistance may 
incrementally increase the weediness of a plant that already had a number 
of weedy characteristics.  Whether or not this is the case will depend on 
the characteristics of the plant itself, the phenotypic changes, and the 
environment to which it will be introduced (receiving environment). 
 
Because plants frequently inhabit environments where water and 
nutritional resources are limited, the ability to more efficiently exploit 
these resources may enable a plant to outcompete its neighbors.  This 
ability could result in the development of plants with invasive or weedy 
characteristics, and the assessment of the impacts from these 
characteristics would need to include considerations of the impacts of the 
movement of stress-tolerance traits to the wild relatives of GE crop plants. 
 
c. Genetically Engineered Virus-resistant Plants 
 
Plant viruses represent a significant threat to global agriculture because of 
their ability to reduce the quality and more important, the yield of food 
and fiber crops (Hull, 2004; Pappu, 1999).  Hundreds of plant viruses have 
been described, affecting a wide range of plants and trees.  In general, 
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most plant viruses consist of genetic material—either RNA or DNA—
enclosed by a protective coat.  This coat, which is made from many 
individual protein molecules (“coat proteins”), plays an important role in 
protecting the genetic material, as well as determining how the virus 
spreads.  Most plant viruses are obligate parasites (parasites requiring a 
living host) which move from plant to plant via insect vectors.  Additional 
means of plant virus transmission include fungal transmission, seed 
transmission, and mechanical transmission, such as grafting (Hull, 2004; 
OECD, 1996). 
 
In cases where plants are susceptible to viruses, common control or 
management strategies have included the use of pesticides for control of 
insect vectors; cultural practices, which include removal of infected plants 
and plant material serving as sources of viruses; use of virus-free planting 
material; or use of resistant varieties (Gooding, 1985; Khetarpal et al., 
1998; OECD, 1996; Superak et al., 1993; Swiezynski, 1994).  While the 
use of these control strategies has been effective in parts of the world, the 
overall effectiveness of these strategies can vary significantly from crop to 
crop and year to year (Hadidi, Khetarpal, and Koganezawa, 1998; OECD, 
1996; Pappu, 1999). 
 
Another control strategy shown to be effective is cross-protection 
(Gonsalves, 1998; Gooding, 1985; Hull, 2004; Sherwood, 1987).  Cross-
protection involves the ability of a mild strain of a virus to prevent or 
delay infection by a second more virulent strain of the virus (Culver, 2002; 
Gooding, 1985; Hull, 2004; Sherwood, 1987).  Cross-protection has been 
attributed to various mechanisms (Culver, 2002; Goregaoker, Eckhardt, 
and Culver, 2000; Beachy, 1999; Culver, 2002; Goregaoker, Eckhardt, and 
Culver, 2000; Sherwood, 1987).  Coat-protein-mediated cross-protection, 
for example, relies upon the coat protein to properly associate with and 
block disassembly of the virulent virus (Culver, 2002).  While cross-
protection has proven to be effective with some viruses, because of the 
labor and time needed to infect plants with the mild virus strain, cross-
protection is generally not a practical means of controlling virus disease in 
large-scale or agricultural systems. 
 
In recent years, much of the research and development for controlling 
plant viruses has focused on development of GE virus-resistant plants.  
Using the concept of pathogen-derived resistance (Sanford and Johnston, 
1985) and cross-protection, genetic modifications of host plants and trees 
are made that allow for expression of viral genes or proteins in the plant 
and tree tissue.  Plant expression of viral genes or proteins often acts to 
delay or prevent infection by the same or related viruses.  This form of 
pathogen-derived resistance was first accomplished in 1986 by Roger 
Beachy and colleagues (Abel et al., 1986).  Beachy’s team found that 
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tobacco plants engineered to express tobacco mosaic virus (TMV) coat 
protein were resistant to TMV infection. 
 
Numerous other virus-resistant plants have been developed and field 
tested.  Most of the virus resistance is based on so-called pathogen-derived 
resistance, most often using viral coat protein (VCP) or VCP gene 
expression as the basis for resistance (ISB, 2004; Tepfer, 2002).  Over the 
past 2 decades, nearly 900 field tests for virus-resistant plants (including 
trees) have been authorized by APHIS in the United States.  In addition, 
several virus-resistant crop plants have been deregulated by APHIS and 
have been grown commercially.  GE virus-resistant plants deregulated by 
APHIS, to date, include those that express VCP genes (e.g., papaya-
ringspot-virus-resistant papaya) or the replicase protein gene (e.g., potato-
leafroll-virus-resistant potato) (EPA, 1998; Gonsalves, 1998; ISB, 2004). 
 
While the development and deployment of GE plants has proven to be 
effective in controlling targeted virus diseases, some concern has been 
raised about the potential risks associated with agricultural use of GE 
virus-resistant plants (NRC, 2000, 2002).  The safety of these plants has 
been the subject of numerous scientific meetings and workshops, as well 
as scientific articles, written by members of the U.S. Government, 
academia, and industry that address potential risks associated with these 
plants (AIBS, 1995; Falk and Bruening, 1994; Miller, Koev, and Mohan, 
1997; OECD, 1996; Tepfer, 2002). 
 
Potential adverse effects that have been identified and studied in detail 
include the development of new virus diseases through any of the 
following mechanisms: 
 
• Heterologous encapsidation (transcapsidation)—the phenomenon 
where the coat protein of one virus is able to enclose (encapsidate) the 
nucleic acid of a separate virus.  When heterologous encapsidation 
occurs, there is some potential for altered phenotypes or host range. 
 
• Virus recombination—the exchange of the genetic material between 
two or more different viruses.  If recombination is possible, there is 
some potential for the generation of new or altered viruses. 
• Synergy—the increase in severity of infection or symptoms when two 
or more viruses infect the same plant.  If synergy occurs, the potential 
result is increased virus disease severity. 
 
• Change in weediness due to gene flow between cultivated crops and 
weeds.  There is some potential for a weedy relative to acquire virus 
resistance from the crop plant. 
 
110 IV.  Environmental Consequences 
 
While the technology and the analysis of potential adverse effects continue 
to evolve, currently available scientific data have been used to study these 
risks (AIBS, 1995; OECD, 1996; Tepfer, 2002).  These data and 
information will be discussed in this section to briefly explore the possible 
risks and other concerns that have been raised with regard to large-scale 
deployment of GE virus-resistant plants. 
 
Many of the issues that will be discussed in this section are similar for 
both RNA and DNA plant viruses.  However, to date, the development of 
GE virus-resistant plants has been mostly limited to plants developed for 
resistance to RNA viruses (ISB, 2004; Tepfer, 2002).  Most GE virus-
resistant plants that have been commercialized express the VCPs or VCP 
genes.  Therefore, the focus of this section will be on GE plants expressing 
VCPs or VCP genes from RNA viruses, although the types of information 
and considerations will be broadly applicable to other methods of virus 
resistance.  More than 30 different species of plants have been developed 
for virus resistance and subsequent field testing, with many developed to 
express genes other than VCP, including replicase protein, nuclear 
inclusion protein, movement protein, nucleocapsid protein, N gene, helper 
component, and other virus-specific proteins (ISB, 2004).  As plants 
continue to be developed with genes other than VCP, the agency will 
assess the safety of these plant–gene combinations on a case-by-case 
basis, using the same level of scrutiny that has been used for VCPs. 
 
(1) Development of New Virus Diseases Through Heterologous 
Encapsidation 
 
There are many instances in nature and in agricultural settings where a 
single host plant is infected by two or more viruses.  In fact, some reports 
about naturally infected plants have identified individual plants that were 
infected by as many as six different viruses (Abdalla, Desjardins, and 
Dodds, 1985; Falk et al., 1995).  Viruses in a naturally-occurring mixed 
infection could interact in a number of scenarios.  One potential scenario 
involving VCPs, which can occur in plants co-infected with two or more 
viruses, is a phenomenon known as heterologous encapsidation (Falk 
et al., 1995; Miller, Koev, and Mohan, 1997; Waterhouse and Murant, 
1983). 
Heterologous encapsidation occurs when the coat protein of one virus is 
able to encapsidate (i.e., surround) the nucleic acid of a second virus.  
Heterologous encapsidation was first described by Rochow (1970) and has 
been the subject of numerous reviews (Falk and Duffus, 1981; Falk et al., 
1995; Miller, Koev, and Mohan, 1997; Rochow, 1977; Tepfer, 2002). 
These interactions occur naturally in both agricultural plant and weed 
plants and are a natural part of virus–virus and virus–plant interactions 
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(Falk and Duffus, 1981; Falk et al., 1995; Rochow, 1977).  In some cases, 
heterologous encapsidation is a specific interaction between two viruses 
that plays an important role in both virus biology and survival. 
 
Because the VCP may determine which insect vector is capable of 
transmitting a particular virus when heterologous encapsidation occurs, 
the RNA of one virus essentially acquires the phenotypic properties of the 
second virus for insect transmission (figure 4-1, virions C and D).  This 
observation means that the insect vector recognizes the coat protein, not 
the RNA inside the coat protein.  In other words, the progeny viruses that 
are the result of heterologous encapsidation often temporarily exhibit new 
or altered biological properties differing from those of the parental viruses 
(Falk et al., 1995).  The impact on vector specificity is likely limited 
because many of the heterologous encapsidation interactions that have 
been identified occur between viruses that are closely related enough that 
they are transmitted by the same vectors (Hull, 2004). 
 
Once heterologous encapsidation occurs, the potential exists for new or 
different “exposure” or host range for the RNA of the encapsidated RNA 
via insect transmission.  If this occurs, the result may be one of the 
following: 
 
• Scenario 1—the virus does not subsequently move. 
 
• Scenario 2—the insect carries the heterologously encapsidated virus to 
a non-host plant. 
 
• Scenario 3—the insect carries the heterologously encapsidated virus to 
a host plant, which would be no different than the normal transmission 
mechanism of the virus. 
 
 
A B
A B C D
 
Figure 4–1. Heterologous Encapsidation.  Possible outcomes of 
heterologous encapsidation interactions as previously described by 
Rochow, 1977 and Falk, 1995.  A and B represent the parental 
viruses.  When two viruses co-infect the same cell, the progeny 
can include virions that are identical to the parental viruses (A and 
B) or progeny that are composed of the capsid protein of one virus 
and the RNA of the second virus (C and D). 
 
If scenario one occurs, the virus whose RNA is encapsidated could 
replicate and move within the plant to which it was transmitted and would 
subsequently be encapsidated in its own coat protein.  However, the virus 
would not be able to move from that plant via insect transmission because 
the plant would not likely be a typical host for an insect vector of this 
virus.  In general, the significance of this scenario is transient because 
once the encapsidated RNA is injected into the host plant, the biological 
properties of the virus will take over and determine its subsequent fate 
(Falk et al., 1995; OECD 1996). 
 
If scenario two occurs where the new plant is not a host for the virus 
whose RNA is encapsidated, it represents a dead-end for the virus.  This is 
because the virus will likely not be able to replicate or move in the new 
plant.  Without the ability to establish an infection—due to its inability to 
move or replicate—the virus would not likely be transmitted from that 
plant.  Heterologous encapsidation that occurs according to this scenario 
would not likely be of any ecological significance (Falk et al., 1995; 
OECD, 1996). 
 
112 IV.  Environmental Consequences 
  
 
IV.  Environmental Consequences 113
If scenario three occurs, the result would be similar to a typical infection 
of the encapsidated virus if the virus is transmitted to a normal host of the 
virus.  Once the virus is inoculated into the plant, its normal replication 
mechanisms would take over and the virus would then produce its own 
coat protein.  However, because the viral RNA was initially transmitted by 
a different insect vector, it is possible that the virus could be introduced 
into a host to which it has not been previously exposed.  Whether or not 
the virus would be subsequently transmitted from this host plant would 
depend upon whether an insect vector was available to transmit the virus.  
In terms of virus biology, this scenario would not be significantly different 
from what naturally occurs, other than the fact that the primary inoculation 
occurred with virus RNA that was the product of heterologous 
encapsidation.  Subsequent virus biology would reflect that of the 
naturally occurring virus. 
 
Overall, despite the potential for heterologous encapsidation to readily 
occur in nature, there have only been a few cases in which heterologous 
encapsidation has been shown to be important in agricultural situations 
(Falk et al., 1995; OECD, 1996).  The likelihood of heteroencapsidation 
would not be significantly different in VCP-expressing plants (Hull, 
2004). 
 
Helper-dependent Transmission 
 
There are a limited number of cases where heterologous encapsidation is a 
natural part of plant virus epidemiology (Falk et al., 1995).  Helper-
dependent transmission occurs when one virus exclusively relies upon 
another virus for heterologous encapsidation for subsequent insect 
transmission from mixed infections (Falk and Duffus, 1981; Falk et al., 
1995; Hull and Adams, 1968; Rochow, 1977).  In cases such as carrot 
motley dwarf, groundnut rosette, and lettuce speckles, the virus diseases 
are caused by co-infection of the plant by two or more viruses (Falk, 
Duffus, and Morris, 1979; Falk et al., 1995; Hull and Adams, 1968; 
Waterhouse and Murant, 1983).  In each of these and other virus disease 
complexes, one of the viruses is insect transmissible and the other is not 
independently insect-transmissible.  The nonindependently transmissible 
virus relies upon the insect-transmissible virus, via heterologous 
encapsidation, for insect transmission.  In each of the complexes that has 
been characterized, the insect-transmissible virus is able to replicate and 
move within the host plant in the absence of the noninsect-transmissible 
virus.  The noninsect-transmissible virus is also able to replicate and move 
within the host in the absence of the insect transmissible virus; however, 
the former lacks a coat protein and therefore must rely on the insect-
transmissible virus for encapsidation and insect transmission (Falk et al., 
1995).  While the noninsect-transmissible virus is able to be spread by 
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mechanical inoculation by itself, it benefits greatly by being associated 
with the insect-transmissible virus which provides for more efficient 
dissemination and potentially a wider host range. 
 
Given the crucial role that the coat protein plays in insect transmission and 
natural plant virus epidemiology, some concern has been raised about 
whether constitutive expression of viral coat protein in GE plants would 
increase heterologous encapsidation interactions.  Because the amount of 
coat protein available in GE plants is so dramatically less than the amount 
of coat protein in virus-infected plants, the potential for heterologous 
encapsidation is reduced. 
 
Reducing the Risk 
 
Even if one assumes that there is risk associated with heterologous 
encapsidation interactions occurring in virus-resistant GE plants, the 
potential exists to reduce ecological impact via modification of the viral 
coat protein gene (Tepfer, 2002).  Research has shown that mutations in 
the coat protein gene can result in loss of insect transmissibility of the 
virus (Tepfer, 2002).  By incorporating such mutations into the coat 
protein gene that is expressed in GE plants, the potential for insect 
transmission of viruses that may have been encapsidated by the plant-
expressed coat protein can be eliminated, without affecting the 
effectiveness of the virus resistance. 
 
(2) Development of New Virus Diseases Through Recombination 
 
Plant virus recombination occurs when the exchange of genetic material 
between two or more different viruses results in production of a new virus 
(OECD, 1996; Tepfer, 2002; Worobey and Holmes, 1999).  
Recombination between viruses in different taxonomic groups has played 
a significant role in virus evolution (AIBS, 1995; OECD, 1996; 
Roossinck, 1997; Worobey and Holmes, 1999).  In terms of virus 
evolution, recombination would be considered a frequent event (Hull, 
2004).  Nucleotide sequence comparisons of different or unrelated viruses 
have identified similar segments of nucleotide sequence, suggesting that 
recombination has occurred (Hull, 2004). 
 
Because of the potential for recombination to occur in GE plants, 
consideration should be given to whether recombinants arising from GE 
plants would be different from those that arise from mixed infections in 
non-GE plants, and whether the recombinants are viable (Hull, 2004).  
Factors affecting the rate of recombination include sequence similarity 
between the two viruses, the location of the virus within the plant, and 
structural similarity between the nucleic acids (OECD, 1996).  The ability 
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of a virus arising via recombination to persist in nature depends upon 
factors such as its ability to replicate or spread systemically or its ability to 
be transmitted to other host plants (Hull, 2004; OECD, 1996).  A 
significant difference between the potential for recombination in non-GE 
plants with mixed infections versus the potential for recombination in GE 
plants is that the virus gene is constitutively expressed, that is, 
continuously produced in every cell in the GE plant which allows for 
greater opportunity for interaction and hence, recombination between the 
expressed gene and the infecting virus (Hull, 2004). 
 
Plant-Expressed Genes-virus Recombination 
 
Looking beyond virus–virus recombination, other studies have focused on 
whether viral transgenes present in virus-resistant plants can either 
complement or recombine with viruses that infect the GE plant.  In the 
mid-1990’s, Greene and Allison were able to show that such 
recombination could occur (Greene and Allison, 1994, 1996).  Their 
experiments were the first to show the potential for recombination 
between plant-expressed genes and viruses infecting that plant.  It is not 
clear, however, from these and subsequent studies (e.g., Borja et al., 1999) 
how closely these experiments performed under artificial conditions 
reflect what occurs in natural or agricultural settings with either GE or 
non-GE virus-resistant plants.  In their review of potential recombination 
in transgenic plants Rubio et al. (Rubio et al., 1999) suggest that the levels 
of recombination seen in the experiments performed by Borja et al. are 
orders of magnitude higher than would be expected in GE plants where 
virus replication is reduced or prevented. 
 
Plant-virus Recombination 
 
Finally, other researchers have shown that over time, plant viruses in 
natural settings have incorporated various plant cellular RNAs into their 
genomes as part of their evolutionary process (Karasev, 2000; Masuta et 
al., 1992; Mayo and Jolly, 1991).  In some cases, it appears that once these 
cellular RNAs become incorporated via recombination, they are 
subsequently maintained as part of the viral genome. 
 
Overall, given that mixed infections are common in nature, the 
opportunity for both related and unrelated viruses to interact in natural 
virus populations is high.  Issues such as selection pressure, adaptation to 
changing environments, competition, fitness, and so forth, likely play 
significant roles in the various types of recombination that have been 
identified.  These factors also help determine what role the resulting 
recombinants play in virus biology and epidemiology.  Based upon 
currently available information, it appears that the potential for 
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recombination in virus-resistant GE plants (i.e., virus–virus and plant–
virus) would be similar to the natural occurrence of recombination in 
virus-infected, non-GE plants (Falk and Bruening, 1994; OECD, 1996; 
Rubio et al., 1999). 
 
(3) Synergy 
 
Synergy occurs when two independent viruses infect a plant 
simultaneously and the resulting disease symptoms are more severe than 
when either virus infects the plant individually (OECD, 1996; Pruss et al., 
1997; Tepfer, 2002).  Several naturally occurring synergistic virus 
interactions have been described (OECD, 1996; Pruss et al., 1997; 
Rochow and Ross, 1955; Tepfer, 2002).  Vance and colleagues have 
shown that when plants are co-infected with both a potyvirus (e.g. potato 
virus Y potyvirus) and potato virus X potexvirus (PVX), the disease 
symptoms are significantly worse than when plants are infected with either 
of the viruses alone (Vance, 1991; Vance et al., 1995). 
 
Subsequent studies have shown that the potyvirus helper-component-
protease (HC–Pro) mediates the increase in PVX pathogenicity (Pruss et 
al., 1997; Tepfer, 2002; Vance et al., 1995).  Pruss et al., also showed that 
the potyvirus HC–Pro can enhance pathogenicity and virus accumulation 
of other viruses including cucumber mosaic virus and TMV (Pruss et al., 
1997).  Researchers continue to explore whether other viral proteins or 
genes play similar roles in virus synergy. 
 
What, if any, risk synergy poses on the environment as a result of the use 
of GE virus-resistant plants is not entirely clear.  However, current 
scientific data suggest that any impact would be minimal for several 
reasons.  The first consideration is that any effect of synergy associated 
with a particular GE crop will be limited to the GE plants themselves 
(OECD, 1996).  Additionally, it is not likely that the potential for synergy 
occurring in GE plants expressing virus genes would be greater than in 
natural mixed infections (Hull, 2004).  Consideration of this type of effect 
on the GE plant should be included as a part of product development by 
the plant developer (OECD, 1996; Tepfer, 2002).  Potential synergistic 
interactions could be identified during development of a plant line by 
inoculating GE plants with widely prevalent viruses of that host plant. 
 
Given the knowledge of the roles that different virus genes play in 
synergy, developers can also select only those genes that likely would not 
contribute to synergism or include mutations in such genes so that their 
potential impact is limited.  Genes such as the potyvirus HC–Pro should 
be avoided, given what is known about its ability to enhance disease 
development and virus titer of some co-infecting viruses (AIBS, 1995; 
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Tepfer, 2002).  Other genes (e.g., those that might aid in virus replication, 
movement, or symptom severity) might also be avoided because of their 
potential to facilitate virus disease development (AIBS, 1995; Tepfer, 
2002). 
 
(5) Change in Weediness Due to Gene Flow Between Cultivated 
Crops and Weeds 
 
Weeds and other noncultivated plants are a primary source of pest- and 
pathogen-resistance genes.  In general, most pest- and pathogen-resistance 
genes used in traditional breeding for resistance have been found in the 
centers of origin and areas of diversification of cultivated plants 
(Khetarpal et al., 1998).  These are the areas in the environment where 
plants have been exposed to selective pressure of pests and pathogens over 
thousands of years and therefore have developed resistance as a 
mechanism of survival (Khetarpal et al., 1998). 
 
The potential for introgression of a virus-resistance transgene into a wild 
or weedy species is another possible outcome of large-scale agricultural 
use of GE virus-resistant plants.  The primary concern is whether 
transgene introgression would result in a wild or weedy species becoming 
invasive should the virus transgene make the wild or weedy species 
resistant to a virus disease that normally plays a role in control of the 
species (Fuchs, Chirco, and Gonsalves, 2004(a); Fuchs et al., 2004(b); 
Tepfer, 2002).  To take into account the potential risk, several aspects of 
virus and plant biology should be considered. 
 
As discussed earlier in this section, plant viruses cause significant 
problems by limiting the amount and quality of agricultural products.  
Most virus epidemics are the result of a virus or a vector moving from 
noncrop plants located adjacent to production areas into cultivated crops.  
Plant viruses are obligate parasites, and as such, total destruction of their 
plant hosts would lead to the extinction of that virus.  Therefore, it is 
assumed that there is a certain level of tolerance by some hosts—possibly 
wild or weedy hosts—that allow for persistence of the virus.  In fact, many 
virus infections do not produce visible symptoms in weeds (Hull, 2004).  
Because of this, there likely exists a number of wild or weedy plant 
species that contain resistance genes that allow these plants to survive 
virus infection and serve as reservoirs for the virus (Raybould et al., 
1999). 
 
This is somewhat different than the relationship between crops and plant 
viruses.  Most of the major crop species used in today’s agriculture (e.g. 
soybean, rice, wheat, beans) have been subjected to intensive artificial 
selection over centuries and have only low survival under most natural 
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conditions.  The vast majority of the crops used in agriculture are much 
less fit, under natural conditions, than wild or weedy plants.  Because of 
this, the impact of virus infection on crop plants is potentially more severe 
than on many wild or weedy plants. 
 
It is known that gene flow from cultivated agricultural crops to wild and 
weedy species has occurred since the domestication of a particular plant 
when sexually compatible wild or weedy species are present (Fuchs, 
Chirco, and Gonsalves, 2004(a); Stewart, Halfhill, and Warwick, 2003).  It 
is also known that gene flow occurs between virus-resistant GE crops and 
non-GE crops (Fuchs, Chirco, and Gonsalves, 2004(a)).  What is not as 
well understood is how much gene flow from GE virus-resistant plants to 
wild or weedy relatives results in introgression of the gene(s) and what 
ecological impact this introgression would have.  Stewart and others 
discuss the basic difference between gene flow, mediated via pollen or 
other mechanisms, and introgression of genes, as well as the frequency of 
introgression and impacts on the frequency (Fuchs, Chirco, and 
Gonsalves, 2004(a); NRC, 2000; Stewart, Halfhill, and Warwick, 2003).  
According to Stewart, there have been a relatively low number of 
confirmed cases of introgression (Stewart, Halfhill, and Warwick, 2003). 
 
However, while confirmatory data may not be available to determine the 
exact frequency of introgression, there is no clear evidence to indicate that 
the rate of introgression of a virus-resistance transgene into a wild or 
weedy species would be any different than introgression of a naturally 
occurring virus-resistance gene from a non-GE plant (Fuchs, Chirco, and 
Gonsalves, 2004(a); Tepfer, 2002).  Further, there is no evidence 
indicating that a weedy plant would become more competitive if it gained 
virus resistance via gene flow from VCP-expressing plants. 
 
Whether or not introgression is considered to be a significant issue with a 
particular crop or crops, there are steps that can be taken in some 
circumstances to reduce any potential risk.  These include use of plants for 
which there are no sexually-compatible relatives present in the geographic 
region; use of plants that have been identified to exhibit low levels of gene 
flow/introgression; and further development of transgene containment 
strategies (Stewart, Halfhill, and Warwick, 2003). 
 
Current knowledge and data suggest that gene flow from a GE virus-
resistant plant to a wild or weedy plant is not likely to provide different 
exposure from that which occurs under natural agricultural and 
environmental settings. 
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d. Herbicide-tolerant Crop Plants 
 
Weed science became an organized discipline with the introduction of 
synthetic herbicides in the 1940s (Duke, 1998) and has resulted in an 
expanding array of new herbicides with increasing efficacy and utility in 
crop production.  The proportion of pesticides used in the United States 
that are herbicides continues to grow and is now close to 75 percent of the 
crop-protection pesticide market.  While some persistent herbicides can 
have serious negative impacts on the environment, and in particular on soil 
and aquatic ecosystems, some of the newer, nonselective and 
nonpersistent herbicides are less hazardous to the environment. 
 
Over the past few years, several herbicide-resistant crops (HRCs), both 
transgenic and nontransgenic, have become available in North America 
(see table 4–1).  Plants genetically engineered to be resistant to post-
emergence, nonselective herbicides (e.g., glyphosate and glufosinate) are 
being widely adopted in North America and other parts of the world.  
HRCs have accounted for nearly one-third of field tests conducted under 
APHIS authority.   
 
HRCs may offer several advantages to the farmer.  In most cases, the 
farmer can design simpler weed-management strategies based on fewer 
herbicides (Young, 2006).  HRCs resistant to nonselective herbicides are 
also useful in no-tillage agriculture, allowing the farmer to spray at or near 
planting and then as needed during crop development (Young, 2006; 
Pilson and Prendeville, 2004; Conservation Tillage Study, 2002). 
 
There is concern among weed scientists that overreliance on fewer weed-
management strategies will result in the evolution of resistance to the 
more useful herbicides or population shifts to naturally resistant weed 
species (Young, 2006; Martinez-Ghersa, 2003).  Alternatively, overuse of 
one management strategy may allow other weed species to become 
adapted in the ecological vacuum created by effective control of the weed 
species now present. 
 
The occurrence of weeds with evolved herbicide resistance has been 
documented (http://www.weedscience.org/in.asp).  This problem has not 
yet reached the severity seen with insecticide resistance, but in isolated 
cases the impact has been significant, resulting in increased weed control 
and energy costs and reduced crop yields and crop quality. 
 
 
 
 
 
Table 4–1.  Herbicide Resistant Crops Now Available 
in North America. 
Herbicide Crop Year Available 
Bromoxynil cotton 1995 
Cyclohexanediones* maize 1996 
Glufosinate canola 1997 
 corn 1997 
Glyphosate soybean 1996 
  canola 1996 
 cotton 1997 
  corn 1999 
Imidazolinones* maize 1993 
  canola 1997 
Sulfonylureas* soybean 1994 
Triazines* canola 1984 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Some scientists propose that resistance to glyphosate and glufosinate 
herbicide will probably evolve more slowly than to many other herbicides 
(Bradshaw et al., 1997; Devine et al., 1993), and there are methods, such 
as crop rotation, to minimize the development of herbicide-tolerant weeds, 
whether or not the farmer uses genetically engineered HRCs.  Most weed 
scientists agree that with these herbicides, population shifts to naturally 
resistant weed species will be a bigger problem than evolution of 
resistance (Owen, 1997).  Nevertheless, glyphosate resistance has already 
appeared in more than one population of ryegrass in Australia (Powles 
et al., 1998; Pratley et al., 1996). 
 
Introgression of crop genes and transgenes into weeds is possible with 
some crops and could occur in the case of herbicide tolerance genes.  For 
example, rice can interbreed with red rice (Langevin et al., 1990), a feral 
form that is a serious weed problem in some rice-growing areas of the 
world.  A herbicide-resistance transgene in a plant can greatly increase the 
chance of survival of interspecies crosses by eliminating competition of 
other herbicide-susceptible weeds (Keeler et al., 1996).  However, a 
herbicide resistance transgene alone confers no fitness advantage in areas 
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where the herbicide is not sprayed.  Thus, if the gene is transferred from 
the HRC to a related weed species, the biggest concern is for the farmer 
who must cope with the herbicide-resistant weed.  In addition, other users 
of herbicides such as natural resource managers, municipalities and 
homeowners may eventually be affected, resulting in costs incurred in 
switching to other weed control methods and herbicide products.  There 
may be environmental costs as well, if these individuals are forced to use 
herbicides with higher toxicity or higher persistence in order to control 
herbicide-tolerant weeds. 
 
e. GE Crop Plants Producing Pharmaceuticals and Vaccines 
 
A new development in biotechnology is the production of pharmaceuticals 
and vaccines in plants (“Plant-Made Pharmaceuticals”—PMPs).  A 
pharmaceutical plant is a plant that has been genetically engineered to 
produce a medical or industrial product, including human or veterinary 
drugs, vaccines, antibodies, blood proteins, or enzymes.   
 
This area of research has expanded over the years because PMPs may 
have advantages in terms of production scale, production costs, ease of 
storage, and distribution (Ma et al., 2005; Stoger et al., 2005).  In addition, 
the production of pharmaceuticals and vaccines in plants may avoid one of 
the major disadvantages of pharmaceuticals produced in animal cells, 
namely, the risk of pathogens in the animal cells that are traditionally used 
to produce vaccines.  
 
While these potential advantages are generally recognized, this technology 
poses new challenges especially for the confinement and segregation of 
these plants.  Confinement and segregation are particularly important 
where there is a possibility of commingling with crops for the food or feed 
chain.  Such commingling with food crops could result in economic losses 
due to loss of domestic and foreign markets, costs to test for the presence 
of transgenes, and possible costs for the destruction of commingled 
commodities. 
 
Pharmaceutical plants fall into a distinct category, and BRS policy makes 
clear that these GE plants are handled differently than those being 
developed for use as food or feed.  Developers interested in field testing a 
pharmaceutical plant must obtain permission from APHIS through a 
permit.  APHIS determines permit conditions to ensure appropriate 
confinement and segregation on a case-by-case basis.   
 
For field tests of pharmaceutical plants, APHIS imposes more stringent 
confinement measures than for field tests of conventional GE plants, such 
as increased isolation distances and fallow zones, and increased 
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inspections and oversight.  During the growing season, measures must be 
taken to achieve reproductive isolation from any sexually compatible 
plants to prevent cross-pollination with cultivated or wild plants that are 
not part of the field test.  Environmental effects considered include 
impacts on threatened and endangered species, toxicity of the GE plant to 
nontarget organisms, and the likelihood of such organisms to be exposed.   
 
f. Silviculture 
 
The United States forest products industry employs 1.6 million people and 
ranks among the top 10 manufacturing employers in 46 States.  The 
industry generates products valued in excess of $230 billion each year, 
including $23 billion worth of exports.  One-third of the United States is 
forested (about 747 million acres), and of this total, 350 million acres 
represent commercial timberland.  More than 270 million acres of Federal 
land have been set aside for use as wildlife refuges, parks, and wilderness 
areas.24
 
Approximately 2.6 million acres of trees are planted annually in the 
United States.  Approximately 1.6 billion trees are produced, harvested, 
and shipped by forest-tree nurseries annually.  Forest product nurseries 
produce 852 million trees, private nurseries produce 366 million trees, 
State nurseries produce 348 million trees, and Federal nurseries produce 
38 million trees. 
 
Most forest tree breeding programs are in only the third or fourth 
generation of tree improvement.  The more advanced tree improvement 
programs were begun in the late 1940s or early 1950s.  The species 
receiving most of the attention in the United States has been loblolly pine 
in the Southern United States, but there is considerable research with other 
species, such as slash pine, hybrid poplar, and cottonwood.  In the Western 
United States the dominant species is Douglas fir. 
 
Historically, most tree breeding programs have been conducted primarily 
using recurrent selection where the best parents are selected to establish 
seed orchards.  The best trees, called “mother” trees, are planted in a seed 
orchard and are allowed to cross among each other.  The seeds that are 
produced are of higher genetic value than seeds collected in the wild.  
Over time, the performance of the progeny is evaluated and trees lacking 
the desired traits can be removed from the orchard.  Most trees resulting 
from such breeding programs are destined for the lumber and paper-
pulping industries, so most of the traits that have been selected are related 
to growth and form.  Trees exhibiting rapid growth and good form with 
 
24  Source of Statistics:  American Forest & Paper Association 
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increased volume are selected to create the next breeding generation.  
Wood quality has been examined in some species, most notably wood 
density for pulp yield.  Traits such as disease and insect resistance are also 
selected.  For example in loblolly pine, trees are selected for resistance to 
southern fusiform rust, while Populus (poplar) species, are selected for 
resistance to fungal diseases such as Septoria leaf spot or Melampsora leaf 
rust.  Resistance to white pine blister rust in pine species in the Western 
United States is another important trait selected by breeders.  Trees that 
are not intended for timber but for landscape use or production of tree 
fruits also are improved through breeding programs in a similar manner; 
however, the desirable traits being selected are different. 
 
Because most tree breeding programs have been in existence only three or 
four generations only limited progress has been made in domesticating 
these species.  As a result, the trees in breeding programs are not far 
removed, genetically, from their wild progenitors, and many can intercross 
freely with their wild relatives.  For example, species of Pinus and 
Populus are indigenous to the continental United States and have been 
selected from the wild for tree breeding programs. 
 
Current forest tree breeding programs are moving toward clonal forestry, 
in which all of the trees planted are genetically identical.  Clonal programs 
are well advanced in some genera, such as hybrid poplar and cottonwood, 
and are under development in others, such as loblolly and slash pine.  By 
selecting superior clones, substantial genetic gains in wood volume can be 
achieved, thus allowing more wood to be grown on less land. 
 
Like other plants, trees are genetically engineered using established 
biotechnological methods that result in stable transgene incorporation.  
However, tree breeding methods differ in some ways from those used with 
annual crops, and these differences may affect the deployment of GE tree 
products.  In the immediate future, it is most likely that any deregulated 
GE trees will be deployed as clones.  Assessing the stability of transgenes 
in GE trees over multiple generations may be more difficult than for row 
crops because breeding cycles take several years.  Also because generation 
times are long, it may require several years to produce new tree cultivars.  
Varieties with stacked traits will initially be produced by multiple genetic 
transformations. 
 
Tree breeders are currently not using GE trees as either pollen or seed 
parents, orchards using GE trees for the production of GE seeds could be 
decades away.  Therefore, all of the GE trees that are produced for 
deployment in the near term will be produced by vegetative propagation.  
This will most likely be done through tissue and cell culture or rooted-
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cutting propagation, and new plantations will be established by 
transplanting vegetative propagules into the landscape. 
 
Forest trees are long-lived perennials.  The lifespan of hardwoods and 
softwoods is decades or centuries.  Thus, the duration of a field test of GE 
trees can span a number of years.  Depending on the trait being measured, 
it could require several years of testing to gather meaningful data. 
 
Many forest trees are wind pollinated, and tree pollen can travel large 
distances.  Pollen from some tree species can live a long time compared to 
that of many plant species.  Therefore, pollen from GE trees could 
potentially travel for miles from one plantation to another or from 
managed plantations to unmanaged areas. 
 
In many forest trees, seed dormancy is common.  Seeds of some species 
can remain dormant for years, and in some species stratification, that is, a 
cold treatment, is required for germination.  Therefore, seeds from GE 
trees could lay dormant for years following harvest and germinate years 
after deposition on the forest floor. 
 
Genetically improved trees are usually grown in plantations.  These 
plantations cover hundreds to thousands of acres.  Plantations are planted 
in large blocks or mosaics and are harvested when the trees are mature.  In 
a plantation the rotation can range from 8 to 12 years for a genus like 
Eucalyptus to 80 years for long-lived conifers such as spruce or fir.  
Therefore, a tree “crop” can last for decades. 
 
So, the use of genetic engineering to control tree flowering through 
sterility is under consideration.  Some stakeholders have expressed the 
opinion that all GE trees will have to be sterile before they can be 
deregulated.  Questions arise as to whether sterility is necessary or 
desirable.  Questions also arise as to whether sterility over a long period of 
time is achievable and whether redundant methods will be required to 
ensure long-term stability of a sterile trait.  APHIS anticipates that these 
questions will be answered on a case-by-case basis. 
 
(1) Tree Traits Under Development 
 
Forest trees have a number of insect pests.  Some insects attack young 
trees, and others attack older trees.  Annual plants engineered for insect 
resistance using Bt toxins are grown with refugia to delay the development 
of resistant insects.  For trees engineered for insect resistance, refugia may 
be useful when grown in a plantation setting.  For some species, these 
resistance genes will need to be effective in plantations for 20 or more 
years.  This timeline could argue for incorporating multiple mechanisms 
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for resistance into these trees.  The potential impact of species that feed on 
insects that are no longer present in resistant plantations may also have to 
be considered. 
 
Forest trees are also subject to a number of devastating disease pests.  For 
example, in 1900, the American chestnut was deemed the “Redwood of 
the East Coast,” standing 100 feet tall and comprising approximately 
30 percent of the eastern-seaboard forests.  A fungal pathogen, 
accidentally introduced in the late 1800s, resulted in the death of 
approximately 3.5 billion chestnut trees, and relegated the species to low 
growing sprouts, unusable as timber. 
 
Resistance to tree diseases, such as fusiform rust in southern pines, is 
being researched using genetic markers and genomics.  There is also a 
potential for engineering resistance to disease using existing genes.  
Projects are underway to engineer resistance to blight in American 
chestnut and to Dutch elm disease in American elm. 
 
Modification of lignin levels and types through genetic engineering of 
forest trees is a project that is well on its way.  These projects are aimed at 
improving pulping traits or solid wood properties.  Changing lignin 
composition will result in a change in wood chemistry and secondary 
compounds.  These changes could affect resistance to insects and diseases 
or the ability of the trees to respond to adverse environments.  These 
alterations could also accelerate or slow the rate at which wood decays.  
These changes would not likely be an issue in a plantation where almost 
all the wood is harvested but could be an issue if the gene were to escape 
into native stands. 
 
Lignin is a chemical compound that is an integral part of the cell walls of 
plants, providing strength.  When trees are used for paper production, 
lignin must be removed from pulp before manufacturing the paper.  This 
extra step is costly, both economically and environmentally (Pilate et al., 
2002); thus, poplar trees have been genetically engineered to reduce lignin 
content (Baucher et al., 1996; Van Doorsselaere et al., 1995).  Lignin also 
has a secondary function as a plant defensive chemical:  it reduces leaf 
digestibility for insect herbivores and functions as a barrier to some 
pathogens.  By decreasing lignin content in GE trees, a possible outcome 
could be an increase in insect herbivore pest populations (Van 
Frankenhuyzen and Beardmore, 2004) as well as an increase in disease 
incidence (Pinçon et al., 2001).  However, a small pilot study investigating 
herbivore and pest pressures on trees genetically engineered for reduced 
lignin content found no change in insect abundance, a similar variety of 
insect species within the GE and non-GE plots, and no difference in 
phytopathogen occurrence (Pilate et al., 2002). 
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Wood products derived from GE trees would likely be viewed no 
differently than other non-viable materials derived from GE plants.  For 
example clothing made from GE cotton is treated no differently from that 
made from non GE cotton.  Manufactured wood products, including waste 
products such as sawdust or wood chips derived from the manufacturing 
process are non viable and are currently not regulated.  
 
(2) Forest Certification 
 
Large amounts of forest land are bought and sold between companies and 
other institutions every year.  If APHIS adopts a conditional approval 
process and requires data to be provided once large acreages of GE trees 
are planted, there will need to be some mechanism to monitor long-term 
tracking of GE trees as they move from one owner to another. 
 
Several different organizations currently certify forestry operations, that is, 
there is no one industry standard and programs often compete with each 
other.  Organizations such as the Forest Stewardship Council (FSC, 
<http://www.fscus.org>), the Sustainable Forestry Initiative (SFI, 
<http://www.aboutsfi.org>), the Pan European Forest Certification 
Council (PEFC, <http://www.perf.org>), and the Canadian Forest 
Certification System (CFCS) are the more prominent organizations.  These 
competing organizations have differing certification standards.  In 
particular some certification programs allow GE trees while others do not.  
For example, the FSC does not allow the planting of any GE trees, even 
for testing purposes, on plantations it has certified.  SFI has no such 
restriction.  This could cause problems both within the United States and 
between the United States and other countries, if certified and noncertified 
products were to become commingled. 
 
Currently no premium is given for products with certification by FSC, 
SFI, PEFC, CFCS and other organizations.  However, more and more 
companies are looking at purchasing forest products with a “seal” of 
certification that justify a higher price for a resource or product.  
Increasingly, retailers of wood and wood products are indicating that they 
will stock products only if it carries a seal of approval.  Consequently 
mills that have been certified may become the preferred supplier for these 
outlets.  More and more retailers, producers, and forest-based companies 
are taking the position that they will deal only in goods from certified 
forest operations. 
 
The sizes of field tests of GE forest trees are smaller, and fewer tests are 
performed compared to other plants.  The current acreages of field tests 
are relatively small but the duration of the field tests cover multiple years.  
APHIS has allowed a limited number of GE trees in field tests to flower.  
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The number of trees that are field tested and the size of field tests is 
limited by the researcher’s ability to monitor for flowering and follow 
multiple confinement practices.  Another limiting factor is that few 
companies or institutions are at the point of producing large numbers of 
GE trees for testing. 
 
APHIS has not deregulated any forest tree products, but the agency 
anticipates that it will be petitioned for the deregulation of a forest tree 
engineered in the United States within 3 to 7 years.  However, entities 
outside the United States could petition APHIS for deregulation sooner.  
Worldwide more than 210 field tests with GE trees have taken place, 
mainly on species such as Eucalyptus, Populus, and Pinus.  With the 
exception of China, none have been deregulated.  China has reported the 
commercial release of GE poplar, with approximately 1.4 million insect-
resistant trees planted on 300 to 500 ha25 (FAO, 2004). 
 
(3) Summary 
 
Unlike crop plants, most of the forest tree species that are being 
considered for deregulation and deployment in the United States are not 
far removed from their wild progenitors, and they persist in the 
environment for a long time.  Many can intercross freely with their wild 
relatives; thus, gene flow can occur from plantations into surrounding 
forests.  
 
Only a limited number of studies have examined how far pollen can move 
within and from a tree plantation.  Few studies have looked at potential 
gene flow from GE trees in a plantation to trees in native forests; however 
some studies have looked at the movement of non-GE markers from an 
established field test.  Because of these limitations the best available data 
APHIS will have for evaluating the potential for transgenes to move into 
native forests may be gene flow models from other perennial species, like 
grasses.  APHIS will need to evaluate the applicability of these data on a 
case-by-case basis, when considering deregulation or conditional approval 
of GE trees. 
 
For some of the traits that are being engineered into trees, it may not be 
possible to gather data on the effect of the trait on the environment over 
many years.  A good example would be genes for lignin modification.  It 
will take years to produce such data.  Therefore, for some traits, APHIS 
may need to make certain assumptions or use incomplete data when 
petitioned for deregulation.  When future decisions regarding transgenic 
trees involve incomplete or unavailable information, APHIS would 
 
25  Food and Agriculture Organization:  Preliminary review of biotechnology in forestry, including 
genetic modification, (Forest Genetic Resources Working Papers, FRG/59E), Rome: FAO: 2004. 
comply with the requirements of CEQ regulations regarding such 
information (40 CFR § 1502.22). 
 
B. Impacts of APHIS’ Current System 
 
This section discusses APHIS’ current regulatory system, which is 
considered the No Action alternative.  It first explains how this system 
serves to protect the environment from potential negative impacts of GE 
organisms and briefly discusses positive impacts.  The system has enabled 
the authorization of more than 11,000 field tests of GE organisms.  A 
combination of rigorous regulation and aggressive compliance 
enforcement has resulted in the completion of these field tests with no 
reported significant impacts to the human environment. 
 
Most of the GE organisms that are released into the environment for field 
testing under APHIS authorization and oversight are experimental 
organisms.  Although the agency has years of experience with many of 
these organisms and the GE traits they contain, there may be some 
uncertainties in the field testing of these organisms as a result of new and 
emerging technologies.  Acknowledging this, APHIS’ response is to 
protect against significant environmental impacts through a regulatory 
framework that requires APHIS authorization and oversight of all 
regulated articles, unless APHIS determines that they pose no plant pest 
risks.  At that time they may be deregulated by the agency.  Release 
authorizations, in the form of notifications and permits, are designed to 
confine regulated articles such that they do not move outside of the field 
test site and do not persist beyond the termination of the field test.  Thus, 
confinement forms the cornerstone of APHIS’ regulatory approach to 
these organisms, effectively protecting against the environmental impacts 
described in section A of this chapter. 
1. Overview of 
Protections in 
the Current 
Regulatory 
Framework:  
Confinement 
of Regulated 
Articles Until 
Risk Issues 
Are Addressed 
 
Appropriate confinement measures are imposed for each field test, 
according to the plant and the trait.  For example, APHIS guidance for 
field tests performed under notification recommends isolation distances 
adapted from AOSCA standards.  These standards vary by plant species 
and are based on the propensity of given plants to cross-pollinate with 
other plants in the vicinity.  Self-pollinating species tend to need smaller 
isolation distances than species which are pollinated by insects or the 
wind.  Isolation distances can also vary by trait.  For example, greater 
required isolation distances are imposed on field tests of plants engineered 
to produce substances intended for pharmaceutical and industrial use.  In 
these cases, the increased distance is due to the greater potential impact 
that any gene flow could have. 
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It is theoretically possible that field tests of GE organisms could have an 
impact on the human environment, even if APHIS-imposed confinement 
measures are effective, due to environmental exposure at the field test site.  
Such impacts would typically be minimal for a variety of reasons, 
including the small size of most field releases.  However, for field tests 
that APHIS determines are not categorically exempt under NEPA, APHIS 
prepares an environmental assessment (EA) prior to authorization to 
carefully consider the potential impacts of the field test. 
 
After several years of field testing and data collection, a company or 
researcher may, and usually does, choose to begin preparing for 
commercialization.  At this point, an applicant typically files a petition for 
the determination of nonregulated status with APHIS, which means they 
have gathered enough data to demonstrate the new crop variety is not a 
plant pest and should no longer be regulated by APHIS.  Depending on the 
product, reviews by FDA and EPA may also be applicable.  Details of the 
petition process are described in chapter 1 of this DEIS.  Most 
importantly, as part of the review process, APHIS prepares an EA or an 
EIS, if necessary, to fully evaluate the organism for deregulation and 
determine whether it can safely be released in the environment.  As with 
authorizations under notification and permit, the deregulation process is 
designed in such a way as to evaluate the environmental impacts described 
in section A of this chapter that may be relevant to that organism. 
 
NEPA requires the preparation of an environmental impact statement for “   
major Federal actions significantly affecting the quality of the human 
environment….”  The CEQ NEPA implementing regulations provide that 
“…economic or social effects are not intended by themselves to require 
preparation of an environmental impact statement.  When an 
environmental impact statement is prepared and economic or social and 
natural or physical effects are interrelated, then the environmental impact 
statement will discuss all of these effects on the human environment.”  
40 CFR § 1508.14.  These regulations require the analysis of economic or 
social effects26 in those instances when there are significant natural or 
physical effects on the environment resulting from the action and the 
potential economic or social effects are closely related to the identified 
environmental effects. 
 
This DEIS will not present an in depth analysis of positive impacts, but the 
agency recognizes that GE organisms can have positive impacts.  
Therefore, regulating beyond what is necessary to control the risks of 
2. Positive 
Impacts 
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26  See appendix G for a discussion of the socioeconomic and sociocultural issues that may be 
associated with genetically engineered organisms. 
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negative impacts could have the indirect impact of delaying or preventing 
the use of GE organisms that could have an environmental benefit.   
 
Several examples exist where positive environmental impacts have been 
attributed to GE organisms that have successfully made their way through 
the current system of field testing and have been deregulated and 
commercially deployed.  One example is Bt cotton, in which the 
engineered trait of insect resistance has led to a reduction in the use of 
toxic chemical pesticides.  Another example would be glyphosate-tolerant 
soybeans.  They have facilitated adoption of “no-till” production which 
saves energy and reduces soil erosion.  Other products may provide other 
economic or cultural benefits (Phipps and Park, 2002).  Virus-resistant 
papaya is often credited with helping to sustain the papaya industry in 
Hawaii.  This is a traditionally important crop to small farms that was 
being threatened with the papaya ringspot virus. 
 
The agency has strived to keep current regulations in balance with risks, 
but there are potential areas where regulatory relief may be appropriate.  
These are discussed by issue in the analysis section C of this chapter 
where applicable.  
 
C.  Impacts of Regulatory Alternatives 
 
This section analyzes the impacts of the various alternatives relative to the 
current system.  The environmental impacts or consequences of 
implementing the various alternatives are discussed here, along with a 
comparison and analysis of those impacts.  The discussion includes 
environmental impacts of the alternatives and where appropriate, local and 
national impacts, environmental effects that cannot be avoided, short-term 
and long-term impacts, irreversible and irretrievable commitment of 
resources, and procedures intended to mitigate adverse environmental 
impacts of program activities. 
 
As mentioned in chapter 1, a decision to revise APHIS regulations may 
involve many individual changes, and the alternatives will be discussed 
and analyzed separately in this chapter for the sake of clarity.  In this 
document, the term “alternative” refers to the individual choices that can 
be made for each issue.  These choices collectively comprise the two 
alternatives:  the “Action Alternative” and the “No Action Alternative.”  
The discussion also specifies the significance of direct, indirect, and 
cumulative impacts.  The conclusions presented in this analysis are 
intended to guide decisionmakers in selecting an alternative for the APHIS 
program.  This chapter will guide decisionmakers in developing the 
Record of Decision in compliance with NEPA. 
 
  
Impacts may be evaluated differently depending upon what is being 
impacted.  For example, impacts on humans are considered at the level of 
one or more individuals.  However, impacts on plants or animals are 
generally considered in terms of the effects on populations, species as a 
whole, communities, or ecosystems.  Impacts on the physical environment 
are most important when they affect humans or resources important to 
humans, and certain impacts on resources may have socioeconomic 
implications.  All of these factors were considered in the identification and 
evaluation of impacts in this DEIS. 
 
Pursuant to the National Environmental Policy Act of 1969 (NEPA), as 
amended, the Council on Environmental Quality (CEQ) regulations for 
implementing NEPA, the USDA regulations implementing NEPA, and 
APHIS’ NEPA Implementing Procedures, this evaluation process is used 
to determine the significance of the impacts.  Four factors were considered 
in the evaluation of biological impacts:  the magnitude of an impact, its 
geographic extent, its duration and frequency, and the likelihood of its 
taking place.  By considering each of these factors, the evaluation of 
impacts is kept uniform and systematic.  Where a quantitative evaluation 
is possible, specific criteria for the magnitude, geographic extent, duration 
and frequency, and likelihood of impacts are used.  Where quantitative 
evaluations are impossible, qualitative comparisons of impacts are used. 
 
1. Issue 1 APHIS is considering the broadening of its regulatory scope beyond 
genetically engineered organisms that may pose a plant pest risk to 
include genetically engineered plants that may pose a noxious weed 
risk and genetically engineered organisms that may be used as 
biological control agents. Do regulatory requirements for these 
organisms need to be established?  
 
Given the rapid advances in biotechnology, the present scope of 
regulations may not be of sufficient breadth to cover the full range of GE 
organisms and the full range of potential agricultural and environmental 
risks posed by these organisms, including risks to public health.  
Historically, APHIS has used only the authority in the PPA that was 
originally granted in the FPPA and the PQA.  Specifically, the agency has 
used its authority to protect against plant pests as the basis for regulating 
GE organisms.  The PPA, however, redefined authorities and 
responsibilities for the agency.  Changes are now being considered in 
recognition of these responsibilities and in light of these new technologies. 
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Alternatives Related to Issue 1 
 
1. No Action—continue to regulate GE organisms as potential plant 
pests and use genetic transformation as the trigger for regulation 
(event-by-event). 
 
2. Expand the scope of what is regulated by adding considerations of 
noxious weed risk and regulating GE biological control organisms 
in addition to evaluating plant pest risks, and use genetic 
transformation as the trigger for regulation.  Continue to regulate 
event-by-event. 
 
3. Expand the scope of what is regulated by adding considerations of 
noxious weed risk and regulating GE biological control organisms 
in addition to evaluating plant pest risks. Use novelty of the trait in 
the species as the trigger for regulation.   
 
In addition, the following alternative could be used in conjunction 
with any of the above to exclude certain organisms based on risk: 
 
4. Exclude specific classes of highly familiar organisms and highly 
domesticated, nonweedy crop plants and also create a mechanism to 
exclude additional organisms from the definition of regulated article 
after a safety review. 
 
a. No Action Alternative 
 
Under this alternative, APHIS will continue to regulate GE organisms, on 
an event-by-event basis, for their potential to pose plant pest risks, and use 
genetic transformation as the trigger for regulation.  Regulating GE 
organisms as potential plant pests has provided effective protection to the 
environment and to American agriculture.  APHIS knows of no impacts 
that have occurred as a result of limitations in the agency’s authority.  
However, it is arguable that some GE organisms that may pose a risk to 
public health, agriculture, or the environment may not meet APHIS’ 
definition of a regulated article.  Specifically, APHIS’ authority could be 
challenged in cases where there are no plant-pest sequences and for which 
there is no “reason to believe” that the organism poses a plant pest risk.  
The agency has been confronted with proposed introductions of GE 
organisms, such as algae, which the current regulations appear not to 
cover.  While the organism may very well not pose a significant danger, 
the agency is not in a good position to make such an argument due to lack 
of familiarity. 
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For example, if GE organisms could be released into the environment 
without regulatory oversight due to a narrow definition of a regulated 
article, there could be negative impacts on agriculture due to genetic traits 
that increase plant susceptibility to disease or insect pests.  Similarly, if a 
GE organism were released into the environment due to a gap in APHIS’ 
regulations and if the GE organism were to become persistent in the 
environment, pesticide usage might increase to effect the eradication of 
the organism.  However, because of the difficulty in predicting 
innovations in genetic engineering technology, the exact nature and size of 
these hypothetical environmental impacts are uncertain. 
 
b. Action Alternatives:  The Scope of Regulations 
 
Impacts resulting from the field testing of GE organisms would likely 
increase in number and significance if a growing number of GE organisms 
with the potential to cause environmental harm were released into the 
environment because APHIS had no regulatory oversight and therefore, 
could not impose safeguards.  As technology continues to advance and the 
variety of genetic material moved between species continues to increase, 
an expansion of regulatory oversight, based on existing statutory authority, 
could reduce the frequency and magnitude of environmental impacts. 
In alternative 2, APHIS would continue event-by-event regulation that 
considers potential plant pest risks and add considerations of noxious 
weed risks and regulating GE biological control organisms.  Under this 
alternative, APHIS oversight would expand to cover all genetically 
engineered plants as well as all potential plant pests.  APHIS recognizes 
that this expansion might result in regulation of classes of organisms that 
could be deemed safe in the future.  Therefore, for this alternative, it might 
be appropriate to consider that certain organisms could be excluded from 
the definitions and removed from APHIS oversight as described below. 
 
Alternative 3 is a trait-based approach.  Under this alternative, APHIS 
would still rely on one or more provisions in the PPA, regulating GE 
organisms based on their potential as plant pests or noxious weeds or both.  
However, it would be assumed that any GE organism with an unfamiliar 
plant/trait combination might pose a risk covered under the act; therefore, 
all GE organisms would initially be subject to APHIS oversight.  To 
determine whether oversight is actually necessary, the key questions are 
whether APHIS is familiar with a particular organism expressing a 
particular transgene or group of transgenes and whether the organism is 
sufficiently safe to be removed from APHIS oversight.  This approach 
differs from the current approach in the treatment of deregulated GE 
organisms.  In the trait-based approach, once a GE organism was found to 
be safe and was deregulated, new transformants representing the same 
familiar plant/trait combination could also be deregulated.  The system 
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should be as protective as the current one, except that it would not account 
for unanticipated changes relating to the transformation process or other 
differences that may exist at the biochemical level among plants having 
the same phenotype.  Based on experience, the probability of 
unanticipated changes appears low.  To address this small risk, an 
applicant might be required to produce an abbreviated data package to 
show that there are no unanticipated phenotypes. 
 
Both alternatives 2 and 3 above allow the expansion of APHIS’ regulatory 
scope to reduce the chances that a GE organism, the field testing of which 
may pose environmental impacts, will fall outside APHIS’ purview.  
Although each of the proposed alternatives sets different criteria for the 
determination of whether a GE organism would be regulated, the adoption 
of either of the proposed alternatives would increase the number and types 
of GE organisms that would be regulated.  Increasing oversight of GE 
organisms that may pose a risk to the environment will be more protective 
of the environment and should reduce environmental impacts which might 
otherwise occur should the agency elect the No Action alternative. 
Although the level of public safety provided by the current regulatory 
system has been demonstrated over the course of its history, the advances 
in genetic engineering technology are rapid, inevitable, and to some 
extent, unpredictable, which could result in the production of GEOs that 
pose a risk but are outside of the current regulatory scope.  Therefore, the 
No Action alternative potentially poses a greater risk of adverse 
environmental impacts to many of the environmental factors under 
analysis than either of the other proposed alternatives. 
 
Alternatives 2 and 3 create regulatory systems that allow APHIS to 
address new and emerging issues as genetic engineering technologies 
continue to advance.  Both of these alternatives would enable APHIS to 
reduce the risk of introducing potentially harmful GE organisms and the 
risk of environmental impacts resulting from the introductions.  Therefore, 
the adoption of either of the proposed alternatives should result in a 
reduced potential for significant adverse impacts to the environment as 
compared to the current system. 
 
Between the two alternatives, the event-by-event approach using the new 
provisions of the PPA may result in APHIS examining a larger number of 
GE organisms than it would using the trait-based approach.  This is 
because with a trait-based approach, entire classes of GE organisms could 
be removed from APHIS oversight, whereas, with event-by-event 
regulation, each GE organism is considered individually.  However, 
selecting either alternative should enable APHIS to exercise regulatory 
oversight for all genetically engineered plants initially, including algae and 
other noncrop species, as well as all micro-organisms and invertebrates. 
  
c. Action Alternatives:  Methods to Exclude Certain Organisms 
Based on Risk 
 
APHIS is also considering whether the new regulations should designate 
specific articles as excluded from regulation.  This is alternative 4.  The 
purpose of this provision is to remove from regulatory oversight articles 
with which APHIS has a great deal of familiarity and which have a long, 
well-documented history of safe use or articles, such as plants with altered 
flower color or similar traits, with no potential to cause significant 
environmental impacts.  The exclusion process would be rigorous and 
NEPA-compliant, and would provide opportunity for public comment.  
This alternative could be adopted in conjunction with any of the other 
alternatives. 
 
APHIS would not exclude any organism from regulation unless it 
determined that exclusion of the article would have no significant adverse 
impacts to the human environment; therefore, a regulatory provision 
allowing exclusions should not have any significant adverse 
environmental effects. 
 
APHIS is considering revisions to the regulations to increase 
transparency and to address advances in technology that may create 
new products and concerns. Should a new system of risk based 
categories be designed to deal with new products and new concern?  If 
so, what criteria should be used to establish the risk-based categories?  
2. Issue 2 
 
There is public interest in understanding how APHIS regulates various 
types of organisms according to risk and familiarity. In addition, there is a 
trend toward more highly varied organisms, and the risk assessment 
process may need greater flexibility to handle this variety. The current 
system of notifications and permits needs to be more transparent to the 
public, and developers have a vested interest in knowing how organisms 
that they are developing will be regulated.  In addition, the term 
“notification” has proven somewhat misleading in that it does not clearly 
convey that these field tests are subject to full APHIS oversight:  no GE 
organisms may be imported, moved interstate, or released into the 
environment without active approval from APHIS.  In recognition of the 
issues above, the agency is considering risk-based categories in which GE 
plants are classified according to risk and familiarity so that oversight and 
confinement vary by category.  Redefined categories may provide added 
flexibility to better regulate diverse organisms and new types of  traits and 
provide better clarity to the regulated community and to the public, which 
may, in turn, promote greater confidence in the system. 
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Alternatives Related to Issue 2 
 
1. No Action—continue to use a two-tiered system (notifications and 
permits). 
 
2. Abolish categories and treat all incoming requests on a case-by-case 
basis. 
 
3. Establish a tiered permitting system for all organisms based on 
newly devised criteria. 
 
4. Establish a tiered permitting system for plants based on newly 
devised criteria and evaluate permit applications for introductions 
of nonplant organisms on a case-by-case basis. 
 
a. No Action Alternative 
 
For this issue, the No Action alternative is to continue with the two-tiered 
system for introductions, which consists of permits and notifications.  
APHIS has been able to meet the demands of the technology and adapt to 
a wide range of organisms field-tested under the permit system.  To date, 
the two-tiered permitting system has been effective at managing risks 
associated with introductions and preventing significant environmental 
impacts. 
 
b. Action Alternatives  
 
Alternatives 2, 3, and 4 have been proposed as revisions to APHIS’ 
current method of authorizing the movement and field testing of GE 
organisms.  Alternative 2 treats each organism/gene combination on a 
case-by-case basis.  Instead of establishing permit types for different 
categories of GE organisms, there would essentially be only one type of 
permit.  Every GE organism proposed for movement or field testing by an 
applicant would be evaluated by APHIS, the potential impacts to the 
human environment would be determined, and APHIS would fashion 
individual permit conditions for that GE organism.  Each permit issued 
under this scheme would be unique, and each GE organism would be 
regulated uniquely. 
 
Alternative 3 would establish permit tiers for requests of all incoming 
organisms based on risk and familiarity and use a case by case approach 
within all risk tiers but the lowest.  APHIS has extensive experience that 
could be drawn upon to establish such a system for plants, but establishing 
such a system for other types of organisms might be more difficult at this 
time.  A system which misclassified a GEO might result in risks to the 
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environment because oversight and confinement of that GEO would be 
based on the tier type to which it was assigned.  
 
Alternative 4 is similar to 3 above and establishes permit tiers for plants, 
but handles all other types of organisms on a case-by-case basis. 
 
Table 4–2 is an example of a tiered permit system for GE plants consisting 
of four tiers.  The first tier, Type 1 permit, is proposed for most of the 
crops that would currently qualify for notifications.  APHIS envisions that 
the eligibility criteria will borrow from APHIS’ existing list of plant pest-
based notification criteria, and also incorporate new considerations based 
on the noxious weed provision.  Examples of the criteria might be as 
follows. 
 
Criteria for Plant Permit Type 1: 
 
1. The regulated article is any plant species that is not on the Federal list 
of noxious weeds in regulations at 7 CFR part 360 under the PPA 
(7 U.S.C. § 7712), and, when being considered for field testing, the 
regulated article is not expected to establish and propagate outside of 
the managed ecosystem.  Examples of organisms that might not 
qualify for this reason are open-pollinated turf and forage grasses, 
forest trees, and aquatic plants. 
 
2. The genetic material is introduced using a method that has been 
demonstrated to result in integration of the new sequences into the 
plant genome, as defined in 7 CFR § 340.1. 
 
3. The function of the introduced genetic material is known and its 
expression in the regulated article does not result in plant disease. 
 
4. The introduced genetic material does not: 
• Cause the production of an infectious entity, or 
• Encode substances that are known or likely to be toxic to nontarget 
organisms known or likely to feed or live on the plant species, or 
• Encode substances with whose function APHIS is unfamiliar (e.g. 
substances intended for pharmaceutical or industrial use).   
 
5. To ensure that the introduced genetic sequences do not pose a 
significant risk of the creation of any new plant virus, plant virus-
derived sequences must be: 
• Noncoding regulatory sequences of known function, or 
• Sense or antisense genetic constructs derived from viral genes 
from plant viruses that are prevalent and endemic in the area where 
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the introduction will occur and that infect plants of the same host 
species and that do not encode a functional noncapsid gene product 
responsible for cell-to-cell movement of the virus. 
 
6. The plant has not been engineered to contain the following genetic 
material from animal or human pathogens: 
• Any nucleic acid sequence derived from an animal or human virus, 
or 
• Coding sequences whose products are known or likely causal 
agents of disease in animals or humans. 
 
 
7. If the GE plant is a food crop, any introduced protein either:  (1) has a 
pesticide tolerance27 from EPA if it is a plant-incorporated protectant, 
or (2) has been evaluated for key food safety issues of toxicity and 
allergenicity.  This requirement should be fulfilled before total planted 
area of tests exceeds 10 cumulative acres in a single year. 
 
8. The plant does not have sexually compatible relatives that are 
threatened or endangered. 
 
9. The proposed test site is not in a habitat designated as critical for a 
threatened or endangered species. 
 
Crops not qualifying for the Type 1 tier would go into the remaining tiers 
based on potential risk and familiarity, with the highest tier, Type 4, being 
used in cases where there is a likelihood that the plants or their transgene 
products would be highly toxic to vertebrates, they would go into the  
Type 4 tier.  Criteria for the four permit types are listed in column 1 of 
table 4–2. 
 
Tier definitions would be based on potential risks and familiarity with the 
organisms.  Familiarity is important because unfamiliar organisms may 
pose risks that the agency does not currently recognize and of which the 
agency has little mitigation experience.  Because the tiers are associated 
with risk and familiarity, the degree of confinement and oversight vary by 
tiers.  Specific regulated articles will be assigned to tiers so that 
appropriate permit conditions, confinement measures, and compliance 
requirements will be imposed to ensure that the impacts resulting from the 
introduction of the article do not significantly impact the human 
environment. 
 
 
27  See EPA’s “Regulations Under the Federal Insecticide, Fungicide, and Rodenticide Act for Plant-
Incorporated Protectants” at http://www.epa.gov/pesticides/biopesticides/pips/pip_rule.pdf . 
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For example, some pharmaceutical and industrial plants might be found 
neither toxic, allergenic, otherwise biologically active in humans, nor 
dangerous to the environment if fully evaluated by all relevant agencies.  
However, until such findings have been made, APHIS would issue Type 3 
permits for these plants in acknowledgement of the unknown potential for 
serious harm. Thus, the proposed Type 3 assignments for this category 
reflect APHIS’ view that there is less familiarity with these plants than 
those assigned to Type 2, and the Type 3 tier provides the strict-
confinement approach the agency feels is prudent, given the nature of the 
organisms.  Also, many plants that are placed in the Type 2 tier may not 
be of higher risk than those in Type 1, but simply of low familiarity.  Type 
2 offers increased flexibility for plants with which APHIS has less 
familiarity and allows confinement to be tailored as needed, as is currently 
done for permits.  The permit tiers will have different oversight with 
respect to confinement, reporting, and other requirements. 
 
An important feature of the proposed tiered permitting system is the 
proposed elimination of the need for a permit for interstate movement of 
some GE plants.  Plants that would qualify for field testing under a Type 1 
permit would not require an interstate movement permit.  Instead, the 
agency is considering a process through which individuals would notify 
the agency that they plan to transport the organisms.  No agency response 
would be required.  APHIS would still regulate the types of containers 
used to safely transport the organisms.  No environmental impacts are 
envisioned from this change because no escape or dissemination of the 
plants is expected.  Information collected from transporters during 
shipping would serve a tracking function for States and other entities 
interested in the development of biotechnology products. 
 
In terms of risk management and environmental impacts for the regulated 
introduction of GE plants, the end result of adopting a permitting system 
based on case-by-case evaluation or one employing tiers should be the 
same.  In either situation, an APHIS biotechnologist would assist the 
applicant in the development of procedures and permit conditions that 
would ensure the confinement of the GE plant and minimize its potential 
impacts on the human environment.  This has always been the goal of 
APHIS’ regulation of GE organisms, and more than 15,000 field tests 
have been successfully permitted in this way without significant adverse 
environmental impacts. 
Table 4–2.  Tiered Permit System for Environmental Releases of GE Plants 
Permit Classes of Genetically Engineered Plants Procedural Requirements for Permits Permit Conditions 
Type 1
• Plants having a low potential as plant pests [and 
noxious weeds] based on meeting criteria 
including a food safety evaluation of newly 
expressed substances, unless acreage is very 
low.28  
• Plants reclassified from Type 2 based on high 
familiarity. 
 
• Information requirements:  Simplified format(s). 
• Review by BRS:  Applications reviewed for 
compliance with criteria. 
• Scope of permits:  Required only for field tests, 
single year. 
 
• Confinement:  APHIS presets standard 
confinement requirements as part of permit 
conditions.  Confinement will be similar to that 
typically used for field tests for notifications 
under current system. 
• Inspections:  A percentage is chosen for 
inspection. 
Type 2  
• Plants having higher plant pest [or noxious weed] 
potential than Type 1. 
• Food crop plants reclassified from Type 3 based 
on increased familiarity. 
• Nonfood crop plants engineered to produce traits 
with which APHIS is unfamiliar (e.g., 
pharmaceutical and industrial nonfood crops). 
 
• Information requirements:  Standard formats.  
APHIS may ask additional information. 
• Review by BRS:  Case-by-case. 
• Scope of permits:  Single- or multi-year permits 
with SOPs.29 
 
• Confinement:  Variable, depending on plant.  
For most, applicants will propose confinement 
standards for APHIS review (modified as 
necessary).  Plants reclassified from Type 3 will 
follow APHIS-set standards consistent with 
those currently used for pharmaceutical and 
industrial plants 
• Inspections:  At least one per permit. 
Type 3  
• Plants having higher plant pest [or noxious weed 
potential] than Class 2. 
• Food crops engineered with traits with which 
APHIS is unfamiliar (e.g., most pharmaceutical 
and industrial plants) or expressing substances 
having food safety profiles with which APHIS is 
unfamiliar.30 
 
• Information requirements:  Standard formats.  
APHIS may ask for additional information. 
• Review by BRS:  Case-by-case. 
• Scope of permits:  Single- or multi-year permits 
with SOPs.31 
 
• Confinement:  Very stringent standards likely to 
exceed those currently used for pharmaceutical 
and industrial plants.  
• Inspections:  Up to 5 annual inspections.  
Type 4 
• Plants with highest plant pest [or noxious weed] 
profile, i.e. likely to pose a hazard to human 
health and environment (e.g., production of a 
compound known to be highly toxic to humans or 
other vertebrates or known to cause severe 
allergenic reactions in some people.) 
 
• Information requirements:  Standard formats.  
APHIS may ask additional information. 
• Review by BRS:  Case-by-case. 
• Scope of permits:  Single-year permits. 
 
• Confinement:  Highly stringent, case-by-case.  
Security/surveillance and restrictive access will 
be required. 
• Inspections:  Not yet determined.  At least as 
often as Type 3.  
                                                                     
28 See text for complete listing of eligibility criteria.   
29 Appropriate for production and routine multi-year research.  APHIS reviews initial permit and SOPs, applicant required to submit changes to APHIS for approval.  
30 Examples of what APHIS will consider in determining familiarity:  1) Agency experience with the gene product, trait, or similar traits.  APHIS currently has extensive experience with 
many agronomic and product quality traits.  2)  Key food safety issues of the new substance have been evaluated.  3)  Origin of the gene (e.g., food crop vs. other).  APHIS 
envisions that most pharmaceutical and industrial compounds will be placed into class 3 initially, but may be moved to other classes as the agency gains experience.   
31 Appropriate for single- or multi-year research as appropriate.  APHIS reviews initial permit and SOPs, applicant required to submit changes to APHIS for approval. 
______________________________________ 
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3. Issue 3 
The adoption of any of the proposed alternatives, including the No Action 
alternative, will not change this level of impact; APHIS would continue to 
exercise appropriate oversight to ensure that all GE organisms released 
into the environment are safe.  APHIS would continue to perform NEPA-
compliant environmental analyses when a proposal to introduce a GE 
organism raises new issues with which APHIS lacks familiarity. 
 
As APHIS gains more experience with GE organisms other than plants, it 
may be possible to incorporate these into a tiered system as proposed in 
alternative 3, but APHIS’ current level of experience with these organisms 
is much less than with plants.  Moving from a case-by-case analysis for 
nonplant GE organisms to the type of tiered system proposed for plants is, 
therefore, premature and could result in negative environmental impacts.  
As for the approach to GE plants, the major differences between 
alternatives 2 and 4 are administrative.  APHIS expects a case-by-case 
approach which includes low risk plants would be more resource intensive 
than the current system, thereby, increasing regulatory burdens. 
 
For example, the notification system requires a fixed data package from 
each applicant.  If every GE plant currently field-tested under a 
notification were to instead receive an individual evaluation, APHIS 
would necessarily need an individual data package with each field test 
application, although APHIS does not anticipate that such additional data 
would make this approach more protective of the environment than the 
current approach or than the multi-tiered approach proposed for GE plants.  
Also, case-by-case evaluations may seem less predictable to the regulated 
community and less transparent to the public.  This may make it more 
difficult to predict how long a particular permit application would require 
for its evaluation, and the resultant permit conditions may be more 
difficult for the applicant to anticipate.   
 
APHIS is considering ways to provide regulatory flexibility for future 
decisions by accommodating commercialization of certain genetically 
engineered organisms while continuing, in some cases, to regulate the 
organisms based on minor unresolved risks. Other regulated articles 
could be treated as they have been under the current system, in which 
all regulatory restrictions are removed.  What environmental factors 
should be considered in distinguishing between these kinds of 
decisions? 
 
Once an article has been deregulated, APHIS cannot place any restrictions 
or requirements on its use, short of re-regulating the article.  Restrictions 
and requirements have not been deemed necessary in the past because 
BRS risk assessments have concluded that the GE plants APHIS has 
deregulated pose no greater risks than conventionally bred plants.  
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However, APHIS recognizes that future development and 
commercialization of plants with less familiar traits may pose new 
challenges for the agency because even a thorough assessment may not 
resolve all unknowns regarding an article proposed for deregulation.  
These unknowns may justify continued scrutiny and data collection or use 
restrictions, even while allowing planting of the article without a permit.  
Therefore, APHIS is exploring a system that could give increased 
flexibility for handling special cases involving less familiar traits by 
creating provisions that allow for imposition of conditions for unconfined 
release.  This could facilitate commercialization, while requiring 
appropriate restrictions or monitoring. 
 
Alternatives Related to Issue 3 
 
1.  No Action—continue with a system granting full nonregulated status 
to crops that removes them from all regulatory obligations under 7 
CFR part 340. 
 
2.  Continue to allow for the option of granting full nonregulated status 
and develop appropriate criteria and procedures through which crops 
can be removed from permitting but some degree of agency 
oversight as necessary to mitigate any minor risks is retained. 
 
a. No Action Alternative 
 
The No Action alternative for this issue is to continue with a system of 
deregulating GE organisms to remove them from all regulatory obligations 
under 7 CFR part 340.  Currently, a GE organism is not deregulated until a 
thorough APHIS review concludes that it poses no plant pest risks. APHIS 
has the authority to deregulate in part, but has not used this approach to 
date. 
 
This approach is highly protective of the environment.  Because the 
agency cannot attach conditions or risk-mitigation measures after full 
deregulation, this approach requires that the agency determine that the use 
of the regulated article poses no plant pest risks.  If all such risks cannot be 
resolved, the organism must remain under regulation, requiring permits or 
notification. 
 
b. Action Alternative  
 
Under alternative 2, APHIS would develop processes and appropriate 
safety criteria to retain oversight, when appropriate, of a GE organism 
after it has otherwise been approved for unconfined release through either 
deregulation in part or some new mechanism designed to deliver such 
  
flexibility.  Partial deregulation could be granted when APHIS determined 
that minor questions remained regarding the regulated article that could be 
managed with appropriate conditions so that environmental impacts would 
not be significant.  An applicant could petition for partial deregulation, or 
the agency could grant partial deregulation in response to a petition for full 
deregulation. 
 
The potential for environmental impacts due to the implementation of 
partial deregulation comes from the possibility that an organism may 
receive partial deregulation and undergo widespread planting before any 
negative environmental impacts could be detected.  First, this possibility is 
extremely remote because applicants cannot apply for deregulation until 
years of laboratory, greenhouse, and field data have been collected.  
Applicants must establish the agronomic and environmental equivalence 
of the regulated article to the non-GE version of the organism. 
 
Second, APHIS would not relax its standards for deregulation in order to 
grant partial deregulation.  That is, a partial deregulation would be granted 
only if APHIS determined that doing so would not significantly impact the 
human environment.  A partial deregulation, like a complete deregulation, 
would be accompanied by an EA or an EIS, as mandated by NEPA.  Draft 
EISs must be published to elicit public comment.  APHIS BRS also 
publishes all EAs for public comment and addresses comments received, 
so that public concerns regarding potential environmental impacts of any 
partial deregulation will be addressed. 
 
4. Issue 4 Are there changes that should be considered relative to environmental 
review of, and permit conditions for, genetically engineered plants 
that produce pharmaceutical and industrial compounds?  
 
Genetic engineering technology has advanced to the point where 
organisms can be developed that produce novel proteins and other 
substances with biological activity or industrial utility.  The gene products 
made by pharmaceutical and industrial plants may have biological activity 
or may pose other hazards not associated with proteins and other 
substances commonly found in the food supply.  APHIS will examine this 
issue in the DEIS, taking into account the current rigorous permit 
conditions, multiple annual inspections required for these plants, and the 
nature of the compounds produced by these plants.  In practice, any 
changes in the confinement of plants producing pharmaceutical and 
industrial compounds would not apply solely to those plants, but to a risk 
tier that might include those plants. 
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Alternatives Related to Issue 4 
 
1. No Action—continue to allow food and feed crops to be used for 
the production of pharmaceutical and industrial compounds and to 
allow field testing under very stringent conditions. 
 
2. Continue to allow food and feed crops to be used for the production 
of pharmaceutical and industrial compounds.  The agency would 
impose confinement requirements, as appropriate, based on the risk 
posed by the organism and would consider food safety in setting 
conditions. 
 
3. Do not allow crops producing substances not intended for food uses 
to be field tested, that is, these crops could be grown only in 
contained facilities. 
 
4. Allow field testing only if the crop has no food or feed uses. 
 
5. Allow field testing of food/feed crops producing substances not 
intended for food uses only if food safety has been addressed. 
 
a. No Action Alternative 
 
Under the No Action alternative, APHIS will continue to allow food and 
feed crops to be used for the production of pharmaceutical and industrial 
compounds and to allow field testing under very stringent conditions.  
While there is no completely failsafe system, APHIS has drawn on 
experience with past compliance issues and devised a system of permit 
conditions that are sufficiently stringent that the field tests pose no 
significant risk to the environment, including human health.   
 
In APHIS’ experience, plants expressing traits with pharmaceutical or 
industrial purposes are no more likely to escape from field tests or to 
persist in the environment than plants expressing other traits.  It is possible 
that confinement measures designed to prevent gene flow under normal 
agronomic circumstances may fail in rare situations, such as extreme 
weather.  A comparison of the environmental impacts of the No Action 
alternative to the impacts of the other alternatives under consideration 
involves two questions:  (1) What is the likelihood that a particular 
confinement approach will prevent unanticipated environmental exposure, 
and; (2) What is the likelihood that unanticipated environmental exposure 
will result in significant impacts? 
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b. Action Alternatives 
 
Alternative 2 is much like the No Action alternative, except that the safety 
of the protein or other substance produced by the transgene could be taken 
into account.  The agency would impose confinement requirements, as 
appropriate, based on the risk posed by the organism and would consider 
food safety in setting conditions.  In this alternative, if there is a food 
safety issue and it has not been addressed, an organism may still qualify 
for outdoor testing, but field test criteria would be made more stringent.  
These measures could include increased auditing, increased isolation 
distances, and geographic restrictions.  Many other possibilities could be 
considered.  If such restrictions are stringent enough and can be 
adequately enforced by the agency, this alternative should be highly 
protective of the environment and human health.  Increasing the 
stringency of protections in which food safety might be at issue should 
provide added protections over the No Action alternative. 
 
Alternative 3 would contain all pharmaceutical or industrial plants in 
enclosed facilities, regardless of the risk posed by the organism, and 
would focus solely on minimizing all potential for unanticipated 
environmental exposure.  Unlike the No Action alternative, which 
prescribes very stringent confinement conditions for the field testing of 
pharmaceutical or industrial plants, the full-containment alternative 
forbids any active releases into the environment.  The likelihood that an 
unanticipated environmental release will result from the No Action 
alternative is low.  However, as acknowledged above, a release could 
result from an extraordinary event that overcomes the effectiveness of the 
confinement conditions prescribed by the permit.  The likelihood that an 
environmental release or any environmental impacts will result from the 
full-containment alternative is extremely low. 
 
Alternatives 4 and 5 rely both on minimizing the likelihood of unintended 
environmental release and on minimizing the impact to the human 
environment, should a release occur.  Both alternatives implicitly assume 
that the risk of pharmaceutical and industrial plants will not vary and any 
unintended releases will have the same consequences for the environment. 
 
In requiring containment for all pharmaceutical or industrial plants with 
food or feed uses, alternative 4 seeks to eliminate the possibility that a 
commodity used in human food or actively fed to animals would contain 
any pharmaceutical or industrial material because these commodity crops 
would have to be grown under contained conditions if they express 
pharmaceutical or industrial traits.  Under alternative 4, only plants with 
no food or feed uses would be allowed to be field tested outdoors if they 
express pharmaceutical or industrial traits.  These plants would be field 
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tested under confinement conditions at least as stringent as those currently 
in use, although, as discussed earlier, there is the remote possibility that 
these confinement conditions could be undermined by extraordinary 
circumstances, resulting in some risk of exposure to these compounds in 
food or feed, or other environmental exposure. 
 
Alternative 5, like alternative 4, restricts food or feed crops expressing 
pharmaceutical or industrial traits from being field tested; however, this 
alternative provides an exception.  If the new protein or other substance 
has been adequately evaluated relative to food safety, then outdoor field 
tests could occur, even if the plant is a food or feed crop.  This alternative 
recognizes that confinement conditions may fail under extraordinary 
circumstances.  If a failure should occur during the field testing of a food 
or feed crop producing a pharmaceutical or industrial substance, the 
commingling of this crop with commodities intended to be used as human 
food or animal feed would not result in any harm where the substance 
poses no food safety concerns.  While all the alternatives will result in 
environmental protection, alternative 5 could mitigate the consequences of 
unintended releases more than alternatives 1, 2, or 4, due to the resolution 
of food safety questions.  Alternative 3 would mitigate the consequences 
of unintended releases to the greatest extent. 
 
To determine if the field testing of plants can cause environmental impacts 
without directly affecting humans and animals through food and feed 
products, analysis would depend on the biological activity of the substance 
in question, and to what extent the field test could result in significant 
environmental persistence.  APHIS evaluates each plant/trait combination 
proposed for field testing under permit for its effect on nontarget 
organisms, including threatened and endangered species (TES).  This 
evaluation includes a determination of the TES likely to be present while 
the field test is taking place and whether any TES is likely to be exposed 
to the substance produced by the plant in question.  APHIS also evaluates 
whether the a trait is likely to make the recipient plant invasive or weedy, 
or likely to make any wild relatives of the recipient plant invasive or 
weedy, which could impact populations of threatened or endangered plant 
species.  From a biological standpoint, and in APHIS’ experience, 
pharmaceutical or industrial traits do not increase the fitness of the plants 
in which they are expressed.  Therefore, none of the alternatives for 
revision, as well as the No Action alternative, will have any significant 
impacts on TES, nor will adopting any of these alternatives result in the 
substantial establishment of pharmaceutical or industrial traits in wild 
plant populations. 
 
Although all four of the action alternatives will minimize, by various 
means, the exposure of humans to substances produced through the field 
  
testing of pharmaceutical or industrial plants, it is not possible to assess 
accurately the impact on humans from the unanticipated release of these 
organisms for the following reasons: 
 
• Effects on humans will depend on the pharmaceutical or industrial 
substance involved, and it is impossible to make general 
predictions. 
• Many pharmaceutical and industrial substances are not toxic. 
• Toxic effects may be different for special subpopulations, such as 
children and people with compromised immune systems. 
• Although current science can predict whether a specific protein has 
the potential to become an allergen, these predictions cannot be 
made with complete certainty. 
 
However, it is not necessary to know the precise impacts from 
unanticipated releases of pharmaceutical or industrial plants for APHIS to 
create a science-based, effective system to regulate these plants safely.  
APHIS’ current focus and its focus under the revised regulations will be 
the imposition of appropriate confinement measures on field tests of GE 
plants to minimize impacts on the human environment.  To date, there 
have been no reports of human- or animal-health impacts from the field 
testing of these plants, and APHIS is not considering any alternatives that 
propose a less rigorous system than the one currently in place.   
 
Given the above rationale and that the four proposed action alternatives 
provide additional environmental protections, adoption of any of those 
alternatives should result, overall, in even fewer and smaller impacts.  The 
adoption of any of the alternatives should result in no significant 
environmental impacts. 
 
The definition of noxious weed in the PPA includes not only plants, 
but also plant products.  Based on that authority, APHIS is 
considering the regulation of nonviable plant material.  Is the 
regulation of nonviable material appropriate and, if so, in what cases 
should we regulate? 
5. Issue 5 
 
In some special cases, certain nonviable material originating from a field 
test (e.g., cell debris, leaves, stems, roots, or seeds) may pose unique types 
of environmental or human health risks. Currently, APHIS regulates 
organisms that pose a plant pest risk and does not regulate nonliving 
material derived from GE organisms.  By definition, plant pests are living 
organisms.  However, the noxious weed definition provides authority to 
regulate nonviable plant products that could “injure or cause damage to 
crops.”  Because there may be cases in which potential risks could justify 
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the regulation of nonviable material, APHIS is considering whether it 
should regulate nonviable material in those cases.  
 
Alternatives Related to Issue 5 
 
1. No Action—do not regulate nonviable GE material. 
 
2. Regulate nonviable GE plant material in certain circumstances, 
based on risks posed. 
 
3. Regulate all nonviable GE plant material. 
 
a. No Action Alternative 
 
Currently, APHIS does not regulate nonviable GE material.  Nonviable 
material has been regarded as not posing a significant plant pest risk, but 
in some circumstances, it might pose other types of environmental risks.  
The potential for environmental impacts from nonviable material depends 
on several factors:  the amount of transgene expression in the tissue in 
question, the rate of release of the transgene product from the tissue, the 
stability of the transgene product, and the biological activity of the 
transgene product.  The noxious weed definition applies not only to living 
plants but also to plant products if they pose a risk to any of a very wide 
array of environmental parameters.  It may be desirable to use this 
provision of the Plant Protection Act as the basis for regulating nonviable 
GE plant material if the material does in fact pose legitimate risks to the 
human environment. 
 
The technology exists to focus transgene expression in specific tissues, 
such as seeds, and minimize it in other tissues through the use of tissue-
specific promoters.  (A promoter is a DNA sequence that enables a gene to 
be transcribed, that is, enables RNA to be produced from the gene.)  Many 
promoters have been identified that enable transcription only in specific 
tissues.  For example, the production of pharmaceutical compounds in 
plants is often accomplished through the use of seed-specific promoters.  
As a result, the pharmaceutical compound is produced only in the seeds of 
the plant, where it can be easily harvested.  However, not every gene 
construct used in the production of GE organisms employs a tissue-
specific promoter; and even when one is used, low levels of transgene 
expression may occur in other tissues.  If these tissues are not harvested, 
there is a potential for environmental exposure to the transgene product. 
 
Once plant tissues are placed in contact with the soil, the tissues and the 
substances contained within those tissues begin to break down.  Soft 
tissues will decompose rapidly, while woody tissues may take much 
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longer.  By extension, the chemical contents of soft tissues will tend to 
enter the environment more quickly than substances contained within 
woody tissues.  In addition, various chemical compounds produced by and 
stored within plant tissues will also begin to breakdown once those tissues 
begin to decompose.  Some of these substances may breakdown in a 
matter of minutes; others may take days or weeks.  Therefore, if one of 
these substances is the product of a transgene, its release into the 
environment will be controlled by the decomposition rate of the plant 
tissue in which it resides, as well as the rate of breakdown for the 
substance itself. 
 
A high level of scrutiny might be needed when the transgene product is 
allergenic, toxic, or has some other physiological effect that would advise 
against allowing environmental exposure.  If the product has none of these 
properties, less or possibly no scrutiny would be necessary.  Even if the 
transgene product has minimal biological activity, there may be some 
concern if the compound is very stable once released into the environment 
or if the nonviable residues left in the environment contained high levels 
of the compound, resulting in high environmental exposure. 
 
b. Action Alternatives 
 
For most environmental factors discussed in section 1 of this chapter, the 
question of potential impacts due to nonviable material is inapplicable.  
For example, APHIS’ regulation of nonviable GE plant material is 
irrelevant to questions of weediness, invasiveness, and gene flow.  
However, there are potential impacts to the soil, and by extension, 
groundwater, and soil-dwelling organisms.  Most field waste left over 
from field tests of GE organisms is incorporated into the soil where the 
field test took place.  Less frequently, the waste is collected and 
devitalized in some way (e.g., via autoclaving or burning), and the 
residues are then placed in a landfill.  Ultimately, the final decomposition 
of the material takes place in the soil. 
 
As discussed above, depending on a number of factors, this decomposition 
could result in direct and indirect impacts to soil, soil water, and soil-
dwelling organisms.  Depending on the transgene product, its buildup in 
the soil could alter soil chemistry and fertility and could change soil 
microbial populations.  If the product or a substance produced through the 
transgene product’s breakdown is water soluble, it could enter the 
groundwater and could eventually end up in surface water.  Furthermore, 
if the transgene product decomposes slowly, and if the product is 
environmentally detrimental, accumulation of the product could result in 
soil and groundwater contamination. 
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APHIS’ regulation of nonviable GE material could also potentially impact 
levels of environmental pollution in certain situations.  If the transgene 
product is a toxin or allergen, the unrestricted presence of nonviable plant 
material containing the product in the environment could increase the 
opportunities for humans and nontarget organisms to come into contact 
with the product.  However, APHIS restricts the size of permitted field 
tests involving traits of this type; therefore, this type of exposure would be 
low. 
 
Impacts on the soil, on environmental pollution, and on allergenic and 
toxic exposure caused by nonviable GE material might be reduced in 
specific cases by the regulation of this material.  Conversely, in some 
cases, the regulation may force growers of GE plants under APHIS permit 
to develop new agronomic practices to collect, dispose of, and monitor 
this material after harvest and ensure that the material does not remain in 
the environment.  These practices could involve additional equipment use 
and concomitant energy expenditures as well as other economic costs. 
 
Alternatives 2 and 3 would create regulatory authority over some or all 
nonviable GE material.  Plants for phytoremediation that have 
accumulated a toxic element or compound might be an example of a 
special case in which APHIS would want to retain authority over 
nonviable plant debris until it is properly disposed.  In addition to 
considering the biological characteristics of the debris and how it was 
generated, APHIS might need to consider if APHIS regulations or permit 
conditions have been violated.  Under normal circumstances, following 
the APHIS-imposed conditions for field testing, including termination and 
disposal requirements, would mitigate any potential risks for nonviable 
material such that it is not necessary to regulate the material.  But when 
violations have occurred, APHIS might want to retain authority over 
materials that may have been moved and possibly become mixed with 
commercial goods. 
 
In alternative 2, APHIS would need to either establish clear criteria to 
enable the regulated community and the public to know which materials 
were of regulatory concern or evaluate permits on a case-by-case basis to 
make this determination.  In alternative 3, all nonviable material would be 
deemed regulated and APHIS would determine on a case-by-case basis 
which items required special permit conditions to minimize environmental 
and agricultural impacts.  The approach in alternative 3 may result in 
overregulation of materials posing only minimal risk of environmental 
impacts. 
 
In most cases of GE organisms with which APHIS has experience, there 
have been no risks posed by nonviable material that has been properly 
  
disposed.  APHIS envisions that this will continue to be true for most GE 
plants.  However, as new transgenes are investigated and transgene 
expression technology advances, the potential exists for environmental 
impacts to result from the release of nonviable residues from field tests 
performed under APHIS permit.  Given the range of plants released under 
permit, a simple blanket rule on all nonviable material raises the potential 
for both over- and under-regulation.  If the regulatory scope is too broad, 
then nonviable materials posing no risk may be unnecessarily regulated, 
but if the regulatory scope is too narrow, materials posing environmental 
risks could be excluded from APHIS oversight.  A regulation might be 
crafted which establishes the biological and chemical properties of GE 
plant debris that would trigger regulation of nonviable material and would 
also establish that when a permit violation occurs, “the applicant may be 
held responsible for any measures deemed by the Administrator to be 
necessary to mitigate adverse environmental impacts resulting from the 
violation.”  This approach, regulating only in cases where there is a 
potential for impacts, might best accommodate the inherent variables and 
minimize both environmental impacts and regulatory burdens. 
 
6. Issue 6 APHIS is considering establishing a new mechanism involving 
APHIS, the States, and the producer for commercial production of 
plants not intended for food or feed in cases where the producer 
would prefer to develop and extract pharmaceutical and industrial 
compounds under confinement conditions with governmental 
oversight, rather than grant nonregulated status.  What should be the 
characteristics of this mechanism? 
 
For organisms that cannot meet the criteria for deregulation, APHIS is 
considering whether a new type of permitting system would be more 
appropriate in terms of efficiency and effectiveness than the current 
system.  In addition, there is much public and State interest in these types 
of plantings and a new mechanism may increase transparency and allow 
for greater State involvement. 
 
Alternatives Related to Issue 6 
 
1. No Action—continue to authorize field tests of crops not intended 
for food or feed use under permit.  Require application and review 
of these permits on an annual basis. 
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2. Allow for special multi-year permits, with ongoing oversight.  The 
new system would maintain these crops under regulation, but 
APHIS oversight would be exercised in a different manner than 
under the current system of permits. 
 
a. No Action Alternative 
 
The No Action alternative is to continue to handle all plants under APHIS’ 
permitting system with annual reviews of complete permit packages.  In 
some cases field tests for plants, especially those not intended for food 
use, are conducted annually, in the same location, with few if any changes 
to the permit conditions.  Each year, therefore, APHIS reviews a full 
permit application for a field test that is essentially the same as the 
previous year’s application.  These reviews ensure a high level of 
protection to a wide array of environmental parameters, but it is an 
inefficient process for both the agency and the applicant. 
 
b. Action Alternatives 
 
For alternative 2, because of the controls that can be put into place, the 
adoption of a new alternative system should not be different than current 
permits with respect to the types or amount of environmental impacts.  
Any new system put in place would merely create a continuing 
enforcement process for permit conditions that APHIS has already 
approved.  APHIS would not compromise any of its technical oversight 
because changes to the field testing would need approval prior to the 
changes occurring.  Nor would there be any compromise of the agency’s 
enforcement authority.  If necessary, a NEPA-compliant EA, or EIS if 
appropriate, would be prepared to determine if indirect or cumulative 
environmental impacts could result from permitting field tests to continue 
for multiple years. 
 
The current regulations have no provision for the low-level presence 
of regulated articles in commercial crops, food, feed, or seed of GE 
plant material that has not completed the required regulatory 
processes.32  Should low-level occurrence of a regulated article be 
exempted from regulation? 
7. Issue 7 
 
As with traditional plant breeding, large scale annual field testing of GE 
crops that have not completed all applicable reviews inevitably results in 
materials from these trials occasionally being detected at low levels in 
commercial commodities and seeds.  Current regulations do not expressly 
allow for any such occurrence, though experience continues to show that 
such occurrences can occur.  In a 2002 OSTP notice,33 APHIS committed 
to conducting a risk-based regulatory program that minimizes the 
 
152 IV.  Environmental Consequences 
                                                                     
32 In the NOI, the term adventitious presence was used to refer to the “intermittent low levels of 
biotechnology-derived genes and gene products occurring in commerce that have not gone through 
all applicable regulatory reviews.”  However, APHIS realizes that this term means different things to 
various interests around the world; hence, we will avoid its use elsewhere in the main body of the 
EIS.   
33  67 FR 50577 
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occurrence of these materials and includes safety criteria under which 
these materials would be allowed at low levels in commercial 
commodities and seeds.  Though the 2002 OSTP notice uses the term 
“allowable,” the agency currently prefers “non-actionable” as it better 
connotes that such materials are still regulated and any introductions not in 
accordance with the regulations or permit conditions are unlawful.  Non-
actionable means that based on safety considerations, agency action to 
restrict movement or otherwise prevent environmental introduction is not 
necessary. 
 
Alternatives Related to Issue 7 
 
1. No Action—allow field testing to continue using current 
confinement strategies to reduce the likelihood of regulated articles 
occurring in commercial commodities or seeds. 
 
2. Establish criteria under which occurrence of regulated articles 
would be allowable, that is, considered not-actionable by APHIS.  
Do not allow field testing of crops that do not meet all of criteria, 
including addressing food safety issues if applicable (i.e., if the GE 
plant is a food crop). 
 
3. Establish criteria under which occurrence of regulated articles 
would be allowable, that is, considered not-actionable by APHIS.  
Allow field testing and impose confinement strategies based on 
whether a plant meets the criteria. 
 
4. Impose a very strict confinement regime on all field tests, as is 
currently done for pharmaceutical and industrial crops that would 
further reduce the likelihood of regulated articles occurring in 
commercial commodities or seeds. 
 
This discussion is limited to low-levels of biotechnology-derived genes 
and gene products occurring in commerce that have not completed all 
applicable regulatory reviews.  This occurrence can originate from various 
activities and sources, one of which is the field testing of GE crops under 
development.  It can also be present in imports, originating from foreign 
field tests of unapproved products or from products approved in another 
country, but not in the United States.   
 
a. No Action Alternative 
 
While some human-health safeguards are built into the system, there is no 
consideration of whether the protein or other substance has been evaluated 
for key food safety issues under the current system for field testing.  In 
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addition, because decisions are made case-by-case, there is poor 
transparency with respect to how these types of incidents are handled.  
Many GE plants under development express common proteins that are 
unlikely to pose an environmental or food safety risk; however, such 
plants are not always reviewed for food safety prior to or during the field 
testing stage.  Still many of these proteins are identical to those that have 
been reviewed for plant pest potential at APHIS and may have completed 
the consultation process at FDA or been reviewed for safety at EPA.  Both 
of these agencies either have mechanisms in place or are in the process of 
establishing mechanisms to provide a food-safety consultation or review 
of the newly expressed substance early in the field testing process.  The 
PPA explicitly gives APHIS responsibility under the noxious weed 
provision to consider risks to public health; however, APHIS is not 
currently using this provision in its regulations. 
 
Under the No Action alternative, APHIS would continue to adjust 
confinement strategies based on the potential for environmental impacts 
and continue to handle incidents on a case-by-case basis.  APHIS 
anticipates that the rigorous confinement conditions it imposes will 
continue to ensure that regulated articles very rarely occur in commercial 
commodities or seeds.  In addition, APHIS’ response to such incidents has 
been aggressive, including large monetary penalties and actions to hold 
and destroy affected commodities.  Remedial measures in those instances 
have resulted in no significant environmental impacts. 
 
b. Action Alternatives  
 
A general discussion about the occurrence of regulated materials in 
commercial commodities and seeds is necessary before presentation of 
new alternatives for dealing with it.  APHIS believes it will be appropriate 
under the new regulations to consider key food safety issues of toxicity 
and allergenicity for most new proteins or other substances expressed 
when imposing confinement regimes on the field testing of GE plants in 
order to minimize public health risk in the unlikely event that material 
escapes confinement.  Plants that are not weedy and that are engineered 
with agronomic traits with which the agency is familiar are often 
authorized for field testing using the notification procedure.  The 
eligibility requirements for notification are preset and listed in the 
regulations at 7 CFR § 340.3.  The vast majority of field-tested GE plants 
are authorized using the notification process.  Confinement of such plants 
is based on long-established industry standards for producing foundation 
seed lines, those of the highest genetic purity.  However, this type of 
confinement could conceivably result in material from regulated field tests 
being found in commercial seeds and commodities. 
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APHIS has taken many steps in recent years to increase the stringency of 
confinement measures and expand APHIS oversight for plants that do not 
qualify under notification.  For example, permit requirements for field 
testing of plants with genes producing pharmaceutical or industrial 
compounds are among the most stringent, reflecting, among other things, 
the agency’s lack of familiarity with the traits in these types of plants.  
Based on these rigorous permit requirements, APHIS does not expect 
materials from these types of field tests to occur accidentally in 
commercial products. 
 
Consistent with the Office of Science and Technology Policy’s Federal 
Register announcement of August 2002, there are two objectives in 
APHIS’ approach.  The first is to establish safety criteria under which 
such occurrences would be non-actionable.  The second is to regulate 
materials that do not meet these criteria in such a way that it is highly 
unlikely that they would ever occur in commercial commodities or seeds.  
As mentioned previously, the agency has made significant progress in 
fulfilling the second objective, namely regulating certain GE plants (e.g., 
those producing pharmaceutical or industrial compounds) in such a way as 
to ensure that no regulated material originating from such plants in 
commercial goods.  The section of the DEIS in this chapter regarding 
crops expressing genes for pharmaceutical or industrial use deals 
specifically with the confinement of pharmaceutical plants.  APHIS will 
continue to refine its regulatory approach for handling these types of 
plants to reflect the latest science and its accrued experience. 
 
This section of the DEIS will focus on the first objective, to establish the 
safety criteria under which such occurrences would be non-actionable.  
Though these safety criteria relate to the tiered permitting system proposed 
for field testing, they will also be used to determine whether the presence 
of a regulated article would be non-actionable.  It is important to 
distinguish between commercial commodities containing low levels of a 
regulated material, and the regulated material when it occurs alone.  “Non-
actionable” in this context means that the commercial commodity 
containing the low level of otherwise regulated material would not be 
treated as a regulated article; the commodity could be moved and planted 
without the need for APHIS biotechnology permits covering the otherwise 
regulated material.  It does not mean that any regulated article would be 
allowed to be released in any unauthorized fashion.  Any violation of 
regulations or permit conditions could result in compliance actions against 
the violator regardless of whether the resultant presence in commercial 
commodities or seeds was considered actionable by the agency and 
required remediation.  The desired outcome is to assure the public, 
including domestic and foreign markets, that safety issues have been 
 
156 IV.  Environmental Consequences 
                                                                    
addressed for regulated materials which, on rare occasions, are detected in 
commercial products. 
 
The tiered permitting system for plants that APHIS is considering is 
central to understanding the four alternatives described below.  Currently, 
GE plants released under notification must meet APHIS eligibility criteria 
which ensure that they are unlikely to pose a plant pest risk (see chapter 2 
for the list of criteria).  These criteria address many of the environmental 
risks that could be posed by occasional low-level occurrence of these 
types of plants.  Previously in this DEIS, under issue 2 of this section, an 
example was presented of possible eligibility criteria for Type 1 permits.  
These criteria were derived by modifying the existing eligibility criteria 
for notification to include additional weediness considerations and adding 
a new seventh criterion requiring that food safety be addressed for food 
crops.  It is envisioned that the criteria that would be finalized in the new 
regulations for Type 1 permits would also be the basis for non-actionable 
presence of regulated articles in commercial commodities and seeds.34   
 
Proposed Criteria Under Which Presence of Regulated Articles in 
Commodities and Seeds Would Be Considered Non-actionable by 
APHIS: 
 
1. The regulated article is any plant species that is not on the Federal list 
of noxious weeds in regulations at 7 CFR part 360 under the PPA 
(7 U.S.C. § 7712), and, when being considered for field testing in the 
environment, the regulated article is not expected to establish and 
propagate outside of the managed ecosystem.  Examples of organisms 
that might not qualify for this reason are open-pollinated turf and 
forage grasses, forest trees, and aquatic plants. 
 
2. The genetic material is introduced using a method that has been 
demonstrated to result in integration of the new sequences into the 
plant genome, as defined in 7 CFR § 340.1. 
 
3. The function of the introduced genetic material is known and its 
expression in the regulated article does not result in plant disease. 
 
4. The introduced genetic material does not: 
• Cause the production of an infectious entity, or 
 
34  The only difference between the requirements for a Type 1 permit and the criteria for 
nonactionable presence is that the 10-acre limit in the permit requirements is not applicable to 
nonactionable presence, meaning that the presence of any such material that is found in commercial 
commodities of seed, originating from either domestic or foreign field tests, should have had protein 
safety issues addressed. 
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• Encode substances that are known or likely to be toxic to nontarget 
organisms known or likely to feed or live on the plant species, or 
• Encode substances with whose function APHIS is unfamiliar (e.g. 
substances intended for pharmaceutical or industrial use).   
 
5. To ensure that the introduced genetic sequences do not pose a 
significant risk of the creation of any new plant virus, plant virus-
derived sequences must be: 
• Noncoding regulatory sequences of known function, or 
• Sense or antisense genetic constructs derived from viral genes 
from plant viruses that are prevalent and endemic in the area where 
the introduction will occur and that infect plants of the same host 
species and that do not encode a functional noncapsid gene product 
responsible for cell-to-cell movement of the virus. 
 
6. The plant has not been engineered to contain the following genetic 
material from animal or human pathogens: 
• Any nucleic acid sequence derived from an animal or human virus, 
or 
• Coding sequences whose products are known or likely causal 
agents of disease in animals or humans. 
 
7. If the GE plant is a food crop, it either has a pesticide tolerance35 from 
EPA or key food safety issues of the new protein or other substance 
have been addressed. 
 
8. The plant does not have sexually compatible relatives that are 
threatened or endangered. 
 
Alternative 2 would forbid the field testing of GE organisms whose 
transgene products do not meet safety criteria to be established for Type 1 
permits in the tiered permitting system described earlier.  If only such GE 
organisms are field-tested, then the detection of their transgene products in 
commercial seeds and commodities should not have significant impacts 
and would be non-actionable.  However, allowing field testing only of this 
type could unnecessarily impede research and prevent the development of 
beneficial products in the future.  For example, under this system it might 
not be feasible to test and develop plants engineered for pharmaceutical 
use, industrial use, or for phytoremediation if they cannot meet the safety 
criteria.  In addition, the agency believes these types of GE plants can be 
safely field tested even though they do not meet the safety criteria for 
being non-actionable should they occur in commodities or seeds.  Safety is 
 
35  See EPA’s “Regulations Under the Federal Insecticide, Fungicide, and Rodenticide Act for Plant-
Incorporated Protectants” at http://www.epa.gov/pesticides/biopesticides/pips/pip_rule.pdf . 
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assured by imposing highly stringent confinement conditions so as to 
minimize the probability of such an incident, and thereby, minimizing 
risks of environmental impacts.  The agency currently draws upon almost 
20 years of experience and the best available science in order to minimize 
the probability of gene flow from these types of experiments; therefore, 
the constraints on field testing created by this alternative may not be 
justified based on risk.  These types of field tests have not resulted in 
reports of environmental harm. 
 
Alternative 3 also incorporates the same safety criteria used in the Type 1 
permit as the basis for whether a given regulated article would be 
considered non-actionable if detected in commercial seeds or 
commodities.  However this alternative differs from alternative 2 in that in 
this alternative field testing of GE plants not meeting the criteria is 
allowed, but more stringent confinement measures are applied.  Though 
this alternative is highly compatible with the tiered permitting system and 
described in those terms, it is in actuality independent and could be 
adopted even if the tiered permitting system is not adopted.  As noted, the 
majority of plants field tested would likely fall under Type 1 permit which 
would require similar confinement strategies to those used for notification 
under the current system.  Given the type of confinement and the large 
numbers of tests that are anticipated to be conducted in this way, it is 
possible that on occasion there will be gene flow in the form of pollen drift 
or commingling such that material derived from these tests may occur in 
commodities or seeds.  If this happens, the criteria above should assure 
that the safety of the material has been addressed and therefore, the 
occurrence would be non-actionable.  Under the proposed tiered approach 
for permits, testing of GE plants that have not been reviewed for food 
safety would be limited to 10 cumulative acres annually, so that 
environmental exposure and the opportunities for significant interaction 
with the environment or commercial production channels would be very 
low.  The food safety review criterion would either have to be met before 
the test acreage was increased or else the plant would have to be moved to 
a more stringent permit type.   
 
In summary, the confinement measures that would be imposed on field 
tests that are most likely to give rise to the presence of regulated material 
in commercial commodities or seeds should provide environmental 
protection that is as effective as the status quo (alternative 1, No Action) 
and only slightly less than alternatives 2 and 4.  GE plants that did not 
meet the safety criteria could also be field-tested under this alternative, but 
under very strict confinement requirements, such that the chance of 
detection in commodities and seed, as well as impacts on the human 
environment, would not be significant.  As discussed earlier, the agency 
has considerable experience in overseeing both types of experiments and 
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regulating them in a way that assures safety.  As a variation on this 
alternative, it would also be possible to use criteria such as those outlined 
for a Type 1 permit for GE plants as the basis for actions on nonregulated 
materials in commercial seed and commodities if APHIS elects not to 
adopt a tiered permitting system. 
 
Alternative 4 focuses on the prevention of gene flow and proposes the 
imposition of much stricter permit conditions, including confinement 
measures on all field tests regardless of which safety criteria are met.  
Under this alternative, all permitted field tests would be performed under 
conditions equivalent to those currently employed for pharmaceutical or 
industrial GE plants—conditions that have been effective in preventing 
gene flow.  By reducing the potential for the unintended movement of 
genes, the likelihood of detecting these genes or their products in 
commercial seed and commodities should similarly be reduced.  Their 
occurrence would not be anticipated but would be actionable in the 
unlikely event that they were detected.  This alternative may increase costs 
and other burdens on the future development of GE plants for general 
agricultural use.  In addition, this alternative would increase the time 
required to review permit applications and to devise appropriate 
confinement measures for each proposed field test.  It is also likely that the 
number of permits issued each year would be reduced.  This alternative 
would result in the lowest potential for the presence of regulated materials 
from domestic field tests in commercial commodities and seeds, short of 
not allowing any field tests at all.  However, safety may be only 
incrementally more protective if at all, than that afforded by a system that 
effectively differentiates risks during field testing and then imposes the 
very high confinement regime only on those GE plants that might give rise 
to a safety concern if detected elsewhere. 
 
A separate but closely related issue is that of coexistence.  The term co-
existence refers to the ability of a farmer to use a particular type of crop 
production, regardless of the production methods adopted by his or her 
neighbors.36  As GE crops continue to be adopted, it is increasingly likely 
that farms on which GE crops are grown will be situated near farms where 
conventional or organic production is practiced.  With the juxtaposition of 
various types of agricultural production, there exists the possibility for 
inadvertent commingling of GE commodities with conventional or 
organically produced crops and vice versa.  In addition, genes may flow 
from fields under one type of production to fields managed under another 
type.  Commingling and gene flow could affect the value of any crop—
                                         
36 See, for example, the Commission recommendation of 23 July 2003 on guidelines for the 
development of national strategies and best practices to ensure the co-existence of genetically 
modified crops with conventional and organic farming.  Commission of the European Communities. 
Brussels. 
GE, conventional, or organic—and there are ongoing research efforts to 
investigate successful methods for minimizing these effects (Messeguer 
and Melé, 2006). 
 
The National Organic Program (NOP) is administered by USDA’s 
Agricultural Marketing Service (AMS).  Organic production operations 
must develop and maintain an organic production system plan approved 
by their accredited certifying agent in order to obtain certification. Organic 
certification of a production or handling operation is a process claim, not a 
product claim.  Organic certification involves oversight by an accredited 
certifying agent of the materials and practices used to produce or handle 
an organic agricultural product. Oversight by a certifying agent includes 
an annual review of the certified operation’s organic system plan and on-
site inspections of the certified operation and its records.  
 
The organic system plan enables the production operation to achieve and 
document compliance with the National Organic Standards, including the 
prohibition on the use of excluded methods. Excluded methods include a 
variety of methods used to genetically modify organisms or influence their 
growth and development by means that are not possible under natural 
conditions or processes. Although the National Organic Standards prohibit 
the use of excluded methods, they do not require testing of inputs or 
products for the presence of excluded methods, unless a certifying agent 
has reasonable suspicion that a prohibited substance or excluded method 
was used. The presence of a detectable residue of a product of excluded 
methods alone does not necessarily constitute a violation of the National 
Organic Standards. 
 
The alternatives proposed here have no impact on the National Organic 
Standards, nor does the adoption of any of the alternatives have any affect 
on an organic producer’s ability to attain NOP certification.  However, the 
adoption of any of the alternatives other than the No Action alternative 
may provide additional safeguards to the organic industry and agriculture 
at large.  A full discussion of potential economic and social impacts on 
organic and other non-GE agricultural products appears later in this 
chapter. 
 
Should APHIS provide expedited review or exemption from review 
for certain low-risk, imported GE commodities intended for food, 
feed, or processing that have received all necessary regulatory 
approvals in their country-of-origin and are not intended for 
propagation in the United States? 
8. Issue 8 
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APHIS anticipates an increasing number of requests to import regulated 
GE organisms that are not intended for propagation, such as organisms 
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that are intended for direct use as food, feed, or for processing.  The 
current regulatory system was designed to handle such requests using 
permits and notifications.  However, in anticipation of this increase, 
APHIS’ goal is to design an efficient system that protects U.S. agriculture 
and human health without erecting unnecessary trade barriers.  To that 
end, the agency has evaluated several different alternatives.   
 
Alternatives Related to Issue 8 
 
1. No Action—continue to evaluate commodity importation requests 
on a case-by-case basis. 
 
2. Establish criteria that will be applied to determine the appropriate 
level of risk assessment for imported GE commodities.  This 
alternative could include a decision to exempt certain products or 
to allow importation under conditions that minimize environmental 
release. 
 
3. Disallow importation of any commodity pending full APHIS 
approval for deregulation. 
 
4. Expedited review of product from a foreign country that has 
evaluated the safety of the product and approved it for unconfined 
environmental release. 
 
5. Expedited review of a product from a foreign country that has 
evaluated the safety of the product and approved it for unconfined 
environmental release using a review process equivalent to 
APHIS’. 
 
a. No Action Alternative 
 
APHIS anticipates an increased volume of imported GE commodities with 
new plant/trait combinations, and the current process may not be able to 
address the needs of international trade efficiently while providing 
adequate environmental protection.  Other nations undoubtedly have 
similar issues when they import from the United States commodities that 
have completed all applicable reviews here but not in the importing 
country.  It is desirable for U.S. regulatory systems affecting international 
trade to foster harmonization with analogous systems employed by foreign 
nations.  A lack of harmonization could result in the imposition of trade 
barriers, making it difficult for GE commodity products to reach markets. 
 
The No Action alternative will continue to treat imported commodities as 
“regulated articles” if they are genetically engineered and have not been 
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deregulated by APHIS.  Importation of regulated GE commodities 
requires either a notification or a permit and may be subject to a risk 
assessment.  Currently, the importation of GE commodities not 
deregulated in the United States happens only rarely because, until 
recently, very few foreign nations were producing GE crops of a type not 
also developed for use in the United States.  In a very few cases, the 
agency has determined that due to the nature and handling of the 
importation, the imported GE organisms do not fit the definition of a 
regulated article.   
 
The principal risk from importing regulated GE commodities for food, 
feed, or processing would be inadvertent spillage into the environment, 
establishment, and subsequent harm to the environment.  This series of 
events may be a very low likelihood in most instances, but would vary 
according to the plant, trait, and handling procedures.  The current policy 
is highly protective of the environment, but is inefficient in the use of 
agency resources.  Also, regulatory burdens may be excessive for 
commodities bound for food, feed, and processing because of their lower 
environmental risk.  In cases where the commodity is highly unlikely to 
establish or persist, either due to its biological nature or its handling, there 
will be a very low likelihood of environmental impact. 
 
b. Action Alternatives  
 
The international situation is changing as foreign nations develop their 
own agricultural biotechnology research programs and begin to release 
products into the market that have undergone a risk analysis process under 
a foreign nation’s regulatory authority.  APHIS anticipates a growing 
number of requests for the importation of GE commodity shipments and 
has considered a number of alternatives to the current practice of 
preparing case-by-case risk assessments to address increased import 
traffic.  It is a goal for the preferred alternative to protect the human 
environment of the United States without becoming a trade barrier, either 
to imports of foreign commodities or to exports of domestic GE 
commodities. 
 
Alternative 2 for dealing with the importation of GE commodities is to 
create criteria that specify which commodities will be exempted from 
APHIS review.  These criteria would take into account several relevant 
factors such as a pathway analysis, including the final intended use of the 
commodity, that is, whether the commodity would be processed or used 
for food or animal feed; whether the protein or other substance has been 
adequately evaluated relative to food safety; and whether the commodity 
is nonpropagable, for example, bananas or polished white rice.  Before 
exempting a GE commodity, APHIS would require that the importer 
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certify that the commodity complies with all appropriate criteria and verify 
that the commodity will be used only for processing, food, or animal feed. 
 
If the criteria for exemption are not met, the commodity could still be 
imported but only under the terms of an import permit.  The terms of the 
permit would specify conditions designed to prevent the dissemination and 
environmental persistence of the GE commodity.  Appropriate permit 
conditions may include shipping container requirements, pathway 
analysis, proper handling conditions, auditing practices, and compliance 
enforcement.  These permits would be analogous to permits currently 
issued by APHIS for the interstate movement of regulated articles. 
 
The exemption criteria proposed above should ensure that exempted GE 
commodities would not result in significant environmental impacts, even 
if an environmental release should accidentally occur.  For the near future, 
only a fraction of GE commodities proposed for importation into the 
United States will comply with all the criteria and qualify for an 
exemption.  Non-exempted commodities could be imported under a permit 
designed to minimize environmental impacts.  Based on APHIS’ 
experience issuing movement permits, the agency is confident that import 
permits can be designed in such a way so that no significant adverse 
environmental impacts occur. 
 
Alternative 3 is for APHIS to treat every importation request as a petition 
for deregulation.  No importation of a GE commodity, regardless of 
biology and intended use, would be permitted unless the commodity is 
deregulated for all uses.  The importer would be forced to provide the full 
data set necessary under 7 CFR § 340.6, regardless of the data collected 
and evaluated by the exporting nation.  As discussed elsewhere in this 
document, APHIS’ current deregulation process has been protective of the 
environment and should continue to result in no significant environmental 
impacts.  Therefore, extending the scope of deregulation to all importation 
requests for commodities to be used for food, feed, or processing should, 
by the same token, have no significant environmental impacts. 
 
The costs of this alternative are primarily in agency resources and 
applicant regulatory burdens.  As the number of import requests increase, 
APHIS anticipates an increase in the amount of resources devoted to the 
consideration of petitions for deregulated importation, even when the 
commodity in question has already been reviewed by the exporting nation.  
This duplication of effort will likely impede the number of commodity 
imports that can be authorized.  Also, in selecting this alternative, APHIS 
is effectively ignoring the regulatory authority and risk assessments of the 
exporting nation.  There is a risk that other nations may respond in kind 
and give no credence to the analyses prepared by APHIS, which would 
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otherwise be used by United States producers hoping to export GE 
commodities to other countries, potentially resulting in export barriers for 
U.S. producers. 
 
Alternative 4 would be to have an expedited review of any commodity that 
had been reviewed by the exporting country.  While this would be 
expected to decrease risks in many cases, it may be erroneous to assume 
that evaluations in all countries would be adequate to assure that there 
would be no negative impacts in the United States.  This approach would 
decrease workload, but would likely have a greater potential for 
environmental impacts than all other alternatives given uncertainty in the 
qualities of the reviews.  The approach in alternative 4 may differ from 
that used by other APHIS programs regulating non-GE organisms. 
 
Alternative 5 would create an expedited APHIS review for GE 
commodities that have undergone a risk assessment in the country of 
origin equivalent to the one performed by APHIS for GE organisms prior 
to their deregulation in the United States.  The goal of this alternative is to 
ensure that an imported GE commodity has received a complete safety and 
environmental review without APHIS duplicating the efforts of foreign 
agencies that have comparable expertise and equivalent regulatory 
processes.  This approach fosters mutual respect for each nation’s 
regulatory authority, facilitates data sharing, and reduces the chance that 
trade barriers will be raised unnecessarily.  However, APHIS’ review of a 
particular GE commodity would not end with the mere acknowledgment 
that the exporting nation has performed a risk assessment.  No two 
countries could be expected to review GE organisms in the same way:  
regulatory authorities will differ, data requirements will vary, 
environmental conditions may be different, and the depth of the analysis 
may not be comparable.  Therefore, APHIS’ review of a particular 
importation request will depend on the thoroughness of the analysis 
performed by the exporting nation. 
 
APHIS could deal with different risk-assessment processes in two ways.  
First, APHIS could review a nation’s assessment process and then 
determine that it is as likely as APHIS’ process to adequately verify that 
the GE commodity poses no greater environmental risk in the 
United States than the conventionally bred version of the commodity.  
Once a nation’s assessment process has been deemed equivalent to 
APHIS’, risk assessments produced by that nation would not require a full 
APHIS review.  Alternatively, APHIS could evaluate each risk assessment 
produced by a given exporting nation on a case-by-case basis to verify that 
a thorough evaluation has been done.  In either case, a finding by APHIS 
that the assessment did not meet agency requirements would result in the 
import request being denied. 
  
The chief benefit to this alternative is in reducing the expenditure of 
agency resources while at the same time providing leadership to the 
international community in the use of science-based approaches to address 
the risks of GE organisms.  In addition, by granting validity to the 
assessments produced by foreign nations, when appropriate, APHIS 
minimizes the development of arbitrary trade barriers.  Because the 
endpoint for each analysis is the determination that the GE commodity has 
received as thorough an analysis as if APHIS itself had performed it in its 
entirety, based on APHIS’ experience with the deregulation of more than 
70 GE crop varieties, this alternative should not result in significant 
environmental impacts. 
 
Currently, genetically engineered Arabidopsis spp. are exempt from 
interstate movement restrictions under 7 CFR 340.2 because they are 
well understood and extensively used in research.  Should the 
movement of genetically engineered Arabidopsis spp. or other GE 
organisms be exempted from movement restriction? 
9. Issue 9 
 
Currently, genetically engineered Arabidopsis spp. and a few other 
organisms are exempt from interstate movement restrictions under 
7 CFR 340.2 because they are well understood and extensively used in 
research.  The agency is considering whether to expand the current 
exemption from interstate movement restrictions to other well-studied, 
low-risk, GE research organisms.  Such a change would create a 
consistent, risk based approach to organisms with similar risk profiles. 
 
Alternatives Related to Issue 9 
 
1. No Action—retain the current list in 7 CFR § 340.2(b). 
 
2. Exempt a class of GE plants or organisms that are well-studied and 
present little or not environmental risk from permit requirements 
for interstate movement as is currently done for Arabidopsis. 
 
3. Create a process to apply for an exemption for a particular species. 
 
a. No Action Alternative 
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The No Action alternative is to retain only the items currently listed in 
7 CFR § 340.2 as being exempted from the requirements of an interstate 
movement permit.  Certain types of organisms, including those currently 
exempted, are inherently lower in risk than others.  In addition, shipping 
organisms interstate in enclosed containers is a low-risk activity that is 
very unlikely to result in release, establishment, or harm.  Hence, the 
current system of limited exemptions is highly protective of the human 
environment has not resulted in environmental impacts and is not likely to 
result in future environmental impacts. 
 
b. Action Alternatives  
 
Alternative 2 would be to exempt the low-risk organisms in Type 1 
permits from the requirements of a permit or notification for interstate 
movement.  These same criteria could be applied for exemption under this 
issue regardless of whether the tiered table was adopted.  Please see the 
analysis of the tiered permitting system under issue 2, discussed earlier in 
this same section and chapter.  The eligibility criteria for a Type 1 permit 
under the proposed system are very similar to those for notification under 
the current system. 
 
If a multitiered system is not adopted in the revised regulations, APHIS 
could select alternative 3, which is to create a process with appropriate 
criteria independent of the tiered system that describes GE plants to be 
exempted from the requirement of any interstate movement permits. 
 
The two alternatives described above should each provide protections 
equal to the present system if the criteria are carefully considered.  Under 
either alternative, researchers would still be bound under the regulations to 
transport using containers that meet APHIS standards for safety.  In 
addition, APHIS may require that they keep or submit records of what is 
transported.  The difference from the current system is that they would not 
have to apply for or wait for receipt of a permit. 
 
What environmental considerations should be evaluated if APHIS 
were to move from prescriptive container requirements for shipment 
of GE organisms to performance-based container requirements, 
supplemented with guidance on ways to meet the performance 
standards? 
10. Issue 10 
 
APHIS regulations prescribe the use of several types of packaging to 
prevent the escape, dissemination, and environmental persistence of GE 
organisms.  However, based on APHIS’ experience there are other types 
of containers that can be used to safely move GE organisms.  APHIS often 
grants applicants a variance to use a different container to transport a GE 
organism in a way other than prescribed by the regulations but reviewing 
these requests takes agency resources.  APHIS is considering alternatives 
that will reduce the need for variances but still facilitate the safe 
movement of GE organisms. 
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APHIS is considering whether to move from prescriptive packaging 
requirements for the shipment of GE organisms to performance-based 
container requirements. 
 
Alternatives Related to Issue 10 
 
1. No Action—retain current list of approved containers and issue 
variances when necessary. 
 
2. Switch to performance-based standards for all shipping containers. 
 
3. Expand current list of approved containers and issue variances 
when necessary. 
 
a. No Action Alternative 
 
Under the current system, several types of transport containers have been 
prescribed in APHIS regulations to prevent the escape, dissemination, and 
environmental persistence of GE organisms.  In cases where specific 
shipments of a GE organism cannot be accomplished using one of the 
specified containers, the applicant may propose to APHIS an alternative 
container and request a variance from APHIS to use that container under 
the terms of a specific permit.  The proposed variant container is evaluated 
by APHIS to verify that it will effectively prevent an environmental 
release of the GE organism in question.  No blanket variances are issued.  
Although the container is nonstandard, its use must result in the same 
endpoint, namely, no release of GE organisms into the environment. 
 
Container failure, in APHIS’ experience, has not been a source of 
significant environmental releases or impacts.  Failures resulting in the 
need for an APHIS investigation and compliance enforcement are rare, 
occurring less than once per year.  Spills, when they do occur, are likely to 
occur indoors, inside vehicles, or in other contained spaces where the 
spills will be readily identified and easily cleaned up.  Therefore, these 
rare events have not resulted in the dissemination or persistent 
environmental establishment of regulated articles.  Thus, there are no 
significant environmental impacts to the No Action alternative. 
 
b. Action Alternatives  
 
If APHIS elects alternative 2, to establish performance standards for 
shipping containers, many permit applicants would continue to select their 
shipping containers from the current list of approved containers that would 
be provided to applicants through guidance documents.  For those 
applicants who opt to design new containers in compliance with the 
performance standards, APHIS anticipates that as long as the containers 
meet the standards, their use should not result in the dissemination or 
persistent environmental establishment of regulated articles.  Therefore, it 
is expected that to switch to performance-based standards for shipping 
containers would pose no significant environmental impacts. 
 
If APHIS elects alternative 3, to add to the list of prescribed containers in 
the regulations, the newly added containers would be designed with the 
same fundamental goal of the original containers, to prevent the accidental 
environmental release of regulated articles.  Variances to these prescribed 
container types would still be evaluated by APHIS if requested, requiring 
agency resources, but APHIS would not expect any new environmental 
impacts from this alternative, when compared to the No Action alternative. 
 
D.  The Proposed Action:  Preliminary Determination 
 
With respect to the issues and associated alternatives, APHIS has made a 
preliminary determination that action should be taken.  APHIS has also 
made a preliminary decision that the action will require revision of the 
APHIS regulations at 7 CFR part 340.  Regulatory revisions under 
consideration are based on agency experience and utilize new provisions 
of the PPA of 2000.  They have the potential to increase effectiveness, 
efficiency, and transparency and decrease negative environmental impacts.  
They reflect the current thinking and should not be considered as final nor 
as a rule proposal. 
 
Scope of Regulatory Oversight1. Issue 1 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Expand the scope of 
what is regulated by adding considerations of noxious weed risk and 
regulating GE biological control organisms in addition to evaluating plant 
pest risks, and use genetic transformation as the trigger for regulation.  
Continue to regulate event-by-event.” 
 
This alternative would eliminate potential gaps that may occur as genetic 
engineering technologies continue to advance.  Because the expanded 
scope would require APHIS to evaluate a wider array of potential risks, 
the risk of introducing potentially harmful GEOs would be reduced, and 
the risk of environmental impacts resulting from the introductions would 
also be reduced.  Therefore, the adoption of this alternative should result 
in a reduced potential for significant adverse impacts to the environment 
as compared to the current system.  Neither regulating by transformation 
“event” nor regulating by trait should increase the potential for impacts to 
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the natural or physical environment or any interrelated economic or social 
impacts. 
 
In addition, APHIS has made a preliminary determination that  
alternative 4—“Exclude specific classes of highly familiar organisms and 
highly domesticated, nonweedy crop plants and also create a mechanism 
to exclude additional organisms from the definition of regulated article 
after a safety review”—which could be used in conjunction with 
alternative 2, will also be included in the preferred alternative because it 
will allow APHIS to exclude classes of organisms which do not pose a 
significant risk and, thereby, allow resources to be focused on those 
organisms which have a greater potential risk,  This will reduce 
unnecessary regulatory burdens for the agency and developers.
 
Because the scope of organisms being regulated is being broadened, it is 
appropriate to have a way to exclude classes of organisms which do not 
pose a significant risk.  This allows resources to be focused on those 
organisms which have a greater potential risk and reduces unnecessary 
regulatory burdens for the agency and developers.  By excluding certain 
GE organisms from regulation and thereby allowing an increasing number 
of GE organisms to be grown, the proposed exclusion provision may 
increase the potential for gene flow from GE crops to non-GE crops.   
 
Providing transparency and predictability within a risk based 
permitting system 
2. Issue 2 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 4—“Establish a tiered 
permitting system for plants based on newly devised criteria and evaluate 
permit applications for field tests of nonplant organisms on a case-by-case 
basis.” 
 
The criteria will be more transparent, allowing developers and the public 
to see that organisms are to be regulated based on risk and familiarity.  
APHIS believes that this system would be as protective of the 
environment as the current system because the agency would continue to 
provide appropriate oversight to ensure that all GEOs released into the 
environment are safe, and would continue to perform NEPA compliant 
environmental analyses when a proposal to introduce a GEO raised new 
issues with which APHIS lacked familiarity. 
 
Granting nonregulated status 3. Issue 3 
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To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Develop appropriate 
safety criteria and procedures through which plants can be either (1) fully 
removed from agency oversight or (2) retained under some degree of 
oversight as necessary to mitigate any minor risks.” 
 
The added flexibility of being able to retain some oversight may be useful 
for some types of GE organisms that might be developed in the future.  
Adding this flexibility does not diminish the agency’s ability to fully 
deregulate GE organisms as it does now or to deny a request for 
deregulation altogether.  Retention of oversight might be handled in one of 
two ways:  (1) use the current system and deregulate “in part,” or (2) 
revise the regulations to create a new mechanism such that regulatory 
oversight is retained for those cases where it is warranted.  The added 
flexibility should not diminish protection of the environment relative to 
the current system. 
 
Permit conditions for genetically engineered plants that produce 
pharmaceutical and industrial compounds 
4. Issue 4 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Continue to allow 
food and feed crops to be used for the production of pharmaceutical and 
industrial compounds.  The agency would impose confinement 
requirements, as appropriate, based on the risk posed by the organism and 
would consider food safety in setting conditions.” 
 
Based on previous experience in field testing of plants producing these 
compounds, the use of highly stringent confinement measures can be used 
effectively to protect the environment from significant impact.  
Consideration of food safety, specifically whether the protein or other 
substance has been characterized for allergenicity or toxicity to humans, 
will further enhance the risk-basis of the regulations with respect to safety 
to humans.  
 
Nonviable GE material 5. Issue 5 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Regulate nonviable 
GE plant material in certain circumstances, based on the risks posed.” 
 
For most GE plants, the resulting nonviable material from field testing will 
not pose a significant risk to the environment.  However, the agency can 
envision special cases where the nature of the material might be such that 
it would require oversight to ensure safe handling and disposal.  In 
addition, the agency may wish to assert authority over nonviable material 
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when there is a need for remediation due to a violation of permit 
conditions or regulations. 
 
Oversight of plants (e.g. pharmaceutical plants) that might be 
produced commercially under permit 
6. Issue 6 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Allow for special 
multi-year permits, with ongoing oversight.  The new system would 
maintain these crops under regulation, but APHIS oversight would be 
exercised in a different manner than under the current system of permits.” 
 
The new system could be just as protective of the environment as the 
current system, but in a manner that is more efficient than the current 
system.  This could be accomplished initially by giving an application full 
APHIS review, including standard operating procedures (SOPs) for 
repetitive activities.  Any changes to the original permit application or 
approved SOPs would have to be submitted to APHIS for approval prior 
to implementation.  These sites would still be subject to inspection and 
would also rely on auditing to ensure activities are conducted according to 
approved permit conditions and SOPs.  APHIS does not anticipate that 
these proposed commercialization permits would be granted frequently.  
As with any regulated article, APHIS would continue to require that any 
permitted field trials, including those under a multi-year permit, must 
always be performed at an appropriate isolation distance to maintain 
confinement and minimize gene flow or other potential impacts on any 
type of surrounding agriculture. 
 
Low-level GE presence 7. Issue 7 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 3—“Establish criteria 
under which occurrence of regulated articles would be allowable, that is, 
considered not-actionable by APHIS.  Allow field testing and impose 
confinement strategies based on whether a plant meets the criteria.” 
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APHIS and the U.S. government have been aware for some time that the 
occasional detection of regulated material in commercial crops as seeds is 
a scientific reality as a result of field tests conducted under confinement 
conditions appropriate for notifications.  This is due to cross-pollination 
and also, commingling from shared equipment and facilities.  In addition, 
new incidents will inevitably result from the importation of seeds and 
commodities from countries where such material has been fully approved 
but has not completed all U.S. reviews.  In the majority of cases, this low-
level occurrence of regulated articles will be of minimal risk, and this 
should be accounted for in any regulatory scheme since oversight should 
be commensurate with risk.  Our analysis indicates that material meeting 
the safety-based criteria of alternative 3 will not pose a risk for significant 
environmental impact and therefore, its occurrence can be considered 
nonactionable by the agency. 
 
Importation of GE commodities not intended for propagation 8. Issue 8 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Establish criteria that 
will be applied to determine the appropriate level of risk assessment for 
imported GE commodities.  This alternative could include a decision to 
exempt certain organisms or to allow importation under conditions that 
minimize environmental release.” 
 
The proposed exemption criteria should ensure that exempted GE 
commodities would not result in significant environmental impacts, even 
if an environmental release should accidentally occur. 
 
Interstate movement of well-studied, low risk organisms 9. Issue 9 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“ Exempt a class of 
GE plants or organisms that are well-studied and present little or not 
environmental risk from permit requirements for interstate movement as is 
currently done for Arabidopsis.” 
 
An analysis of the impacts indicates that expansion of the exempted list to 
other well-studied research organisms would present little or no risk of 
significant environmental impact.  This expansion could offer substantial 
regulatory relief to small startup companies, public institutions, and 
academic researchers whose resources are often strained to comply with 
regulations for GE organisms. 
 
Shipping standards 10. Issue 10 
 
To address this issue, APHIS has made a preliminary determination that 
the preferred alternative will include alternative 2—“Switch to 
performance-based standards for all shipping containers.” 
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Having performance-based standards for shipping containers would 
obviate the need for variances and would, therefore, reduce the burden on 
applicants, as well as increase the efficient use of APHIS resources while 
providing protections to the environment that equal the current 
prescriptive-based system of regulations. 
  
E.  Cumulative Impacts 
 
Cumulative impact is defined by the Council on Environmental Quality’s 
NEPA implementing regulations (40 CFR § 1508.7) as “the impact on the 
environment which results from the incremental impact of the action when 
added to other past, present, and reasonably foreseeable future actions 
regardless of what agency (Federal or non-Federal) or person undertakes 
such actions.  Cumulative impacts can result from individually minor, but 
collectively significant actions taking place over a period of time.”  For 
example, local soil and groundwater impacts could result from the 
repeated use of a particular field for the production of a GE crop if the 
crop residues released a substance into the soil that did not readily break 
down. 
 
This is a programmatic environmental document dealing mainly with 
broadening the scope of APHIS’ regulations and increasing the efficiency 
and transparency of APHIS’ regulatory system for various actions with 
GE organisms.  Cumulative effects in this document will consider the 
potential environmental impacts of the proposed regulatory changes as 
well as the past, present, or future actions of other agencies that regulate 
biotechnology.  The focus of the cumulative impact discussion will be 
those aspects of the environment identified by APHIS in chapter 3, 
Affected Environment. 
 
The purpose of this analysis is to assess potential effects of making any of 
the proposed changes in APHIS regulations.  Its purpose is not to analyze 
the cumulative impacts resulting from specific GE organisms.  Cumulative 
impacts analyses related to specific projects, such as permit applications 
and deregulation decisions, may be prepared at the individual project 
level, as appropriate, and made available for public comment as part of 
any NEPA processes necessary for that project.  These analyses will be 
tiered to this EIS and other applicable NEPA documents. 
 
APHIS currently regulates the introduction of GE organisms that are plant 
pests or may be plant pests and also determines when these organisms are 
no longer regulated by the agency.  These functions have been performed 
for almost 2 decades and, under the No Action alternative, would continue 
into the future.  APHIS has considered whether its program has had 
cumulative impacts on the environment, that is, impacts caused by the 
aggregation of past, present, or reasonably foreseeable future actions of 
this agency or any other entity.  The only aspects of APHIS’ regulatory 
program with the potential to aggregate with any past, present, or 
reasonably foreseeable future actions are the increasing number of GE 
plants being grown and the increasing number of products on the market 
1. The No 
Action 
Alternative 
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derived from the safe introduction of GE plants.  APHIS anticipates that 
these increases will continue in the future, however, due to the stringency 
of APHIS’ current regulatory program, the agency does not expect any 
cumulative impacts from the adoption of the No Action alternative. 
 
At the Federal level, the other agencies that were considered with respect 
to cumulative impacts are EPA and FDA.  APHIS has a history of 
regulating in coordination with these agencies, and takes the regulatory 
programs of these agencies into account in major regulatory decisions.  
Since 1986, the Office of Science and Technology Policy (OSTP) has 
been coordinating the regulation of biotechnology among the agencies.  
This office ensures that all areas of potential risk are being adequately 
covered and also tries to minimize overlap where feasible. 
 
Because of the nature of the enabling statutes and the specific areas of 
responsibility, most GE organisms are regulated by multiple agencies.  An 
organism may be regulated by one, two, or all three agencies.  The fact 
that many products are regulated by multiple agencies does not necessarily 
imply redundancy.  Under the varying authorities, the agencies are 
generally looking at different types of risks for a given organism.  Table 
4–3 shows examples of certain plant/trait combinations and indicates 
which agencies exercise regulatory oversight.  Importantly, APHIS has a 
regulatory role in every example and will be the sole regulator for some 
organisms.  In these cases, it is especially important to have regulations 
that are sufficiently broad in scope to ensure that GE organisms which 
could have an adverse impact are regulated and that relevant 
environmental issues are being addressed. 
 
The cumulative impacts for APHIS’ regulatory decisions on individual GE 
organisms are considered in other NEPA documents prepared on a case-
by-case basis as decisions are made.  In addition, ongoing coordination 
with the other Federal agencies through the OSTP process allows 
individual agencies to adjust policies as needed without affecting other 
agencies’ ability to regulate.  Under the Federal system of coordinated 
regulation, effective regulation at the individual agencies and 
collaboration, when needed, reduce the likelihood of incremental and 
cumulative adverse impacts. 
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The discussions that initiated the process of revising the regulations were 
conducted by OSTP in consultation with the other Federal regulatory 
agencies.  One of the primary goals was to ensure an adequate scope of 
regulation, recognizing the rapidly evolving technology and the increased 
interest and research activity in using field crops to produce commercially 
valuable compounds such as those with pharmaceutical and industrial 
uses.  The group explored available alternatives for addressing the issue 
2. The Action 
Alternative 
(Revise the 
Regulations) 
  
 
IV.  Environmental Consequences  175 
and concluded that it was appropriate and advantageous for APHIS to 
revise its regulations to fully utilize the PPA of 2000. 
 
There is one clear example of a specific effect that these regulatory 
revisions might have on other Federal agencies.  Since the nature of the 
new permitting system may provide motivation for developers to go to 
either EPA or FDA early in the field testing process to address food safety 
issues, there could be an increase in workload to one or both of those 
agencies.  However, both agencies are fully aware of APHIS’ plans and 
either already have processes in place or are implementing processes to 
handle such requests.  The Action Alternative will offer new levels of 
protection to human health by encouraging developers to address key 
issues of food safety early in the development stage and thus, should 
reduce the risk of adverse impacts. 
 
Table 4–3.  Examples of Federal Regulation of Various Types of GE Plants 
by EPA, FDA, and USDA 
New Trait/Organism 
Regulatory 
Oversight by Regulatory Authority 
Insect resistance in a food 
crop, e.g., Bt corn 
APHIS 
 
 
EPA 
 
 
 
FDA 
Safety for agriculture and the 
environment 
 
Safety for the environment, and 
food/feed safety of pesticidal 
compound 
 
Safety for food and feed use 
Modified oil content in a 
food crop, e.g., oleic acid in 
soybean seed 
APHIS 
 
 
FDA 
Safety for agriculture and the 
environment 
 
Safety and labeling for food and feed 
use 
Herbicide tolerance in a 
food crop, e.g., glyphosate-
tolerant corn 
APHIS 
 
 
EPA 
 
FDA 
 
Safety for agriculture and the 
environment 
 
Safe use of companion herbicide 
 
Safety for food and feed use 
Insect resistance in a forest 
non-food tree species 
APHIS 
 
 
EPA 
Safety for agriculture and the 
environment 
 
Safety for the environment and 
food/feed safety of the pesticidal 
compound 
Modified flower color in an 
ornamental crop, e.g., blue 
carnation 
APHIS Safety for agriculture and the 
environment 
Because the general concepts of the regulatory revision were developed in 
consultation with the other Federal agencies which regulate GE organisms, 
it is not anticipated that these revisions would increase the potential for 
adverse cumulative impacts.  In fact, broadening the regulatory scope and 
strengthening the regulations should provide additional protection to the 
environment, incrementally and cumulatively.  In implementing any new 
regulations, APHIS will continue to work closely with the other agencies 
to ensure that revised regulations neither produce unnecessary regulatory 
duplication nor affect the other agencies’ regulatory oversight in some 
way that would result in adverse cumulative impacts.  NEPA documents 
prepared in conjunction with case-by-case decisionmaking at APHIS will 
continue to be used to examine cumulative impacts on regulatory 
decisions for specific GE organisms. 
 
APHIS has long-standing working relationships with State regulatory 
officials and strives to keep them informed regarding introductions of GE 
organisms under APHIS’ oversight.  There have been no cumulative 
impacts resulting from the aggregation of effects from APHIS’ current 
regulations and State actions.  APHIS anticipates that the proposed 
regulatory revisions will not result in changes to cumulative impacts from 
any regulation of biotechnology at the State or local levels. 
 
APHIS has determined that each of the proposed actions to be adopted in 
the preferred alternative is either as environmentally protective or more 
protective than the provisions in the current regulations.  Should APHIS 
adopt the preferred alternative, no past, present, or reasonably foreseeable 
actions by APHIS or other agencies will change the magnitude of the 
cumulative impacts resulting from our regulatory program.  APHIS has 
therefore determined that there will be no new significant cumulative 
impacts as a result of the proposed regulatory changes. 
 
F.  Other Considerations 
 
APHIS is also using this rule-revision process to implement several 
administrative changes to its rules.  Unlike revisions discussed elsewhere 
in this DEIS, these changes are intended to improve the clarity, 
coordination, and execution of the rules themselves.  Proposed changes 
include the following:   
 
• Additional information requirements for applicants. 1. Adminis-
trative 
Changes to 
APHIS Rules 
• Clarification of the relationships between various sections of the rule. 
• Inclusion of provisions for electronic permit applications. 
• Modification of time limits for agency response to applicants. 
• Requirements for additional data reports for field tests. 
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• Clarification of permit expiration dates. 
• Clarification of permit renewal processes. 
 
There is no evidence that any of these administrative changes could have 
significant environmental impacts. 
 
Threatened and Endangered Species (TES) are plants and animals at risk 
of becoming extinct throughout all or part of their geographic range.  
Species can be designated (listed) under the Federal Endangered Species 
Act of 1973, listed under parallel State laws, or both. 
 
APHIS’ BRS program has no known direct adverse effects on threatened 
or endangered plants or animals, on species proposed for listing, or on 
designated critical habitats.  Similarly, BRS program activities thus far 
have not directly protected or benefited listed TES, species proposed for 
listing, or designated critical habitats.  However, there may be indirect 
beneficial or adverse effects.  For example, as discussed in chapter 3, the 
deregulation of plants resistant to insects via Bt toxin production has 
resulted in a reduction in the use of chemical insecticides, which indirectly 
reduces adverse impacts on many nontarget organisms, some of which 
could be TES.  On the other hand, if a threatened or endangered insect 
species feeds on a Bt crop, that insect species may be adversely affected.  
Herbicide-tolerant plants may also have indirect beneficial or adverse 
effects on TES via changes in herbicide use and changes in cultivation 
frequency or other agronomic practices. 
 
Theoretically, other GE traits could result in indirect beneficial or adverse 
effects.  For example, traits improving crop nutritional quality could 
benefit TES feeding on those crops.  Alternatively, if a crop plant is given 
a gene which creates a plant sufficiently competitive to become invasive 
in natural habitats, threatened and endangered plant species could be 
displaced or threatened and endangered animal species may lose a 
preferred food plant or be otherwise affected by the alteration of their 
habitat. 
 
Indirect impacts are difficult to quantify or even detect in many cases, 
especially when the analysis is at the programmatic level.  Although 
APHIS acknowledges the possibility of programmatic impacts on TES, on 
species proposed for listing, or on designated critical habitat, APHIS’ 
approach is to analyze these impacts at the project level, as described 
below, in order to avoid or minimize any impacts.  The analysis depends 
on the regulated activity under consideration: 
 
2. Impacts on 
Threatened 
and 
Endangered 
Species 
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• Under normal circumstances, the interstate movement and importation 
of regulated articles should have no effect on TES, species proposed 
for listing, or designated critical habitat because persons shipping 
regulated articles are required to use packaging that prevents 
environmental releases.  In APHIS’ experience, package requirements 
have been extremely effective in preventing accidental environmental 
releases.  However, should an accident occur that causes a package to 
fail to completely contain the regulated article, APHIS anticipates any 
release from the package will be localized and readily cleaned up, 
resulting in no significant impacts on TES, species proposed for 
listing, or designated critical habitat. 
 
• Impacts to TES, proposed species for listing, or designated critical 
habitat due to field tests of regulated articles are currently and would 
continue to be evaluated for every permit application that involves a 
field trial, taking into account the size of the trial, the plant species, the 
GE trait involved, APHIS familiarity with the plant/trait combination, 
and the geographic location.  APHIS currently uses a TES decision 
worksheet which asks a series of questions regarding proposed field 
trials.  Answers to these questions enable APHIS to determine the 
likelihood that a proposed field trial will affect TES, proposed species 
for listing, or designated critical habitat and whether consultation with 
the FWS is appropriate.  In special cases, such as plants producing 
pharmaceutical or industrial compounds, APHIS may also consult with 
other agencies, such as FDA and EPA, regarding effects on 
endangered species. 
 
• Petitions for deregulation or approval may result in an APHIS 
determination that the plant in question may be planted without any 
restrictions, essentially anywhere in the United States.  APHIS, 
therefore, must determine which, if any, TES or species proposed for 
listing will come into contact with the deregulated plant, and whether 
that contact will affect those species or any designated critical habitat.  
APHIS will consult with the FWS if species or habitats are identified 
that may be affected.  In the special case involving Bt crops, EPA 
performs an analysis in addition to the one prepared by APHIS, and 
EPA may restrict the planting of the crop in areas where an 
endangered insect, such as a butterfly, may feed on the crop and suffer 
adverse effects. 
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 A 
Abiotic Stress Stress due to non-living, environmental factors such as cold, heat, 
drought, flooding, salinity, toxic substances, and ultraviolet light. 
Agrobacterium 
tumefaciens 
A bacterium that causes crown gall disease in some plants. The 
bacterium characteristically infects a wound and incorporates a piece 
of its own DNA into the host plant genome, causing the host cell to 
grow into a tumor-like structure. This DNA-transfer mechanism is 
commonly exploited in the genetic engineering of plants. 
Agrobacterium 
tumefaciens-
mediated 
Transformation 
The process of DNA transfer from Agrobacterium tumefaciens to 
plants, which occurs naturally during crown gall disease and can be 
used as a method of transformation. 
Allele One of several alternate forms of a gene occupying the same location 
on the chromosome. 
Allelochemical A chemical produced by a plant of one species that has a detrimental 
effect on plants of other species. 
Antibiotic 
Resistance Marker 
Gene 
Genes (usually of bacterial origin) used as selection markers in 
transformation because their presence allows cell survival in the 
presence of normally toxic antibiotic agents. 
Antisense DNA The DNA strand complementary (hence "anti") to the mRNA, i.e., the 
non-transcribed strand. 
Antisense Gene A gene that produces an mRNA complementary to the transcript of a 
normal gene.  (See Antisense RNA.) 
Antisense RNA An RNA sequence that is complementary to, and binds, with all or part 
of a functional mRNA molecule, thereby, blocking its translation. 
AOSCA American Organization of Seed Certifying Agencies. 
APHIS Animal and Plant Health Inspection Service. 
Arabidopsis 
thaliana 
A small plant in the mustard (Brassicaceae) family, also known as 
thale cress.  Arabidopsis is commonly used as a model for studying 
plant genetics. 
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 B 
Backcrossing Crossing an individual with another organism that is genetically 
identical to its parent.  The offspring of such a cross are referred to as 
the backcross generation or backcross progeny. 
Bacillus 
thuringiensis (Bt) 
A common soil bacterium, notable for its ability to produce proteins 
which are toxic to certain categories of insects.  (See Cry proteins.) 
Bioaccumulation The increase in the concentration of a chemical in biological systems 
over time as compared to the chemical’s concentration in the 
environment. 
Biological Control 
Agent, Biocontrol 
Agent 
Any enemy, antagonist, or competitor used to control a plant pest or 
noxious weed. (See Plant Protection Act of 2000, 7 U.S.C. 7702.) 
Biolistics A technique to generate genetically engineered cells, in which DNA-
coated microscopic metal particles, usually tungsten or gold, are 
propelled by various means (“gene guns”) fast enough to puncture 
target cells.  Provided that the cell is not killed, the DNA may be taken 
up by the cell and incorporated into the cell’s genome. (Synonym:  
microprojectile bombardment.) 
Biomagnification The process that results in the accumulation of a chemical in an 
organism at higher levels than are found in its food; occurring when a 
chemical becomes more and more concentrated as it moves up the food 
chain. 
Biotechnology Making specific modifications to the genome of an organism using 
techniques based on molecular biology, such as genetic engineering, 
gene transfer, DNA typing, and cloning of plants and animals. 
BLASTP BLASTP (Altschul, 1990) is a computer program that searches for 
similarities between the amino acid sequence of a protein and other 
amino acid sequences. 
BNF Biotechnology Notification File. 
BRAD Biopesticides Registration Action Document. 
Breeding The process of sexual reproduction and production of offspring.  Plant 
breeding is an applied science for the development of plants suited for 
the use of humans, rather than their ability to survive in the wild. 
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Breeder Seed Seeds of a particular plant variety maintained by a plant breeder, 
usually at a very high level of purity, that serves as the source for all 
subsequent generations of seed production.  (See Foundation Seed.) 
BRS Biotechnology Regulatory Services (USDA–APHIS). 
Bt Bacillus thuringiensis. 
Bt Proteins, Bt 
Toxins 
See Cry proteins. 
 C 
CBI Confidential business information. 
CEQ Council on Environmental Quality. 
Certified Seed Seed produced to specific standards to assure purity and freedom from 
weed seeds and seedborne pathogens, which is used for commercial 
production of the crop. 
CFR Code of Federal Regulations (U.S.). 
Codex 
Alimentarius 
Commission 
An international food safety standard setting body (part of the Food 
and Agriculture Organization and the World Health Organization of 
the United Nations) responsible for developing international food 
standards.  
Coding Sequence That portion of a gene which directly specifies the amino acid 
sequence of its product.  Non-coding sequences of genes include 
introns and control regions such as promoters, operators, and 
terminators. 
Confined Describes a field test or other environmental release of a transgenic 
organism performed under terms and conditions intended to minimize 
establishment and spread into, and interaction with the environment of 
the transgenic organism and any progeny derived from it. 
Competent 
Bacteria 
Bacteria able to take up and stably incorporate foreign DNA. 
Conservation 
Tillage 
A broad range of soil tillage systems that leave crop residue on the soil 
surface, substantially reducing the effects of soil erosion from wind 
and water. 
 
 
A–4 Appendix A.  Acronyms and Glossary 
Constitutive 
Expression 
Describing a gene that is expressed (i.e., “turned on”) at a relatively 
constant level in all cells of an organism without regard to cell 
environmental conditions. 
Construct An engineered piece of DNA designed to be transferred into a cell or 
tissue.  Typically, the construct comprises a gene or genes of interest, a 
marker gene, and appropriate control sequences, often from different 
organisms, as a single package.  A repeatedly used construct may be 
called a “cassette.” 
CPB Cartagena Protocol on Biosafety 
Cross Protection Complete or partial resistance to a plant virus that is generated by the 
introduction of a similar, usually less virulent, plant virus. 
Cry Proteins A class of crystalline proteins produced by strains of the soil 
bacterium, Bacillus thuringiensis.  These proteins are toxic to certain 
categories of insects (e.g. corn borers, corn rootworms, mosquitoes, 
black flies, armyworms, tobacco hornworms, some types of beetles, 
etc.), but are harmless to mammals and most beneficial insects. 
Synonyms: delta endotoxins, Bt toxins. 
 D 
Deoxyribonucleic 
Acid (DNA) 
A nucleic acid that carries the genetic information of a cell.  The 
structure of DNA is two long chains, consisting of chemical building 
blocks called ‘nucleotides,’ twisted into a double helix.  The order of 
nucleotides determines hereditary characteristics. 
Dicot A flowering plant with two embryonic seed leaves.  Examples include 
oaks, maples, roses, beans, mustards, and cacti.  (See Monocot.) 
Disease 
Resistance 
The genetically determined ability to prevent the invasion or 
reproduction of a pathogen, thereby allowing the resistant individual to 
remain healthy.  Disease resistance may operate by pathogen 
exclusion, by preventing pathogen spread, or by tolerating pathogen-
produced toxins. 
DNA  See Deoxyribonucleic Acid. 
Deoxyribonucleic 
Acid 
A nucleic acid that carries the genetic information of a cell.  The 
structure of DNA is two long chains, consisting of chemical building 
blocks called ‘nucleotides,’ twisted into a double helix.  The order of 
nucleotides determines hereditary characteristics. 
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Donor An organism that provides a gene or gene fragment used in the genetic 
transformation of another organism, called the “recipient.” 
 E 
ELISA (enzyme-
linked 
immunosorbent 
assay) 
A sensitive assay for detecting a specific protein that uses antibodies to 
bind to the protein. 
Encapsidation The process by which the genetic material of a virus is enclosed in a 
protein coat (the capsid). 
Endospermatic 
Seed 
Seed having an endosperm, the nutritive tissue surrounding the seed 
embryo. 
EPA U.S. Environmental Protection Agency. 
Epistatic Effects The result of one gene suppressing the effect of a different gene. 
EUP Experimental Use Permit. 
Event See Transformation Event. 
Expression The means by which a gene’s information stored in DNA (or RNA in 
some viruses) is turned into biochemical information such as RNA or 
protein. 
 F 
FASTA FASTA (Pearson, 1988) is a computer program that searches for 
similarities between one nucleic acid sequence and other sequences. 
FDA Food and Drug Administration.  
Fecundity The capacity for producing offspring.  In a scientific context, this 
usually refers to the number of offspring (i.e. seeds). 
FFDCA Federal Food, Drug, and Cosmetic Act. 
FIFRA Federal Insecticide, Fungicide and Rodenticide Act. 
Flanking Region The DNA sequences extending on either side of a specific sequence. 
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Foundation Seed Seed of a particular plant variety that is produced from breeder seed 
and is then planted to produce certified seed used for commercial 
production.  (See Breeder Seed and Certified Seed.) 
FPPA Federal Plant Pest Act. 
 G 
GE See Genetically Engineered. 
Gene The basic unit of heredity transmitted from generation to generation 
during sexual or asexual reproduction; an ordered sequence of 
nucleotide bases comprising a segment of DNA. A gene contains the 
sequence of DNA that encodes an individual RNA or protein. 
Gene Expression The process by which a gene produces mRNA and protein and 
ultimately exerts its effect on the phenotype of an organism. 
Gene Flow The spread of genes from one population to another by the movement 
of individuals, pollen, seeds, or spores. 
Gene Insertion The incorporation of one or more copies of a gene into a chromosome. 
Gene Product A RNA or a protein (e.g. an enzyme), the production of which is 
directed by the corresponding gene. 
Gene Silencing Loss of gene expression either through an alteration in the DNA 
sequence of a structural gene or its regulatory region or through 
interactions between its transcript and other mRNAs present in the cell.  
(See Antisense RNA.) 
Gene Splicing The enzymatic attachment of one gene or gene fragment to another. 
Genetic 
Engineering 
Genetic engineering refers to the process in which one or more genes 
and other genetic elements from one or more organism(s) are inserted 
into the genetic material of a second organism using recombinant DNA 
techniques. 
Genetically  
Engineered (GE) Modified in genotype and, hence, phenotype using recombinant DNA techniques. 
GE Organism  Genetically engineered organisms.  (See Genetically Engineered.) 
GE Plant Genetically engineered plant.  (See Genetically Engineered.) 
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Gene Stacking The use of plant breeding to combine two or more genetically 
engineered traits into a single plant variety. 
Genetic Marker A gene that is a reliable indicator that a particular organism possesses a 
specific trait of interest. Markers may be used to select certain 
individual organisms, e.g., cells that have inherited resistance to an 
antibiotic will be the only ones in a population that survive an 
antibiotic treatment. 
Genetic 
Transformation 
See Transformation. 
Genome All of the hereditary material in a cell including DNA present in the 
cell nucleus, as well as in other locations such as plant chloroplasts and 
mitochondria. 
Genomics The study of the entire genome of an organism, often in comparison to 
the entire genome of another organism (i.e. comparative genomics). 
Genotype The total genetic makeup that an individual receives from its parents. 
GRAS Generally recognized as safe. 
GUS Beta-glucuronidase; a reporter of gene system used to analyze the 
activity of promoters (in terms of expression of genes under those 
promoters) either quantitatively or qualitatively through visualization 
of its activity in different tissues.    
 H 
Halophyte A plant adapted to living in very salty (saline) soils. 
Herbicide 
Resistance or 
Tolerance 
The ability of a plant to remain relatively unaffected by the application 
of what would otherwise be a highly damaging dose of an herbicide. 
Heterologous 
Encapsidation 
The phenomenon where the coat protein of one virus is able to 
encapsidate the nucleic acid of a different virus.  (See Encapsidation.) 
HGT Horizontal gene transfer 
High Dose Twenty-five times the dose necessary to kill all susceptible insects. 
 
Homologous 
Recombination 
The physical exchange of genetic material between two closely related 
or similar genetic sequences. 
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Horizontal Gene 
Transfer 
The transfer of genetic material from one organism (the donor) to 
another organism (the recipient) that is not sexually compatible with 
the donor. 
Human 
Environment 
According to the Council on Environmental Quality, the term human 
environment "shall be interpreted comprehensively to include the 
natural and physical environment and the relationship of people with 
that environment." 40 CFR § 1508.14 
Hybrid The offspring of two genetically dissimilar organisms. 
 I 
Industrial Plant A plant genetically engineered with a gene whose effect is primarily of 
industrial use, as opposed to an agricultural or nutritional purpose. 
Inserted Gene A piece of DNA that has been inserted into an organism using 
recombinant DNA technology. 
Instar A stage in the development of an insect between two successive molts. 
Interfertile Two plants or groups of plants capable of interbreeding and producing 
offspring. 
Introgression The introduction of genes from one species into the gene pool of 
another via sexual crossing.  The process begins with hybridization 
between the two species, followed by repeated backcrossing to one of 
the parent species. 
IPM Integrated pest management.   
IRM Insect resistance management. 
 L 
LD See Lethal Dose. 
LD50 Median lethal dose or dose needed to kill 50 percent of a population of 
test organisms. 
LD99.9 The dose that kills 99.9 percent of a population of test organisms. 
Lethal Dose (LD) The amount of a test substance that will kill one or more individuals in 
a test population. 
LMO Living genetically modified organisms 
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LMOFFP Living genetically modified organisms imported only for food, feed, or 
for processing 
 M 
Marker Gene A gene of known function or known location that is inherited in 
Mendelian fashion and facilitates the study of inheritance of a nearby 
gene. 
Marker-assisted 
Selection 
The use of DNA markers to select the organisms that possess genes for 
a particular phenotype desired for subsequent breeding/propagation. 
This allows selection without having to screen for the performance trait 
itself, which may be difficult. 
Monocot A flowering plant with only one embryonic seed leaf.  Examples 
include grasses, irises, lilies, and onions.  (See Dicot.) 
MOU Memorandum of Understanding.  
Mutagen A chemical or dose of radioactivity capable of producing a genetic 
mutation by causing changes in the DNA of living organisms. 
Mutagenesis Induction of heritable change(s) in the genetic constitution of a cell 
through alterations to its DNA, most often via treatments with 
chemicals or ionizing radiation. 
 N 
NASDA National Association of State Departments of Agriculture. 
NCIE National Center for Imports and Exports. 
NEPA The National Environmental Policy Act of 1969 and subsequent 
amentments. 
NOI Notice of Intent. 
Non-propagative See Non-viable Plant Material. 
Non-viable Plant 
Material 
Broadly speaking, all plant tissues other than viable propagules, such 
as seeds, bulbs, tubers, etc. That is, all tissues dead or alive which 
cannot directly result in the propagation of a new plant. 
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Noxious Weed Any plant or plant product that can directly or indirectly injure or cause 
damage to crops (including nursery stock or plant products), livestock, 
poultry, or other interests of agriculture, irrigation, navigation, the 
natural resources of the United States, the public health, or the 
environment. (Plant Protection Act of 2000, 7 U.S.C. 7701 et seq.) 
NRC National Research Council. 
 O 
Obligate Parasite A parasite that cannot live independently of its host. 
OECD Organisation for Economic Co-operation and Development. 
Open Reading 
Frame (ORF) 
A sequence of nucleotides in a DNA molecule that has the potential to 
encode a peptide or protein.  The term is generally applied to 
sequences of DNA for which no function has yet been determined.  
The number of ORFs provides an estimate of the number of genes 
transcribed from the DNA sequence. 
ORF See Open Reading Frame. 
Osmoprotectant Compounds accumulated by plants during drought conditions to reduce 
water stress. 
OSTP Office of Science and Technology Policy. 
Outcrossing The tendency of a plant species to produce offspring that result from 
the mating of two different individual plants.  (See Self-pollinated.) 
 P 
Pathogen-derived 
Resistance 
Resistance to a disease conferred by something derived from the 
disease-causing agent itself.  Example:  coat protein mediated viral 
resistance. 
Performance-
based Standards 
A form of regulation in which required outcomes are defined by 
regulation, but the actions or conditions necessary to attain the 
outcomes are not defined by regulation.  Contrast with a prescriptive 
standard, which specifies actions or conditions that must be followed 
to attain the required outcome. 
Phenotype The appearance or other characteristics of an organism, resulting from 
the interaction of its genetic constitution with the environment. 
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Phytoremediation The use of plants to remove or reduce pollutants in soil by production 
of compounds that stimulate their degradation or by uptake of 
pollutants through roots and accumulation in plant tissues. 
PIP See Plant Incorporated Protectant. 
Plant Incorporated 
Protectants (PIPs) 
Plant-Incorporated Protectants (PIPs) are pesticidal substances 
produced by plants and the genetic material necessary for the plant to 
produce the substance. 
(http://www.epa.gov/pesticides/biopesticides/pips/current_pip_eups.htm) 
Plant Pest Any living stage (including active and dormant forms) of insects, 
mites, nematodes, slugs, snails, protozoa, or other invertebrate animals, 
bacteria, fungi, other parasitic plants or reproductive parts thereof; 
viruses; or any organisms similar to or allied with any of the foregoing; 
or any infectious agents or substances, which can directly or indirectly 
injure or cause disease or damage in or to any plants or parts thereof, 
or any processed, manufactured, or other products of plants. (7 CFR 
340.1) 
Pleiotropic Effects A phenomenon in which a single genetic alteration affects multiple 
phenotypic characteristics, such as a single gene affecting flowering, 
leaf shape, and growth rate. 
PMP Plant manufactured pharmaceutical. 
Post-translational 
Modification 
The addition of specific chemical residues to a protein after it has been 
translated.  Common residues are phosphate groups (phosphorylation) 
and sugars (glycosylation). 
PPA Plant Protection Act. 
PPQ Plant Protection and Quarantine (USDA, APHIS). 
PQA Plant Quarantine Act. 
Primer A short, single-stranded piece of DNA or RNA that, when annealed to 
a long template of single-stranded DNA, provides a doubled-stranded 
structure from which DNA polymerase will synthesize a new DNA 
strand to produce a duplex molecule. 
Proline An amino acid. Some plant cells accumulate proline as an 
osmoprotectant. 
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Promoter A region of DNA located upstream of a gene that controls to what 
degree, where, and/or when a gene is expressed. 
Propagules Any part of a plant that can be detached from the organism and 
propagated in order for it to grow into a new plant. 
Proteomics A research approach that seeks to identify and characterize proteins 
and protein–protein interactions in a given species. 
Protoxin A precursor of a toxin that requires additional modification before 
acquiring its toxic properties. 
Pyramid In the context of PIPs, the presence of multiple resistance genes that 
target the same pests with possible overlap in the mode of action.  For 
example, a corn or cotton plant containing a Cry1A protein and a 
Cry2A protein active against the same lepidopteran pest such as the 
European corn borer or tobacco budworm is termed a "pyramid.” 
 R 
Recombinant DNA 
Technology 
The manipulation of DNA in which DNA, including DNA from 
different organisms, is cut apart and recombined using enzymes. 
Recombination The physical exchange of genetic material between two genetic 
sequences that produces new combinations of genetic information.  
(See Homologous recombination and Non-homologous 
recombination.) 
 
Refuge Part of a habitat where an individual can avoid a mortality agent.  In 
the context of Bt crops a refuge consists of non-Bt host plants that are 
managed to provide sufficient susceptible adult insects to mate with 
potentially Bt-resistant adult insects to decrease the number of resistant 
insects and dilute the frequency of resistance genes. 
Regulated Article Subject to APHIS regulation under 7 CFR part 340. 
Rhizosphere The root surface together with that region of the surrounding soil in 
which the microbial population is affected by the presence of the root 
and root exudates. 
Ribonucleic Acid 
(RNA) 
A nucleic acid composed of a long, often single-stranded chain of 
chemical building blocks called ‘nucleotides.’  RNA has multiple 
functions in the process of translating information stored in genes 
(DNA) into proteins. 
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Risk Analysis A process consisting of three components—risk assessment, risk 
management, and risk communication—that is performed to 
understand the nature of unwanted, negative consequences to human 
and animal health or the environment. 
Risk Assessment A scientifically based process consisting of the following steps: (i) 
hazard identification; (ii) hazard characterization; (iii) exposure 
assessment; and (iv) risk characterization. 
Risk 
Communication 
The interactive exchange of information and opinions throughout the 
risk analysis process concerning hazards and risks, risk-related factors, 
and risk perceptions, including the explanation of risk assessment 
findings and the basis of risk management decisions. 
Risk Management The process, distinct from risk assessment, of weighing policy 
alternatives, in consultation with all interested parties, considering risk 
assessment and other factors relevant for the protection of consumer 
health and for the promotion of fair trade practices, and, if needed, 
selecting appropriate prevention and control options. 
RNA See Ribonucleic Acid. 
 
Rotation • In forestry, the number of years required to establish and grow trees 
to a specified size, product, or condition of maturity.  A pine rotation 
may range from as short as 20 years for pulpwood to more than 60 
years for sawtimber.  Full rotation is the total time from planting to 
harvest.  Half rotation would be approximately half the time to reach 
maturity or harvest.  
• In crop production, the cycle of crops grown in successive years in 
the same field.  Rotations are instituted to limit the spread and 
accumulation of diseases (especially soil-borne diseases) and pests 
and to manage plant nutrients. 
 S 
Secondary 
Metabolism 
The production by living organisms of substances not essential for 
primary metabolic functions or physiology. Their role is associated 
with interaction with the environment, for example as defense or as 
attractants. Some of these have useful pharmacological or nutritional 
properties, while others are toxic. 
Self-pollinated The tendency of a plant species to produce offspring that result from a 
flower pollinating itself.  (See Outcrossing.) 
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Stratification Chilling or warming seeds, for a period of time, to improve 
germination. 
Stress Tolerance 
Gene 
A gene which confers upon a plant an increased ability to withstand an 
environmental stress, such as drought, temperature extremes, or soil 
salinity. 
Synergy The interaction of two or more factors so that their combined effect is 
greater than the sum of their individual effects. 
 T 
TES Threatened and Endangered Species. 
Trait A characteristic of an organism that manifests itself in the phenotype. 
Traits may be the result of a single gene or may be polygenic, resulting 
from the simultaneous expression of more than one gene. 
Transcription The process by which a messenger RNA (mRNA) is created from the 
nucleotide sequence of a gene (DNA). 
Transencapsi-
dation 
See Heterologous encapsidation. 
Transformant A cell or organism that has been genetically altered through the 
integration of a transgene(s). A “primary” transformant is the first 
generation following the transformation event. 
Transformation The uptake and integration of DNA in a cell’s genome, in which the 
introduced DNA is intended to change the phenotype of the recipient 
organism in a predictable manner. 
Transformation 
Event 
A single successful integration of a gene or gene fragment into a cell or 
a successful deletion of a gene or gene fragment from a cell. 
Transgene A foreign gene that is inserted into the genome of a cell via 
recombinant DNA techniques. 
Transgenic 
Organism 
An organism whose genome has been modified via the stable 
incorporation of a piece of foreign DNA (a transgene). 
Translation The process by which the sequence of nucleotides in a messenger RNA 
(mRNA) directs the sequence of amino acids in a new protein during 
protein synthesis. 
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Trophic Relating to the feeding habits or food chain of different organisms in a 
food chain. 
TSCA Toxic Substances Control Act. 
 V 
VCP See Viral Coat Protein. 
Vector The agent, such as a plasmid, used by researchers to carry new genes 
into cells. 
Viral Coat Protein A protein produced by a virus that forms a protective layer, or capsid, 
around the genetic material of the virus. 
Volunteer Plants resulting from crop seed that escapes harvest and remains in the 
field until subsequent seasons, where it germinates along with the 
succeeding crop. 
 W 
Weediness The ability of a plant to colonize a disturbed habitat and compete with 
cultivated species. 
 
 
A–16 Appendix A.  Acronyms and Glossary 
(This page is intentionally left blank.)
 
Appendix B.  List of Preparers B–1 
Appendix B.  List of Preparers 
 
May Berenbaum, Ph.D. 
Dept. Entomology 
320 Morrill Hall 
University of Illinois at Urbana–Champaign 
505 S. Goodwin 
Urbana, IL  
 
Michael Blanchette, B.S. 
Environmental Protection Specialist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Paul Christensen, Ph.D. 
Visiting Scientist 
Iowa State University 
Seed Science Center 
Ames, IA 
 
R. James Cook, Ph.D. 
Professor and Dean Emeritus 
Departments of Plant Pathology and Crop and Soil Sciences 
College of Agricultural, Human & Natural Resource Sciences 
Washington State University 
Pullman, WA 
 
John Cordts, M.S., M.B.A. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Terri Dunahay, Ph.D. 
Team Leader, International Policy 
USDA, APHIS, BRS 
Riverdale, MD 
 
B–2 Appendix B.  List of Preparers 
Rebecca Edelstein, Ph.D. 
U.S. Environmental Protection Agency 
Office of Pesticide Programs 
Biopesticides & Pollution Prevention Div. 
 
Samantha Floyd 
Biological Scientist 
USDA, APHIS, PPD 
Environmental Services 
Riverdale, MD 
 
Paul Gepts, Ph.D. 
Department of Plant Sciences 
Section of Crop and Ecosystem Sciences 
University of California, Davis 
 
Susana Goggi, Ph.D. 
Assistant Professor 
Seed Science Center 
Iowa State University 
Ames, IA 
 
Vickie Hage 
Environmental Scientist 
St. John’s River Water Management District 
Palatka, FL 
 
Levis Handley, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Andrea Huberty, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Appendix B.  List of Preparers B–3 
Bruce MacBryde, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Virgil Meier, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Manjit Misra, Ph.D. 
Director 
Dept. of Agricultural and  
 Biosystems Engineering 
Iowa State University 
Ames, IA 
 
Therese Murtagh, M.S. 
Office of the Administrator 
USDA, Agricultural Research Service 
Washington, D.C. 
 
Clint Nesbitt, Ph.D. 
Regulatory Analyst 
USDA, APHIS, BRS 
Riverdale, MD 
 
Catherine Preston, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Steven G. Pueppke, Ph.D. 
Assistant VP for Research and  
 Graduate Studies 
Michigan State University 
 
Andrew Roberts, Ph.D. 
AAAS Risk Policy Fellow 
USDA, APHIS, BRS 
Riverdale, MD 
 
B–4 Appendix B.  List of Preparers 
Robyn Rose, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Peter Schmeissner, Ph.D. 
Fellow, American Association for the Advancement of Science 
USDA, Foreign Agriculture Service 
Washington, D.C. 
 
Carmen Soileau, Ph.D. 
Biotechnologist 
USDA, APHIS, BRS 
Riverdale, MD 
 
Rhey Solomon, M.S. 
Environmental Consultant 
Resource Solutions 
4123 Galesbury Lane 
Chantilly, VA 
 
Stephanie Stephens  
Budget Analyst 
USDA, APHIS, PPD 
Environmental Services 
Riverdale, MD 
 
John Turner, Ph.D. 
Director, Policy Coordination Division 
USDA, APHIS, BRS 
Riverdale, MD 
 
Piet van der Meer, Ph.D. 
Rue d'Alaumont 16 
B–1380 Lasne 
Belgium 
 
Michael Wach, Ph.D., J.D. 
Chief, Regulatory Analysis Branch 
USDA, APHIS, BRS 
Riverdale, MD 
 
Appendix B.  List of Preparers B–5 
Michael Watson, Ph.D. 
Chief, Plant Pests and Protectants Branch 
USDA, APHIS, BRS 
Riverdale, MD 
 
Mark Westgate, Ph.D. 
Professor 
Department of Agronomy 
Iowa State University 
Ames, IA 
 
Jeff Wolt, Ph.D. 
Professor 
Biosafety Institute 
Iowa State University 
Ames, IA 
 
Christine Zakarka 
Chief, Planning, Evaluation, and Monitoring 
USDA, APHIS, PPD 
Riverdale, MD 
 
B–6 Appendix B.  List of Preparers 
(This page is intentionally left blank.)
 
Appendix C.  Public Scoping Comments C–1 
Appendix C.  Public Scoping Comments 
 
Members of the public were invited to participate in the scoping process for this DEIS through 
an announcement of a notice of intent (NOI) to prepare an environmental impact statement (EIS) 
on options under consideration to change 7 CFR 340 in the Federal Register (FR) (Docket 
Number 03–031–2, 69 FR 3271–3272).  In this NOI, APHIS asked for comment on 11 issues. 
The public responded to these 11 issues and provided other information outside of the scope of 
these issues.  The comment period opened on January 23, 2004.  During this comment period, 
which closed on April 13, 2004, APHIS received 3,996 comments.  Comments were made by 
public interest groups, industry representatives, industry trade organizations, private individuals, 
State and Federal agency representatives, agricultural producers (including growers and food 
processors), and marketing groups. 
 
Full text of the comments received during the open comment period is available online at:  
http://www.aphis.usda.gov/brs/eis/eis_comments.html
 
Many of the comments were submitted as form letters.  The issues raised by the form letter 
submissions include: 
 
• GE corn, Bt crops, and pharmaceutical and industrial crops should not be allowed to be 
grown outdoors. 
• New regulations must include a comprehensive assessment of the economic impacts 
genetically engineered (GE) crops have had on family farmers and rural communities, and a 
socioeconomic assessment for all new GE crop and food varieties. 
• There should be no exemptions for the occurrence of low levels unapproved GE varieties in 
the food supply. 
• Plant and animal species used for food or feed should not be used to produce pharmaceuticals 
or industrial chemicals. 
 
Several comments address issues related to maintaining biological or physical confinement of 
GE varieties from non-genetically engineered varieties.  These include several comments that 
relate to:  
 
• Concern for pollination of non-GE crops by GE crops. 
• Concern for food choice for consumers who do not wish to purchase GE food. 
• Maintenance of non-GE seed stocks. 
• Segregation of plants that are engineered to produce pharmaceutical and industrial 
compounds from the food and feed supply. 
• Implications for international trade.  
• Implications for biodiversity abroad. 
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Several comments suggest possible rule changes or agency practices: 
 
• Elimination of petitions for non-regulated status. 
• Establishment of a two-tiered permitting process, with experimental permits for field trials 
and commercial permits for GE crops that are to be sold in commerce. 
• Publication of applications for notifications, permits, and petitions upon receipt, before 
environmental analysis or risk assessment. 
• Soliciting public comment before any permit can be granted. 
 
Some comments focused on the eventual development of resistance of natural populations to the 
intended actions of the genetically incorporated molecules.  There is a concern that tools will be 
lost to growers or land managers as the targeted populations develop resistance to these tools. 
In addition, APHIS also received many comments that directly address the 11 issues that were 
presented in the NOI.  These comments are summarized by issue below. 
 
Question 1—APHIS is considering broadening its regulatory scope beyond GE organisms 
that may pose a plant pest risk to include GE plants that may pose a noxious weed risk and 
GE organisms that may be used as biological control agents.  Do regulatory requirements 
for these organisms need to be established?  What environmental considerations should 
influence this change in regulatory scope?  
 
The majority of comments agreed that APHIS should broaden its regulatory scope to include GE 
organisms that may pose a noxious weed risk or that may be used as a biological control agent.  
Some comments raised environmental risk concerns as a reason to broaden APHIS’ authority.  
Others cite a belief that GE plants are inherently a greater environmental risk than conventionally 
bred plants. 
 
Some respondents disagree because they believe that APHIS’ current practice of evaluating plant 
pest risk is more than adequate to protect American agriculture.  Many of these comments cite 
the belief that these plants are not inherently different from conventionally bred plants. 
A few comments suggest that it is important that APHIS coordinate any changes to its practices 
with the other agencies in the coordinated framework.   
 
Question 2—APHIS is considering revisions to the regulations that would define specific 
risk-based categories for field testing, including (a) product types shown to pose low pest 
and environmental risks; (b) product types considered to pose a noxious weed risk, of 
unknown plant pest or noxious weed risk, containing sequences of unknown phenotypic 
function, and involving new plant-incorporated protectants that have not completed 
applicable review at EPA; and (c) pharmaceutical or industrial crops not intended for food 
or feed.  What environmental factors should be considered in further delineating such 
requirements?  What criteria should be used to establish the risk-based categories?  Should 
certain low-risk categories be considered for exemption from permitting requirements?  If 
so, what criteria should apply?  
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Several comments support the use of specific risk-based categories for field testing.  Several 
factors were presented for considering risk groups.  These include the origins of the trait (e.g. is 
the gene from the same species or a closely related species), the type of trait expressed (e.g. plant 
incorporated protectants), the ability of the plant to reproduce sexually (e.g. male sterile, 
complete sterility, degree of selfing), potential environmental impacts, the end use of the product 
(e.g. plants engineered to produce pharmaceuticals or industrials), size of the field trial, or 
APHIS’ familiarity with the trait-crop combination.   
 
Other comments did not support the use of specific risk-based categories.  These comments 
support the use of case-by-case evaluations of each new GE plant.   
 
Question 3—APHIS is considering ways to provide regulatory flexibility for future 
decisions by allowing for commercialization of certain GE organisms while continuing, in 
some cases, to regulate the organisms based on minor unresolved risks.  Other regulated 
articles could be treated as they have been under the current system, in which all 
regulatory restrictions are removed.  What environmental factors should be considered in 
distinguishing between these kinds of decisions?  
 
Most comments do not support this type of regulatory flexibility without clearly defining the 
methods, mechanisms, and criteria by which products will be evaluated.  Legal, environmental 
and economic risks are cited as reasons for apprehension in adopting this type of regulatory 
vehicle.  Comments include conditional support for commercialization of regulated articles if, for 
example, commercial approval could not be revoked.  Others believe that commercialization of 
regulated articles could be prudent if data is collected on large-scale environmental impacts and 
the product could be withdrawn from the market if significant environmental impacts were 
documented.  One comment suggests that APHIS already has the authority to allow 
commercialization of regulated articles under its current regulations.   
 
Some comments support the proposal but again suggest that “minor unresolved risks” be defined.  
Some of these comments support the use of tiered systems for the commercialization of crops, 
and crops that have low risk could be commercialized while data is collected.  For other cases, 
for example, plants that produce pharmaceutical compounds, one comment suggested that a 
gradual reduction in restrictions could be mandated as more information and familiarity are 
gained with a particular crop. 
 
Question 4—Are there changes that should be considered relative to environmental review 
of, and permit conditions for, GE plants that produce pharmaceutical and industrial 
compounds?  Should the review process, permit conditions, and other requirements for 
non-food crops used for production of pharmaceutical and industrial compounds differ 
from those for food crops?  How should results of a food safety evaluation affect the review, 
permit conditions, and other requirements for these types of plants?  How should the lack 
of a completed food safety review affect the requirements for these types of plants?  
 
Several comments demonstrate concern for the use of food or feed crops to produce 
pharmaceutical and industrial crops.  Some comments suggest that these crops can be used with 
 
C–4 Appendix C.  Public Scoping Comments 
strict confinement conditions.  Other comments suggest that the current system, or one that is 
more relaxed, would be preferred.  Many comments suggested that FDA protein safety review 
should be sought before permits for field trials can be granted.  The issues raised include: 
 
• These products should remain regulated after they are commercialized.  
• They should be grown under strict isolation so they cannot contaminate the food and feed 
channels.   
• They should be considered high risk due to the hazards of the GE traits entering wild 
relatives or food, forage, or fiber crops through cross-pollination.   
• Food or feed crops should not be used to produce plant-manufactured pharmaceuticals 
(PMPs) or plant-manufactured industrial compounds (PMICs) commercially without 
effective controls, multiple containment measures, and procedures to ensure no 
contamination of the food supply occurs.  
• All industrial feedstock and PMP/PMIC crops are not necessarily a separate class of crops 
that require regulation, particularly where a similar phenotype could be obtained via 
conventional means.   
• Simply because these proteins are in the environment does not necessarily make them 
environmental contaminants or human health hazards.  Regulations should be highly 
differentiated for different classes of PMP/PMIC crops based on the level of risk from 
inadvertent consumption/contact by humans and animals.  If warranted, due to the 
toxicological properties of the product in question, USDA should coordinate with EPA and 
FDA to establish acceptable, legal levels of adventitious presence for different classes of 
compounds based on such early assessments, which can be revised as toxicological data 
grow. 
• Additional allowances towards relaxed regulation of PMP/PMIC crops should be made 
when:  
• The plant is not a food or feed crop, nor capable of crossing with a food or feed crop, 
or only inert materials are used as minor components in food (e.g., non-nutritive 
fiber). 
• The crop is grown far outside of its normal area of production.  
• The crop outcrosses at a very low level (e.g., usually below 1 percent in small grain 
cereals). 
• The transgene is in the chloroplast genome or the GE plant is a female in a dioecious 
species.  
• The seed parent of a hybrid crop is male-sterile and the pollen donor is not transgenic. 
• Genetic markers are used to easily distinguish the PMP/PMIC crops from their 
commercial counterparts (e.g., purple corn, black soybean, modified leaves in 
vegetative crops, etc.), such that mixtures could be readily detected.  
• Crops are engineered to have complete (male and female) sexual sterility and can be 
vegetatively propagated. 
• Regulatory approval should not be granted to any GE organism without an appropriate food 
safety review.  
• The Iowa Protocol for Risk Assessment of Genetically Enhanced Crops was suggested as a 
basis for developing a factual and consistent methodology on an application-to-application 
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basis for developing risk tolerances.  Based on the risk factor, appropriate growing conditions 
within a permit can be established.  
• Specific risk categories are worth considering for PMP/PMIC GE crops:  
• Whether the host plant is a food crop or a non-food crop. 
• The potential toxicity of the engineered compound. 
• It is the responsibility of FDA to determine whether GE crops pose any food-safety risks.  
Although the noxious weed provisions of the Plant Protection Act may allow USDA to assess 
and address how noxious weeds might affect humans, those provisions should not be 
interpreted so broadly as to provide APHIS with the legal responsibility or authority to 
determine the food safety of GE crops or to prevent engineered crops from entering the food 
supply.  
• The current permit conditions for PMP and PMIC crops are adequate to protect the 
environment considering the current scale of production.   
• The agency should work with FDA through the Coordinated Framework to establish a 
mechanism for food safety evaluations that would be appropriate for these products. 
 
Question 5—“Noxious weed,” as defined in the Plant Protection Act, includes not only 
plants, but also plant products.  Based on that authority, APHIS is considering the 
regulation of nonviable plant material.  Is the regulation of nonviable material appropriate 
and, if so, in what cases should APHIS regulate?  
 
The majority of comments do not support the regulation of nonviable plant material by APHIS.  
Most respondents agree that FDA or EPA would already have regulatory authority over the 
nonviable material.  However, some comments support the extension of APHIS’ regulatory 
authority to nonviable plant material in specific cases.  Some comments express the opinion that 
if the nonviable material could pose a plant pest risk or a risk to the food supply then it should be 
regulated.  A few comments suggested that nonviable GE plant materials should be regulated to 
segregate them from non-GE crops and products. 
 
Question 6—APHIS is considering establishing a new mechanism involving APHIS, the 
States, and the producer for commercial production of plants not intended for food or feed 
in cases where the producer would prefer to develop and extract pharmaceutical and 
industrial compounds under confinement conditions with governmental oversight, rather 
than use the approval process for unconfined releases.  What should be the characteristics 
of this mechanism?  To what extent should this mechanism be employed for commercial 
production of plants not intended for food or feed?  What environmental considerations 
should influence the development of this mechanism?  
 
Some of the issues raised include: 
 
• Confinement measures must address pollen movement and microorganism dispersal. 
• Confinement measures should ensure that the food and feed supply are not affected. 
• APHIS should consult with other USDA departments (e.g., Federal Crop Insurance 
Corporation and the Commodity Credit Corporation) to explore the issues of food chain 
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liability and means for companies developing products to assume appropriate liability for 
their actions.   
• APHIS should consider limiting the production of plant-made pharmaceuticals to nonfood or 
nonfeed crops. 
• GE material must be rendered 100 percent nonviable before leaving the facility in any form. 
• Where PMP/PMIC crops are producing high-risk compounds, such that minimal tolerances 
cannot be established, APHIS might consider limiting their deployment to enclosed 
conditions, at least until data to the contrary can be provided. 
• Closed systems should be used with appropriate checks and traceability reflective of a 
certified seed and identity preserved program with a monitoring system incorporated. 
• A starting point for the types of regulations required might be NIH’s guidelines for managing 
experimental GE plants in greenhouses 
• The product development process for pharmaceuticals and industrials should be a stepwise, 
laddered approach in which all products would initially start out under high restrictions and 
move, as the data supports, to less restrictive conditions  
 
Question 7—The current regulations have no provision for adventitious presence (AP)— 
intermittent and low-level presence in commercial crops, food, feed, or seed of GE plant 
material that has not completed the required regulatory processes.  Should APHIS 
establish a separate component within a revised regulatory system to address adventitious 
presence?  Should the low level occurrence be exempt from APHIS regulation?  If so, what 
are the conditions under which the low level occurrence should be allowed?  What 
environmental considerations would apply to establishment of such allowances?  
 
Most respondents support the establishment of regulatory guidelines for AP of regulated 
materials in non-regulated materials.  Many of the responses support APHIS regulating AP.  A 
few comments question APHIS’ authority, and suggest that other agencies or groups would be 
better equipped to set the levels.  One comment suggests that setting levels is difficult if there are 
no inexpensive methods available to test for the regulated articles.  Most respondents agree that 
the level of AP should be related to the risk presented by the regulated article.  Several comments 
suggest that practices should still be used to attempt to prevent AP from occurring, even if 
regulations allow for low levels of AP.   
 
Question 8—Should APHIS provide for expedited review or exemption from review of 
certain low-risk GE commodities intended for importation that have received all necessary 
regulatory approvals in their country of origin and are not intended for propagation in the 
United States?  What environmental considerations should be applied to determination of 
any such allowances?  
 
Some comments support the proposal, others support the proposal in part, and some do not 
support the proposal at all.  Some of the issues presented include: 
 
• Potential for escape, or unauthorized planting. 
• Differences in regulations between countries. 
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• Differences in wild relatives in the exporting country. 
• Differences in potential environmental effects. 
• Opportunity for the United States to set precedent for other countries. 
• Comments that support expedited review suggest that the evaluation of the commodity focus 
on the environmental issues that were not covered in the original country’s assessment. 
• The Biosafety Clearing-House, as defined by the Cartagena Protocol, would be another 
mechanism to assess the biosafety of plants intended for import. 
 
Question 9—Currently, GE Arabidopsis spp. are exempt from interstate movement 
restrictions under part 340 because they are well understood and extensively used in 
research.  Should the regulation of other similar GE plants be consistent with the 
regulation of GE Arabidopsis spp.?  Should the exemption from interstate movement 
restrictions apply only to those products that meet specific risk-based criteria?  What 
should these criteria be?  What species and/or traits should be considered for this 
exemption?  What environmental factors should be considered?  
 
Most comments support the exemption of regulation during interstate movement for well-known, 
well-characterized, low-risk regulated articles.  Some comments suggest that APHIS should 
grant exemptions for regulated articles that APHIS deems are unlikely to persist in the 
environment.  Another comment suggests that movement and release permits (notifications) be 
integrated if the final destination of the regulated article is a field trial.   
 
A few comments feel that the States have a right to know that the movement is taking place so 
that they can consider public health and safety issues. 
 
Question 10—What are other areas where APHIS might consider relieving regulatory 
requirements based on the low level of risk?  
 
Several respondents shared their ideas for reducing the regulatory burden in areas that they felt 
were low risk.  Many of these comments suggested reducing data requirements for certain types 
of regulated articles.  A summary of these views are presented below. 
 
• Expedited reviews for renewals of existing permits, or multi-year permits, when there are no 
significant changes proposed in the permitted activity. 
• If a crop-trait combination has been assessed by APHIS to be of low risk, there should be a 
ready and transparent mechanism to create and deregulate that crop-trait combination across 
multiple cultivars of that same crop. 
• Deregulation should bridge to a deregulated antecedent organism using a notification 
procedure. 
• APHIS should officially broaden its definition of non-transformed controls to include not 
only isogenic lines, but, also, near-isogenic lines and other appropriate genotypes or 
populations of the same species (e.g., appropriate and similar reference varieties, etc.). 
• There should be exemptions from review or accelerated review of petitions for deregulation 
involving very low-risk biotech products.  For example, products for which multiple, similar 
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antecedent organisms have been deregulated by APHIS, and/or for which familiarity is very 
high and prior environmental safety has been demonstrated by the trait-species combination. 
• APHIS should allow renewal of authorized movement and release notification/permits.  It 
would make the APHIS inspection and audit process more straightforward and transparent by 
allowing a single test area to continue to use one (or a few) APHIS permit numbers, rather 
than multiple overlapping permits each with a different number for the same group of 
regulated plants or plant types.  The current 1-year-only permit system is ill-suited to 
perennials and is not efficient for permanent research facilities. 
• APHIS could relieve regulatory requirements efficiently by instituting a new, additional type 
of site permit that would allow the applicant to test a variety of constructions made from a 
larger set or suite of user-defined genetic elements.  Such a permit would be very efficient for 
early-phase trait development, proof-of-concept, or event-sorting studies.  For example, an 
applicant would apply for release of any combination of identified promoters, genes (within a 
related gene or trait family), and termination sequences that could be tested in unspecified 
combinations. 
• Low-risk GE plants should be exempted from interstate movement permit requirements on a 
case-by-case basis. 
• APHIS should work with other Federal agencies to broadly deregulate GE tools for all crop 
species where scientific knowledge and experience suggest a high level of safety.  These 
should include:  
• Selectable marker and reporter genes used widely in transformation. 
• Most Agrobacterium DNA, some of which is already known to be naturally present in 
plant genomes. 
• DNA from plant viruses used as promoters/terminators or other functional elements, 
or when used in non-functional form to suppress viral genes (and, thus, impart disease 
resistance). 
• General gene suppression methods such as antisense or RNAi.  
• Non-toxic proteins that are commonly used to modify development.  
• The following exemptions of GE-associated genetic changes based on advances in genome 
and gene regulatory science:  
• Mutagenesis or pleiotropic effects associated with gene transfer and in vitro culture. 
• Random or directed transgene-imparted gain or loss of native gene expression. 
• APHIS could develop a “best management practices” policy that would need to be agreed to 
by organizations seeking exemptions from requirements that specifies how growers of GE 
plants for field research should monitor, devitalize, and dispose of plants after completion of 
field trials. 
• Determinations of transgene, vector, and flanking sequences, and transgene expression and 
toxicological properties should not be required for each insertion site prior to commercial 
use.  Requirements for intensive characterization of insertion sites tend to limit 
commercialization to single-copy events due to expense, and such single-copy events, as 
discussed elsewhere, are not always desirable. 
• Transformation-specific regulation is not warranted. 
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Question 11—What environmental considerations should be evaluated if APHIS were to 
move from prescriptive container requirements for shipment of GE organisms to 
performance-based container requirements, supplemented with guidance on ways to meet 
the performance standards?  
 
Several comments suggest that the APHIS regulations are out of date.  Some of these comments 
also suggest that APHIS should move from a prescriptive- to a performance-based standard for 
containers.  Some of the issues cited include improvements in containers and specialized 
requirements of the material being shipped.  Some of the considerations also suggested include 
(1) the potential for persistence in the environment should an accidental release occur during 
transport, (2) the likelihood that the regulated article will cross-pollinate with related weedy 
species or sexually compatible crop species, and (3) the potential safety hazard posed to any 
wildlife or humans who may come in contact with the regulated product in the event of an 
accidental release.  A few comments suggested that APHIS should continue with a prescriptive 
regulation and avoid performance-based standards. 
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Appendix D.  Stakeholder Scoping Meetings 
 
Representatives from stakeholder groups met individually with officials from APHIS’ 
Biotechnology Regulatory Services in Riverdale, MD, in February 23, 25–27, and March 11–12, 
2004.  Participants were requested to respond to questions posed in APHIS’ notice of intent to 
prepare an environmental impact statement on proposed changes to 7 CFR 340 (Docket Number 
03–031–2, 69 FR 3271–3272).  The following groups participated in the sessions: 
 
• ArborGen 
• Biotechnology Industry Organization  
• Center for Food Safety  
• Center for Science in the Public Interest  
• Chlorogen  
• Coalition for the Advancement of Biotechnology Based Perennial and Specialty Plants  
• Consumers Union  
• Controlled Pharming Ventures  
• Dow AgroSciences  
• Edmonds Institute  
• Friends of the Earth  
• International Paper  
• MeadWestvaco  
• Monsanto  
• National Grain and Feed Association  
• National Cotton Council of America  
• National Food Processors Association  
• North American Millers’ Association  
• Oregon State University (Prof. Steven H. Strauss)  
• ProdiGene  
• United States Public Interest Research Group  
• Union of Concerned Scientists  
• Ventria Bioscience  
 
In general, each participant read a statement into the record, and their statement was followed by 
a question and answer period.  Each session lasted approximately 45–60 minutes.  The complete 
transcripts of the stakeholder meetings—over 500 pages of transcribed proceedings—are 
available on the APHIS–BRS Web site at:  
http://www.aphis.usda.gov/brs/stakeholder_minutes.html. 
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General Summary of Comments 
 
Due to the diverse interests of the participants, the scoping comments raised during the 
stakeholders’ sessions were equally diverse.  The relevant scoping comments are listed below, 
grouped by topic, without attribution to a specific stakeholder. 
 
Plants Producing Pharmaceutical or Industrial Substances 
 
• Not all plants producing pharmaceutical or industrial compounds pose equal risks, and 
APHIS risk assessment processes should take this into account. 
• The rules should provide an avenue to regulate plants producing pharmaceutical or industrial 
compounds after commercialization. 
• Field tests for plants producing pharmaceuticals should be restricted to non-food crops. 
• There should not be any open-air field trials for plants producing pharmaceutical compounds; 
they should be grown in contained facilities. 
• Because food crops are so well understood and produce economically useful amounts of 
biomass, they must be available as hosts for pharmaceutical and industrial genes. 
• The FDA food safety evaluation system for pharmaceutical plants is inadequate because it is 
voluntary. 
• Considerations for crops producing pharmaceuticals should include the effect on herbivores. 
 
Risk Analysis 
 
• Some stakeholders preferred a tiered approach to risk analysis, while others favored a case-
by-case approach. 
• Confinement measures should be tested for adequacy and efficacy. 
• GE technology should progress but not at the expense of the safety of the food supply. 
• The overall size of a field test may not be relevant to risk; many small trials may be more 
difficult to manage, and, therefore, riskier than one larger test. 
• Confinement systems should be redundant. 
 
Regulatory Structure 
 
• Regulations should have built-in flexibility to allow for developments in science and 
technology. 
• Regulatory transparency must not compromise intellectual property rights or foster unfair 
competition. 
• Conditional deregulation could raise unintended enforcement and liability issues. 
 
Importation of GE Commodities 
 
• Rules regarding commodity importation must not give foreign companies a competitive 
advantage. 
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Adventitious Presence (AP) 
 
• There were requests for no tolerance as well as requests for tolerances to be set based on 
familiarity with the host plant and the compound produced by the plant. 
• Coordination with FDA is necessary. 
 
Organism-specific Concerns 
 
• GE trees and turfgrass should be regulated differently from other GE plants. 
• Insects should have separate regulatory status. 
• APHIS should develop guidance documents for specific crops. 
• Perennials may need special consideration. 
 
Miscellaneous 
 
• Nematodes may move genetic material from one plant to another. 
• Exemptions for the movement of research materials should be limited to non-food plants. 
 
Summary of Comments by Stakeholder Group 
 
The following section summarizes a few representative points made by each stakeholder group.  
The complete transcript of each meeting is available online at the link provided. 
 
ArborGen 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Arborgen.pdf
 
• Believes that the current system works well; would like to see flexibility to address new crop 
and trait combinations 
• Create risk categories based upon trait and species combinations, on a case-by-case basis, as 
opposed to broad, general categories (like ‘trees’). 
• Would like a clearer definition of ‘familiarity’—scientific literature and professionals may 
show a great deal of familiarity with some applications with which APHIS is relatively 
unfamiliar.  
 
Biotechnology Industry Organization 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Bio_Meeting.pdf
 
• Advocates the term ‘approval’ as opposed to ‘granting non-regulated status;’ previous lines 
granted non-regulated status should be grandfathered into the new system. 
• Wanted clarification on whether the intended use of a crop would put it into a risk category 
(e.g., pharmaceutical-producing crops); some crop-trait combinations in such categories 
might be lower risk than others. 
• Need a policy for AP now; should be considered for imports as well as exports.  
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Center for Food Safety 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Center_for_Food_Safety.pdf
 
• Restrict biopharmaceutical crops to restricted conditions (greenhouses/underground, limited 
geographical areas). 
• Wants the ability to list specific GE crops as noxious weeds 
• Wants field tests of biopharm crops never to be categorically excluded from NEPA; clarify 
terminology related to categorical exclusions.   
• Several recommendations to update Confidential Business Information (CBI) policy. 
• Trees and grasses should have a separate category of regulations. 
• Insects raise a need for separate regulatory status.   
• No tiered categories of risk categories; each event requires the same review. 
• Minor risks should be characterized prior to commercialization.  
• No food crops should be used for pharmaceutical production. 
• No acceptable AP without a safety review. 
 
Center for Science in the Public Interest  
The transcript of this meeting was lost by the transcription company.  The points below have 
been summarized from notes taken during the meeting. 
 
• Wants greater access to APHIS documents, more opportunity for public participation. 
• Supports commercialization under permit to allow continued oversight. 
• Supports more careful review of CBI justification by APHIS and challenge when 
appropriate. 
• Tiered risk system should differentiate between non-food crops and food crops with non-food 
uses. 
• Food safety assessments and AP policy should be FDA’s responsibility. 
 
Chlorogen 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Chlorogen.pdf
 
• Support risk-based tiered approach to permitting and sub-tiers for PMIs and PMPs. 
• Support process for keeping PMIs and PMPs under regulation even after commercialization.   
• Do not support an AP policy for products not intended for food or feed.  
• Supports more transparency to the public, while protecting intellectual property rights and 
competitiveness. 
• Wants better communication between APHIS and applicants, and APHIS and State officials 
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Coalition for the Advancement of Biotechnology Based Perennial and Specialty 
Plants 
Transcript:  
http://www.aphis.usda.gov/brs/stakeholder/Coalition_for_Advancement_of_Biotech.pdf
 
• Wants guidance documents developed for additional crops, such as perennials. 
• Having a simplified way to renew annual notifications would help. 
• Assess risk case-by-case and by trait and species combination. 
• Investments in perennials are long-term; investors will be concerned if there is a possibility 
that risks or status could change from year-to-year. 
• Burdensome for companies to push new species through the process of being added to the list 
of ‘exempt’ species. 
 
Consumers Union 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Consumer_Union.pdf
 
• Would like development of regulations to cover all GE insects. 
• There should not be a ‘low risk’ category because there could be unintended effects even 
with low risk organisms. 
• Supports some regulatory oversight after commercialization. 
• No allowance for AP of unapproved varieties. 
• Supports environmental assessment of importations of viable plant materials. 
 
Controlled Pharming Ventures 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Controlled_Pharming_Ventures.pdf 
 
• Discussed a new business venture involving production of GE plants in an abandoned 
limestone mine in Indiana. 
 
Dow AgroSciences 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Dow_Agro_Sciences.pdf
 
• Need AP policy which should be coordinated with FDA; concern for international 
implications. 
• Supports current stringent standards for PMP and PMICs. 
• Supports performance-based container requirements. 
• Don’t want new rules to affect products overseen by Center for Veterinary Biologics. 
• Concerned about having enough data on novel proteins for early FDA consultation. 
• Limiting acreage may not help to manage risk; producers might increase risk by planting in 
many smaller plots than a few larger plots. 
• Does not advocate limiting PMPs/PMICs to non-food crops. 
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Edmonds Institute 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Edmonds_Institute.pdf
 
• Recommends examination by the Edmonds Institute on GMO biosafety. 
• Wants more transparency in the coordinated framework, how agency makes decisions. 
• Concerned that CBI claims reduce transparency.  Advocates long-term economic analysis of 
any AP policy. 
• Concerned that CBI claims reduce transparency.  Advocates long-term economic analysis of 
any AP policy. 
• Supports PMP production indoors with strict containment standards. 
• Wants to close any regulatory gaps so that everything genetically engineered is regulated.  
 
Friends of the Earth 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Friends_of_the_Earth.pdf
 
• Does not support establishment of AP policy; APHIS regulates experimental crops and are 
evaluated for environmental effects, so to allow for any presence before the petitioner applies 
for deregulation prejudges the outcome. 
• Use strip tests to confirm compliance to permit conditions. 
• Concerned with contamination of seed supply. 
• Low-risk categories should not be exempted from permit conditions. 
• Supports continued regulation as opposed to deregulation in some cases, and/or the ability to 
cancel deregulation. 
• Supports a ban on all outdoor plantings of food crops containing PMPs. 
 
International Paper 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/International_Paper.pdf
 
• Believes risk should be assessed on a case-by-case, crop by trait basis, including trees. 
• Does not support regulation of all non-viable material. 
• Supports expedited review for imported GE commodities. 
• Supports the use of performance standards for shipping containers. 
 
Mead Westvaco 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Meadwestveco.pdf
• Assess risk on a case-by-case, trait/species basis; don’t lump all trees together in one risk 
category. 
• Discussed various types of ecological forest management systems. 
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Monsanto 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Monsanto.pdf
 
• Considers AP policy to be an urgent need. 
• Supports oversight that is proportional to the level of risk. 
• Wants the ability to be flexible in the size of field trials for various traits. 
• Resists the idea of commercialization under continued oversight, monitoring. 
• Might support post-deregulation adverse effects reporting. 
• Concerned that deregulation/approval is tied to both the product and the petitioner. 
• Wants the EIS to include an economic analysis of regulatory costs to industry. 
 
National Grain and Feed Association 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/National_Grain_and_Feed_Assoc.pdf 
 
• Does not support reduced permit requirements for PMPs due to export concerns.  
• Concerned how conditional approval would be interpreted by export markets. 
• Permit conditions/requirements for PMPs should be different than food applications. 
• Food safety assessment is irrelevant to marketing issues. 
• AP policy is difficult; United States needs a policy, but most markets have zero-tolerance for 
unapproved varieties. 
• Supports expedited review of imported GM varieties if approved in exporting nation. 
 
National Cotton Council of America 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Natl_Cotton_Council_of_America.pdf
 
• Concerned that companies that produce an early product may end up subsidizing companies 
that produce later ones, if data requirements are lowered for “familiar” crops. 
• Cautions against arbitrary familiarity standards; novel traits should not be considered 
familiar.  
• Does not support conditional approvals, due to marketing issues. 
• Supports stringent regulation and monitoring of PMP/PMIC crops. 
• Imports should be evaluated with the same stringency as crops produced in the  
 United States. 
• If there are exceptions (such as Arabidopsis), they should be fully deregulated. 
• Supports shipping container standards. 
 
National Food Processors Association 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Natl_Food_Processors_Assoc.pdf
 
• Very concerned about issues associated with commercialization of PMP crops. 
• Suggest issuing ‘letterhead statements’ about which crops APHIS has deregulated or not, 
especially regarding PMPs.   
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• How would APHIS regulate ‘botanicals,’ that is, crops with enhanced nutritional properties, 
but not necessarily a PMP/PMIC? 
• Support keeping PMP/PMICs under regulation even after commercial production. 
• Encourage the use of HACCP protocols for confinement/commercialization. 
• Concerned about liability if PMP/PMICs enter the food supply. 
 
North American Millers’ Association 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/North_American_Miller_Assoc.pdf
 
• Suggests having a scientific meeting to determine how far viable corn pollen travels. 
• Wants regulations to be science based but concerned about human error. 
• Wants a large increase in compliance and enforcement. 
• Concerned about PMPs in food crops like corn, especially in corn production areas. 
• Concerned about liability of companies producing PMPs. 
• PMPs should have either full food-safety approval or a very low acceptable AP level. 
 
Prof. Steven H. Strauss, Oregon State University 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Oregon_State_University.pdf
 
• Important that regulations are not too expensive for small companies and public researchers. 
• Support a science-based three-tiered risk system; low-risk tier could be exempt from 
regulation. 
• Trigger for regulation should not be process, but characteristics of the product. 
• Should not deregulate on an event-by-event basis. 
• Wants an AP policy to protect developers. 
• Allow unregulated interstate movements for most classes of GE crops. 
• Deregulate a list of common genetic engineering tools, like promoters, etc. 
 
ProdiGene 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/ProdiGene.pdf
 
• Regulation should be based upon risk, not the class or products based upon end-use. 
• Everything should start in the high-risk tier until evidence supports a lower risk. 
• Some PMP/PMIC crops might be deregulated if they are low risk.. 
• Supports the idea of long-term regulation under a ‘compliance contract.’ 
• AP policy should consider not just hazard, but also exposure; proposed such a model. 
 
United States Public Interest Research Group 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Public_Interest_Research.pdf
 
• Complained about difficulty getting information from APHIS. 
• PMP/PMIC should be restricted to non-food crops; no open field tests. 
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• Questions definitions of risk and their implications for regulations, e.g., “minor unresolved 
risk,” “low level of risk.” 
• Need more monitoring and testing, none currently done by government. 
• Need better quality control for confinement. 
 
Union of Concerned Scientists 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Union_of_Concern_Scientists.pdf
 
• Support adoption of the noxious weed authority from the Plant Protection Act. 
• Support a risk-based tiered permitting system. 
• Don’t support the idea of AP policy being tied to pre-testing food safety evaluation. 
• Support lessening of regulation of interstate movements, particularly for research. 
 
Ventria Bioscience 
Transcript:  http://www.aphis.usda.gov/brs/stakeholder/Ventria_BioScience.pdf
 
• Want USDA to establish a risk-based AP policy. 
• Support a risk-based tiered permitting system. 
• Some criteria for risk:  host biology, impact of gene, expression of selectable markers, 
quantity of active material, selective advantage of material in host plant.     
• Do not intend to seek deregulation of PMP/PMIC crops. 
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Appendix E. NADSA–USDA Conference,  
 June 17–19, 2004 
 
The National Association of State Departments of Agriculture (NASDA) met with APHIS’ 
Biotechnology Regulatory Services on June 17 and 18, 2004, in Washington, D.C., to discuss 
APHIS’ proposed revisions to its existing regulations.  The 60 participants discussed the specific 
questions raised in a notice of intent to prepare an environmental impact statement on proposed 
changes to 7 CFR 340 (Docket Number 03–031–2, 69 FR 3271–3272).  The main points offered 
by meeting participants, as summarized by APHIS staff attending the meeting, are presented 
below. 
 
The Regulation of Crops Producing Pharmaceutical Compounds 
 
Encouraging Industrial Production:  State and Federal Policies 
 
Representatives from several States were optimistic about the present and future business 
activities of the plant-made pharmaceutical (PMP) and plant-made industrial compound (PMIC) 
industry.  Companies have been inquiring about PMP/PMIC crop production in their States, and 
the States were also seeking to contact additional technology companies.  Policies to encourage 
production of specialty products were proposed as useful for some States.  Growers also 
recognized possible opportunities and were interested in initiating and furthering these types of 
projects.  The State representatives said that the public did not seem to have any objections to 
these plant manufactured products, or at least hadn’t voiced any.  Companies had not been 
complaining about existing regulatory burdens, either. 
 
Some said APHIS should continue to effectively regulate field tests, but should have a “forward-
looking attitude” and not attempt to over-regulate (and, thereby, inhibit progress of an industry).  
New restrictions shouldn’t be set if the standards could not be readily attained.  Reasonableness 
of confinement plans was contrasted with imposing excessive burdens on industrial production.  
Some of the representatives noted that they were not familiar with the confinement standards, but 
if they exceed AOSCA standards, they are probably adequate. 
 
Concerns About Permits and Conditions Set for Field Testing 
 
Some States did not want to allow flexibility in permit conditions.  Some would rather move in a 
more restrictive direction, especially when there were possible impacts on humans.  Due 
deliberation for individual releases might well result in enhanced confinement standards.  More 
stringent conditions should be allowed if significantly increased toxicity or allergenicity were 
apparent.  If the industry is taking new steps to insure confinement and quality, these changes 
should be included in the new regulations.  If industry were only using minimal restrictions for 
safety, they should consider additional restrictions.  Concerns were expressed about new and 
small companies:  they may not adhere to applied restrictions or conditions due to inexperience 
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or lax attitudes about safety issues.  Other concerns were raised about contamination by 
PMPs/PMICs, especially in putting conventional variety growers at risk. 
 
Concerns were expressed about the lack of science available for determining proper isolation 
distances.  Extra measures of redundancy were thought useful, especially to refute opponents of 
the technology.  Some saw gene flow as an important consideration for regulations, and others 
noted antibiotic resistance as an issue. 
 
Some inherent differences between PMP and PMIC crops may require differences in how these 
are regulated.  That is, PMICs are more likely to be produced on large acreages, but PMPs may 
well be produced on only small acreages.  These differences would need to be acknowledged in 
conditions assigned to field production. 
 
Long-term Concerns for Effects of PMP/PMIC Crop Policy on Markets 
 
Some States had limited experience with PMP/PMIC crop projects, and the possibilities of 
mistakes and harm to markets was raised.  At present, there is often no authority in the States for 
dealing with GE crops.  Some said that State regulations regarding PMP/PMIC crops should be 
adopted.  Some are looking for guidance to deal with the issues surrounding these plants.  Some 
States have a plant pest authority, although it varies by jurisdiction.  Nevertheless, these could be 
the basis for some additional State oversight if it would not conflict with Federal authority. 
Some were concerned that certain products may not be plant pests but were, instead, “market 
pests” and that some balance should be struck between science-driven restrictions and market-
driven restrictions.  Confidence in the measures taken should be instilled in the public once the 
appropriate conditions are designed.  While companies could assist with this, they have, so far, 
not been helpful. 
 
Use of Contained Facilities for PMP/PMIC Crop Production 
 
Some thought that producing PMP/PMIC crops under only completely contained conditions may 
be unreasonable, although there could be some cases where this protocol should be required.  
Some products might be produced economically in a greenhouse (or other completely contained 
facilities).  Some thought that PMP plants should be tested first in contained facilities before 
being allowed in a field release.  Perhaps small-scale testing should precede larger scale 
production.  Others responded that APHIS should keep in mind that the PMP production process 
is aimed at speeding up synthesis of these PMP products—an “instant factory”—and that 
additional steps might reduce the advantages.  Finally, some noted that existing performance 
standards should be adequate to confine PMP plants. 
 
Public perception was considered quite important, and public perception might motivate more 
stringent requirements.  Growing conditions need to be correctly (scientifically) assigned and 
also generally perceived as adequate for confinement.  However, one State suggested that 
regulations could not be based on science alone, but also should consider what was physically 
possible, and administratively possible, too.  If the protocols were good ones to begin with, then 
compliance with them should be expected.  Others said that all conditions for field tests should 
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be determined with science considerations, rather than public perception.  For both the growers 
and the public, conditions of the field production should be acceptable ones.  Finally, criteria for 
evaluating the risks should be well-developed and transparent. 
 
Use of Only Non-food Crops to Produce Pharmaceuticals 
 
If PMP production could be accomplished in non-food crops, industry could move in this 
direction.  However, if APHIS required that only non-food crops could be used for PMP 
production, some companies could be put out of business.  Regulatory authorities shouldn’t be 
overcautious but might encourage the use of non-food crops like tobacco.  Others noted that 
tobacco is actually a consumer commodity, but, nevertheless, might provide a safer production 
vehicle than other actual food crops.  Still others thought tobacco may be as risky as corn, 
soybean, and wheat.  Another stated that alternative host plants should be encouraged. 
 
Science needs to be considered in such decisions (e.g., exclusion from certain food or feed 
crops), but some regulatory flexibility needs to be exercised, too, which includes permitting the 
expression of PMP products in food or feed crops.  Alternatively, regulations could be made 
more stringent for food crops than for non-food crops.  More public acceptance could be found 
for production in non-food crops and in crops without wild relatives.   
 
Other types of restrictions might be pursued.  For example, industry could be encouraged to 
produce pharmaceuticals in plants that were not open-pollinated.  Some would have a greater 
comfort level in PMP/PMIC crops if the expression were confined only to seeds.  Some States 
suggested broadening their role in both assignment of conditions and mitigation.  While the 
Federal government coordinates with the biotech companies to determine conditions and, 
together, may mitigate possible failures involving plants or plant products, the States could also 
do this work. 
 
New Oversight Mechanisms for PMP/PMIC Crop Production 
 
Some States would support some kind of “commercialization permit” for PMP/PMIC plants.  
One State thought that a contract system might be helpful so that States (or even counties) could 
have greater control over possible gene flow.  Participation issues were important to some States.  
If any new system were adopted, there would have to be consideration of a company’s past 
performance and how it might change the production scheme or other protocols from the permit 
based system.  The States would need to be more involved in setting up the system and 
periodically audit performance.  Any new mechanism for PMP/PMIC crops should keep the 
“gene owner” accountable under the terms of a contract. 
 
Any new regulatory mechanism should be extremely conservative, but it may be premature to try 
to set up a new one.  The public may not be ready for any process of pharmaceutical production 
in plants unless it is conducted under a permitting system.  Some States noted that they would 
like a continued permit system with regulatory oversight. 
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Some States would be very uncomfortable with any type of deregulation of PMP/PMIC crops.  If 
deregulation occurred, there would need to be some mechanism to maintain continued control 
over these crops.  Inspections should remain under USDA control, especially while any system 
was new.  One State pointed out that the public expects accountability in regulation, not 
efficiency. 
 
Concerns were expressed about any new regulatory framework unless they necessarily include 
more frequent assignment of unique confinement conditions on a case-by-case basis.  Agency 
guidelines may need to be provided to the producer if their own SOPs were lacking or 
inadequate.  This might bring complaints about unfairness in the way that the regulations were 
applied.  The opposite strategy, in which all permit holders would abide by more general 
protocols, may also be perceived favorably by the public.  
 
Questions were raised about who would do the inspections under a new system and their 
qualifications.  The States would like an inspection reporting mechanism that automatically 
reports to the State containing the release site.  They also wanted to have planting reports sent to 
them since the State might need to know which sites are to be inspected.  
 
A list of the characteristics of a new system for oversight of PMP/PMIC crops should include: 
 
• Equal enforcement of biotech regulations of both States and Federal governments. 
• Flexible regulations that keep up with the technology. 
• Provision of guidelines for companies that do not have adequate SOPs. 
• Training for State regulators to be able to answer questions from the public. 
• Initiating an extremely conservative system. 
• Provision of clear guidelines for the State regulators. 
• Involving the State regulators, including inspectors. 
 
Special Concerns From States 
 
When asked to concur on a permit, States would like some kind of workshop to train them in 
what issues to consider.  Because many are not molecular biologists, presenters would need to 
make allowance for that fact in any workshops.  Some would like to establish a new mechanism 
or relationship with the States and Federal government for field testing.  For example, an 
opportunity for the State to discuss local concerns should be offered before field trials are laid 
out by the company.  Others noted that the State representatives should be included in the 
relationship more as partners than does the relationship at present.  Without good Federal-State 
partnering, establishing credibility in the system will be a difficult task.  Good partnering should 
also include accompanying all APHIS inspectors on their assignments.   
 
One question raised was, “What can the State do when there are special State concerns over a 
field test?”  APHIS replied that it has always allowed supplemental conditions to be placed on a 
permit, trying to balance the needs of industry and the States.  
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A second concern was for issues arising over CBI.  Here the States noted that because CBI 
prevented full knowledge about the details of field testing, the States could not assure the citizens 
that rigorous reviews had been done.  One State noted that CBI deletions provided a credibility 
problem for them, namely how can the States say they’re reviewing information that is not 
provided?  Could some abstract be provided that was pertinent to the tests when CBI information 
cannot be divulged?  They would like to know about the genes and intentions of the developers 
for the field tests:  whether the active principle is expressed only in seeds or other specific tissues 
should be shared by APHIS, as well as how the material will be used (what parts are harvested, 
how they are extracted or activated, what products they will become). 
 
Compliance issues were deemed important, and, if the protocol called for 28-day temporal 
separation, for example, there should be records showing the dates of compliance.  Without 
verification, protocols and conditions are of little value.  The States should be called on to help in 
compliance efforts because they have better knowledge of the crops and situations. 
 
Concerns were expressed for the availability of APHIS inspectors.  APHIS replied that it is 
developing a Memorandum of Understanding (MOU) with PPQ to assure the cooperation of 
PPQ in inspection efforts.  Also, APHIS is developing a program to certify State inspectors to do 
the inspection work. 
 
Adventitious Presence 
 
APHIS should be concerned about adventitious presence (AP) especially because it can be 
detected at very low levels.  When undesirable AP is found, there must be a mechanism in place 
for assuring the public of the safety of the gene product.  Criteria for AP have been set in some 
places, such as allowances by the EU of 0.3 percent of GE in non-GE seed, and as much as 0.9 
percent in food or feed commodities.  
 
Concerns were expressed about the absence of U.S. policies regarding AP because, without these 
policies, decisions about AP will necessarily be made abroad.  A second consequence of no AP 
policy is that other countries will send us commodities without any U.S. input into their AP.  
Additional outcomes of inaction were discussed.  For example, other economies may produce the 
very products developed here, and an absence of tolerances for presence of AP will drive their 
production abroad. 
 
If the United States sets AP standards, the rest of the world will be attentive since other countries 
would need to meet any new U.S. requirements.  A U.S. decision for AP tolerances would be a 
precedent-setting international model.  APHIS needs to formalize U.S. policy, assure that it is 
appropriately transparent, and, thereby, satisfy the concerns of U.S. trading partners.  When 
others are confident in our system, then the United States will be able to meet existing export 
market needs.   
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Expedited Review Process for Unapproved Commodities 
 
If the United States sets tolerances or exemptions, they should be set on a case-by-case basis. 
Several States did not favorably view the setting of numerical, across-the-board tolerances.  One 
proposed exempting families of traits as allowable AP.  Others proposed setting AP tolerances 
for each crop.  If exemptions were permitted, it should be done because APHIS or FDA has 
taken responsibility for the commodity.  
 
Zero tolerance was recognized as an unrealistic policy by one State representative.  Another, 
knowing that tolerances will not necessarily be found acceptable to the public, suggested a 
second option:  rather than develop a system of exemptions and tolerances, APHIS should 
consider setting extensive protocols for quality assurance.  North Carolina developed one for 
production of non-GE tobacco with basic similarities to those for organic crop production.  
Compliance with approved protocols assured GE-free status, and no direct testing was done.   
 
FDA approvals of tolerances would be helpful, and may be possible, since FDA currently 
specifies thresholds for fungal presence in foods.  Is APHIS then moving toward setting a 
threshold?  Two States proposed some sort of testing regime, one able to establish the safety of 
exempted proteins.  In 2002, FDA proposed establishing, in some cases, a process for early food 
safety assessment.  Is APHIS planning to force applicants into a pre-approval meeting with the 
FDA?  APHIS suggested that petition applicants could be compelled to submit food safety 
assessment documents to FDA.  Simultaneously, they would submit an environmental 
assessment to APHIS.  If APHIS approved both assessments, designation of exempt status for a 
gene product would be made if it were to be found as AP. 
 
If a product has been approved elsewhere, such as in Canada, then that approval should be an 
adequate basis for our acceptance.  If the United States has sufficient confidence in another 
country’s regulatory system, then the United States should routinely accept their approvals.  
However, if a product is unapproved elsewhere, then the United States should have concerns 
about accepting it here.  The United States should always retain its concern for possible 
environmental impacts in any approvals that are finalized. 
 
Tolerances 
 
If APHIS decided to set AP tolerances, two audiences may receive them adversely.  The first is 
the international and export markets, and favorable approval by these buyers is highly critical for 
growers and marketers.  The second is the public.  Will they accept the presence of low levels of 
AP without criticism?  The public will want to know whether the food is still safe even after 
tolerances are set.  While the food may, indeed, be safe, a more difficult question might be, “how 
safe is it?”  If some exemptions are set, then the policy should be thoughtfully presented to the 
public.  One can envision that a gap may arise between scientific acceptance and public 
acceptance.  One commenter suggested that it is perception that drives the market and that 
scientific facts would not make a difference in what the public expected. 
 
 
Appendix E.  NASDA–USDA Conference E–7 
Disapproval was expressed for blanket exemptions of unapproved events.  One reason against 
exemptions is that some growers or middlemen will always be pushing against reasonable limits 
and allowing incorporation of something unacceptable.  A second reason is that such exemptions 
would provide easy targets that anti-GE activists could take aim at.  Another thought is that there 
should be no exemptions, but that the whole process of the U.S. system should be brought to 
consider each AP component.  Standards for importation should be no more lax than standards 
used for products produced here.  However, stricter standards for imported commodities should 
not apply either. 
 
Representatives raised questions about the effects of these policies on trading partners.  Would 
USDA need to rely on the trading partner’s opinions for setting the policies for exemptions?  
Others thought that the commodity groups should themselves address this issue; yet others 
suggested that these groups were the ones asking for the Federal policy.  Still others wanted to 
know why our present standards should be relaxed.  By suspending the full process of review, 
the concern was that our producers may become less competitive.  Why should the United States 
allow a foreign producer some exemption that their own system may not allow them?  What is 
the present process for AP in other countries?  APHIS noted that our producers must meet those 
countries’ standards, and that some do not permit any GE, or may require a certificate for import 
(China).  The United States has allowed entry of unapproved canola for processing here. 
 
Concerns were raised about accepting something that was “not intended for planting” but was, 
nevertheless, viable.  How would you prevent something from being planted if it were viable?  If 
any imported commodity is viable, APHIS should have the same concerns as it would have for a 
Monsanto product produced here.  However, if it can’t grow here, then accepting it would not be 
a problem. 
 
Some were concerned about the means for testing the presence of unapproved events.  Because 
the allowed levels might likely be quite small, the sampling procedure would need to be very 
well thought out and carefully conducted.  The testing locations would also need to be 
considered, and could include random testing within the general commodity or, alternatively, be 
limited to fields near the test sites, or to grain elevators near test sites.  One State representative 
also wanted a requirement for testing of fields containing any exempted pharmaceuticals.  The 
focus for regulation of field testing is determining the needed safety criteria in the field.  A 
question was raised about the level of importing that would trigger an analysis of AP content: 
would research-scale as well as commercial-scale imports be assessed? 
 
Exemptions for Research Organisms 
 
One State representative agreed that exemptions should be specified, but posed the question of 
how it could be done.  Another raised the issue of adequate detection methods and wondered 
whether it was possible to write regulations when the methods for detecting AP are continually 
changing.  Finally, if decisions were to be made, then an effort should be made to describe the 
need to the public. 
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Some wanted the exemption to be explicitly laid out in the regulations and some did not.  While 
some thought that written regulations would be useful, others thought that specifying anything 
too precisely would be cumbersome.  There should be a case-by-case allowance for AP, and no 
general level set except for generally recognized as safe (GRAS) substances.  It would be a 
mistake to spell out a single level.  If a component was GRAS, then low-level presence could be 
accepted, but if not, then an FDA consultation would need to be arranged.  These consultations 
should remain voluntary.  Companies that were serious about the acceptance of their product 
would have gone to FDA already, early in the process.  If USDA were to approve the presence of 
a PMP crop before FDA approval, it would be seen as an ill-advised decision.  Questions were 
raised about GRAS and it was noted that, although a material may have GRAS status, the status 
may be awarded for a single use and not for its presence in all food materials or at all 
concentrations.  Early on in the development of PMPs, a company is not likely to seek GRAS 
status.  A problem might exist because of detection methods, which are constantly changing, and 
these might need to be included if a regulation was written.   
 
The representatives raised a number of other issues.  Would large scale production be needed 
before FDA would do a consultation?  Should APHIS compare AP to pesticide presence in a 
non-target situation?  Are there levels which might be acceptable?  Can some constituents be 
undesirable but not a health threat?  Setting AP thresholds might allow growers to just barely 
meet the standards, without doing anything exceptional, to assure minimal presence in food or 
feed.   
 
Certain advantages were obvious if FDA were to do a consultation before AP levels were set.  
For setting field testing protocols, less stringent conditions should be based on acceptance of 
food safety by FDA, and, if none were given, then protocols suitable to higher risk materials 
would be required. 
 
Growers should begin production using every standard procedure that would contribute to 
confinement.  Then, if something happened, let the grower explain what went wrong.  Another 
suggested he could not understand the term “unavoidable” circumstance.  There is always the 
potential for an oversight. If APHIS keeps a policy of 0 percent AP as the goal (even if it is 
unattainable), then APHIS should set protocols for attempting to have 100 percent containment.   
 
If unapproved AP were reported or detected, what is the appropriate response?  APHIS should 
try to avoid giving penalties for accidental AP if the incident was truly unavoidable.  APHIS 
really needs a balance between promoting good production processes and preventing unwanted 
outcomes.  In the end, the United States still need acceptable results, however.  The good 
practices selected for the production process should help to attain the chosen threshold.  Again, 
the desire is to have a marketable product at the end of the farm production effort.  
 
The question was raised, why should there be one standard for seed for planting (deregulation) 
and another for seed arriving as commodity (exemption)?  In the future, there may be many 
commodities containing plant parts that APHIS has not reviewed.  If they have been reviewed 
elsewhere already, would it be worth United States resources to repeat such a review?  Other 
countries would follow our lead if APHIS accepted foreign standards, and, thus, by example, 
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steer them from a new local review of U.S.-approved products.  Should there be an 
environmental review even if the only release would be accidental?  APHIS should remember 
that environmental reviews are also used to leverage trade issues.  The United States would need 
to have a reciprocal set of agreements.  Better still would be just a level playing field—
reciprocity is important.  Otherwise, other countries can use lack of agreements as trade barriers. 
 
Topics Related to APHIS Authority 
 
Scope of Current APHIS Authority 
 
Although APHIS is currently addressing potential environmental impacts under present 
authorities, there is no reason not to expand this authority.  However, will invoking additional 
authorities require additional resources to implement them? 
 
There is no way to predict what technologies may be developed in the future so it’s wise to 
broaden APHIS’ authority.  It is better to be proactive than to find that you need expanded 
authority later.  Using the noxious weed definition from the Plant Protection Act would allow 
additional categories of GE products to be evaluated. 
 
The use of the phrase “noxious weed” could be used against us because of the emotional impact 
that it carries.  Although the noxious weeds designation has a negative connotation, it also has a 
precise legal status.  APHIS would gain more than it lost by using the noxious weed definition. 
 
Biological Control Organisms 
 
Doesn’t APHIS–PPQ already regulate biocontrol organisms?  Why should two programs 
regulate the same organisms?  If PPQ had a GE biocontrol organism, wouldn’t they consult with 
APHIS anyway? 
 
Exemption of Low-risk Items  
 
The exempting of low-risk items from the permitting process should be decided on a case-by-
case basis.  One of the beneficiaries of new exemptions would be researchers, but APHIS should 
note that the States often have problems with compliance of such individuals in educational 
institutions.  Researchers and small companies often do things without following designated 
procedures.  Others agreed with the need for exemptions, but were insistent that APHIS should 
allow these exemptions only if there were indeed a low risk, and it was accurately determined to 
be low risk.  If the regulated article were clearly not a high risk, the issue of exemptions would 
often not be a problem. 
 
While a system of exemptions has some merits, the public still wants to know what has entered 
the State.  Issues of risk assessment were considered to be variable from one State to the next.  
Risks must be evaluated by the perceptions of the public in each of the States.  Thus, decisions 
on exemptions would need to be coordinated between States.  The notification process must 
remain the same between States, even if the assessment process differs. 
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Establishing Risk-Based Categories 
 
The three APHIS-proposed categories should be broader.  Tiered assessment processes should 
also be considered.  These tiers could be based on the three categories, but one representative 
proposed that APHIS should add as many tiers as necessary. 
 
Yet another opinion proposed that the number of categories is not critical, but multiple categories 
were probably needed.  Some mechanisms should be incorporated to add additional categories 
without any formal rulemaking, but only on evidence of hazard and exposure. Still others 
suggested that few categories should be created, and they should be broad, inclusive categories. 
 
Additional Issues 
 
Problems in Exchanging Documents With APHIS 
 
APHIS mailing lists need to be updated with current addresses. Some things have been sent to 
incorrect cross-town addresses, and delivery was extremely slow to the correct address.  Some 
items are FedEx'ed when they could be sent by fax, as similar items are sent.  Regular mail is an 
acceptable means for sending permit concurrences. 
 
A fax black hole exists where documents have to be faxed to APHIS multiple times. 
 
APHIS and EPA Field Tests 
 
Experimental Use Permits (EUP) field test locations may have a similar USDA permit but 
sometimes do not.  However, EUPs contain information about things that are deleted in the 
APHIS permits.  The two agencies should cross list them so they can match them up, and so do 
not inspect sites twice. 
 
Permit Conditions 
 
For specifying permit conditions, growers suggest that degree days should be used, not calendar 
days.  Because temperature greatly impacts growing conditions, these are highly inaccurate as 
compared to events calibrated in calendar days. 
 
Concerns About the Permitting Process 
 
What if the State doesn’t sign off on a permit?  If the failure to sign is a consequence of the State 
not desiring to approve the conditions of the permit, then APHIS should be apprised of the 
concern so as to resolve it. 
 
The State may not have enough information to approve or deny the application.  What, for 
example, is if something that is described in the permit application as a “novel protein?”  From 
this information, it is hard for the state regulator to comment on the permit.  Another 
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representative said that it was ridiculous to ask the States to concur on permits, because they 
often do not know exactly what they are concurring with. 
 
Suggestions for the Permitting Process  
 
For PMP/PMIC crop permits, APHIS should give the States more than 30 days to concur.  States 
need more time to consult with reviewers, such as university personnel, and they cannot be 
recruited on short notice. 
 
There are problems with the adequacy of information provided by the Federal government.  For 
example, information about planting site locations in notifications is inaccurate.  In other cases, 
the State may plan an inspection but then finds out that the planting was not done as stated on the 
notification.  Often there is not adequate contact information about the notification holders.  The 
lack of access to CBI information also makes the process difficult.  In other cases, the State had a 
concern about conditions on the permit and only after much interaction were these concerns 
addressed.  Sometimes there is an interstate or import quarantine at issue which is not addressed 
by APHIS.  While the burdens on the State are not excessive at present, should the number of 
permits rise, while the State may simultaneously experience financial exigencies, a future burden 
may be incurred. 
 
The State representatives want to attempt to quantify risks, if possible, and avoid using the 
reasoning of the precautionary principle, especially if that means suspending permits when 
complete certainty for the safety mechanisms could not be guaranteed. 
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Appendix F. Issues Associated With Importation of 
Regulated Articles into the United States 
 
Trade agreements such as the North American Free Trade Agreement (NAFTA) 
(http://www.fas.usda.gov/info/factsheets/NAFTA.asp) and the General Agreement on Tariffs and 
Trade (GATT) (http://www.wto.org/english/tratop_e/gatt_e/gatt_e.htm) have increased 
agricultural trade and expanded the crucial role for the U.S. Department of Agriculture's (USDA) 
Animal and Plant Health Inspection Service (APHIS).  APHIS facilitates agricultural trade for 
both importers and exporters, and its Plant Protection and Quarantine (PPQ) unit is central to the 
successful flow of healthy commodities into and out of the United States.  APHIS safeguards 
agricultural and natural resources from the risks associated with the entry, establishment, or 
spread of animal and plant pests and noxious weeds.  Its safeguarding role ensures an abundant, 
high-quality, and varied food supply, strengthens the marketability of U.S. agriculture in 
domestic and international commerce, and contributes to the preservation of the global 
environment. 
 
APHIS’ Role in the Importation of Agricultural Products 
 
Over the years, Americans have come to count on a diverse array of agricultural products.  In 
order to fulfill these needs, the United States imports commodities from around the world.  For 
example, in FY 2003, the United States imported $45.7 billion dollars worth of agricultural 
products.  By far the largest U.S. agricultural imports are horticultural products, which, by 2002, 
accounted for half of all U.S. agricultural imports.  Horticultural products include fruits, 
vegetables, nuts, wine, malt beverages, and nursery products.  Many of these imports come from 
two leading suppliers, Canada and Mexico.  Animals and animal products from Canada, Mexico, 
and Oceania are next in importance among U.S. agricultural imports.  Tropical products (such as 
coffee, cocoa, and rubber), which the United States does not produce in significant quantities, are 
the third-largest U.S. import group.1
 
However, some foreign countries have agricultural pests and diseases that do not exist in this 
country.  These pests and diseases can cause devastating damage to U.S. agriculture if 
introduced.  Consequently, APHIS strives to ensure that imported products are free of harmful 
pests and diseases.  APHIS does this by regulating the importation of agricultural products with 
phytosanitary (plant health) certificates, importation rules, and inspections. 
 
Anyone wishing to import certain plants and plant products into the United States is required to 
have a phytosanitary certificate.  The intended purpose of a phytosanitary certificate is to 
expedite the entry of plants or plant products into the United States while protecting American 
agriculture.  A phytosanitary certificate is an official document issued by an exporting country, 
which certifies that the shipment has been inspected and meets the phytosanitary regulations of 
the United States.  In addition, the phytosanitary certificate indicates that the shipment is free of 
                                                 
1 From the USDA Economic Research Services’s web page: http://www.ers.usda.gov/Briefing/AgTrade/overview.htm#imports. 
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pests and diseases that do not exist in the United States.2  The use of phytosanitary certificates is 
prescribed for the movement of such commodities under the International Plant Protection 
Convention, to which the United States is a party. 
 
The National Center for Import and Export (NCIE), a part of APHIS’ Veterinary Services 
program, also plays an integral role in APHIS’ mission of protecting U.S. agriculture.  NCIE 
regulates the import and export of animals, animal products, and biologics, and monitors the 
health of animals presented at the border.  NCIE’s animal health experts work closely with other 
Federal agencies, States, foreign governments, industry and professional groups, and others to 
enhance international trade and cooperation while preventing the introduction of dangerous and 
costly pests and diseases.  Generally, a USDA veterinary permit is needed for live animals and 
materials either derived from animals or exposed to animal-source materials.  These materials 
may only enter the United States through a small number of ports and the materials are inspected 
upon arrival into the country.3
 
Balancing Homeland Security and Agricultural Trade 
 
On November 21, 2002, President Bush signed legislation creating the U.S. Department of 
Homeland Security (DHS) to unify Federal inspection forces and protect our nation from a new 
host of terrorist threats.  Programs and staff from more than 22 Federal agencies were 
consolidated into the new department, including portions of USDA–APHIS.  Although DHS is 
now responsible for conducting inspections at our nation’s borders, APHIS continues to 
determine which agricultural products can enter the country and which products pose a risk and 
should be kept out.  Through risk assessment, pathway analysis, and rulemaking, APHIS 
continues to set agricultural policy that is then carried out by DHS. 
 
Importation of Genetically Engineered (GE) Commodities 
 
For the past decade, the United States has been primarily a producer and exporter of products of 
agricultural biotechnology, two primary examples being soybean and corn varieties developed in 
the United States.  APHIS has deregulated many other products that may be produced and used 
domestically or exported.  Currently, few nations are exporting GE agricultural products to the 
United States, and the United States remains a net exporter of these products.  However, as 
research and development of new GE products increases worldwide, and other countries approve 
agricultural biotechnology products for domestic use or for export, the United States will likely 
see an increase in requests to import GE organisms for research or for commercialization, both as 
seed for planting and for use in food and feed.  As APHIS considers revisions of its regulations, 
the agency needs to ensure that it has appropriate oversight over imported products, as well as 
products produced domestically, and to ensure equitable treatment of imported products. 
 
 
2 From the USDA APHIS PPQ web page: http://www.aphis.usda.gov/lpa/pubs/fsheet_faq_notice/fs_aphisimport.html. 
3 From USDA APHIS Veterinary Services Web page: http://www.aphis.usda.gov/vs/ncie/. 
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Current Status 
 
GE agricultural products imported into the United States are subject to the same APHIS–PPQ 
regulations covering the importation of non-engineered varieties, such as 7 CFR §§ 319–37 
(covering importation of plants and seeds for planting) and 7 CFR §§ 319–56 (covering fruits 
and vegetables imported for non-propagative use).  Therefore, the commodity would have to be 
“allowed” for importation from a particular country under APHIS–PPQ regulations.  Currently, 
under 7 CFR part 340, any product containing a GE event that has been deregulated by APHIS 
may be imported into the United States without further regulation by APHIS, except those 
regulations that APHIS imposes on the non-engineered variety of that product, for example, 
phytosanitary considerations.  The United States does not require any special permission to 
import crops produced overseas that have been deregulated by APHIS, nor is there a requirement 
to label or declare GE content for shipments containing only products deregulated within the 
United States. 
 
Importation of any regulated articles into the United States requires an import permit or an 
import notification issued by APHIS.  The majority of the import permits issued by APHIS over 
the past 19 years have been for small amounts of seeds, insects, or micro-organisms to be used 
for contained research.  A list of these permits can be found on the BRS Web site 
http://www.aphis.usda.gov/brs/database.html.  A separate release permit or release notification 
would be required for field testing any of these regulated articles. 
 
If a foreign company or government wants to import a currently regulated GE plant into the 
United States without APHIS’ regulatory oversight, it must first submit a petition to APHIS 
through a domestic agent requesting deregulated status for that product.  The plant is subjected to 
the same case-by-case assessment required for domestic products.  If APHIS determines that the 
plant poses no more of a plant pest risk than the same plant without GE traits, APHIS may grant 
the GE plant nonregulated status, and the plant, its progeny, and products derived from the plant 
can be imported into the United States subject only to phytosanitary or other requirements 
imposed on the non-engineered varieties of that species, and any requirements imposed by other 
U.S. regulatory agencies such as FDA or EPA. 
 
Currently, APHIS regulations do not distinguish between requests for deregulation of imported 
GE products intended for large-scale environmental release (commercial production) in the 
United States and GE products imported only for non-propagative uses (food, feed, or 
processing, often abbreviated “FFP"), which the importer intends to deliberately release into the 
environment.  In most cases, the developer of a new GE plant with commercial value will seek 
full deregulation in the United States, allowing use for food and feed, as well as for cultivation or 
propagation.  However, situations may occur where the developer wishes to import a GE plant or 
a viable GE plant product only for food, feed, or processing with no intent to grow that plant in 
the United States.  However, unintended release of the plant may result due to spillage, improper 
disposal, transportation accidents, theft, vandalism, undigested seed from food or feed use, or 
processing byproducts, and these releases could pose an unintended plant pest risk.   
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To date, APHIS has received only a small number of requests to import GE crops for FFP (such 
as processing of canola seed into oil), and these have been addressed on a case-by-case basis 
based on familiarity with the crop, the inserted gene or new trait, and the import conditions and 
intended use.  In the past, APHIS has allowed importation of a product into the United States 
only for processing, following an assessment based on APHIS’ familiarity with the crop and the 
trait.  In the assessment, APHIS determined that the product was not considered to be a regulated 
article under the conditions proposed.  In each case where an importation was authorized by 
APHIS, FDA had previously completed a consultation on the crop. 
 
Rationale for Re-evaluation of APHIS Requirements for Importation of 
Non-propagative Regulated Articles 
 
As part of the regulatory revision process, APHIS may need to address requirements for 
environmental risk assessment for products imported only for non-propagative use.  Risk 
assessment is based on the concept that  
risk = (hazard or potential harm) X (exposure or frequency) 
and, therefore, GE FFPs can be presumed to pose less of a risk than the equivalent product 
intended for large scale planting due to a large reduction in the magnitude of environmental 
exposure.  Reasons for APHIS to re-evaluate its requirements for imported, GE FFPs include: 
 
• A recognition that GE crops intended for food, feed, or for processing will generally pose a 
substantially lower potential risk to the environment or to biodiversity than GE crops 
intended for environmental release. 
• A decision that a full environmental risk assessment is not necessary to ensure environmental 
safety for products imported for non-propagative use could provide some regulatory relief for 
the regulated industry and make more efficient use of agency resources while continuing to 
ensure environmental protection. 
• The United States currently exports large amounts of GE commodities, mostly corn and 
soybeans, that are intended only for use as food, feed, or for processing.  The United  States 
could provide an example for countries in the early stages of developing their own biosafety 
regimes if it implements a simplified, yet science-based, system for GE FFP imports. 
 
Regulated Articles in Commodity Shipments 
 
The first section of this discussion presents options for environmental risk assessment 
requirements with respect to decisions to import specific GE events or products for the purposes 
of food, feed, or processing only.  However, there is also the broader question of how the   
United States, and, specifically, APHIS should address issues related to unintentional or 
unauthorized importation of GE products into the United States that have not completed APHIS 
regulatory review.  This would include low level, unintended presence of regulated GE products, 
and could also include larger amounts of regulated products from exporters who are unfamiliar 
with, or do not comply with, U.S. domestic regulations. 
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Currently, the United States is a major exporter of bulk grain products, so the importation of GE 
varieties of these crops that are developed elsewhere is currently a minor concern.  The United 
States does import large amounts of agricultural products such as canola, including GE canola, 
from Canada for processing into oil.  APHIS works closely with Canada as new GE varieties are 
introduced to facilitate synchronous approvals when possible.   
 
However, as noted above, GE products are in development in a number of countries and it is 
likely that within a few years these could end up in seed, commodity, or food shipments to the 
United States.  As new GE products are developed (including grains, fruits, and vegetables) and 
commercialized overseas, the United States needs to consider development of mechanisms to 
ensure these products have undergone appropriate safety assessment before entering the U.S. 
food supply or environment. 
 
Trade Considerations in the Rule Changes 
 
APHIS works actively in international standards-setting organizations, including the North 
American Plant Protection Organization (NAPPO) and the International Plant Protection 
Convention (IPPC), to establish internationally shared, science-based standards.  In addition, 
BRS helped establish a unified U.S. Government Web site that contains key information, such as 
safety assessments, on all products that have completed regulatory review in the United States.  
This site is linked to the Biosafety Clearinghouse that was established under the Biosafety 
Protocol to help facilitate transboundary movement of living biotechnology products.  APHIS 
decision documents are accessible through these sites. 
 
The United States supports the World Trade Organization (WTO) view that if regulations are set 
arbitrarily, they could be used as an excuse for protectionism.  Under the WTO, the Technical 
Barriers to Trade Agreement (TBT) tries to ensure that regulations, standards, testing, and 
certification procedures do not create unnecessary obstacles.  The TBT agreement recognizes 
countries’ rights to adopt the standards they consider appropriate—for example, to ensure 
human, animal or plant life or health, for the protection of the environment, or to meet other 
consumer interests.  Moreover, members are not prevented from taking measures necessary to 
ensure that their standards are met, and the agreement encourages countries to use international 
standards where these are appropriate, but it does not require them to change their levels of 
protection as a result. 
 
The regulatory revisions under consideration by APHIS will be science based, consistent with 
international standards, and designed solely to protect the environment, including plant health 
and human health.  The proposed alternatives are consistent with the TBT agreement and would 
not be technical barriers to trade. 
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Appendix G. Socioeconomic and Sociocultural Effects 
 
Introduction 
 
Society's views and attitudes about biotechnology are shaped by many factors such as a person’s 
moral principles or values, available scientific data, fears of the unknown, and so on.  Society’s 
views and attitudes increasingly influence the acceptance of biotechnology.  It is not the purpose 
of this section to explore the sources of prevailing societal views and attitudes about 
biotechnology; rather, this section will focus on the key themes that have emerged.  These 
themes include the potential benefits of biotechnology, the public’s perception of risk, the 
choices people have regarding biotechnology, and the distribution of benefits and burdens or 
risks of biotechnology across society.  Each theme is discussed below. 
 
Potential Benefits of Biotechnology to Society  
 
Experts agree that there may be numerous agriculture, human health, and environmental benefits 
of genetic engineering.  Potential benefits include, but are not limited to increased crop 
production, crops that resist pests and diseases, decreased use of pesticides, crops that can 
tolerate long-term storage and resist adverse environmental conditions, diagnostic tools and 
vaccines that help control animal disease, increased nutritional value and improved digestibility 
of foods, new products for health and industrial uses, decreased presence of undesirable 
substances in foods (saturated fats, natural toxicants, antinutrients, and allergens), and new 
sources of renewable materials such as vaccines, drugs, and bioplastics (Devernoe, 2000; Vogt 
and Parish, 2001; WHO, 2004). 
 
Public Perception of Risk 
 
With biotechnology, as with many sophisticated technologies, the pace of scientific research may 
move faster than the public's ability to understand and accept products developed from that 
research.  A survey conducted by agricultural scientists at the Virginia Cooperative Extension 
Service examined the sources of public concern regarding biotechnology.  The study examined 
the issues raised by the public and discussed by the media and correlated the frequency with 
which each issue was cited by the public or the media.  These agriculture- and food-related 
concerns, including the frequency with which they were cited by both the public and the media, 
are summarized below in table G–1. 
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 Table G–1. Agriculture- and Food-related Concerns As Expressed By the Public and 
Appearing in the Media 
Frequency (%) 
Category of Concern 
Public 
(opinion survey) 
Media 
(keyword search) 
Weediness of genetically engineered (GE) plants 50 43.7 
Gene transfer to wild plant relatives 30 39.1 
Invasion by GE plant to sensitive habitats 20 31.6 
Value and nutrition of GE foods 75 54.1 
Safety of GE food 66.7 65.8 
Labeling of GE food 58.3 59.5 
Consumer acceptance of GE food 33.4 44.2 
Use of biotechnology products 73.3 56.7 
Ethical, religious, and/or moral concerns 60.0 44.2 
GE patents and freedom of information 46.6 49.3 
Impact of GE products on farming 26.7 37.4 
Public safety concerns 78.5 71.2 
Public input concerns 64.3 63.1 
Explanation and acceptance of risk 57.1 48.4 
Impact of GE education 72.7 76.5 
Role of television and press in GE education 63.6 63.1 
Academic responsibility to public 26.3 42.9 
Public safety in developing countries 55.5 57.6 
GE product availability in international countries 44.4 46.5 
Source:  Hagendorn and Allender-Hagendorn, 1995. 
 
In the above study, 60 to 70% frequency was identified as high frequency.  For the public, high 
frequency concerns were the value and nutrition of GE foods; the safety of GE foods; use of 
biotechnology products; ethical, religious and/or moral concerns; public safety concerns; public 
input concerns; impact of biotechnology education; and the role of television and the press in 
biotechnology education. 
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However, biotechnology does not appear to be a major concern of American consumers when 
compared to other issues impacting the food supply (Alexander and Toner, 2004).  In January 
2004, a survey group was asked “What, if anything, are you concerned about when it comes to 
food safety?”  Responses to this survey are in table H–2, below. 
 
Table G–2.  Public Concerns Regarding Food Safety. 
Concern Percent 
Food handling/preparation 29 
Disease/contamination 22 
Packaging 10 
“Mad cow” disease 9 
Ingredients 9 
Chemicals/pesticides 6 
Biotechnology 1 
                         Source:  Alexander and Toner, 2004 
 
Some social scientists have also proposed that one major factor in the difference between 
biotechnology research and public acceptance of biotechnology relates to changing social 
attitudes towards scientific advancements over time.  They acknowledge that the underlying 
reasons for these changes in attitude are “vast and complex.”  However, according to one social 
science research source, public concerns regarding agricultural biotechnology can be generally 
categorized in three areas (Albrecht, 2004): 
 
1. Concern that the release of GE organisms could potentially result in unforeseen permanent 
damage to the environment; 
2. Concern that GE crops may become weedy and unable to be controlled in the environment; and 
3. Concern that large farms that utilize biotechnology will have a competitive advantage over small 
farms, resulting in further loss of small farms in the United States. 
 
Social scientists have also explored the link between the public’s familiarity with biotechnology 
and public perception of the risks associated with this technology.  This research indicates that 
the relationship between public support of biotechnology, in general, and an individual’s 
knowledge of the scientific aspects of biotechnology is inconsistent (Chess, 1998).  One such 
study concluded that “perceived risk did not decrease as perceived knowledge of the potential 
hazard increased” (Frewer et al., 1994).  However, other studies concluded that there were links 
between acceptance of technology and knowledge about that technology (Zechendorf, 1994; 
Hallman et al., 2004).  For example, a survey found that a majority of those surveyed would be 
likely to purchase foods which were protected from insect damage and required fewer pesticides 
due to biotechnology.  Therefore, knowledge about GE crops and foods, especially knowledge 
relating to the benefits of the technology, can increase favorable attitudes and public support 
(Alexander and Toner, 2004).  However, while Americans think the topic of GE foods is 
interesting and would like more information about the topic, especially in reference to human 
health, most Americans know very little about GE foods (Hallman et al., 2004). 
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Some studies suggest that the issue of biotechnology resembles other issues that have become 
stigmatized in the public’s opinion (Slovic, 2000).  These factors include:  
 
• a technology that is perceived to have involuntary exposure; 
• a technology that is perceived to have disproportionate effects on sub-populations; 
• a technology that is perceived to have unbounded effects (i.e., the effects are not well 
understood or the magnitude is not known); and 
• a perception that the technology has violated what is “right.” 
 
Stigmatization is, therefore, generally a result of perceptions rather than factual information, and 
stigma can be addressed through risk communication efforts that provide information to the 
public (Slovic, 2000). 
 
Choice 
 
A contributing factor in the gap between scientific thought and public acceptance of 
biotechnology is the perception by some members of the public that the adoption of 
biotechnology-derived products results in a lack of consumer choice.  Specifically, some 
individuals believe that the use of biotechnology will preclude the availability of non-GE derived 
products in the marketplace.  The issue of how to address the concern about lack of choice has 
been discussed and debated frequently for GE food products.  Product labeling has been one 
option suggested to address this concern (Chess, 1998).  Some parties argue that product labeling 
that discloses the existence of GE-derived materials in food is the best way to offer consumers a 
choice between GE and non-GE products.  Others argue that product labeling can actually 
misinform the public (Teisl et al., 2003).  For example, labeling may be interpreted as a warning 
when none is implied (Carter and Gruère, 2003).  Labeling can also be misleading:  a label on 
canned peaches stating "Contains No GMOs" implies that there are genetically engineered 
peaches, when, in truth, none exist, and the label also implies that cans without the label may 
have GE content.4  In addition, the complexity and cost of separating products in the marketplace 
make this option very difficult (Heritage, 2005). 
 
Distribution of Benefits and Burdens 
 
Society’s views and attitudes regarding GE products are partly shaped by people’s perception of 
how the benefits and burdens that result from the use of the technology are distributed.  
However, the distribution of benefits and burdens of biotechnology is disputed.  Some critics 
claim that biotechnology research has largely taken place in the private sector with proprietary 
technologies and an orientation to commercial agriculture and may, therefore, disproportionately 
benefit wealthy individuals and countries.  Unless there are policies in place to ensure that small 
farmers have access to delivery systems, extension services, productive resources, markets, and 
infrastructure, larger farmers are likely to capture most of the benefits through early adoption of 
the technology, expanded production, and reduced unit costs (Persley, 2000).  An FAO report, 
 
4 FDA's rules covering the misbranding of foods can be found at 21 CFR 101.18. 
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The State of Food and Agriculture 2003–2004, voices similar concerns, stating that there are no 
major public- or private-sector programs to apply biotechnology to the critical problems of the 
poor or to target crops and animals that they rely on (FAO, 2004).   
 
However, the same report by FAO states that biotechnology is capable of benefiting small, 
resource-poor farmers.  Some GE crops, especially insect-resistant cotton, are yielding 
significant economic gains for small farmers (FAO, 2004).  While technologies that require a 
certain institutional and managerial environment to function properly may not be effective for 
poorer farmers, GE crops may be relatively easy for farmers to adopt because the technology is 
embodied in the seed—rendering it scale-neutral and easily transferable (FAO, 2004).  FAO also 
reports that since the benefits of GE crops have been distributed widely among industry, farmers, 
and consumers, intellectual property protection does not necessarily lead to excessive industry 
profits, and the producers and consumers are reaping the largest share of the economic benefits 
of GE crops, not the companies that develop and market them (FAO, 2004). 
 
APHIS has attempted to conduct its programs, policies, and activities in a manner that does not 
preclude individuals or populations from participating in making decisions regarding GE crops.  
As previously mentioned, two of APHIS’ guiding principles that set program direction and 
provide the foundation for decisionmaking are: 1) transparency of the regulatory process and 
regulatory decisionmaking, and 2) communication, coordination, and collaboration with a full 
range of stakeholders.  Throughout the current process to determine whether and how APHIS 
will revise its regulations, APHIS has attempted to ensure that individuals and groups are 
informed of and comment on their regulatory actions.  Specific actions that APHIS has taken in 
order to educate and inform individuals and groups are outlined in the section titled, “Executive 
Order 12898—Environmental Justice in Minority Populations and Low-income Populations,” 
under “Special Considerations,” which follows.   
 
Another topic about which some have raised concern is the benefits and/or burdens infants and 
children could experience as a result of the use of biotechnology.  For example, public comments 
have raised concerns that infants and children may benefit and/or suffer disproportionately from 
the consumption of GE crops, particularly in regard to nutrition and allergenicity due to their 
developmental stage, greater metabolic activity levels, and behavior patterns (see “Potential 
Allergenicity of Newly-Expressed Proteins in Foods Derived from GE Plants,” in chapter 4, 
section A).  However, to APHIS' knowledge, no scientifically substantiated human nutritional or 
allergenicity concerns, including concerns for children, have been identified with any of the GE 
crops currently on the market. 
 
Although some individuals may be concerned that scientists might unknowingly create food 
allergens through genetic engineering, researchers are also attempting to use the technology to 
eliminate or reduce allergens, such as those found in peanuts, wheat, and soy (Bren, 2003).  For 
example, researchers have genetically engineered soy (Herman et al., 2003) and rice (Matsuda et 
al., 1993) to eliminate expression of common allergenic proteins.  Soy allergies are particularly 
common in infants and young children, according to the National Institute of Allergy and 
Infectious Diseases, and it is difficult to avoid eating soy because of its wide use in many 
processed foods including infant formula, cereals, and salad dressings” (Bren, 2003). 
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Infants and children may also be more susceptible to nutritional imbalances than the adult 
population because of their developmental stage as well as the limited number of foods that they 
consume.  Grains, fruits, and vegetables that contain more nutrients are being developed and, in 
some cases, nutrients are being added to foods in an attempt to help prevent diseases (Bren, 
2003).  While the objective is to make food more nutritious, some people are concerned that 
modifying foods could unintentionally decrease the nutritional value of food.  For children, this 
risk could be magnified if the modified food was one on which children's diets depended 
(Donaldson and May, 1999).  The FDA’s Office of Nutritional Products, Labeling, and Dietary 
Supplements is responsible for the development of policy and regulations regarding food 
nutrition and standards (see http://www.cfsan.fda.gov/~dms/onplds.html).  For a discussion on 
analyzing the nutritional quality of GE plants, see section titled, “Composition of Foods from 
Genetically Engineered Plants Compared to Their Traditional Counterparts” (see chapter 4, 
section A). 
 
Special Environmental Considerations 
 
The National Environmental Policy Act  
 
In the planning and implementation of its programs and actions, APHIS complies with the 
National Environmental Policy Act of 1969 (NEPA) and the regulations promulgated by USDA, 
APHIS, and the Council on Environmental Quality (CEQ) under NEPA. Together these have the 
underlying objective of requiring Federal decisionmakers to comprehensively consider the 
environmental consequences of their actions before making any firm decisions.  In addition, 
NEPA and associated regulations provide guidance in the procedures that must be followed, the 
analytical process itself, and the ways of obtaining public involvement.   
 
NEPA requires Federal agencies to consider potential environmental consequences in their 
planning and decisionmaking processes, and it requires them to prepare detailed statements 
(environmental impact statements) for major Federal actions which significantly affect the 
quality of the human environment.  These statements must consider the environmental impact of 
the proposed action, adverse effects which cannot be avoided should the proposal be 
implemented, alternatives to the proposed action, the relationship between local and short-term 
uses of the human environment, and the maintenance and enhancement of long-term 
productivity, and any irreversible and irretrievable commitments of resources necessary to 
implement the action.  This DEIS is prepared specifically to meet the needs of NEPA, 42  
United States Code (USC) 4321, et seq. 
 
Executive Order 12898—Environmental Justice 
 
Executive Order (EO) 12898, “Federal Actions to Address Environmental Justice in Minority 
Populations and Low-Income Population,” requires each Federal agency to make achieving 
environmental justice part of its mission by identifying and addressing, as appropriate, 
disproportionately high and adverse human health or environmental effects of its programs, 
policies, and activities on minority populations and low-income populations in the United States 
and its territories and possessions.  In addition, the EO requires Federal agencies to conduct their 
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programs, policies, and activities in a manner so as not to exclude persons and populations from 
participation in or benefiting from such programs.   
 
Certain proposed program actions require APHIS to prepare an environmental document that, 
among other things, considers the potential that the action could cause disproportionately high 
and adverse human health or environmental impacts on minority or low-income populations.  
While the analysis of environmental justice is treated within the context of the NEPA process, 
disproportionate effects on minorities and the poor will be considered even when actions are 
categorically excluded under NEPA.   
 
In an attempt to ensure that APHIS’ actions will not exclude persons and populations from 
participating in or benefiting from the potential regulatory changes, APHIS has communicated 
with a wide range of individuals and organizations.  APHIS has informed the public of the 
potential changes to their regulations via the Federal Register (FR) (69 FR 16181 and 69 FR 
3271–3272) and its website (http://www.aphis.usda.gov/brs/index.html) which includes such 
links as “News and Hot Topics” (http://www.aphis.usda.gov/APHIS/new_info.html) complete 
with recent press releases, meetings, revised regulations, compliance and enforcement, FR 
notices, and free-of-charge stakeholder registration.  APHIS has also a Web page entirely 
devoted to the NEPA process as it pertains to the proposed rulemaking 
(http://www.aphis.usda.gov/brs/eis/index.html).  APHIS has sought public and stakeholder 
opinion throughout the decisionmaking process by soliciting public comments via the Federal 
Register (69 FR 16181 and 69 FR 3271–3272) and holding stakeholder meetings to enable 
interested parties and APHIS scientists and policymakers to hold discussions.  In addition, while 
the exact location of a field test site is considered confidential business information, in the 
interests of disclosure, concerned individuals and groups may obtain the State and county where 
field test sites are located.  
 
In APHIS' opinion, agency oversight of regulated articles under 7 CFR part 340 does not 
currently have any disproportionate impacts on either minority or low-income populations, and 
APHIS does not anticipate any change in impacts on these populations should the Preferred 
Alternative be adopted.  APHIS will continue to publicly announce potential modifications to 
policy, update its Web site with current information, and provide the public and stakeholders 
with opportunities to voice their opinion and potentially influence the decisions made. 
 
EO 13045—Protection of Children From Environmental Health Risks and Safety 
Risks 
 
EO 13045, “Protection of Children From Environmental Health Risks and Safety Factors,” 
acknowledges that children may suffer disproportionately from environmental health and safety 
risks because of their developmental stage, greater metabolic activity levels, and behavior 
patterns, as compared to adults.  This EO requires each Federal agency (to the extent permitted 
by law and when appropriate and consistent with the agency’s mission) to identify, assess, and 
address environmental health risks and safety risks that may disproportionately affect children.   
Certain proposed program actions require APHIS to prepare an environmental document that, 
among other things, considers the potential for the action to cause disproportionately high and 
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adverse health and safety impacts on children.  While the protection of children must be 
considered within the context of the NEPA process, disproportionate effects on children must be 
considered even in actions that are categorically excluded under NEPA.  In APHIS' opinion, 
agency oversight of regulated articles under 7 CFR part 340 does not currently have any 
disproportionate impacts on children, and APHIS does not anticipate any change in impacts on 
this population should the Preferred Alternative be adopted.   
 
EO 12114—Environmental Effects Abroad of Major Actions 
 
Executive Order (EO) 12114, “Environmental Effects Abroad of Major Federal Actions,” was 
written to require Federal officials to become informed of pertinent environmental considerations 
and take them into account, along with other national policy considerations, when making 
decisions on certain kinds of Federal actions (generally those that would have significant effects 
outside the jurisdiction of the United States).  The EO specifically covers major Federal actions 
that significantly affect:  (1) the global commons (environment outside the jurisdiction of any 
nation), (2) the environment of nations not participating in or involved in that action, (3) the 
environment of a foreign nation by providing to that nation a product that is toxic or radioactive 
and prohibited or regulated in the United States, and (4) natural or ecological resources of global 
importance designated by the President. 
 
If the proposed action could potentially have significant affects on the “the global commons” and 
“the environment of nations not participating in or involved in that action,” EO 12114 stipulates 
that the preparation of an EIS is appropriate. 
 
As previously discussed in this document as issue 8 and in appendix H, APHIS recognizes that 
U.S. regulations on imported commodities have international implications.  Many countries have 
implemented environmental regulations, and as indicated in the aforementioned sections, APHIS 
needs to consider how its regulatory changes might coordinate with existing international 
agreements related to agriculture, food, or trade, while providing leadership for countries in the 
early stages of developing their own regulations.  APHIS is aware that this is a complex process 
and is committed to working with all outside parties to participate in developing an efficient 
regulatory process for agricultural biotechnology products as necessary. 
 
Other Federal, State, and Local Statutes 
 
APHIS must avoid “possible conflicts between the proposed action and the objectives of Federal, 
regional, State, and local (an in the case of a reservation, Indian tribe) land use plans, policies 
and controls for the area concerned” (40 CFR 1502.16(c)).  In order to meet the terms of this 
requirement, APHIS complies with a number of other environmental acts, statutes, and 
regulations including the following Federal environmental acts:  Plant Protection Act; the 
Federal Insecticide, Fungicide, and Rodenticide Act; the Toxic Substances Control Act; the 
Comprehensive Environmental Response, the Compensation, and Liability Act of 1980; and the 
Food Quality Protection Act.   
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In addition to APHIS, two other Federal agencies have a major responsibility in the oversight of 
biotechnology, FDA and EPA.  While FDA is responsible for ensuring the safety of GE food and 
products for human and animal consumption, EPA is responsible for ensuring that pesticides, 
including those produced in living plants, are safe for human health and the environment.  
Through continuing interagency communication, APHIS remains informed of and involved in 
the development of EPA and FDA regulations and policies regarding biotechnology.  APHIS is 
committed to the goals of the Framework for Regulation of Biotechnology as set out by the 
President’s Office of Science and Technology Policy, and APHIS operates its biotechnology 
regulatory program in an integrated and coordinated fashion with FDA and EPA to minimize any 
potential environmental effects. 
 
The States have implemented various environmental statutes and regulations (see table H–3).  
Many of the regulations and regulatory organizations that enforce them are direct parallels of the 
Federal regulations and regulatory organizations.  However, there has been a diverse range of 
regulatory responses by States on GE crops and food.  A report published by the Pew Initiative 
on Food and Biotechnology in December, 2004, recognized that the States have long shared 
responsibility with the Federal government for the enforcement of laws regulating pesticides and 
plant pests, some of which also cover GE crops.  In addition to participating in the review of 
notifications and permits for GE crops, States have a particular interest in APHIS' oversight of 
field trials to ensure that experimental GE crops do not accidentally commingle with crops 
headed for the food supply (Taylor et al., 2004). 
 
It is not anticipated that any State regulations regarding GE crops or food would conflict with 
any of APHIS’ proposed regulation changes.  APHIS will work closely with States to be sure 
that they are aware of field tests taking place within their jurisdiction to allow them to request 
any additional conditions.   
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Table G–3.  Statutes Regarding Genetically Engineered Organisms  
State Has the State Enacted Legislation? Description 
Arizona No AZ does not have a statute regarding GEOs but does have 
a regulation that reinforces APHIS regulations for 
notifications and permits and allows for additional 
information to be obtained by the department to ensure 
proper confinement of the GEO.  Genetically Engineered 
Organisms and Products (Ariz. Admin. Code Supp. § R3-4-
901 (2004)). 
California No -- 
Colorado No -- 
Hawaii Genetically Modified Organisms (19 Haw. 
Rev. Stat. § 321-11.6 et seq. (2003)) 
Requires applicants to submit a copy of Federal notification 
or permit application to the state. 
Illinois Release of Genetically Modified Organisms 
Act (430 III, Comp. Stat. § 95/0.01 et seq. 
(2004)) 
Requires applicants to submit a copy of Federal notification 
or permit applications to the state and county official where 
release will occur, including a summary of CBI-redacted 
information.  The state may seek public input or expertise in 
its review of a Federal permit or notification. 
Iowa No -- 
Kansas No -- 
Maine Genetically Engineered Plants and Seeds (7 
Me. Rev. Stat. Ann. § 1050 et seq. (2003) 
and The Labeling Foods Free of Genetic 
Engineering (7 Me. Rev. Stat. Ann. 530-A et 
seq. (2003)) 
Requires dealers or manufacturers of genetically 
engineered seed to keep a list of growers who purchase GE 
seed.  Foods containing 1% or less of GE materials can be 
labeled GE-free. 
Minnesota Genetically Engineered Organisms Minn. 
Stat. (§ 18F.01 et seq. (2003)) and 
Experimental Genetically Engineered 
Pesticide Product Registration (Minn. Stat. § 
18B.285 (2003)) 
Provides comprehensive authority to the state to issue 
permits and notifications for field testing of GE plants and 
the release of experimental pesticide producing GE plants.  
Provides for inspections, penalties for violations, and 
process to commercialize GE crops. 
Montana No -- 
New York No -- 
North 
Carolina 
No; a GEO-specific statute passed in 1989 
was allowed to “sunset” in 1995 
-- 
North 
Dakota 
No -- 
Oklahoma Oklahoma Agriculture Biotechnology Act (2 
Okla. Stat. § 11-35 et seq. (2004)) 
Provides comprehensive authority to regulate GE crops 
only if applicants are not regulated by a Federal agency 
Oregon No -- 
Texas No -- 
Vermont Pest Survey (6 Vt. Stat. Ann. § 1030 et seq. 
(2003)) and (6 V.S.A  § 611 (c) et seq. 
(2004)) 
Requires applicants to obtain a state permit for sale, 
movement, or release of a GE plant determined to be a 
plant pest.  Requires all GE seed to have labeling 
specifying the traits of the seed and safe handling 
instructions. 
Source:  Taylor, 2004. 
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